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Abstract 
Testosterone (T) administration is prohibited in sport by the World Anti-Doping Agency (WADA). 
Following T administration, both T concentration and the ratio to its inactive stereoisomer, 
epitestosterone (E), increases. WADA recommends that their accredited laboratories undertake 
further analysis on urine samples with a T/E greater than 4.0. Acute alcohol consumption (2.0 g/kg) 
appears to increase this ratio but there is little supporting published data.  
This thesis describes the testing of different hypotheses based on the influence of alcohol 
administration on the T/E ratio and attempts to establish the underlying mechanisms. 
Alcohol was administered to eugonadal men and women (4 and 8 units), and also to hypogonadal 
men (8 units) receiving T replacement therapy. Hypogonadal men were selected as changes in T 
would be due solely to altered clearance rather than gonadal production, the data obtained making 
a useful comparator model. 
Following alcohol administration, the urinary T/E increased significantly in all the volunteers, in 
women (8 units) rising from approximately unity to greater than the WADA threshold. 
Serum analysis showed a decrease in T in males, which indicates that the increase in urinary T/E is 
most likely due to an increase in the hepatic formation of T glucuronide, which is rapidly excreted, 
not to an increase in gonadal production. The increase in serum T in females will most likely be due 
to a suppression of phase 1 metabolism of T, via enzyme inhibition (17 -HSD2), which is likely to 
also occur in men but is masked by the proportionately much larger concentration of circulating T. 
There is no evidence that EtOH displaces T from its binding proteins increasing T clearance with a 
resulting increase in urinary T/E, as tested in vitro by equilibrium dialysis and ultrafiltration, nor is 
there any evidence that an increase in T/E is due to an increase in lutenising hormone. 
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1.1 Doping in sports and forbidden substance 
1.1.1 Foreign (xenobiotics) and pseudoendogenous substances 
The will to succeed in competitive sports is such that an athlete may use performance enhancing 
substances to help him/her go the extra-mile. Many of  these substances may be harmful to the 
athlete and/or raise ethical issues with regard to what is considered a ‘fair competition’ and are thus 
prohibited within this setting. The practice of using prohibited drugs is often referred to as ‘doping’, 
which is  defined in the Oxford English Dictionary as the “act of taking a drug to improve the 
performance of an athlete, racehorse or greyhound”.  
The financial, personal and national prestige can put pressure on an athlete to succeed, and 
therefore taking substances that will increase his/her performance may seem like an attractive 
option (Figure 1.1). 
 
 
Figure 1.1 Doping in sport (Ariens, 1965)  
 
The death of the Danish cyclist Knud Enemark Jensen linked to the use of amphetamines during 
the Olympic Games of 1960 led to drastic changes to the rules and regulations of sporting events. 
The sporting community recognised that some form of control was needed with regard to the use of 
performance enhancing substances to prevent future tragedies (World Anti-Doping Agency, 2009a). 
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In 1967, the International Olympic Committee (IOC) compiled a list of forbidden substances and 
anti-doping tests took place in the Winter Olympic Games in Grenoble the following year. Since 
then, the list of banned substances and classes of drugs they fall under has grown. 
In some countries, such as France, doping is a criminal offence. In 1998, a police raid performed 
during the Tour de France apprehended a large amount of prohibited substances. Since doping 
sanctions were sometimes overruled in criminal courts, there was a need to create an international, 
independent organization that would produce a harmonised set of anti-doping standards, as well as 
work with sports associations and public authorities. The World Anti-Doping Agency (WADA) was 
therefore created in 1999 after a world conference on “Doping in Sports”.  
One of the WADA’s main accomplishments is the creation of an international World Anti-Doping 
Code, which brings together anti-doping policies, rules and regulations for sports associations and 
guidelines on co-ordination between anti-doping organizations, testing laboratories, therapeutic use 
exemptions, the list of prohibited substances and analytical methods (World Anti-Doping Agency, 
2009b). 
The Prohibited List is published every year and it contains the substances and methods prohibited 
at all times, both in- and out-of-competition. Section S1 of the Prohibited List comprises the banned 
anabolic androgenic steroids including testosterone (T) (17 -hydroxy-androst-4-ene-3-one) and its 
isomer epitestosterone (E) (17 -hydroxy-androst-4-ene-3-one) (Figure 1.2 ). These substances are 
prohibited at all times (in- and out-of-competition). An approved test for the detection of 
testosterone administration is based on a urinary ratio (peak height) of testosterone to 
epitestosterone (T/E>4), above which WADA accredited laboratories are required to report an 
atypical finding.  
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Figure 1.2 Testosterone & epitestosterone 
  
1.2 The endocrine system – gonadal and adrenal hormones 
1.2.1 The endocrine system 
The endocrine system, the nervous system and the immune system regulate the human body. They 
help maintain the body in a state of internal homeostasis altering it if necessary in response to 
external changes (Greenstein, 1994a). 
The endocrine system comprises a number of glands which secrete hormones into the blood 
stream. Hormones are “chemical substances that are produced by a specialised ductless gland in 
one part of the body and secreted directly into the blood stream and then carried to a distant organ 
where a regulatory response or action is elicited, e.g. cortisol secreted by the adrenal gland, 
testosterone by the testis, estradiol by the ovary” (Kicman, 2007) 
This system regulates most metabolic activities, and the rate of most endocrine secretions 
(hormones) is activated by the brain.  
Hormones are chemical messengers that control and co-ordinate organ and tissue function. They 
are secreted as a result of nerve impulses that are triggered by physical or psychological stress 
(Emanuele and Emanuele, 1997). Sensitive feedback mechanisms reduce or increase the amount 
of hormones released into the blood stream. 
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A feedback mechanism is a closed-loop system where the returning signal results in a reduction or 
increase in system output (Reichlin, 1992). A negative feedback mechanism responds by reducing 
the output of the hormone whereas positive feedback responds by increasing the hormone. 
A list of the principal endocrine glands and their corresponding secreting hormones can be found in 
Appendix 8.1. 
For glands present in the human body, please see Figure 1.3. 
 
 
Figure 1.3 Location of endocrine glands (Greenstein, 1994a) 
 
The hypothalamus and the pituitary gland regulate much of the endocrine system and these glands 
are intimately associated.  
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Figure 1.4 shows a diagram of the human brain to illustrate the location of the hypothalamus and 
pituitary gland. 
 
Figure 1.4 Modified brain map (E-MedicineHealth, 2007) 
 
The pituitary gland is divided into three lobes: 
- Anterior lobe (also called the anterior pituitary, adenohypophysis, pars distalis or pars 
glandularis) 
- Posterior lobe (also called the neural lobe or infundibular) 
- Intermediate (also called the pars intermediate) 
The intermediate lobe is not found in adult humans since, although we are born with it, it is 
distributed evenly by the anterior and posterior lobes (Reichlin, 1992) during the first two decades of 
life (Figure 1.5). 
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Pituitary secretion of hormones is dependent upon hypothalamic secretion of the corresponding 
releasing hormone, and the hypothalamus selectively secretes the appropriate releasing hormone 
to control the concentration of the related hormone as required. 
The hypothalamus secretes its releasing hormones into the anterior pituitary via the funnel-like 
hypothalamic-hypophyseal portal veins (Figure 1.6). These connect the hypothalamus to the 
anterior pituitary via a branch of blood capillaries in the lower hypothalamus, that are in their turn 
connected to a neural stalk, the neural lobe and another capillary bed within the anterior pituitary. 
These capillaries also carry hormones secreted by the anterior pituitary gland, such as luteinising 
hormone, follicle-stimulating hormone, thyroid stimulating hormone and growth hormone, and end-
up combining with blood vessels that will transport these hormones into the systemic venous blood. 
These veins also collect capillary blood from the posterior pituitary gland (Bowen, 2001, Reichlin, 
1992, Constanti and Bartke, 1998). 
 The posterior pituitary hormones, arginine vasopressin and oxytocin, are produced in the 
supraoptic and paraventricular nuclei of the hypothalamus, respectively (Porterfield, 2001b). 
These are transported to the posterior pituitary via the nerve endings in the hypothalamus. 
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Figure 1.5 Pituitary gland (Bowen, 2001) 
 
 
Figure 1.6 Hypothalamic-hypophyseal portal system (Constanti and Bartke, 1998) 
 
1.2.2 Hypothalamic-Pituitary-Gonadal axis   
The hypothalamic-pituitary-gonadal (HPG) axis comprises the hypothalamus, the anterior 
pituitary gland and the gonads (testes for men and ovaries for women), and is responsible for 
the secretion of androgens. 
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Androgens are steroid hormones secreted by the gonads and the adrenal cortex. Androgens 
have their effect in reproductive tissues, muscle, bone, hair follicles in the skin, liver and 
kidneys, the immune and the central nervous system (Kicman, 2008). The effects of these 
hormones mainly linked to masculinisation and anabolic effects such as protein building in 
skeletal muscle and bone. In males, androgens are responsible for the development and 
maintenance of the male accessory reproductive glands, prostate and seminal vesicles, size of 
the testes, scrotum and penis (Gower, 1984a). The secondary sexual characteristics during 
puberty may be divided into what results from androgenic and anabolic effects. The androgenic 
effects are responsible for the enlargement of the larynx which causes deepening of the voice, 
the growth of terminal hair (pubic, axillary and facial regions), an increase in sebaceous gland 
activity (which may lead to acne), and central nervous system effects (increased libido and 
aggression). The anabolic effects are responsible for growth of skeletal muscle and bone 
(Kicman, 2008).  
Testosterone is the most important androgen secreted, and it is regulated by a negative 
feedback mechanism in which the hypothalamus releases the gonadotropin releasing hormone 
(GnRH), also called luteinizing hormone releasing hormone (LHRH), that stimulates the anterior 
pituitary gland to release the two gonadotropins luteinizing hormone (LH) and follicle stimulating 
hormone (FSH) into the blood stream (Emanuele and Emanuele, 1997). 
In men, when LH reaches the testes it stimulates T synthesis in the Leydig cells whereas FSH 
alongside with T stimulates the Sertoli cells prompting spermatogenesis. The circulating T will 
then return to the hypothalamus and control the secretion of GnRH, and consequently the 
secretion of LH and FSH by the anterior pituitary gland (Griffin and Wilson, 1992) (Figure 1.7).  
In summary, in this closed loop system (hypothalamus-anterior pituitary gland-testes), the 
returning signal (T) results in a reduction in system output (LH and FSH).  
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Figure 1.7 Negative feedback mechanism in men where the (+) indicates excitement and (-) 
inhibition (Kicman, 2010) 
 
Radioimmunoassay studies have shown that the release of GnRH is episodic, occurring 
approximately every 90 min (Brook and Marshall, 2001c, Greenstein, 1994d) into the 
hypothalamic-hypophyseal portal veins described earlier. GnRH binds to its receptor in the 
anterior pituitary gland, causing the pulsatile release of LH and FSH every 90 min in response 
to pulses of GnRH (Brook and Marshall, 2001a).  
The contributions of T and estradiol (E2) to LH secretion and the importance of E2’s 
aromatization in T’s effects in the HPA axis were debateable, but the study by Pitteloud et al, 
showed that T and E2 have independent effects in LH secretion (Pitteloud et al., 2008).  
This study was performed in eugonadal men and men with idiophatic hypogonadotropic 
hypogonadism who are GnRH deficient, during 7 days (n=22 for both). These men were on a 
hormone replacement therapy to normalize their hypothalamic-pituitary axis. Since the dose and 
frequency of GnRH was controlled, any effect on consequential gonadal steroids by GnRH 
could only come from the pituitary.  
Chapter 1: Introduction  Doping in Sports: The effect of alcohol on the urinary increase of T/E 
 
- 34 - 
 
In both groups, ketoconazole was administered in high doses to produce a biochemical 
castration. Ketoconazole is a potent inhibitor of C17-20 lyase (rate-limiting step in androgen 
biosynthesis) that suppresses T to castrate levels in 24 h. In high doses (1 mg/day) it also 
inhibits cortisol’s biosynthesis and aromatase activity (Weber et al., 1991, Wouters et al., 1988). 
Subsequent sex-steroid replacement was employed. Both groups were administered with T and 
E2 independently, and their concentrations were monitored together with LH.  
In eugonadal men, following T administration, there was a decrease in GnRH’s pulse frequency 
while E2 levels were suppressed indicating that T feedback in the hypothalamus could occur 
without aromatization but by direct androgen effect. By contrast, when T was administered to 
hypogonadal men, the LH concentration did not decrease thus indicating that T’s negative 
feedback mechanism in the pituitary is mediated by aromatization to E2. 
After E2 was administered in eugonadal men, there was a decrease in GnRH pulse frequency 
thus confirming a hypothalamic effect of E2. In the hypogonadal group of volunteers, after E2 
intake, the concentration and pulse amplitude of LH decreased. Since this group does not 
produce GnRH, the LH suppression is indicative of a pituitary site of negative feedback 
mechanism. 
In women, both LH and FSH release are stimulated by GnRH, but the negative feedback 
mechanism is inhibited by E2 and progesterone (Figure 1.8). Progesterone is synthesised from 
pregnenolone which in turn comes from cholesterol (for a detailed synthesis please see Figure 
1.11 and Figure 1.15). Progesterone concentrations in normal females range from 0.2-
1.2 ng/mL (0.6-3.8 nM) in the follicular phase, 0.72-17.8 ng/mL (2.3-56.6 nM) in luteal phase, 
0.2-1 ng/mL (0.6-3 nM) in postmenopausal women and 0.34-0.92 ng/mL (1.1-2.9 nM) in women 
taking oral contraceptives. In men over 16 years-old, progesterone concentration range from 
0.27-0.9 ng/mL (0.86-2.9 nM) (National Institute of Health, 2009, Stricker et al., 2006, D.B. 
Gower and J.W. Honour, 1984). 
In women, progesterone is produced in the ovaries, before ovulation by influence of LH, and 
during pregnancy in the placenta. It is responsible for preparing the ovaries for a fertilized ovum, 
and if the ovum is not fertilized then progesterone levels decrease and menstruation occurs. 
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The biosynthesis of progesterone occurs from pregnenolone via 3 HSD enzyme, with 
cholesterol being the precursor of pregnenolone (Figure 1.15) (Wood and Gower, 2010). 
It has also been suggested to use serum 17 -hydroxyprogesterone’s (17-OHP) ratio with T 
(T/17OHP) as a marker to monitor exogenous T intake for doping purposes, in studies 
performed in 7 males (Carlstrom et al., 1992, Palonek et al., 1995) and 11 males (Palonek et 
al., 1995). One of the precursors of testicular T is 17OHP with 75 % of it coming from testicular 
synthesis (Crilly et al., 1981). Administration of synthetic anabolic steroids suppresses 17-OHP 
concentrations by ~ 75 % (Alen and Hakkinen, 1987) and in an increased serum T/17-OHP 
could be used as an additional marker.  
However, the use of T/17OHP is not described in the WADA’s technical document for T’s 
detection (World Anti-Doping Agency, 2004). This may be due to the fact that there are already 
two ancillary methods such as urinary T/LH and urinary androsterone/testosterone (A/T) put in 
place thus serum T/17OHP becomes obsolete; or perhaps because conversion of 17OHP into T 
follows 
4
 pathway from pregnenolone which is a minor route in males. The most common 
biosynthetic pathway for T in humans is via 
5 
pathway from pregnenolone (for more details on 
biosynthesis of T please see section 1.3.2). 
LH will act on the ovaries to initiate steroidogenesis in the ovarian follicle, causing ovulation and 
maintenance of the ovulatory functions of the corpus luteum. FSH will stimulate the 
development of the ovarian follicles and their secretion of E2. 
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Figure 1.8 Negative feedback mechanism in women (Emanuele and Emanuele, 1997) 
 
The only situation in which LH is not controlled via a negative feedback mechanism happens 
just before ovulation where high concentrations of estrogens are associated with a sudden rise 
in LH (Brook and Marshall, 2001a) (Yen and Lein, 1976). 
In men, as mentioned previously if the system is working normally then a lowering of the 
circulating T concentration will result in a rise in GnRH and consequently LH and FSH and vice 
versa (Emanuele and Emanuele, 2001, Griffin and Wilson, 1992).   
This is valid only for males, since LH is suppressed in females with oral contraception. The 
urinary concentration in healthy men (n=120) is approximately 0.5-20 IU/L (international units 
per litre) (Drug Control Centre, 2010). 
In contrast, an increase in the circulating concentration of T will suppress LH, and this is why LH 
measurements are useful in sports. Doping with T results in a lower circulating concentration of 
LH, reflected in a higher excretion of T and a lower excretion of LH, and samples with a high 
urinary T/LH ratio are considered suspect. Analysis of healthy male urine (n=120) has shown 
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that the reference interval for urinary T/LH ratio should be between 1-150 nmol/IU (Drug Control 
Centre, 2010). 
The reference range for LH in serum is 5-20 IU/L (Griffin and Wilson, 1980). A previous study, 
that analysed LH during daytime from 8 hours (h) to 14 h, and at night time from 20 h to 2 h, 
showed no difference in the amount secreted in these two periods of time (n=12), nor did it 
show any significant difference in  the half-life between sexes (Clark et al., 1997).  
The metabolic clearance rate
1
 (MCR) of LH is 24 mL/min in men (Veldhuis et al., 1986), and in 
post-menopausal  women is 0.14 mL/min (Keller, 1966). 
After both sexes reach puberty the secretion of LH increases, causing a maturation of the 
Leydig cells and consequent secretion of T. Whereas in women the increase of T although 
significant is smaller than in men partly because about half originates from secretion by the 
ovaries and the adrenal cortex, and the other half from peripheral conversion of 
androstenedione (AD) (Wheeler, 1995, Horton and Tait, 1966).  
 
1.2.3 Hypothalamic-Pituitary-Adrenal axis  
The hypothalamic-pituitary-adrenal (HPA) axis, like the HPG axis described above, is controlled 
via a negative feedback mechanism that comprises the hypothalamus, the anterior pituitary 
gland and the adrenal glands.  
The HPA axis is also regulated by the hypocampus, amygdala, bed nucleus of the stria 
terminalis (BNST) and paraventricular nuclei (PVN).  
This axis mediates the response to stress levels, so situations of physical or emotional stress 
activate the HPA axis.  
The adrenal gland is situated above the  kidneys and can be divided into two sub-organs: the 
adrenal cortex, which secretes steroid hormones, and the adrenal medulla that secretes 
catecholamines such as adrenaline and noradrenaline that increase serum glucose and fatty 
acid levels (Greenstein, 1994b). 
                                                     
1
 Volume of biological fluid completely cleared of substance in unit time.  
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The adrenal cortex is divided into three zones: 
- Zona glomerulosa (synthesizes aldosterone) 
- Zona fasciculata (synthesizes cortisol) 
- Zona reticularis (synthesizes dehydroepiandrosterone (DHEA) and AD) 
 
For the purpose of this review only steroid hormones secreted by the adrenal cortex are of 
relevance. These are mineralocorticoids, glucocorticoids and sex hormones.  
Mineralocorticoids regulate mineral metabolism, and the two most potent ones are aldosterone 
and deoxycorticosterone (DOC). Aldosterone also has some mild glucocorticoid activity. 
Glucocorticoids regulate blood glucose, have potent anti-inflammatory and immunosuppressive 
properties and are used to treat arthritis and dermatitis. Their use is prohibited in sports; the 
most potent one is cortisol, which also has some mineralocorticoid activity (Porterfield, 2001c).  
The PVN cells in the hypothalamus secrete 2 hormones: corticotrophin-releasing hormone 
(CRH) and arginine vasopressin (AVP). These act on the pituitary gland via the hypothalamic-
hypophyseal portal system. When CRH reaches the anterior pituitary gland, it will bind to the 
specific receptors – the corticotropes – that in their turn will secrete adrenocorticotropic 
hormone (ACTH) (Emanuele and Emanuele, 1997). 
CRH is the primary regulator of stress response and, if CRH is stimulated, secretion of ACTH 
will increase. ACTH is then carried in the blood to the adrenal cortex and, in its turn, interacts 
with the receptors on the adrenocortical cells that stimulate the production and release of 
cortisol (Figure 1.9) (Varghese et al., 2001). 
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Figure 1.9 Negative feedback mechanism from HPA axis (Emanuele and Emanuele, 1997) 
 
Cortisol (Figure 1.10) is the main glucocorticoid in humans and is interconverted to cortisone 
(another glucocorticoid) in the liver. It triggers metabolic effects with the purpose of relieving 
stress states in the body. The adrenal gland also produces corticosterone, which mainly has 
mineralocorticoid activity but some glucocorticoid one as well. 
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Cortisol exerts a negative feedback at the level of the hypthalamus and pituitary glands similar 
to that of the HPG axis described earlier. Stress increases secretion of CRH by the 
hypothalamus, which in turn increases ACTH by the anterior pituitary, thus releasing cortisol by 
the adrenal glands (Porterfield, 2001c). 
Both ACTH and cortisol have a diurnal variation, which is a function of the diurnal secretion of 
CRH. Secretion of ACTH has its peak in the early morning just before sunrise and slowly 
decreases throughout the day (Porterfield, 2001c). The main sex hormones secreted by the 
adrenal glands are AD and DHEA. These weak androgens can be converted into more potent 
ones, like T, or into estrogens in peripheral tissues. (Porterfield, 2001c) (Figure 1.11). This is of 




Figure 1.11 Synthesis of adrenal steroid hormones (Brook and Marshall, 2001b) 
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1.3 Androgens 
Androgens are sex steroids, primarily responsible for the maintenance and function of the 
prostate and seminal vesicles, particularly with spermatogenesis, and cause an increase in the 
testes size, scrotum, penis, seminal vesicles and prostate, (Brooks, 1975b, Gower, 1979). 
Testosterone is one of the most biologically active androgens, together with 5 -
dihydrotestosterone (5 -DHT), both having a 17 -hydroxyl group and a 3-oxo group.  
Androgens are secondarily responsible for protein muscle increase due to their anabolic effects, 
and finally they also have an effect on non-sexual organs and tissues such as the growth of 
sexual, axillary and facial hair throughout puberty, deepening of the voice in boys, and an 
increase in the activity of sebaceous glands resulting in acne in most cases (Brooks, 1975b, 
Gower, 1979, Gower, 1984a). The steroids T, 5 -DHT and 5 -androstane-3 ,17 -diol have 
higher androgenic activity. Oxidation of the 17 -hydroxyl group or reduction of the 3-oxo group 
lead to loss in androgenic activity (AD and 5 -androstenediol), and when both happen in the 
steroid molecule it leads to an even weaker androgenic effect like in DHEA and androsterone. 
Etiocholanolone and E have no androgenic activity. 
The changes in the 17 -hydroxyl and/or 3-oxo groups compared to T and 5 -DHT may be 
found in bold in Figure 1.12. 
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Figure 1.12 Structure of C19 endogenous androgens based on (Kicman, 2010) 
 
1.3.1 IUPAC nomenclature 
A steroid is a molecule that has the “skeleton of cyclopentanophenanthrene or a skeleton 
derived therefrom by one or more bond scissions or ring expansions or contractions” 
(International Union of Pure and Applied Chemistry, 2009). 
Steroids are four fused ringed compounds that originate from cholesterol in the form of 
cholesterol esters, lipoproteins or de novo synthesis. Each steroid is named using the 
carbocycle as the main structure: estrane (C18), androstane (C19) or pregnane (C21) as seen on 
Figure 1.13. 
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Figure 1.13 5 -estrane (i), 5 -androstane (ii) and 5 -pregnane (iii) 
 
The carbon numbering of steroids in the cholestane molecule is shown in Figure 1.14.  
 
Figure 1.14 Labelling of a steroid molecule (cholestane) 
 
1.3.2 Biosynthesis and production of testosterone 
Biosynthesis of T occurs mainly in the testes (Leydig cells) and the adrenal cortex, and to a 
lesser extent in the ovaries and placenta.  
Serum concentration for eugonadal males is usually 3 – 10 ng/mL (10 – 35 nmol/L) and for 
females less than 1 ng/mL (3.5 nmol/L). 
In women, T is produced in the ovaries to a lesser extent and the peripheral conversion of 
androgens is the major contributor to T production. The androgens that the adrenal cortex 
mainly secretes are AD, DHEA and DHEA sulfate (Weigel and Moore, 2007b, Mendelson and 
Stein, 1966). There is peripheral interconversion between DHEA sulfate and DHEA (Kakihana 
et al., 1971), DHEA is peripherally interconverted to AD, and there is peripheral interconversion 
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between AD and T. This peripheral conversion, although happening to an extent of 12 – 14%, 
accounts for half of the circulating T in women (Bardin and Lipsett, 1967b).  
There are two synthetic pathways for T’s biosynthesis: one via 5-ene-3 -hydroxysteroids such 
as 17-hydroxypregnenolone and DHEA (
5
 pathway); and the 4-en-3-oxosteroids such as 
progesterone and 4-AD (the 
4
 pathway) (Figure 1.15).  
The 
5
 pathway is the most common in males (Ruokonen et al., 1972) and the path shown in 
bulky arrows is the main route in humans. 
The enzymes involved in this biosynthesis are cytochrome P17 (CYP17) and 
17 hydroxysteroid dehydrogenases (17 HSD) (Payne and Hales, 2004). 
 
 
Figure 1.15 Biosynthethic pathway of T with respective enzymes involved. The first pathway is 
5
 
and the second 
4
 (Payne and Hales, 2004, Slaunwhi.Wr and Burgett, 1965, Kicman, 2010) 
 
Pregnenolone and progesterone are hydroxylated at carbon 17, followed by side chain 
cleavage, catalysed by CYP17 and resulting in C19 steroids, DHEA and AD. 
Conversion of 17-hydroxypregnenolone into DHEA by side chain cleavage was shown by 
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no noticeable increase in AD was verified for the first 15 mins, suggesting that this oxidation 
was not happening to a high extent. However, at the same time T was being formed rapidly, 
showing that the reduction from DHEA to androstenediol, and subsequently the oxidation from 
androstenediol to T, were occurring at a fast rate. 
These results suggested that there was an alternative pathway from 17-hydroxypregnenolone to 
androstenediol, without involving DHEA to a great extent since this is rapidly converted to AD. It 
was suggested that AD was biosynthesized by the 
4





 pathway originates 17-hydroxypregnenolone, DHEA, androstenediol and T; whereas the 
4
 pathway originates 17-hydroxyprogesterone, AD and T. 
Work on incubated mouse and rat testes with 
14
C-labelled sodium acetate, found radioactivity 
associated with cholesterol and T, and also to AD but to lesser extent (Delatorre et al., 1977). 
No labelled C21 steroid (pregnenolone, progesterone and their 17-hydroxylated derivatives) or 
DHEA (C19 steroid) was found. This indicated that, if DHEA was formed directly from 
cholesterol, it must have been transformed into AD and the majority of it reduced to T by the 17-
hydroxysteroid dehydrogenase.  
This study contrasts with human testicular preparations, which were also incubated under the 
same conditions as above but resulted in the formation of AD and T and of some (or all) C21 and 
C19 steroids intermediates expected. 
The enzymes involved in T’s biosynthesis can be divided into two categories of protein: the 
cytochrome P450 haeme-containing proteins, or the hydroxysteroid dehydrogenases (Payne 
and Hales, 2004). 
The first family of enzymes has the nomenclature of CYP for human genes (Cyp for animals) 
followed by a number indicative of the P450 family in which the enzyme can be found. In cases 
of existing subfamilies, the numbers are followed by a capital letter (eg. CYP11A, enzyme 
responsible for the synthesis of cholesterol to pregnenolone).  
These enzymes are responsible for the hydroxylation and cleavage of the steroid substrate in 
the biosynthesis of steroid hormones from cholesterol. They act as mono-oxygenases utilizing 
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reduced nicotinamide adenine dinucleotide phosphate (NADPH) as the electron donor for the 
reduction of molecular oxygen (Payne and Hales, 2004). The oxygen (O2) is activated by P450 
and while one atom is introduced into the RH substrate as an hydroxyl group, the other atom is 
reduced to H2O:  
RH + O2 + NADPH + H
+
          ROH + H2O + NADP
+
  
The second family of enzymes (hydroxysteroid dehydrogenases) includes the 3 HSDs and the 
17 HSDs. These enzymes are oxidoreductases and are involved in the reduction and oxidation 
of steroid hormones requiring the cofactors nicotinamide adenine dinucleotide (NAD(H)) and its 




 work as acceptors and their reduced forms as 
donors.  
It is the oxidised form of the cofactors that work in the catalysis as hydrogen acceptor and the 
reduced species as a donor: 
NAD
+
  + 2H
+
          NADH + H
+
    
17 -HSD3 has a reductive primary activity converting AD to T, preferring NADPH as a cofactor. 
17 -HSD reactions are catalyzed by multiple isozymes that favour, in general, the reduction of 
the biologically inactive 17-ketosteroids to active 17 -hydroxysteroids in the gonads, and the 
reverse oxidative reaction in peripheral tissues. 
The main difference between this family of enzymes and the P450 one, is that the first has 
several isoforms (several different forms of the same protein) for 3 HSDs and several 
isoenzymes (enzymes that differ in amino acid sequence but catalyze the same chemical 
reaction) for the 17 HSDs, whereas the last family of enzymes is the product of a single gene. 
 
1.3.3 Biosynthesis of epitestosterone 
Epitestosterone is an epimer of T, and a reference steroid for T’s abuse for doping purposes, 
excreted mainly as a glucuronide.  
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Its concentration in serum is age dependent, reaching its peak in men at 35 years old and in 
women at 20 years old, whereas the average concentration in an adult men averages 
2.5 nmol/L (0.72 ng/mL) and 1.2 nmol/L (0.34 ng/mL) in women (Havlikova et al., 2002). As for 
the urinary excretion of E, the average for normal males is 166.4 (range 8.7-396) g/24 h, and 
for normal females 11.1 (range 6.5 – 19.6) g/24 h (Denicola et al., 1966), or 578 (range 30 – 
1375) nmol/24  h for males and 39 (range 23 – 68) nmol/24 h. 
In humans, a small part is converted from AD or DHEA (Brooks and Giuliani, 1964) and 
peripheral metabolism from T to E is negligible (Dray and Ledru, 1966, Starka, 2003). 
One of the suggested pathways for E’s synthesis is from the oxidation of epiandrostenediol 
(androst-5-ene-3 , 17 -diol) by 3 HSD since this diol was found in human testis (Ruokonen et 
al., 1972, Starka, 2003). Its correlation with concentrations of epitestosterone in the spermatic 
vein has been documented (Dehennin, 1993), also showing the secretion of E by the human 
testes. The testes are the main source of E secretion, with a modest contribution from the 
adrenal gland (Kicman et al., 1999). 
The other one is via the synthesis of AD, shown by (Catlin et al., 2002) that by orally 
administering AD to healthy male volunteers provoked an increase in urinary excreted E via 
17 HSD, confirmed in human embryonic kidney cells by Bellemare et al. (Bellemare et al., 
2005). 
The efficiency of 3 HSD for DHEA and of 17 HSD for AD shows that the main pathway is from 
conversion of DHEA to AD and then reduction to E, and the minor pathway from the reduction 
of DHEA to epiandrostenediol and the oxidation to E (Bellemare et al., 2005). 
Furthermore, it has also been proposed that the epiandrostenediol is further converted to E by 
3 HSD via its synthesis from pregnenolone in a single step through a 16-ene-synthase 
(Weusten et al., 1989, Starka, 2003). 
The biosynthetic pathway of E is illustrated in Figure 1.16. 
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Figure 1.16 Proposed pathway for the synthesis of E. The thicker arrows represent the major 
routes (Weusten et al., 1989, Kicman, 2010) 
 
1.3.4 Mechanism of action 
Steroid-converting enzymes within target tissues are responsible for modulating androgen’s 
effects at cellular level (Kicman, 2008).  
Testosterone acts as a prohormone as well as a hormone, and in reproductive target tissues 
(cells that contain androgen receptors) and skin it may be converted by 5 -reductase into DHT, 
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1994c). In parts of the brain and fatty tissue, T is converted by aromatase into E2 (Greenstein, 
1994c, Kicman, 2010). 
When steroid hormones bind to the androgen receptor (AR) or steroid receptor (SR) they 
produce a conformational change releasing a heat shock protein (HSP) from the receptor. This 
causes the dissociation of the receptor, already activated, from its protein and thus an increase 
in the DNA-binding sites hence allowing the ligand-bound receptor to bind to the hormone 
response element of the DNA (Kicman, 2010, Porterfield, 2001d). After dissociation, the 
activated androgen receptor is translocated into the nucleus and binds to the DNA thus 
triggering the formation of a transcription complex (Figure 1.17). The androgen receptor belongs 
to the steroid-thyroid-retinoic acid superfamily of receptors and comprises of a DNA-binding 
domain, a ligand-binding domain and an N-terminal region. 
 
Figure 1.17 Mechanism of steroid receptor action (Kicman, 2008), based on Weigel et al, (Weigel 
and Moore, 2007a) 
 
In the absence of hormone, the steroid receptor is an inactive oligomeric complex with the 
molecular heat shock protein Hsp90 and p23, and tetratricopeptide (TPR) motifs.  
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1.4 Pharmacokinetics of testosterone 
1.4.1 Distribution, metabolism, excretion 
Steroid hormones bind to plasma proteins for transport and can be found in the blood circulation 
as bound and unbound (Dunn et al., 1981). There are four main plasma proteins: albumin, sex-
hormone binding protein (SHBG), corticosteroid binding globulin (CBG) and thyroid-binding 
globulin (TBG). Albumin is the principal steroid binder available in the blood stream and it will 
bind T, E, E2, cortisol and P (Bruning et al., 1976, Yen and Jaffe, 1999a). The other binding 
globulins are available for specific hormones: SHBG is available for androgens and estrogens 
such as T, dihydrotestosterone (DHT) and E2; CBG for cortisol, progesterone and T (in small 
amounts); and TBG for thyroxine and triiodothyronine (Yen and Jaffe, 1999b).  
The clearance rate is the volume of blood completely cleared of drug and/or metabolites as 
measured in unit time (L/day). The clearance rate of a steroid from the total amount of blood in 
the body is the sum of steroid clearance rates for each tissue or organ, and the overall value will 
be the often referred to as metabolic clearance rate (MCR) in steroid endocrinology. 
The MCR was usually measured using a continuous infusion of a radioisotopically labelled 
steroid at a constant rate and determining the concentration of the unconjugated radioactive 
steroid in peripheral venous blood. When equilibrium is reached, the concentration of the 
isotopic steroid in blood will be constant, the rate of clearance of the steroid from the blood will 
be equal to the rate of entry, and the MCR will be equal to the rate of infusion of the isotopic 
steroid divided by the concentration of the labelled steroid in the blood (Yen and Jaffe, 1999a). 
Of course, undertaking such investigations now would be met with difficulty, as ethical 
committees would be concerned about the administration of radio-nucleides to healthy 
volunteers. For this reason, stable isotopes may be administered instead and steroid 
concentrations measured by hyphenated mass-spectrometry. 
Elimination occurs as a result of metabolic processes that occur in the kidney, liver, saliva, 
sweat, intestine, heart, brain or other site of the body (Centre for Cancer Education, 2007). 
The main metabolites of testosterone excreted in urine are androsterone glucuronide, 
etiocholanolone glucuronide and, to a lesser extent, testosterone glucuronides.  
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In women, AD is converted to testosterone in the liver and conjugated with glucuronic acid 
without being released into the blood stream as free hormone (Horton and Tait, 1966). 
Therefore, the excretion of testosterone glucuronide in women is not a good reflection of their 
circulating T concentration and may not be a good way to calculate the blood concentration of 
testosterone (Brooks, 1984). 
The MCR and the production rate of T have been determined under basal conditions (Table 
1.1). The production rate is obtained by multiplying the MCR by the plasma concentration. 
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(Rivarola et al., 1966) 
Male 2 1030 26.8 7.7 
Female 2 529 0.7 0.2 
(Bardin and Lipsett, 1967b) 
Male 6 1240 32 9.2 
Female 5 590 0.8 0.23 
(Vermeulen and Ando, 1979) 
Male 12 1026 26.7 7.7 
Female (postmenopausal) 10 503 0.7 0.2 
(Wang et al., 2004b) 
Male 11 1219 31.7 9.1 
Female NA NA NA  NA 
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The MCR for males is about twice as high as the MCR for females, and the production rate is 
about 38 times higher; this might have to do with protein binding, since the MCR is inversely 
proportional to the concentration of SHBG in plasma, therefore women that have higher SHBG 
plasma concentrations than men will have a lower MCR (Mendel, 1989).  
Steroids are hydrophobic substances that undergo reductive catabolic reactions through the 
action of enzymes to be rendered more water soluble so they can be excreted through water-
soluble means (urine, sweat). Although this is not always the case, for example, the major 
metabolites of T, androsterone and etiocholanolone, must have very similar hydrophobicity. It is 
really phase 2 metabolites in the form of sulfate and glucuronide conjugates, which makes them 
even more water soluble and able to be excreted in urine (Gower, 1984b). Androgen 
metabolism and catabolic reactions happen mainly in the liver. 
Testosterone is subject to phase 1 metabolism, which makes it more polar and more water 
soluble, oxidizing T to AD via 17 -HSD, the reduction of the A-ring to yield the 5 - and 5 -
androstenediones, and via 3 - and 3 -HSD to form mainly androsterone and etiocholanone to a 
lesser extent (Kicman, 2010, Brooks, 1975a, Ring, 2006, Weigel and Moore, 2007b). Even after 
undergoing phase 1 metabolism, it is not water soluble enough to be excreted by water-
mediated excreting organs. Therefore it will undergo phase 2 metabolism.  
This type of metabolism excretes T as conjugated sulfate and glucuronide metabolites through 
the conjugation with 3’-phosphoadenosine-5’-phosphosulfate (PAPS), and uridine diphosphate 
glucuronic acid (UDP-glucuronic acid) respectively.  
Sulfation is a high affinity, low capacity pathway because PAPS is present in the cells in low 
amounts. On the other hand, glucuronidation is a low affinity, high capacity pathway because 
glucuronic acid is present in high abundance in liver cells due to its important role in glycolysis 
and glycogenesis. When high doses of androgens are administered, due to the low availability 
of PAPS the remainder will undergo glucuronidation, even though the initial preferred pathway 
is sulfation. 
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Metabolic pathways of T can be seen in Figure 1.18 and, although testosterone can be excreted 
as a sulfate conjugate, only the glucuronide is shown as it is excreted in higher amounts 
(Gower, 1984b).  
 
Figure 1.18 Metabolic pathway of T (Brooks, 1975a) 
 
1.4.1.1 Glucuronidation pathways 
Steroid glucuronic conjugates are excreted in urine when glucuronic acid is transferred from 
UDP-glucuronic acid to the aglycone moiety catalysed by glucuronosyltransferase enzymes 
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(glucose, glucuronic acid, xylose and galactose) to lipophilic substrates to render them more 
hydrophilic (Guillemette, 2003). 
The addition of a sugar acid to a steroid increases its hydrophilicity, helping with its urinary 
excretion. 
The mammalian UGT gene has 117 members divided into four families: UGT1, UGT2, UGT3 
and UGT8, with UGT2 divided into 2 subfamilies: UGT2A and UGT2B (Mackenzie et al., 1997, 
Mackenzie et al., 2005). The enzymes from UGT1 and UGT2 donate more readily the 
glucuronic acid, but UDP glycose and UDP xylose are also available. The UGT3A1 uses UDP 
N-acetylglucosamine; UGT3A2 uses UDP glucose and UDP xylose, but not UDP N-
acetylglucosamine (MacKenzie et al., 2011). The sugar donor that UGT8 uses is UDP galactose 
(Ichikawa et al., 1996). 
There are twenty-seven active human enzymes (Mackenzie et al., 2005) but only four have 
significant activity concerning androgen metabolism: UGT2B4, UGT2B7, UGT2B15 and 
UGT2B17 (Sten et al., 2009b). UGT2B4 is the one with lower steroid glucuronidation activity. 
UGT2B7 is specific for a wide range of steroids, including C19 steroids with a hydroxyl function 
at the 3 -, 16 -, and/or 17  positions. Its glucuronidation activity includes 5 -androstan-3 -
17 -diol (5 -diol) and E (Girard et al., 2003, Sten et al., 2009a, Sten et al., 2009b, Coffman et 
al., 2003).  
UGT2B15 catalyzes the major androstanediols (5 -and 5 -androstane-3 ,17 -diol) , but it 
shows a higher stereoselectivity towards the first one (Sten et al., 2009b). This enzyme 
specifically conjugates 17-hydroxyl groups.  
UGT2B17 has a high capacity for 5 -DHT conjugation, and mainly  testosterone glucuronidation 
(Beaulieu et al., 1996, Sten et al., 2009a). Although it does not glucuronidate E, it binds it with a 
similar affinity as T. 
UGT2B7 and UGT2B17 exhibits the highest activity rates in the glucuronidation of androsterone 
and etiocholanolone, both being excretion products of T (Sten et al., 2009b). 
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In doping in sports the method to test for testosterone abuse is through a urinary T/E ratio 
obtained via GC-MS, as mentioned previously. Testosterone is mainly excreted as a 
glucuronide conjugate which is subjected to a hydrolysis step to cleave the glucuronide and 
thus only the steroid moiety undergoes the remaining analysis. There is, therefore a high 
interest in testosterone glucuronidation. The large variation in testosterone glucuronide (TG) 
excretion is associated with a genetic polymorphism in UGT2B17 (Schulze et al., 2008, 
Jakobsson et al., 2006, Sten et al., 2009a).  
If an individual carries a del/del genetic polymorphism in the UGT2B17 gene, the excretion of 
TG will be approximately 20 times inferior to those of individuals with an ins/ins. (Schulze et al., 
2008).  
This will ultimately affect the T/E ratio for doping purposes, with an athlete carrying the del/del 
polymorphism being able to mask any exogenous T administration. 
  
1.4.1.2 Sulfation pathways 
Sulfoconjugation of steroids involves the transfer of a sulfonate group (SO3) from PAPS to an 
hydroxyl group, via a sulfotransferase enzyme (Strott, 1996) to form a sulfate (SO4). Sulfation 
occurs mainly in the liver, but it can also occur in the testes and adrenal gland (Jaffe and Payne, 
1971, Ruokonen et al., 1972, Falany et al., 1989). 
There are two types of sulfotransferase enzymes: cytosolic and membrane associated, but only 
the cytosolic ones are involved in steroid metabolism. 
There are ten human sulfotransferase genes encoding eleven cytosolic sulfotransferase 
proteins (Glatt and Meinl, 2004). The SULT2 family is the most relevant for hydroxysteroids, 
with SULT21A being more active for DHEA and able to conjugate androsterone and T as well. 
The clearance rate of steroid sulfates is low when compared to unconjugated steroids, mainly 
because of their affinity to albumin, thus showing that they are not directly excreted from the 
body (Strott, 1996). For example, the average clearance rate of DHEA in men is 1059 L/day and 
854 L/day in women; the corresponding sulfate having a clearance rate of 16.7 L/day in men 
and 16.5 L/day in women (Wang et al., 1967). With T, the average clearance rate in men is 
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225 L/day and in women 2029 L/day. The sulfate is cleared in men at an average rate of 
24.5 L/day and in women at 21.5 L/day (Wang et al., 1967). 
Generally, it is thought that steroid sulfates form a pool of inactive steroids in the blood 
circulation which can be locally activated by sulfatases. 
Due to the low excretion of testosterone sulfate, this metabolite is not a good biomarker for 
testosterone abuse (Schulze et al., 2011). 
1.5 Plasma binding proteins & testosterone 
Steroid hormones bind to plasma proteins for transport and can be found in the blood stream as 
bound and unbound (Dunn et al., 1981). There are four binding proteins in blood: albumin, sex-
hormone binding globulin (SHBG), corticosteroid binding globulin (CBG) and thyroid-binding 
globulin (TBG). Out of these four only the first three have the ability to bind testosterone to any 
extent (Dunn et al., 1981, Bruning et al., 1976, Yen and Jaffe, 1999a, Yen and Jaffe, 1999b).  
The affinity of an analyte to a protein is the tendency it has to be bound to that protein. The 
higher the affinity between them, the more tightly bound the analyte is. Testosterone’s affinity 








) (Table 1.2). 
Although testosterone’s affinity is lower with albumin, it is of high capacity since albumin 
accounts for ~60 % of proteins in plasma. The binding capacity is a measure of the quantity of 
analyte that can be bound by a given protein. 
The higher binding affinity of T with SHBG is due to its high affinity for 17 -hydroxy-androgens 
and estradiol (Wheeler, 1995, Dunn et al., 1981).  
Testosterone binds mainly to SHBG followed by albumin and CBG although to lower extent with 
the latter (Wheeler, 1995). It is estimated that, of the circulating T in adult men, approximately 
45% is bound to SHBG, 50% to albumin and the other 5% circulates as free and bound to CBG 
(Karagiannis and Harsoulis, 2005).  
For an estimate of the bound circulating T in eugonadal males and females, please see  
Table 1.3 and Figure 1.19 (Dunn et al., 1981). For the concentrations in mass see Table 1.4. 
Chapter 1: Introduction  Doping in Sports: The effect of alcohol on the urinary increase of T/E 
 
- 58 - 
Steroid binding is temperature and pH dependant, and it is 2.5 times higher at 4 C than 37 C. 
It becomes irreversibly destroyed at temperatures higher than 60 C and at pH below 5 (Selby, 
1990). 
Alterations in binding may lead to changes in peripheral metabolism and alter T concentration in 
serum (Gordon et al., 1976b). 
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Table 1.2 Binding proteins’ association constants for testosterone in blood  
Binding protein Binds to Association constant (M
-1
















 115 2.2 x 10
-12
 
CBG Testosterone, cortisol & progesterone 5.3 x 10
6














T bound to SHBG 
(%) 
T bound to albumin 
(%)  
T bound to CBG 
(%) 
Unbound T  
(%) 
EM 23 28 0.56 0.7 44.3 49.9 3.56 2.23 
EF-FP & LP
2
 1.3 37 0.56 0.7 66 30.4 2.26 1.36 
 






T bound to 
SHBG (ng/mL)  
T bound to albumin 
(ng/mL)  




EM 23 6.6 2.9 3.3 0.2 0.1 
EF-FP & LP 1.3 0.4 0.2 0.1 0.01 0.01 
                                                     
2
 EM stands for eugonadal men and EF for eugonadal females. LP stands for lutheal phase and FP for follicular phase 
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Women in 3rd trimester of pregnancy
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SHBG is a homodimeric glycoprotein synthesized in the liver and is made by the association of 
two identical subunits differently glycosylated (Yen and Jaffe, 1999b). Each monomer has 373 
amino acid residues that are released along with water from a condensation reaction between 
amino acids, and a tandem series of laminin G-like domains (Figure 1.20). (Walsh et al., 1986). 
Laminins are large heterotrimeric glycoproteins that play a key role in membrane architecture 
and function (Tisi et al., 2000). 
 
Figure 1.20 - Representation of two homodimeric SHBG showing its two steroid-binding sites. The 
steroid present is 5 -DHT (Grishkovskaya et al., 2000) 
 
It used to be thought that there was one binding site per mole leading to the assumption that a 
single steroid-binding site could be found in the dimer interface (Hammond, 1990, Petra, 1991). 
However, recent crystal studies (Avvakumov et al., 2001) have shown that each monomer in the 
homodimeric SHBG protein has one binding site (Grishkovskaya et al., 2000) amounting to two 
binding sites per protein.  
 
1.5.1 Hormone availability 
Regarding hormone availability for tissues there are two different theories: the free hormone 
and the bound hormone.  
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Proponents of the free hormone fraction theory argue that this form is the main component of 
most hormone biological activity, and only in this fraction will the hormone be able to reach 
target tissues (Mendel, 1989, Ekins, 1990, Brooks, 1984) and, in the absence of significant 
cellular metabolism, the concentration of free hormone in nuclear compartments is the same as 
measured in vitro (Pardridge, 1988). This idea mainly comes from observing abnormal 
concentrations of protein bound hormone and its hormonal effects correlating with the free 
hormone concentration rather than that of the bound (Ekins, 1990).   
In vitro studies have been performed to assess the amount of free testosterone available to 
tissues in the body.  
It seems unlikely that only the free T reaches certain tissues, especially the liver due to its high 
concentration in this organ. The intracellular concentration of testosterone present in the liver is 
thought to come from the rapid dissociation of testosterone from albumin during sinusoidal 
transit and there may be little or no contribution from SHBG bound T due to its much higher 
affinity constant (Mendel, 1989). This is sustained by the second theory that claims plasma 
steroid-binding proteins are found in target tissues because the protein-bound fraction is also 
available for them and that the rate limiting effects of protein-bound hormone dissociation may 
affect hormone uptake, thus invalidating the first hypothesis (Siiteri et al., 1982, Pardridge, 
1981). Studies on the albumin-bound fraction indicate that this bound-protein has an influence 
in the free steroid theory due to the rapid equilibrium between binding and dissociation (van den 
Beld et al., 2000, Mendel, 1990). Plasma binding proteins have not been proved solely to help 
steroid entry into cells, but this has not been disproved either. 
In summary, the free hormone hypothesis is currently the most accepted, but it is not flawless 
as it does not explain the availability of every hormone and the existence of specific binding 
proteins in certain target tissues is yet to be determined (Mendel, 1989). The concentrations of 
hormones are measured in serum bearing in mind that only free hormones are physiologically 
active and that their in vitro concentrations are indicative of an in vivo behaviour even though 
the relationship between bound and free hormone is a dynamic one (Ekins, 1992).  Therefore, 
changes in the blood flow, composition or temperature can change the free hormone level as 
studied in vitro (Pardridge, 1988, Yen and Jaffe, 1999b). 
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Whether the reason for the of remaining existence of these two theories rather than just one 
after so many years is due to the difficulty carrying out this type of research (will the 
experiments performed in vitro ascertain that the same conditions happen in vivo in terms of 
hormone availability to all the organs in the body), or the importance this has to the scientific 
community is a matter of speculation. 
The plasma concentration of T is 20 times higher in males than in females reaching 
concentrations of 26 nM (7 ng/mL) for males and 1.3 nM (0.4 ng/mL) for females, as calculated 
from the data associated with the selected studies from Table 1.5. 
 






in plasma (nM) 
Concentration in 
plasma (ng/mL) 
(Bardin and Lipsett, 
1967a) 
Normal men 24 26 7.5 
Normal women 20 1.4 0.4 
(Gandy, 1977) 
Normal men NA 23 6.6 
Women in LP & FP NA 1.3 0.4 
(Gaidano et al., 
1980) 
Normal men 20 26 7.5 
(Dunn et al., 1981) 
Normal men NA 23 6.6 
Women in LP & FP NA 1.3 0.4 
 
 
1.6 Analysis of testosterone & epitestosterone – misuse in sports 
Analytical screening and confirmation method for anabolic steroids is performed using gas-
chromatography mass-spectrometry (GC-MS) (Donike et al., 1983, Wheeler, 1993, 
Weathermon and Crabb, 1999). The ratio of the aglycone and the unconjugated urinary T and E 
is approximetely 1 (Donike et al., 1983, Van Renterghem et al., 2010). This screen also 
incorporates a test for testosterone administration, based on the determination of the ratio of 
testosterone to epitestosterone (aglycone plus free steroid). If the T/E ratio exceeds a threshold 
of 4, then further confirmatory tests need to be performed (Figure 1.21) (World Anti-Doping 
Agency, 2004). 
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Figure 1.21 Diagram showing normal T/E and above the threshold T/E 
 
About 1 % of T  and 30 % of E is excreted in urine unchanged (Brooks, 1975a, Wilson and 
Lipsett, 1966), and intramuscular injection of both at a ratio of 30:1 might give a T/E of 
approximately 1 (Kicman et al., 1990). However, because the increase in T concentration would 
provoke a decrease in LH, a urinary T/LH immunoassay test for males is used as a marker of T 
intake, since the ratio would substantially decrease (Kicman et al., 1990). There have also been 
reported cases of athletes with a naturally occurring T/E > 4 (Carlstrom et al., 1992, Dehennin 
and Matsumoto, 1993, Kicman et al., 1993, Catlin et al., 1997, Kicman and Gower, 2003), and 
the use of this ratio as a marker of T intake also helps to diferentiate false positives. Further 
confirmatory tests using gas-chromatography carbon ion-ratio mass-spectrometry (GC-C-IRMS) 
are also performed. 
More recently, the introductin of the athlete’s biological passport may help monitor T/E levels, as 
well as other performing enhancing drugs (Sottas et al., 2010). This profiling method uses the 
athlete’s individual values for within-subject comparison purposes, rather than a population 
based value. Such monitoring method is particularly useful when the marker presents a low 
ratio of within-subject to between-subject variations. 
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Testosterone has a molecular weight of approximately 288 g.mol
-1
. During derivatisation, two 
trimethylsilyl (TMS) (molecular weight of 72 g.mol
-1
) groups are attached to T via the hydroxyl 
groups. The resulting mass of the testosterone di-TMS is thus 432 g.mol
-1
. 
An internal standard is also added to each urine sample to account for any product losses 
during extraction or analysis. The internal standards used are trideutero testosterone, with 
deuterium (atomic mass = 2) replacing hydrogen (atomic mass = 1) at positions C16 (twice) and 
C17. Thus, the molecular weight of the deuterated derivatised testosterone is 435 g.mol
-1
.  
Epitestosterone, being the 17-epimer of testosterone, has the same molecular weight but the 
two can be distinguished chromatographically. 
 
1.7 Alcohol & hormones 
1.7.1 Alcohol consumption 
Ethanol (EtOH) is most commonly known as alcohol, a sociably accepted drink that despite 
having its benefits (boost of cardiovascular health) also causes addiction (Sadler, 2007). The 
effects alcohol can cause in the human body tissues are dependent upon the blood alcohol 
concentration (BAC), which is determined by alcohol’s absorption rate, distribution, metabolism 
and excretion; and affected by the rate consumed, presence of food in the stomach, type of 
alcoholic beverage and genetic factors such as variations in the main metabolic enzymes 
(Zakhari, 2006, Jones, 2011). 
The metabolism of alcohol results in the production of acetaldehyde, a toxic byproduct which is 
responsible for tissue damage, formation of damaging molecules known as reactive oxygen 
species (ROS) and a change in the redox state of cells present in the liver (Zakhari, 2006). 
One unit of alcohol is the equivalent to one standard drink which is approximately 8 grams (g) of 
alcohol. 
The recommended maximum alcohol intake for males and females is shown in Table 1.6. 
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(g/ week) (g/ week) 
Safe 168 – 224 (24 – 32 g/day) 112 – 168 (16 – 24 g/day) 
Hazardous 168 – 400 112 – 280   
Dangerous > 400 > 240  
 
For convenience it is normal to write alcohol consumption in terms of units. One unit of alcohol 
is the equivalent to one standard drink, which is approximately 8 grams of alcohol. 
Moderate consumption of alcohol is seen as socially acceptable and a male or female is 
considered a social drinker if they drink an alcohol beverage occasionally or regularly in 
moderation. A heavy drinker is someone that drinks heavily and regularly and normally above 7 
units/day in males, and above 5 units/day in females. A binge drinker drinks irregularly and 
heavily. 
The alcohol content of a drink is expressed in terms of percentage. For example, a pint of beer 
with 4.5 % alcohol by volume means that there is 4.5 mL of alcohol in 100 mL of beer. 
 
1.7.2 Absorption, distribution, metabolism & excretion 
Of all the alcohol ingested, 20 % is absorbed in the stomach and 80% in the upper small 
intestine by passive diffusion (diffusion across a membrane) providing the alcohol concentration 
in the stomach and small intestine exceeds that in blood (Sadler, 2007).  
The BAC rises according to how fast the alcohol leaves the stomach and the extent of this first 
pass metabolism (through stomach and liver) where alcohol’s concentration is reduced before it 
reaches the systemic circulation (Zakhari, 2006). 
Absorption is normally complete in 1 – 3 h and is normally faster if the individual has an empty 
stomach since the alcohol will pass more rapidly to the small intestine. This happens with 
diluted mixtures of alcohol, not in the case of spirits.  
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Alcohol is metabolised into an aldehyde via alcohol dehydrogenase (ADH) mainly present in the 
liver and some in the stomach; and by CYP450 enzymes and catalase in non-liver tissues such 
as the brain. This metabolism may be oxidative (add oxygen or remove hydrogen), or 
nonoxidative. 
Oxidative alcohol’s metabolism via ADH is the main metabolic pathway of alcohol in the liver. 
This results in the production of acetaldehyde, which is a toxic byproduct responsible for tissue 
damage and possibly the addictive process (Figure 1.22) (Zakhari, 2006). 
 
 
Figure 1.22 Metabolism of alcohol (oxidative pathway) (Zakhari, 2006) 
 
ADH is found in the cytosol (cell’s fluid) and there are five types in humans. ADH1 and ADH2 
are found in higher quantities in the liver and are mainly responsible for alcohol’s metabolism 
(Ring, 2006). 
When at high concentrations, alcohol is eliminated more rapidly due to the presence of 
enzymes with high activity levels such as ADH4 and ADH1B. This oxidative process involves 
the reduction of NAD
+
 by two electrons to NADH, which acts as an intermediate carrier of 
electrons. This whole oxidative process results in hepatocytes (liver cells) being more prone to 
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the consequences of alcohol’s byproducts (free radicals and acetaldehyde) resulting in liver 
damage (Zakhari, 2006). 
Cytochrome’s P450 isoenzymes CYP2E1, 1A2 and 3A4, all of which are present in 
microsomes, are also involved in oxidative alcohol’s metabolism in the liver. The first enzyme, 
CYP2E1, is present not only in the liver but also in the brain where ADH activity is smaller. It is 
stimulated by chronic alcohol consumption and acts when alcohol is present at high 
concentrations metabolizing it into acetaldehyde. 
Catalase, found in peroximes
3
, also oxidises ethanol in vitro in the presence of NADPH, a H2O2 
generating system but this is considered a minor pathway in alcohol’s oxidation. Nevertheless, 
catalase may have an important role in alcohol’s metabolism in the brain that can lead to 
alcohol addiction, as discussed elsewhere (Zimatkin and Deitrich, 1997). 
Regardless of the path ethanol undertakes to be oxidised into acetaldehyde, there are two main 
products as a result of this process: acetaldehyde and acetate. 
Acetaldehyde is highly toxic, hence why few studies directly involving acetaldehyde have been 
performed in humans. Studies in humans have been mainly performed involving carriers of the 
deficient gene variant (allele) that encodes acetaldehyde dehydrogenase (ALDH), ALDH2*2, 
which produces an inactive ALDH enzyme. Carriers of this allele (40% of East Asian population 
(Ring, 2006)) cannot metabolise acetaldehyde, which accumulates in the body and increases 
peripheral concentration. If the concentration of acetaldehyde increases by inhibition of ALDH, it 
is then very difficult to determine its dose-response pattern (Quertemont and Didone, 2006). 
Some of acetaldehyde’s physiological effects include increased skin temperature and facial 
flushing, increased heart and respiration rates, lowered blood pressure, narrowing of the 
airways, nausea and headache. For the mechanisms that induce these symptoms the reader is 
referred to the article by Quartermont et al.(Quertemont and Didone, 2006). 
Acetaldehyde is oxidized in the liver by ALDH to form acetate, which then enters the peripheral 
circulation. It is oxidised into carbon dioxide (CO2) in the heart, skeletal muscle and brain cells. 
                                                     
3
 Peroximes are an organelle found in eukaryotic cells that contain enzymes like catalase and 
urate oxidase. They are surrounded by only a single membrane, and they do not contain DNA 
and exist with a genome of their own. 
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It is then metabolised into acetyl coenzyme-A, which in turn is involved in lipid and cholesterol 
biosynthesis (Zakhari, 2006). Physiologically, acetate increases blood flow into the liver and 
depresses
4
 the central nervous system (CNS).  
Alcohol may also be metabolised via a non-oxidative pathway. Although this pathway is 
minimal, it will be briefly mentioned. 
Through this pathway, alcohol may be metabolised in two different ways. One will lead to the 
formation of fatty acid ethyl esters (FAEE), involving the reaction of alcohol with fatty acids; 
whereas the other one leads to the formation of phosphatidyl
5
 ethanol (Zakhari, 2006). 
Chronic alcohol consumption causes an initial increase in estrogens in postmenopausal 
females, followed by a decrease (Gavaler and Vanthiel, 1992). Moderate consumption, in 
females, induces a rise in estrogen possibly due to the increased rate of aromatisation of 
testosterone to estradiol (Gavaler et al., 1993). This rise may reduce the risk of cardiovascular 
disease, but one must not forget the risk of breast cancer associated with it. In males, chronic 
alcohol consumption causes a decrease in T, which will in turn lead to testes atrophy, 
impotence and loss of secondary sexual characteristics (Emanuele and Emanuele, 2001). 
Elimination of alcohol follows a zero-order kinetics in which ethanol is being eliminated at a 
constant rate from unit of time, when ingested in lower amounts (blood alcohol concentration of 
up to 0.2 g/L). Excretion is a first-order process, hence more alcohol is excreted unchanged with 
higher amounts (Jones, 2011). 
Excretion of alcohol is done in breath, urine and sweat (3 – 10 %), and as its conjugates ethyl 
glucuronide (EtG) and ethyl sulphate (EtS) (< 1 %) (Jones, 2011). 
The rate of elimination of ethanol varies accordingly to gender, diet, age, time of day and 
degree of alcohol consumption. 
The average blood alcohol clearance rate by the liver in a healthy person is 15 mg of 
alcohol/100 mL of blood/h (equivalent to 1 unit/h), with the range being 10-40 mg/100 mL of 
blood/h (Sadler, 2007). 
                                                     
4
 Depression of the CNS involves decreased rate of breathing, decreased heart rate, and loss of 
consciousness possibly leading to coma or death. 
5
 A type of lipid molecule containing phosphorous. 
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A typical blood alcohol concentration curve depends on absorption, metabolism and excretion. It 
starts off with the alcohol concentration reaching a maximum, then a fall due to diffusion in the 
tissues to reach an equilibrium (which takes approximately 15-30 min), falling progressively in a 
linear way (elimination) (Sadler, 2007). 
At high blood alcohol concentrations such as 200 mg %, the decrease is not linear due to losses 
via breath and urine. In cases such as these it takes about 12 h to eliminate this amount. 
In summary, approximately 3 – 10 % of alcohol is excreted in breath, urine and sweat, less than 
1 % as conjugates. 
 
1.7.3 Alcohol & the endocrine system 
1.7.3.1 HPA axis & alcohol 
Cushing syndrome is a disease arising from excess cortisol, which is sometimes caused by an 
excess of prescribed glucocorticoids, or from ACTH-producing pituitary tumours.  
This disease resembles that of alcohol’s effects in humans. Symptoms of this disease include 
redistribution of fat causing central obesity and purplish stretch marks, round red face (‘moon’ 
face) and osteoporosis. In women, terminal hair on the face may appear and also menstrual 
irregularities (Emanuele and Emanuele, 1997). Alcohol drinkers develop a pseudo-Cushing 
syndrome physically indistinguishable from the true one, although it is milder. It is called 
‘pseudo’ because its effects disappear after 2-4 months of alcohol abstinence.  
The similarities are also noticeable on a biochemical level with glucose intolerance, high plasma 
cortisol concentrations, loss of normal diurnal variation of cortisol in plasma and increased 
urinary glucocorticoid excretion (Cobb and Vanthiel, 1982). 
It is still unclear whether this disease originates from alcohol’s effects on the brain, pituitary or 
adrenal glands but it is an indication of alcohol disturbing the HPA axis. 
Studies in chronically intoxicated mice showed a decrease in corticosteroid plasma level after 
an acute alcohol ingestion (1.6 g/kg body weight) when compared to control mice kept on a 
water based intake (Kakihana et al., 1971). The rate of corticosterone metabolism in chronically 
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intoxicated mice was no different from the controls, hence the differences between the two 
groups could not be justified as an influence of alcohol in corticosterone metabolism. 
Further studies on mice’s ACTH pituitary levels showed no increase after the same alcohol 
dose (1.6 g/kg body weight). This suggested that alcohol may not have been stimulating the 
adrenal glands by releasing ACTH, which contradicts previous studies that supported the 
hypothesis that the pituitary gland was stimulated before the adrenal glands (Noble et al., 1971). 
This was also supported with evidence from another study, in which rats were administered 
alcohol and their ACTH levels had not increased when compared to the control group (Gambert 
et al., 1981). 
However, later studies in the 80s showed that acute alcohol administration (3.2 g/kg body 
weight of 12% ethanol solution in physiological saline) had the ability to activate the HPA in 
animals by significantly increasing plasma levels of ACTH, corticosterone and plasma 
catecholamines (Thiagarajan et al., 1989). These findings were in accordance with previous 
studies in which a single alcohol dose that raised blood ethanol concentration to more than 
100 mg/100 mL resulted in increased plasma concentration of ACTH and glucocorticoids (Noth 
and Walter, 1984, Guaza et al., 1983, Rivier et al., 1984, Rivier and Lee, 1996).  
In rats with chronic alcohol consumption, the HPA function decreases and therefore plasma 
ACTH and corticosterone levels decrease (Nolan et al., 1991). 
These discrepancies, although not entirely clear, may be due to dose response problems. 
In humans, studies with a control group and alcoholic patients where they were administered 
1 mL EtOH/kg of body weight (19.7 g of alcohol) showed an increase in urinary and plasma 17-
hydroxy corticoids, while 17-ketosteroids remained the same (Kissin et al., 1960). 
Another study done in the 60s (Mendelson and Stein, 1966) showed that the effect of alcohol in 
non-alcoholic volunteers was an increase in cortisol serum concentration only when the 
volunteer developed gastrointestinal distress due to drinking. In comparison, alcoholic drinkers 
had high cortisol serum concentration in response to alcohol administration even when drinking 
was not linked to alcohol-induced gastrointestinal distress. However, these volunteers had their 
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higher cortisol serum levels when they had stopped drinking, suggesting that the cortisol 
increase was stimulated by stress rather than an adrenal direct stimulation. 
These studies were supported with evidence showing that acute alcohol administration in 
volunteers and in chronic alcoholics resulted in an increase in hydrocortisone concentration 
when the blood alcohol concentration was higher than 100 mg % (Fazekas, 1966, Jenkins and 
Connolly, 1968, Bellet et al., 1970, Stokes, 1973, Merry and Marks, 1972). 
A recent study in volunteers with acute alcohol intoxication (AAI) also showed ACTH and 
cortisol significantly increased and that the increase was higher in women than in men (Frias et 
al., 2002). 
 
1.7.3.2 HPG axis & alcohol 
Chronic alcohol consumption has long been associated with the increase in 5 -reductase 
activity in the liver, a rate limiting enzyme for the metabolism of T in the liver thus enhancing the 
catabolism of T (Rubin et al., 1976). 
In alcoholics, FSH, LH, and E2 levels were signiﬁcantly increased, and T and progesterone 
levels were signiﬁcantly decreased (Muthusami and Chinnaswamy, 2005). No signiﬁcant 
change was noted in prolactin levels. Semen volume, sperm count, motility, and number of 
morphologically normal sperm were signiﬁcantly decreased. Chronic effect appears to have an 
effect on the hypothalamic-pituitary-gonadal axis by inhibiting testicular steroidogenesis, as well 
as by blocking the release of LH and its releasing hormone. 
Acute intoxication in men can cause a temporary decrease in serum T (Frias et al., 2000, Frias 
et al., 2002, Karila et al., 1996). Since T decreases, LH values were expected to increase due to 
the negative feedback mechanism. However, this did not occur, which shows a defect in the 
human hypothalamic-pituitary-gonadal unit (Cicero, 1982).  
Acute alcohol intoxication in healthy premenopausal women (0.4 – 0.5 g/kg) shows a rise in 
plasma T, a decline in AD, an increase in the T/AD urinary ratio and a decrease in urinary 
androsterone and  etiocholanolone (T’s main catabolic metabolites) (Sarkola et al., 2001). Other 
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studies corroborate this (Karila et al., 1996, Frias et al., 2000). Regarding urinary T/E, acute 
alcohol intoxication significantly increases this ratio (Falk et al., 1988, Karila et al., 1996, 
Seppenwoolde-Waasdorp et al., 1996, Geyer et al., 1996, Mareck-Engelke et al., 1996). 
More details of acute alcohol intoxication and testosterone may be found in the following 
section. 
 
1.8 Why are we interested in the influences of alcohol on T? 
The effects of acute alcohol intoxication on the endocrinology, metabolism and excretion of T in 
the male is being investigated as the result of several reported findings of T/E increase after 
alcohol intake (Falk et al., 1988, Karila et al., 1996, Seppenwoolde-Waasdorp et al., 1996, 
Geyer et al., 1996, Mareck-Engelke et al., 1996), the most recent one being a sports tribunal 
where the defendant argued that his high urinary T/E ratio was caused by the fact that he had 
been drinking the night before. A summary of these results may be found in Table 1.7 at the end 
of this section, after a more detailed analysis on the published data. 
In 1988, an anti-doping laboratory in Sweden found a positive result for testosterone, and the 
athlete justified it with previous alcohol ingestion. A study was performed by giving two different 
doses of alcohol to 4 healthy male volunteers over a 4 h period in the morning (Falk et al., 
1988). The first dose, acting as a pilot study, at 0.8 g per kilogram body weight (g/kg) had a 
negligible effect on the T/E ratio. The second dose at 2 g/kg showed an increase in T/E ratio in 
urine from 1.14 to 1.52 within 14 h, with one subject showing an increase of 90%.  Samples 
were collected at 0 h, 6 h, 14 h and 22 h. The authors speculated that the “increased 
NADH/NAD
+
 ratio obtained in connection with the metabolism of ethanol may reflect a block in 
oxido-reductive formation of androstenedione from endogenous testosterone.  Because the 
increased NADH/NAD
+
 ratio is likely to displace the equilibrium between testosterone and 
androstenedione towards testosterone, the concentration of testosterone may increase”.  
In 1996, more studies were performed by different research groups.  
One analysed serum T concentration and urinary T/E ratio in 4 healthy females and 4 healthy 
males (Karila et al., 1996). Volunteers were first administered 1.2 g/kg of EtOH in the morning, 
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for 4 h, provoking a 25% increase in serum T in females and a 7% increase in males compared 
to the baseline value. Their T/E ratio did not show an increase (T/E = 1.2 for males and T/E = 
2.5 for females). More interesting results came from a higher dose. The volunteers were 
administered with 2 g/kg, and within 5 h the serum T concentration in women had increased by 
25% (9.25 pM to 11.34 pM) but no significant change was noticed in men (2.93 pM to 2.95 pM), 
which the authors justify by the low number of volunteers (four) and high testosterone variation. 
As for urinary testosterone concentrations, these showed a 200 % increase in females and 25% 
in males. Urinary T/E ratio increased 500 % in women (0.7 to 4.4) but decreased in males (1.69 
to 1.3). Serum concentrations of T in females are lower than in males, which makes a distinct 
difference even with small changes. This is supported by the fact that alcohol may change both 
the synthesis and metabolism of testosterone, since it stimulates steroid production by a direct 
mechanism in the weaker adrenal androgens which can then be converted to T by peripheral 
metabolism. 
In another study, 1 g/kg was administered to 6 females and 6 males during 3 h (Seppenwoolde-
Waasdorp et al., 1996). Urine was collected 1 day before the experiment took place, and then at 
timed intervals for 3 days. The time collection points are not described in the publication and it is 
hard to retrieve that information from the graphs presented. There was a significant increase in 
T/E in all subjects with females showing a 200 % increase from the pre-administration value 
(1.1 to 3.4), whereas the males had  50 % increase (0.8 to 1.2). In males, the increase in T/E 
was always followed by an increase in the concentration of excreted T, with either a decrease or 
slight increase in excreted E. In females, the increase in urinary T/E was not always followed by 
a consistent change on T and/or E. 
The research group in the WADA accredited anti-doping laboratory in Germany (Cologne) 
investigated urinary T/E ratio in 1 male volunteer after ingestion of 2 g/kg, and there was 300 %  
increase (0.8 to 3.3) after 10.5 h of ingestion (Geyer et al., 1996). 
The same group performed another study, with 5 females and 5 males (Mareck-Engelke et al., 
1996). The initial experiment design was to administer 2 g/kg over a 4 h period in the morning. 
However, perhaps due to the early start, only 2 volunteers managed to drink the specified 
amount with the rest vomiting. Therefore, for these volunteers the amount of alcohol was 
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between 1.4 – 1.9 g/kg. Urine samples were collected every 4 h the day before the experiment 
took place; then after alcohol intake every 2 h up to 10 h; and finally every 4 h the day after the 
experiment. Average T/E values of females and males were compared in samples taken the 
day before the experiment, 8 h after alcohol administration and the day after. All the samples 
showed a highly significant increase due to alcohol with males increasing by 100 % (1.2 to 2.4) 
and females approximately 600 % (0.98 to 6.7). 
Although there was an increase in urinary T/E in almost all volunteers, only females with a dose 
of 2 g/kg showed a urinary T/E > 4.  The production of T differs in men and women, with men 
having  the majority of T synthesised in the testes, women’s T production comprises of ovarian 
and adrenal contributions (approximately 25 % each), and 50 % from peripheral interconversion 
from AD. It is also thought that, since women have less serum T than men any perturbance in 
that system will cause an increase in T.   
All the above experiments were undertaken by administering a known amount of alcohol 
(maximum 2 g/kg) in a limited time. Although this is the best a researcher can do to mimic a 
social drinking session, it is possible to drink more than what the volunteers had in a longer 
period of time. Suffice to think of a Friday night pub-outing with your friends or work colleagues, 
where one could easily drink more than the volunteers were given, and for a longer period of 
time. Perhaps if one had ethical permission to do such study, changes in T/E ratio would be 
higher, or detectable in urine for a longer period of time. 
A summary of the urinary T/E mean values found in the literature described above may be 
found in Table 1.7. 
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Female Male Before After Before After 
(Falk et al., 1988) 





NA NA NA 
1 1.13 13 
2 g/kg 4 1.14 1.52 33 
(Karila et al., 1996) 
1.2 g/kg 4 4 2.6 2.5 -4 1.69 1.3 -23 
2 g/kg 4 4 0.7 4.4 529 1.2 1.2 0 
(Seppenwoolde-Waasdorp et al., 1996) 1 g/kg 6 6 1.1 3.4 209 0.8 1.9 138 
(Geyer et al., 1996) 1.2 g/kg NA 1 NA NA NA 0.8 3.3 313 
(Mareck-Engelke et al., 1996) 1.4 – 1.9 g/kg 5 5 0.98 6.7 583 1.2 2.4 100 
                                                     
6
 NA stands for ‘not available’ 
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At the turn of the century, more studies were performed regarding the analysis of serum T in 
females and males. 
In 2000, a study with teenagers (13-17 years old) arriving at the emergency department 
suffering from acute alcohol intoxication (AAI) was undertaken (0.8 g/L of EtOH) (Frias et al., 
2000). Blood samples were collected between midnight and 3 a.m for both volunteers with AAI 
and for the control group (alcohol free). These samples showed increased serum T 
concentration in females contrasting with males, which showed a decrease when compared to 
the control group. This was believed to be due to the decrease of testicular T production 
through modifications of the NADH/NAD
+
 ratio, and also the increase in -endorphin which can 
decrease the testicular T production through their autocrine and paracrine effects on the testes. 
Similar results were obtained when the same type of study was perfomed in young adults 
between 20 – 27 years old (Frias et al., 2002). 
In 2001, an analysis of premenopausal women (21 on oral contraceptives and 10 not) 
administered with 0.4 – 0.5 g/kg showed an significant increase in serum T, with levels 
increasing 300 % (Sarkola et al., 2001). Blood samples were collected hourly up to 7 h after 
alcohol ingestion, and a urine sample was taken 4 h after. The acute testosterone increase was 
more prominent in the women on oral contraceptives. Serum T concentration may be affected 
by changes in its synthesis in the adrenals and ovaries, by peripheral conversion from blood AD 
and DHEA or by a change in the catabolism in the liver. Since the increase of serum T was 
followed by a decrease in AD, and an increase in urinary AD and etiocholanolone, the authors 
postulate that the increase in serum T is due to alcohol’s effect on the liver’s metabolism of T. 
The rise in NADH to NAD
+
 after alcohol intake may suppress the activities of the enzyme 
responsible for T’s catabolism into AD. 
A similar study by the same authors was undertaken in male volunteers after an intake of 
0.5 g/kg (Sarkola and Eriksson, 2003). Similarly to what happens with women, serum T 
increases 19 % while AD decreases 22 %. 
In 2006, 256 grams of alcohol was administered to healthy male volunteers for a period of 26 h 
starting with 20 g and then 10 g/h (Danel et al., 2006). Serum T levels were found to be 
significantly higher when compared to controls, with an increase of 26% (13.4 – 17 mmol/L), 
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and cortisol levels remained the same contrary to other findings following acute alcohol 
intoxication (Waltman et al., 1993). The authors present two hypotheses for the cortisol findings. 
The first is that the blood alcohol concentration (BAC) obtained was not enough to stimulate the 
HPA axis, hence there was no increase in cortisol. The second is that continuous administration 
over a 24 h period desensitises the HPA at the time it should be active. With the latter 
hypothesis, two different mechanisms need to be taken into account: the sensitivity to ethanol of 
the HPA, also having a circadian variation; and the repeated exposure to alcohol, which will 
induce tolerance. Therefore, the continuous administration of alcohol during the day may have 
desensitised the HPA, impeding the normal reactivation of the axis. Regarding serum T 
increased levels, it contrasts with previous studies where serum T decreased after acute alcohol 
intoxication (Frias et al., 2000, Frias et al., 2002). The authors postulate that such differences 
may have come with the different collection points since they collected blood samples every 2 h 
over 26 h, and in the other studies the collections were done between midnight and 3 am 
without taking into account nocturnal serum T levels. 
A summary of the serum T concentrations mentioned previously may be found in Table 1.8. 
Serum T concentrations were performed by immunoassay. 
A positive percentage increase is the increase over the total amount, and a negative percentage 
increase is a decrease over the total amount. 
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Female Male Before After Before After 
(Karila et al., 1996) 
1.2 g/kg 4 4 0.3 0.4 25 5.3 5.7 7 
2 g/kg 4 4 0.2 0.3 54 5.2 4.6 -11 
(Frias et al., 2000) 0.8 g/L 16 11 0.45 2.21 391 4.7 3.7 -22 








(Sarkola and Eriksson, 2003) 0.5 g/kg NA 13 NA NA NA 3.9 4.6 19 
(Danel et al., 2006) 
256 g 
NA 11 NA NA NA 3.9 4.9 26 
(0.5 – 0.7 g/L) 
                                                     
7
 Premenopausal women on oral contraceptive 
8
 Premenopausal women not on oral contraceptive 
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1.9 Hypotheses  
There is some concern in the sports anti-doping community as to the extent which ethanol 
ingestion affects the androgen balance and perturbs the T/E ratio (Falk et al., 1988, Karila et al., 
1996, Frias et al., 2002).  
This research project attempts to verify if: 
1. Alcohol in serum can reach a concentration sufficient to displace T from its binding 
proteins such that serum T is raised, resulting in an  increase in urinary T excretion and 
a raised urinary T/E ratio (protein binding – Chapter 2) 
2. Two different doses of alcohol ingested within an hour in separate occasions will 
influence urinary T/E in females and males (excretion – Chapter 3) 
3. Any increase in urinary T concentration is due to an increase in LH (production – 
Chapter 4) 
4. Alcohol suppresses catabolism of T by enzyme inhibition, e.g. 17 -HSD2 (metabolism – 
Chapter 5) 
5. Alcohol has an effect on hepatic metabolism of T (clearance – Chapter 6) 
For the first hypothesis, an in vitro study with serum samples collected from volunteers was 
performed. For the remaining hypotheses, 20 volunteers were recruited (10 females and 10 
males) and adminstered 4 and 8 units of alcohol in 1 h period, in two separate occasions. For 
the last hypotheses, this was done by investigating the effects of alcohol administration to 
hypogonadal men (do not produce T) receiving testosterone replacement therapy. This may 
help to clarify the effect of the liver to any transient increase in serum testosterone, as there 
should be a negligible contribution from testicular production. 
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2.1 Introduction 
This chapter will verify in-vitro, if alcohol in serum can reach a concentration sufficient to 
displace T from its binding proteins such that serum T is raised, resulting in an  increase in 
urinary T excretion and a raised urinary T/E ratio. 
As mentioned in Chapter 1, section 1.5, in the blood stream, testosterone binds non-covalently 
to SHBG, albumin and to a much less extent to CBG (Wheeler, 1995). To summarise, of the 
circulating T in adult eugonadal men, approximately 45% is bound to SHBG, 50% to albumin 
and the other 5% circulates as free (Karagiannis and Harsoulis, 2005, Dunn et al., 1981). In 
eugonadal women, 66 % is bound to SHBG, 30 % to albumin and 4 % unbound. Testosterone 









respectively) but of lower capacity when compared to albumin due to the fact that the latter 
accounts for 60 % of the proteins present in plasma. 
SHBG saturates when T reaches a concentration in the order of 10
-5
 M (Dunn et al., 1981) 
above which, the proportion of T binding to albumin can continue to rise. The percent of 
unbound T remains approximately the same since it would be necessary that albumin’s binding 
sites would be saturated before there is an increase in free T (fT)  (10
-3
M) (Dunn et al., 1981). 
 
2.1.1 Alcohol and SHBG 
One of the first studies that investigated the effect of ethanol on SHBG consisted in a group of 
five male patients, maintained under an adequate nutritional program, which included three 
social drinkers and two alcoholics that had been abstinent for a week; and a second group of six 
male non-alcoholic patients (Gordon et al., 1976a). To both groups, an alcohol dose of 3 g/kg of 
body weight was administered for approximately a month.  
Acute administration of alcohol (1-5 days) restrained episodic bursts of T, which caused an 
overall fall in the circulating T concentration. The plasma LH concentration did not decrease, 
indicating no suppression of secretion of this gonadotropin due to the decrease of episodic 
secretion of T in the first five days of alcohol administration, which may be linked with direct 
gonadal effect of alcohol. Prolonged administration (12-24 days) further reduced the mean 
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plasma concentration of T. Alcohol consumption also altered the peripheral metabolism of T, 
noticeable through the MCR increase. This might have been due to the decreased plasma 
binding capacity for T showed in this study in the non-alcoholic volunteers, as opposed to the 
increased concentration found in cirrhotic patients, and to the increased hepatic T A-ring 
reductase activity, which is likely to increase its hepatic extraction.  
Abstinence studies in alcoholic male patients that had consumed at least 72 g/alcohol/day for 
the past five years (most had consumed 100-200 g/daily for 10-40 years) and were tested for T, 
fT, E2, DHT and SHBG showed normal values for T and DHT, E2 and fT were above normal in 
50% of the patients and SHBG was high in 60% of the cases with no distinction between 
cirrhotic and non-cirrhotic patients. (Lindholm et al., 1978).  
Plasma steroid concentrations in 30 abstinent male alcoholic patients without liver failure have 
been reported with an alcohol intake of 150 g/day for the past 2 years uninterrupted for the 
month prior to the trial was investigated (Iturriaga et al., 1995). Although none suffered from 
liver failure, 9 had normal liver, 14 moderate alterations and 7 showed marked liver alterations. 
Testosterone, E2, FSH, LH and SHBG were measured on admission and discharge. Alcoholic 
patients showed normal T values regardless of the presence of liver damage, but the 
concentrations of SHBG were remarkably raised in all alcoholic patients. SHBG values 
decreased after a short abstinence period without ever reaching normal values.  
Low concentrations of T have been found in alcoholic cirrhotic patients (Bannister et al., 1987) 
and in cirrhotic patients (Gordon et al., 1975, Luppa et al., 2006) with the latter showing high 
concentrations of SHBG as well as E2, the raised estrogen stimulating SHBG production. 
In 21 non-cirrhotic male alcoholic patients (150 g/day for the past 2 years  uninterrupted during 
the month previous to the trial) that had to remain abstinent for 12 weeks, measurement of the 
total plasma T concentrations were below the lower reference limit at admission but being within 
the reference range by day 10 (Iturriaga et al., 1999). The low concentration of fT and high 
concentration of LH are indicative of hypoandrogenism (deficiency of androgens in the body). 
Free T was low at admission reaching normal concentration by day 10, and correlating 
negatively with SHBG, which showed a 3-fold increase and still remained above the controls, 
slowly decreasing after abstinence. There is also a relative dissociation between SHBG and T, 
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since the values for fT remained the same even though SHBG concentration increased. Due to 
the high levels of SHBG provoked by alcohol intake it is possible that it might be used as a 
marker of excessive alcohol intake. 
 
2.1.2 Determination of free T and total T 
Equilibrium dialysis was the first method to be used in the determination of fT in serum 
(Sandberg and Slaunwhite, 1957) and will be described in more detail in the next section. 
In this experiment, the authors used a portion of the radioactive testosterone (C
14
), diluted it with 
a saline solution, put it in a cellulose casing (dialysis bag of semipermeable membrane) and 
equilibrated for 72 h. Small molecules, such as fT pass through the membrane from the bag into 
the buffer. Larger molecules and protein-bound ones are retained inside the bag. Solutions on 
both sides were extracted, hydrolysed and analysed. The percentage of unbound steroid was 
7% for undiluted plasma, 9% if it was diluted 1:4 and 62% if diluted 1:40.  
The same approach for an in vitro study was performed, by diluting with saline (1:5) a plasma 
sample with a known T concentration (Vermeulen et al., 1971). The sample was then dialysed 
for 15h at 37°C under shaking. The mixture was placed in 10 mL of saline with a tracer amount 
of tritiated T (
3
H-T) in the presence of merthiolate used as a preservative. After reaching 
equilibrium, 0.5 mL of the portions were taken from the solutions inside and outside the dialysis 
tubing. The extracted portions were redissolved in 10 mL of scintillation fluid and the 
radioactivity determined in a liquid scintillation counter. The scintillation fluid converts that the 
radioactive energy to light which is detected by the  - scintillation counter thus measuring the 
ionizing radiation. 
Other studies have estimated fT, and total T using the same type of technique (Vermeulen et 
al., 1999, Vermeulen et al., 1971, Vermeulen, 1973, Fritz et al., 2008). The total T concentration 
is calculated by analysing the dialysate, and fT by analysing the retentate. 
The downsides of this type of experiments are the long equilibrium period, the fact that a high 
number of samples cannot be performed simultaneously,the dilution factor and the usage of 
knots or clamps in the dialysis bags which could loosen resulting in a leak, the extraction 
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process and working with radioactive substances which can be a health hazard (Wheeler, 
1995). 
Measurement of fT and total T by equilibrium dialysis can be time consuming but it is the most 
physiologically representative method and the most exact for estimating these concentrations. 
Care must be taken so that impurities do not bind to SHBG thus the labelled tracer T used must 
be highly purified hence the use of diluted serum samples as a precaution to avoid this situation 
(Vermeulen et al., 1999). 
Recently, similar equilibrium dialysis investigations have been undertaken analysing the 
compounds using LC-MS/MS rather than immunoassay (Ji et al., 2005, Wan and Rehngren, 
2006).  
 
2.1.3 Equilibrium dialysis 
Equilibrium dialysis is a  separation technique for the study of molecular interactions. The 
results obtained in equilibrium conditions make it possible to study the low affinity interactions 
that would probably not be detected otherwise (Bioscience, 2002).  
Its principle is to establish a state of equilibrium between serum containing a drug and a drug-
free buffer (200-300 times the volume of the sample), after an incubation period at a set 
temperature. The chambers containing serum and buffer are separated by a semipermeable 
membrane with the appropriate molecular weight cut-off such that it will retain the receptor 
component of the sample which is what will bind the ligand (Thermo Scientific, 2008, Kwon, 
2001).   
The water molecules in the buffer (dialysate) are small enough to pass through the membrane 
and will diffuse into the serum chamber (retentate) because of the difference in osmotic 
pressure. This is called ‘volume shift’ and comprises of an increase in serum volume and a 
decrease in buffer volume. Please see the figure below for an illustrative description (Kwon, 
2001). 
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Figure 2.1 Equilibrium dialysis schematic. The analyte molecules (filled circles) not bound to 
proteins (empty circles) pass through the semipermeable membrane due to the osmotic pressure 
of the plasma containing the analyte. The volume changes from the buffer to the plasma side whilst 
reaching an equilibrium between the two chambers (Kwon, 2001)  
 
In this project, initial experiments were performed using a dialysis cassette, Slide-A-Lyzer ,  
(Figure 2.2), which required 2 mL of serum.  Another dialysis device in the shape of a tube, 
Float-A-Lyzer , which required 1 mL of serum and less buffer volume thus decreasing serum 
dilution, was found in the market (Figure 2.3). No increase in sample volume was noticed with 
the Float-A-Lyzer , so there was no need to adjust concentrations. Although the membrane in 
both devices is a very low protein binding membrane (regenerated cellulose in Slide-A-Lyzer  
and cellulose ester in the Float-A-Lyzer ), the cylindrical geometry in the Float-A-Lyzer  is 
possibly the key factor to preventing sample dilution. 
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Figure 2.2 Dialysis cassette in a 400 mL 
beaker (Slide-A-Lyzer
®




Figure 2.3 Dialysis tube in a 100 mL beaker 
(Float-A-Lyzer
®
, by Spectrum Labs)
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The disadvantages of this technique are the length of time it takes the serum to reach 
equilibrium (18 h in previous published work (Fritz et al., 2008)), the need of a large volume of 
buffer and non specific binding to the membrane device.   
A rapid equilibrium dialysis device (RED), by Thermo Scientific is now available and offers the 
possibility of reduced preparation and equilibration time. This device is based on a Teflon base 
plate holding up to 48 dialysis cells. Each cell consists of two side-by-side chambers separated 
by a vertical cylinder of dialysis membrane with a high membrane surface area-to-volume ratio 
(Cook et al., 2006, Waters et al., 2008). In the study by Cook et al., the authors placed plasma 
containing T in one of the chamber and added the buffer to the other chamber. To determine 
non-specific binding a buffer sample containing the drug was added to both chambers and then 
incubated at 37° C under shaking at 100 rpm for 4 h. An aliquot was removed from each 
chamber and equal amounts of fresh plasma and buffer were added to respective incubated 
aliquots. Both mixtures (plasma and buffer) were precipitated with an organic/aqueous solution 
with 0.1% formic acid containing an internal standard mixture. After mixing and centrifugation, 
the supernant was transferred to a vial for LC-MS analysis. 
Although this device solves the problem of the small number of samples that can undergo 
equilibrium dialysis in one day, it is also very expensive since the kit would cost a few hundred 
pounds. Each RED kit takes up to 48 samples, and with the number of experiments to be 
performed in this study (approximately 25) these costs were not considered justifiable. 
 
2.1.4 Ultrafiltration 
Another approach to test T’s displacement involved ultrafiltration (Figure 2.4 and Figure 2.5) of a 
serum sample, and the analysis of the retentate and filtrate. 
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Figure 2.4 Ultrafiltration with semi-permeable 
membrane inside 
 
Figure 2.5 Semi-permeable membrane (left) 
and ultrafiltration tube (right) 
 
This technique is not an equilibrium and relies on the rapid separation of the free and bound 
fraction of a protein through centrifugation. It is similar to equilibrium dialysis in using a semi-
permeable membrane to separate small molecules (free fraction) from large ones (protein 
bound) (Wheeler, 1995). Choosing an appropriate separation membrane allows the unbound 
fraction (fT) of low molecular weight to be separated (filtrate) from the protein-bound fraction 
(retentate). In our case, the separation membrane had a 30,000 molecular weight cut-off, since 
SHBG’s molecular weight was 115,000, albumin’s was 60,000, and CBG’s was 50,000 Da. 
With ultrafiltration, separation of the free and bound T can be performed much more rapidly, and 
it also avoids the problem of dialysis where T is naturally released from albumin as the system 
tends towards equilibrium. 
However, ultrafiltration suffers from possible sources of error, including adsorption to the 
ultrafiltration device and protein leakage through the filter, which can cause misleading high 
concentrations of the apparent free fraction measured for strongly bound compounds (Eriksson 
et al., 2005), the volume of the filtrate may not be enough for the assay, constriction of 
membrane pores and the Donnan ion effect (Kwon, 2001). 
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2.1.5 Immunoassay 
An immunoassay measures the concentration of a substance by means of an antibody/antigen 
complex. The antigen is normally the substance to be measured, and the antibody is generated 
by injecting the immunogen (in this case testosterone conjugated to a large protein such as 
albumin) into a host animal (usually a sheep or rabbit), stimulating the generation of the specific 
antibody which is then collected and used in the immunoassay. 
There are two types of immunoassay: non-competitive and competitive, the latter being the one 
used for the detection of total T in serum. In the competitive fluoroimmunoassay described in the 
Materials and methods section of this chapter, there is competition between europium-labelled T 
and the sample T for anti-T antibodies. This is a specific type of assay called DELFIA (Delayed 
Enhanced Lanthanide Fluoroimmunoassay). The samples containing T inhibit the binding of the 
europium-labelled T to the antibody molecules. There is a blocking agent in the T assay buffer, 
which will facilitate the release of T from binding proteins in the sample; and a second antibody 
coated to the solid phase, which will bind the IgG-testosterone complex separating the antibody-
bound and the free antigen. An enhancement solution will dissociate the europium ions from the 
labelled T into solution, forming fluorescent chelates which will then be measured. The 
fluorescence of each sample is inversely proportional to the concentration of T in the sample. 
 
2.1.6 Gas-Chromatography Mass-Spectrometry 
Chromatography is an analytical technique that separates the components of a mixture from 
each other.  
Gas chromatography (GC) separates volatile compounds based on their relative partitioning 
between a stationary and mobile phase. In GC the mobile phase is an inert gas, and the 
stationary phase  is coated onto the inside of a narrow capillary tube with an internal diameter of 
less than 1 millimetre (mm).  
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Since GC requires the analytes to be volatile it may be necessary to derivatise them. This 
involves a chemical reaction to turn the less volatile groups into more volatile ones. 
The flow of the mobile phase or carrier gas (normally helium) is controlled by pressure 
regulators into a sample injection inlet heated to a temperature high enough to vaporise the 
compounds to be analysed at a defined temperature (Karasek and Clement, 1988). The GC 
column is attached to the injection port and the samples are introduced with a syringe through a 
flexible septum in the injection port at a temperature that is high enough to vaporise all the 
compounds. Sample introduction in capillary columns can be a delicate procedure because the 
open cross section of the capillary is very narrow, and the sample volume should be small so as 
not to overload the column. To prevent this type of situations, a split/splitless injector can be 
used  (Rubinson and Rubinson, 2000c). Samples at a low concentration are injected in splitless 
mode and travel through the column with the carrier gas. In split mode, the carrier gas flows 
continuously through the inlet at a faster rate than the gas that flows through the column. The 
excess gas is vented and only a portion of the sample carries on to the column. 
The most common ionisation modes in GC-MS are electron and chemical ionisation. 
Chemical ionisation produces ions with little excess energy, producing a spectrum that is not so 
fragmented. It produces those ions by collision of the molecule with primary ions that are 
present in the source (Hoffmann and Stroobant, 2002a).  
In electron ionisation, the ions are bombarded with a high-energy beam and producing more 
fragmented ions, so the molecular ion may not always be observed (Hoffmann and Stroobant, 
2002a, Christian, 2004a). 
The mass spectrometer (MS), is attached to the column exit (Figure 2.6) and monitors the 
sample components that elute from the column.  
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Figure 2.6 GC-MS schematic diagram 
 
Mass-spectrometry is a powerful analytical tool used in the analysis of complex mixtures. Mass 
spectrometry analyses compounds in their gas-phase ions, for example by electron ionisation. 
Since most analytes are neutral, this is accomplished normally by bombarding the sample with 
high-energy electrons in an electron-ionisation source. The molecular ion undergoes 
fragmentation forming the product ions, which in turn may undergo fragmentation. 
All the ions are separated according to their mass to charge ratio (m/z) and their detection 
proportional to their abundance (Hoffmann and Stroobant, 2002b). The fragments of a 
compound can thus tell us the structure of their precursor ion. 
The mass-spectrometer used in the research was a quadrupole mass filter. The quadrupole 
consists of four rod shaped electrodes (Figure 2.7). 
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Figure 2.7 Quadropole mass filter (Bull, 2008) 
 
A combination of alternating current (AC) and direct current (DC) fields filters the required ions 
by a m/z ratio using electric-field effects. A beam of ions passes through the middle of the rods, 
and since the voltage going through the rods is constant, separation of the different m/z ions is 
done because a radiofrequency AC is superimposed on the DC potential. Before the ions collide 
with the rod, the AC field drives them away in a complex oscillating path unique to each m/z 
ratio exiting through to the detector (Rubinson and Rubinson, 2000a). 
 
2.1.7 Study untertaken 
This chapter describes an in vitro study using serum spiked with alcohol, and monitoring the 
displacement of fT. Alcohol experiments’ initial concentration was 350 mg% to mimic a sports 
case in which the athlete with a high urinary T/E had that blood alcohol concentration, estimated 
based on uncorroborated statements of the total amount of alcohol that the athlete had drunk. 
Chapter 2: Displacement of testosterone from its binding proteins 
 
- 94 - 
 A competitive immunoassay technique was employed to ascertain the amount of total T present 
in the retentate before and after the equilibrium dialysis, and GC-MS to measure fT in the 
dialysate. 
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2.2 Materials and methods 
2.2.1 Materials 
T and E were obtained from Promochem (Teddington, UK). Potassium carbonate, sodium 
sulphate, sodium chloride, sodium hydrogenphosphate anhydrous, potassium phosphate 
(analytical grade), hydrochloric acid, diethyl ether and methanol (HPLC grade) were all obtained 
from Fisher Scientific (Loughborough, UK). Potassium chloride and ammonium iodide (both 
analytical grade) were obtained from BDH Chemicals (Leicestershire, UK). MSTFA (N-methyl-N-
trimethylsilyl-trifluoroacetamide) and bamethan sulphate were obtained from Sigma-Aldrich 
(Germany), and ethanethiol from Sigma-Aldrich (Poole, UK). The tri-deuterated internal 
standards of d3T, d3E, d35 -AD and d35 -DHT, all labeled at positions 16, 16, 17  except for AD 
which is at position 19, were supplied by the National Analytical Reference Laboratory (Sidney, 
Australia). Vacutainers™ were acquired from BD Diagnostics (Oxford, UK). The Amicon® Ultra-
4 centrifuge filter devices (4 mL) with a membrane of 30,000 MW were obtained from  Millipore 
and the bovine serum albumin (RIA grade) was obtained from Sigma-Aldrich (Steinheim, 
Germany). The Slide-A-Lyzer  dialysis cassette was obtained from Thermo Scientific 
(Leicestershire, UK) and the Float-A-Lyzer  G2 from Spectrum Labs (Breda, Netherlands). The 
immunoassay auto-DELFIA  Testosterone kits were obtained from PerkinElmer
®
 (Northwhich, 
UK), and the platewasher was a DELFIA  1296-026. 
 
2.2.2 Preparation of testosterone aqueous solution 
2.2.2.1 Combined internal standard mixture 
The laboratory’s internal standard solution containing d3T, amongst other deuterated 
compounds, was used.  
Individual stock solutions of d3T, d3E, d35 -AD and d35 -DHT at a concentration of  100  g/mL 
and bamethan at a concentration of 1 mg/mL were prepared in methanol. These were then 
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diluted in distilled water and methanol (50:50, v/v, in final solution) to make the combined 
internal standard mixture which contained the above compounds at the following concentrations: 
1 g/mL (d3T and d3E ), 2 g/mL (d35 -AD ), 0.5  g/mL (d35 -DHT) and  5 g/mL (bamethan). 
In a 2 mL solution, spiked with 100 L of  internal standard mixture, the concentrations would 
have been 50 ng/mL for d3T and d3E,  100 ng/mL (d35 -AD ), 25  ng/mL (d35 -DHT) and  
250 ng/mL (bamethan) 
A dilution (1:500) of the combined internal standard mixture was made to have d3T at 
0.10 ng/mL for the experiment involving aqueous T solution with SHBG. 
 
2.2.2.2 Testosterone stock solution 
Testosterone stock solutions were prepared in water:methanol 7:3, v/v, and then diluted to the 
required  concentrations with distilled water. 
The samples were labelled as JLV standing for the author’s initials, followed by a chronological 
number. 
 
2.2.2.3 Experimental design 
2.2.2.3.1 Testosterone aqueous solution at room temperature 
To determine the time it takes to achieve equilibrium, and in line with previous in vitro 
experiments analysing male serum (Sandberg and Slaunwhite, 1957), equilibrium dialysis 
experiments were initially performed with testosterone in aqueous solution, at room temperature, 
at three different concentrations: 22.5, 45 and 375 ng/mL. These concentrations were chosen in 
order to obtain 0.15 ng/mL, 0.3 ng/mL and 2.5 ng/mL in the dialysate. 
Each solution (2 mL) was placed inside an individual dialysis cassette, which in turn was put in 
300 mL of deionised water in a beaker and left under stirring at room temperature (RT), covered 
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with tin foil to minimise evaporation. Two mL was taken from the beaker every 2 h until 10 h for 
all the samples to determine the time it would take to reach equilibrium. The dialysate samples 
were extracted and analysed by GC-MS. 
 
2.2.2.3.2 Testosterone aqueous solution with alcohol at room temperature 
To check if the presence of alcohol affected the extraction procedure, 350 mg% of ethanol 
(44 µL) was added to 10 mL of a 4.5 ng/mL aqueous solution of testosterone (JLV074), left 
standing for 30 min at room temperature and  then extracted and analysed by GC-MS. 
 
2.2.2.3.3 Testosterone & SHBG aqueous solution with alcohol at room temperature 
Testosterone (2 mL) at a concentration of 7.5 ng/mL (SHBG saturates at this concentration) in 
aqueous solution along with 6.44 g of SHBG was placed inside a dialysis cassette, which was 
then put in 300 mL of deionised water and left under stirring at room temperature for 24 h 
(6.44 g would produce an SHBG concentration of 28 nM, which is the plasma concentration 
reported previously (Dunn et al., 1981)). After 24 h, 8.8 L of ethanol was added to the sample 
(giving 350 mg% of ethanol) which was then left under stirring for another 24 h, finally 10 mL of 
dialysate was taken, extracted and analysed under GC-MS (JLV076). 
 
2.2.2.4 Extraction procedure (2 mL extracts): 
For the extraction, 2 mL of water blank and four calibration standards (0.1, 0.2, 0.5 and 1 ng/mL) 
in water were placed in a 20 mL glass tube along with 20 L of internal standard (0.1 ng/mL of 
internal standard in 2 mL of solution). Potassium carbonate was added to each sample (100 mg) 
followed by 5 mL of diethyl ether prior to vortex mixing for 30 seconds, with the organic layer 
subsequently removed and placed into a 20 mL glass tube.  
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Anhydrous sodium sulphate was then added whilst vortexing and the sample allowed to stand 
for 2 min. The samples were then centrifuged at 100 g for 5 min before decanting off the organic 
phase into a 10 mL glass tube. The test tubes used for liquid/liquid extraction (now containing 
sodium sulphate) were rinsed with 2 mL of diethyl ether, which was then pooled with the 
previous fraction. The solvent was then evaporated to dryness under nitrogen at 30 °C ± 5 °C 
and the dried extracts placed a desiccator for at least 30 min. 
The test tubes were flushed with nitrogen and the steroid extracts converted to trimethyl silyl 
derivatives under forcing conditions to ensure that complete enol as well as ether derivatisation 
occurred, to achieve this MSTFA:NH4I:ethanethiol (20 L) was added. Samples were heated 
(60 °C ± 5 °C ) for 20 min, and then allowed to cool. Finally 20 L of dodecane was added and 
the samples vortexed before transfering into an autosampler vial and analysed by GC-MS. 
 
2.2.2.5 Extraction procedure (10 mL extracts) 
The free concentration of testosterone in serum is less than 2.5 ng/mL (assuming normal T 
concentration in males as ~7 ng/mL, then fT would be ~0.14 ng/mL). In the experiments with 
serum,the volume of dialysate taken was changed to 10 mL rather than 2 mL to increase the 
amount of analyte analysed. The volume of internal standard was also increased five times 
(100 L). 
For the extraction, 2 mL of water blank and four calibration standards (0.1, 0.2, 0.5 and 1 ng/mL) 
were extracted as above (section 2.2.2.4) for quantification. To 10 mL of dialysate, 100 L of 
internal standard was added. 
Potassium carbonate was then added to each 10 mL sample (300 mg). Liquid/liquid extraction 
was performed with 5 mL of diethyl ether, which was added prior to vortex mixing for 30 seconds 
with the organic layer subsequently removed into a 20 mL glass tube. This extraction was then 
repeated a further two times with the organic layer being pooled. 
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The solvent was then evaporated to dryness under nitrogen at 30 °C ±5 °C and  put into the 
desiccator for at least 30 min and the samples were derivatised and analysed by GC-MS. 
 
2.2.2.6 GC-MS conditions 
Methods validated by the Drug Control Centre for urinalysis were used, but the urine replaced 
by water. The GC column was HP-1 (methylsiloxane) (25 m, 0.2 mm, 0.11 m) from Agilent, 
used for both methods. For the calibrants the laboratory method ‘TETCAL’ was used, consisting 
of an initial oven temperature of 180 °C for 1 min, ramping at 8 °C/min until it reached 220 °C, 
and then 3 °C/min to 244°C. The total run time was 14 min. 
For the samples, the method ‘TETSAMP’ with an initial oven temperature of 180 °C for 1 min, 
ramping at 8 °C/min to 220 °C, then 3°C/min to 250 °C, and then 14°C/min to 280 °C held for 
5 min. The total run time was 23.14 min. 
The method was run in selective ion monitoring (SIM) mode and the ions monitored were 
432.3/435.3 for T/d3T. The ion source used was electron ionization and T’s retention time was 
13.1 ± 0.15 min.. 
 
2.2.2.7 Immunoassay serum analysis 
The DELFIA  Testosterone immunoassay kit was used following the instructions protocol 
provided with the kit. This assay has been validated by the manufacturer according to the Food 
and Drug Administration regulation, and the analytical sensitivity was determined to be better 
than 0.09 ng/mL. 
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2.2.3 Volunteer study and sample collection 
Ethical approval was sought from the King’s College London Ethics Committee and given for the 
collection of 10 mL of blood (2 teaspoons) from male volunteers from a suitable arm vein. 
Recruitment was done via King’s College London (KCL) mailing list. The blood collection was 
performed by a trained phlebotomist and took between 5-10 minutes. 
To maintain anonymity of the volunteers, a numeric code was given to each volunteer’s sample. 
The samples were coded and kept in a restricted access freezer within the Drug Control Centre 
(DCC), an evidential laboratory, which itself has restricted access. Only the study’s investigators 
had access to the volunteers’s details and the consent forms were kept in a box inside a locker. 
 
2.2.4 Experimental design with serum using equilibrium dialysis 
2.2.4.1 Sample preparation 
Each sample of blood was collected in 8 mL Vacutainers™ and then left to clot for 30 minutes 
(min), after which it was centrifuged at 1000 g for 10 min. The supernatant (serum) was 
transferred into a polypropylene tube and stored at -20 C, until needed, at which point rapid 
thawing was performed employing a water bath at 37 C. 
2.2.4.1.1 Serum testosterone equilibrium at room temperature 
A volume of 2 mL of serum was placed inside a dialysis cassette, which was then immersed in 
300 mL of phosphate buffer saline (PBS) at a pH of 7.4 (Sambrook, 1989) and left under stirring 
for 24 h at room temperature. The PBS solution was prepared to yield the concentrations of 
sodium chloride at 137 mM, potassium chloride at 2.7 mM, potassium phosphate at 2 mM and 
sodium hydrogenphosphate anhydrous at 10 mM. The serum was removed from the dialysis 
cassette and analysed by immunoassay (IA) (JLV113). 
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2.2.4.1.2 Serum testosterone with alcohol at room temperature 
A volume of 2 mL of serum was placed inside a dialysis cassette which was then immersed in 
300 mL of PBS with a pH of 7.4 (same as serum) and left under stirring for 24 h at room 
temperature. After that time, 8.8 L (350 mg%) of ethanol was added to the sample and 1.33 mL 
to the PBS and left under stirring for another 24 h after which the serum was removed and 
analysed by IA (JLV083).  
 
2.2.4.1.3 Total testosterone measurement by immunoassay 
Using a DELFIA Testosterone kit it was necessary to reconstitute the standards, the tracer and 
the antiserum by leaving them to dissolve for 30 min in 1.7 mL of distilled water. The tracer and 
antiserum were then diluted according to the manufacturer’s instructions. The necessary strips 
were washed once in the DELFIA platewash with a wash solution containing tris-HCl buffered 
salt (pH 7.8) with Tween 20 and the standards and unknowns were added (25 L) to it followed 
by the tracer and antiserum solutions (100 L). The strips were left incubating (slow shaking) for 
2 h at room temperature and afterwards washed four times with the wash solution. The 
enhancement solution (200 L) provided with the kit was added and the strips were left for 5 min 





2.2.4.1.4 Serum & alcohol immunoassay 
To verify if the presence of alcohol had any influence in the serum immunoassay, 5 L of EtOH 
(approximately 350 mg%) were added to 1 mL of serum (JLV097) and analysed by 
immunoassay against the control (JLV 084). 
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2.2.4.1.5 Subsequent experimental changes 
To assess the influence of some of the major experimental variables the following changes were 
made to the previously described experimental procedure with serum: 
1. Temperature raised to 37 °C rather than room temperature (JLV130)  
2. Double the amount of ethanol (JLV107) 
3. Variation in the volume of buffer from 300 to 250 mL (JLV105) 
4. Variation in dialysis device by using a tube dialysis (Float-A-Lyzer) instead of cassette:  1 mL 
of serum in 54 mL of buffer (1:54 dilution rather than 1:150) (JLV104), at room temperature 
5. Variation in dialysis device, (Float-A-Lyzer) and temperature at 37 °C (JLV158) 
 
2.2.5 Experimental design with serum using ultrafiltration 
Serum samples were obtained as detailed in 2.2.3. 
Four aliquots of 1 mL each were put into 2 mL plastic tubes. The first sample was used as a 
control (JLV145). Ethanol was added to the remaining samples in the following concentrations: 
350 mg% (JLV146), 700 mg% (JLV147) and 1400 mg% (JLV148). The four samples were then 
placed on a rotatory mixer, for 2 h 30 min in a 37°C incubator. Each sample was put into an 
ultracentrifugation device and centrifuged in a swinging bucket rotor at 4000 g. 
The ultracentrifugation devices were rinsed  with a 10 % BSA/PBS solution, and 50 L of a 1 % 
BSA/PBS solution was placed at the bottom of each tube to prevent nonspecific binding to the 
walls of the tube or to the ultrafiltration membrane. The tubes were weighed before and after the 
sample was put in, and by assuming the serum density to be 1 g/mL, the volume of filtrate and 
retentate could be determined. 
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The retentate was then reconstituted in PBS so as not to be as concentrated and both retentate, 
filtrate and control were analysed by immunoassay for T. 
 
2.2.6 Intra-assay precision 
For the intra-assay variability experiment, six aliquots (2 mL) of dialysate were pipetted out of 
each beaker (section 2.2.2.3.1), extracted and analysed by GC-MS (Appendix 8.2). 
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2.3 Results and discussion 
2.3.1 Lower limit of quantification 
The lower limit of quantification (LLOQ) was defined as the concentration at which the signal to 
noise ratio (S/N) was 10:1 in aqueous solution. For T, the LLOQ was 0.1 ng/mL (Figure 2.8). 
 
Figure 2.8 Lower limit of detection for testosterone at 0.1 ng/mL 
 
2.3.2 Testosterone aqueous solution  
2.3.2.1 Intra-assay precision  
Equilibrium dialysis was performed using three different concentrations of testosterone in 
aqueous solution to ascertain the equilibrium time, and to verify if the concentration had any 
influence on the equilibration time (Table 2.1).  
Table 2.1 Initial & expected concentrations for equilibrium dialysis (initial retentate volume = 2 mL, 
dialysate volume = 300 mL) 
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In order  to be able to better interpret the equilibrium time course data, a separate experiment to 
assess assay variability was conducted and the data obtained shown below. 
The data are labelled using the prefix JLV for each sample, and results are shown in Table 2.2, 
Table 2.3 and Table 2.4. These numbers are assigned in chronological order but for clarity the 
results of the intra-assay variability experiment are presented before those of the equilibrium 
dialysis data. 
 
Table 2.2 Intra-assay 
variability for an  expected 












RSD (%) 9.8 
  
Table 2.3 Intra-assay 
variability for an expected 












RSD (%) 5.9 
 
Table 2.4 Intra-assay 
variability for an expected 












RSD (%) 3.9 
The intra-assay variability was found to be less than 10 %.  
Regarding the time course experiment using initial retentate T concentrations of 22.5, 40 and 
375 ng/mL, dialysate samples (2 mL) were taken every 2 h starting at 0 h until 10 h and 
analysed by GC-MS (Appendix 8.3). Results are shown in Table 2.5, Table 2.6 and Table 2.7. 
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Table 2.5 Time course of equilibrium dialysis. 
Initial retentate T concentration = 22.5 ng/mL. 
Expected dialysate T concentration 0.15 
ng/mL  




JLV 010 0 0.01 
JLV 011 2 0.08 
JLV 012 4 0.09 
JLV 013 6 0.09 
JLV 014 8 0.08 
JLV 015 10 0.1 
 
Table 2.6 Time course of equilibrium dialysis. 
Initial retentate T concentration = 40 ng/mL. 
Expected dialysate T concentration 0.30 
ng/mL  




JLV 016 0 0 
JLV 017 2 0.25 
JLV 018 4 0.34 
JLV 019 6 0.28 
JLV 020 8 0.30 
JLV 021 10 0.29 
Table 2.7 Time course of equilibrium dialysis. 
Initial retentate T concentration = 375 ng/mL. 
Expected dialysate T concentration 2.50 
ng/mL 




JLV 022 0 0.03 
JLV 023 2 1.91 
JLV 024 4 1.89 
JLV 025 6 1.94 
JLV 026 8 1.90 
JLV 027 10 1.97 
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For the experiment where the final dialysate T concentration should reach 0.15 ng/mL, at 10 h, 
67 % of this expected concentration had been reached, notwithstanding experimental variability 
for the sample (Table 2.5, measured dialysate T = 0.1 ng/mL) which is to be expected given that 
most of the concentrations were less than the assay’s LLOQ of 0.1 ng/mL. 
In the experiment where the final dialysate T concentration should reach 0.30 ng/mL, at 2 h, 
83 % of this expected concentration had been reached. Thus the same percentage (67 %) as in 
the previous experiment, where the dialysate T concentration should reach 0.15 ng/mL, must 
have been reached before 2 h rather than 10 h. At 10 h, 97 % of the expected T dialysate 
concentration was obtained (Table 2.6). 
In the experiment where the final dialysate T concentration should reach 2.5 ng/mL, at 2 h, 76 % 
had been reached and at 10 h, 79%. 
Graphs were plotted (Figure 2.9, Figure 2.10 and Figure 2.11) using the data from Table 2.5, 
Table 2.6 and Table 2.7, describing the expected asymptotic behaviour, and ± 2 standard 
deviation (SD) plotted in the graph to indicate which concentration changes could be considered 
due to the dialysis rather than assay variability. 
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Figure 2.9 T concentration against time 
(expected maximum of 0.15 ng/mL) with ±2 
SD 
 
Figure 2.10 T concentration against time 




Figure 2.11 T concentration against time 
(expected maximum 2.5 ng/mL) with ±2 SD 
 
Equilibrium was reached at 2 h for an expected dialysate T concentration of 0.15 and 
0.30 ng/mL, and at 4 h for an expected dialysate T concentration of 2.5 ng/mL. This shows that 
equilibrium of fT in an aqueous solution is fairly rapid and does not appear to be concentration 
dependent. 
However, because this experiment was performed with fT in an aqueous solution as the 
retentate, it was not possible to be sure if serum T would behave in the same way with 
equilibration being achieved within 2 h, or even 4 h. 
The next logical step would have been to investigate the time course equilibrium with serum, by 
analysing the dialysate, in order to check if the rate of displacement of T from binding proteins 
was of the same time order as the fT in the aqueous solution. However, the lack of sensitivity of 
the assay made this impossible (since the serum T concentration would be in the order of only 
7 ng/mL giving a dialysate concentration of 0.046 ng/mL).  Furthermore since fT comprises 1 % 
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multiple analysis of the serum retentate would not have been possible due to sample handling. 
The dialysis cassette is not designed for repeated sampling since it has a fragile membrane that 
is easily torn. 
Previous published work used an equilibration time of 18h, therefore, from a practical point of 
view, we thought that 24 h would be a sufficient time for serum T binding to reach equilibrium 
(Fritz et al., 2008). 
 
2.3.2.2 Testosterone aqueous solution with alcohol at room temperature 
The calibration plot analysis by GC-MS (Appendix 8.4) of the extract containing 4.5 ng/mL of T 
and 350 mg% of EtOH showed that the extract had 4.52 ng/mL T (JLV074), therefore showing 
that EtOH does not affect the extraction procedure. 
 
2.3.2.3 Testosterone & SHBG aqueous solution at room temperature 
The apparent concentration obtained for JLV076 was of 0.03 ng/mL (Appendix 8.5) when it was 
expected to be 0.0005 ng/mL. However, the LLOQ of the GC-MS methods is 0.1 ng/mL so the 
apparent difference between the obtained and the theoretical concentrations is probably simply 
due to analytical error. In fact, the internal standard (d3T) contains about 0.3 % of T. Since a d3T 
concentration of 0.1 ng/mL was used, this would contribute 0.0003 ng/mL of T, i.e. 60 % of the 
expected concentration, which was not corrected in the calibration. Another possible reason for 
this increased measured T is that the SHBG was not given enough time to equilibrate with the T 
present in solution, and therefore may have diffused before binding to SHBG took place. 
Since the same is applicable to T in serum, the dialysate was not analysed by GC-MS in the 
experiments that followed. The theoretical calculations follow: 
If we assume a total T concentration in serum of 22.5 nmol/L (6.5 ng/mL) the maximum 
concentration in 300 mL, so that the concentration in 2 mL is the same as in the 300 mL, will be 
0.31 nmol/L (0.09 ng/mL). 
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Another pertinent question would be, is the fT in the smaller compartment (2 mL) more or less 
than 0.09 ng/mL? If it is less, then it will not be dissociated from that protein. This can be 
calculated theoretically as follows: 
T bound to albumin: 
[Albumin] = 0.56 mmol/L (33.6 mg/mL) 





Ka = ([albumin] x [T]) / [bound-T] 
Free T is estimated to be 1 % and hence total T is approximately the same as bound T at 
22.5 nmol/L (6.5 ng/mL22.5 nmol/L). Since about 50 % (Dunn et al., 1981) is bound to albumin 
at a concentration of 11.25 nmol/L (3.2 ng/mL), the maximum of bound T that could be 
dissociated from albumin is 0.57 nmol/L (0.16 ng/mL). 
T bound to SHBG: 
[SHBG] = 28 nM = 3.22 x 10
-6
 g/mL = 3220 ng/mL 





Ka = ([SHBG] x [T]) / [bound-T] 
Assuming the same as above, total T will be about the same as bound T, and approximately 
44 % (Dunn et al., 1981) is bound to SHBG accounting for 10 nM (2.9 ng/mL), the T 
concentration that will be displaced form SHBG is 0.22 nmol/L (0.06 ng/mL). 
These calculations also show us that it is not very likely that T is dissociated from SHBG by 
equilibrium dialysis but that the T found will probably come from the natural dissociation of T 
from albumin that equilibrates between the two compartments on either side of the dialysis 
membrane with time. Nevertheless, it was considered necessary to confirm these deductions 
experimentally. 
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2.3.3 Serum testosterone experiments using equilibrium dialysis 
2.3.3.1 Serum testosterone equilibrium at room temperature 
Using 24 h as the time for an aqueous T solution to equilibrate in the cassette with no protein 
binding, an experiment with serum was necessary to verify how much T was displaced (and 
equilibrated) from the retentate to the dialysate. Since the concentration of fT in the dialysate 
would be too small to be determined by GC-MS, the retentate only was analysed by 
immunoassay and compared to a control. 
The immunoassay results for the control (JLV101) were 20.2 nmol/L (5.8 ng/mL), and for the 
sample (JLV113) 11.8 nmol/L (3.4 ng/mL) (Appendix 8.6). However, the final volume was not 2 
mL but had increased 2.9 mL, due to diffusion of buffer into the dialysis cell, so after adjusting 
the concentration to 2 mL it would have 17.1 nmol/L (4.9 ng/mL), meaning that there was a 15 
% displacement of T from the retentate to the dialysate (Table 2.8). 
As described in section 2.2.4.1.4, a 1 mL serum sample was spiked with 5 L of EtOH to verify 
if it had any influence in the immunoassay. The control (JLV084) was 13.4 nmol/L (3.9 ng/mL) 
and the sample (JLV097) was 13.1 nmol/L (3.8 ng/mL), therefore we can conclude that EtOH 
does not affect the immunoassay analysis. 
 
2.3.3.2 Serum testosterone with 350 mg% alcohol at room temperature 
After 24 h of dialysis, and immediately before the addition of 350 mg% of EtOH, a small sample 
(~70 L) of serum was taken from the dialysis cassette. Both the 24 h dialysed serum (JLV091) 
and the serum taken from the dialysis cassette 24 h after the addition of alcohol were measured 
(JLV096) and compared against its control (JLV090). The final volume of sample taken from the 
dialysis cassette was 2.8 mL. 
The concentration of T for JLV091 was 9.1 nmol/L (2.6 ng/mL) and for JLV096 was 6.5 nmol/L 
(1.9 ng/mL) (Appendix 8.7). Adjusting both concentrations to a 2 mL sample serum, one would 
have 12.7 nmol/L (3.7 ng/mL) for the serum sample before the addition of EtOH, and 9.1 nmol/L 
(2.6 ng/mL) after the addition (assuming the final volume of 2.8 mL at 48 h was the same as at 
24 h). The control was at a concentration of 19.7 nmol/L (5.7 ng/mL) therefore there was a 35 % 
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displacement from the retentate to the dialysate, before the addition of EtOH and a 54 % 
displacement after its addition (Table 2.8). It was not possible to be sure if this displacement 
was due to the addition of EtOH causing a displacement of T (~ 50%), or if it was the natural 
occurring displacement from albumin. To verify this, further experiments were performed. 
 
2.3.3.3 Serum testosterone with 350 mg% alcohol at 37 °C 
The same experiment as above was repeated, but using a 37 °C incubator and a positive 
control. The serum to which EtOH was added (350 mg%) was JLV130, and the positive control 
JLV129. After 48 h both samples were analysed by immunoassay and compared to the 
negative control (JLV116). The negative control had a concentration of 19.7 nmol/L (5.7 ng/mL), 
the positive control 3.8 nmol/L (1.1 ng/mL) and the sample to which EtOH had been added was 
3.7 nmol/L (1.1 ng/mL) (Appendix 8.8). The final volume of the positive control was 3.9 mL and 
for the sample 3.2 mL. Therefore the adjusted total T concentrations were 7.4 nmol/L 
(2.1 ng/mL) for JLV129 (62 % displacement), and 5.9 nmol/L (1.7 ng/mL) (70 % displacement) 
(Table 2.8). Since the displacement of the sample to which EtOH was added is not much 
greater than the positive control’s displacement, it does not seem likely that the displacement of 
T from binding proteins is due to alcohol. However, this displacement is higher than the 
approximately 50 % expected from the natural displacement that occurs from albumin. Alcohol 
does not have an effect on the displacement, but temperature does affect the affinity constant 
and/or the equilibrium time.  
 
2.3.3.4 Serum testosterone with alcohol 700 mg% at room temperature 
In order to verify if an increase in EtOH would force the displacement of T from its binding 
proteins, the same type of experiment was performed at room temperature but at the end of 
24 h, 700 mg% of EtOH were added instead of the usual 350 %mg (Appendix 8.9). The 
negative control was JLV101 with a concentration of 20.2 nmol/L (5.8 ng/mL) (Appendix 8.8), 
and the serum sample JLV107 with a total T concentration of 7.2 nmol/L (2.1 ng/mL) (Appendix 
8.8). The final volume of the serum sample was 3.1 mL and the adjusted concentration 
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11.2 nmol/L (3.2 ng/mL), showing a displacement in T of 45% (Table 2.8), hence the increase in 
alcohol does not have an influence in the displacement of T from its binding proteins. 
 
2.3.3.5 Serum testosterone in a 250 mL volume of buffer with 350 mg% of EtOH at room 
temperature 
Using a smaller beaker, the same experiment was performed but with 250 mL of PBS rather 
than 300 mL, and with an EtOH concentration of 350 mg% being added at the end of 24 h. 
The negative control (JLV101) had a concentration of 20.2 nmol/L (5.8 ng/mL) (Appendix 8.10), 
and the sample (JLV105) was 6.5 nmol/L (1.9 ng/mL). The final volume of the sample was 
found to be 3.1 mL and therefore the adjusted total T concentration for 2 mL was 10.1 nmol/L 
(2.9 ng/mL), which implies a displacement of 50 % (Table 2.8). There isn’t a significant 
difference between using 250 mL buffer and 300 mL (section 2.3.3.2). 
 
2.3.3.6 Serum testosterone in tube dialysis at room temperature with 350 mg% of EtOH 
After the above experiments were performed, the Float-A-Lyzer device became available, a 
device where the dialysate volume should remain constant, and the same type of experiment 
was performed but using 1 mL of serum in 54 mL of buffer. The control (JLV101) had a 
concentration of 20.1 nmol/L (5.8 ng/mL) and the sample (JLV106) was 12.3 nmol/L (3.5 ng/mL) 
(Appendix 8.11). The displacement of T from its binding proteins was 40 % (Table 2.8) showing 
no significant difference between this dialysis device at room temperature and the dialysis 
cassette (section 2.3.3.2). 
 
2.3.3.7 Serum testosterone in tube dialysis at 37 °C with 350 mg% of EtOH 
The same experiment as above was performed at 37 °C with a positive control. The negative 
control (JLV118) had a concentration of 20.1 nmol/L (5.8 ng/mL). After 48 h the positive control 
(JLV157) was 4.1 nmol/L (1.2 ng/mL), and the sample (JLV158) 4.0 nmol/L (1.2 ng/mL) 
(Appendix 8.12). There was no need to adjust the concentration to the initial volume since the 
Chapter 2: Displacement of testosterone from its binding proteins 
 
- 114 - 
final volume was approximately the same as the initial one. The displacement of the positive to 
the negative control, and from the sample to the negative control was 80 % (Table 2.8). 
It was observed that this device allows a better retention of the sample volume, thus not being 
necessary to adjust the concentrations to the final volume in the dialysis device. Comparing this 
experiment with the previous one (section 2.3.3.6) performed at room temperature there was a 
higher displacement, but when comparing the positive control with the sample, alcohol does not 
appear to influence the displacement. 
When comparing the displacement values from this experiment and its analogue with the 
dialysis cassette (section 2.3.3.3) we can verify that both had a similar type of displacement 
(80 % and 70 % respectively). This is also true for the same experiments at room temperature. 
The tube dialysis experiment at room temperature (section 2.3.3.6) showed a displacement of 
40 % and the dialysis cassette one a displacement of 54%.  
According to these results, temperature does have an influence in the displacement of T from its 
binding proteins but it is still not possible to know if this displacement is due to the influence of 
temperature on the affinity constant of the binding proteins, or on the equilibrium time. 
 
2.3.3.8 Summary of equilibrium dialysis and immunoassay results 
The results for the equilibrium dialysis involving the above experiments (2.3.3.1 to 2.3.3.7) can 
be found in Table 2.8. The (+) indicates the positive control. 
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Table 2.8 Summary of results from serum equilibrium dialysis experiments 
Experiment type IA (negative control)  IA (sample)  
V of sample 
(mL)  
Adjusted [T] 
to 2 mL  
% of displacement between sample & 
control 
24h equilibrium 
JLV101 = 20.2 nmol/L 
(5.8 ng/mL) 






Serum + 350 mg % 
EtOH at RT 
JLV090 = 19.7 nmol/L 
(5.7 ng/mL) 
JLV091 = 9.1 nmol/L 
(2.6 ng/mL) 2.8 
12.7 nmol/L 
(3.7 ng/mL) 35 
  
JLV096 = 6.5 nmol/L 
(1.9 ng/mL)   
9.1 nmol/L 
(2.6 ng/mL) 54 
Serum + 350 mg % 
EtOH at 37°C 
JLV116 = 19.7 nmol/L 
(5.7 ng/mL) 
(+) JLV129 = 3.8 nmol/L 
(1.1 ng/mL) 3.9 
7.4 nmol/L 
(2.1 ng/mL) 62 
  
JLV130 = 3.7 nmol/L 
(1.1 ng/mL) 3.2 
5.9 nmol/L 
(1.7 ng/mL) 70 
Serum + 700 mg % 
EtOH at RT 
JLV101 = 20.2 nmol/L 
(5.8 ng/mL) 






250 mL buffer + 
350 mg % EtOH 
JLV101 = 20.2 nmol/L 
(5.8 ng/mL) 







JLV101 = 20.2 nmol/L 
(5.8 ng/mL) 
JLV106 = 12.3 nmol/L 
(3.5 ng/mL) 
1  - 40 
Tube dialysis at 
37°C 
JLV118 = 20.1 nmol/L 
(5.8 ng/mL) 
(+) JLV157 = 4.1 nmol/L 
(1.2 ng/mL) 1   80 
  
JLV 158 = 4.0 nmol/L 
(1.2 ng/mL) 1   80 
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2.3.4 Ultrafiltration results 
As mentioned in the introduction of this chapter, ultrafiltration is a similar method to equilibrium 
dialysis, and it was used as a confirmatory method to our research.  
The percentage of displacement is minimal, possibly representing fT in serum thus showing that 
EtOH does not displace T from its binding proteins. 
The results can be found in Table 2.9 and Appendix 8.13. 
 
Table 2.9 Summary from serum samples using ultrafiltration 
IA (control)  
Experiment 
type 










JLV149 = 9.7 nmol/L 
(2.8 ng/mL) 







350 mg % 
JLV151 = 10.9 
nmol/L (3.1 ng/mL) 







700 mg % 
JLV153 = 10.5 
nmol/L (3.0 ng/mL) 







1400 mg % 
JLV155 = 10.2 
nmol/L (2.9 ng/mL) 




Chapter 2: Displacement of testosterone from its binding proteins 
 
- 117 - 
2.3.5 Conclusions 
The work developed was to verify if an acute intoxication of EtOH, performed in vitro, was 
enough to displace T from its binding proteins in order to increase the concentration of 
circulating fT. 
Although dissociation was verified through equilibrium dialysis, it was not enough to prove this 
hypothesis. In the experiments at room temperature, and with variations in the amounts of 
EtOH, there was a dissociation of approximately 50 %, which corresponds to the fraction 
released from albumin that would naturally occur through diffusion after that period of time due 
to the weaker binding affinity T has with that protein. 
In the cases where the percentage of displacement was high (37 °C experiments), there was 
however no significant difference between the positive control and the sample to which EtOH 
had been added. 
The fact that T is not displaced from its binding proteins due to alcohol was also supported with 
the ultrafiltration experiments, where no displacement was observed. 
The hypothesis that, alcohol in serum could reach a concentration sufficient to displace T from 
its binding proteins such that T is more rapidly cleared than normal, and thereby increase T in 
urine and hence T/E ratio, was therefore disproved. 
In the next chapter, we will verify if two different doses of alcohol ingested within an hour will 
influence urinary T/E in females and males, with all the samples being analysed by GC-MS. 
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3.1 Introduction 
This chapter will describe the effect of rapid drinking of alcohol on the urinary T/E in women and 
men. 
In this chapter urinary T/E, based on peak height ratios was calculated, and the concentrations 
of T, E and 5 DHT (a product of T biosynthesis) in urine determined after 4 and 8 units of 
alcohol ingestion in 1 h, in females and in males. For that, a sufficiently sensitive validated GC-
MS method was employed. This analytical technique has already been described in detail in 
Chapter 2. 
In the UK 1 unit of alcohol is the equivalent to 10 mL. In the case of spirits which are 40 % 
alcohol by volume (ABV), 1 unit corresponds to 25 mL. 
Exogenous testosterone is the most common finding in anti-doping laboratories. The urinary 
excretion of T and E is approximately equal as shown by Donike et al. with 50 healthy men 
(non-steroid users) having a T/E of 1.13 ± 0.57 SD (range 0.12-4.44) and 47 normal females 
having a T/E at 1.29 ± 0.89 SD (range 0.26-2.90) (Donike et al., 1983); and also reported by 
Van Renterghem et al. in an athlete population, 2,027 male samples showing a mean value for 
T/E of 1.64 (0.95-2.06 inter-quartile range, and 1,004 female samples having a mean of 1.14 
(0.72-1.38) (Van Renterghem et al., 2010)). The inter-quartile ranges were calculated as the 
data did not follow a Gaussian distribution.  
The method employed in the Drug Control Centre for the measurement of T/E in urine 
incorporates solid phase extraction (SPE), enzyme hydrolysis, liquid-liquid extraction and 
derivatisation by trimethylsilylation (Donike and Zimmermann, 1980, Kicman, 2010) followed by 
GC-MS with measurement of peak heights as an initial estimate. 
 
3.1.1 Choice of calibrants 
The chromatographic method chosen (Kicman et al., 1995) enabled the good separation of the 
steroids to be analysed.  
Chapter 3: Validation and sample analysis of a GC-MS method for urinary T, E and 5 -DHT 
 
- 120 - 
The upper population range for urinary testosterone and epitestosterone concentrations has been 
previously reported (Ayotte et al., 1996, Geyer et al., 1996) and may be found in  
Table 3.1. 
 






Testosterone 60 140 
Epitestosterone 40 110 
 
Since our purpose was to investigate increases in urinary T/E, and subsequent changes in T, E and 
5 -DHT urinary concentrations, the 97.5
th
 percentile from the published work by Van Renterghem 
et al. will be presented in the table below ( 
Table 3.2) and discussed in section 3.3 (Van Renterghem et al., 2010). The authors analysed 
samples from Caucasian males (n=2,027) and Caucasian females (n=1,004). Quartile 1 of the 
population is represented by Q1, and quartile 3 by Q3. 
 
Table 3.2 Comparison between females and males in monitored relevant steroids in a sports 
population 




Females 0.72 1.14 1.38 2.65 
Males 0.95 1.64 2.06 4.33 
Testosterone  
Females 7 12 14 29.4 
Males 21 29 35 103 
Epitestosterone 
Females 7 13 17 28.5 
Males 15 29 35 88.9 
5 -DHT 
Females 6 9 12 20.5 
Males 5 7 9 21.5 
 
A check of the calibration range required was made by analysis of some 33 routine samples 
(Table 3.3). 
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Table 3.3 Estimated concentration in routine samples (ng/mL) 
Steroid Lowest concentration Mean concentration Highest concentration 
Testosterone 4 40 211 
Epitestosterone 3 31 103 
5 -DHT 2 15 35 
 
Men and women excrete androgens, predominately as conjugated steroids, at different 
concentrations. Eleven calibrants were, therefore, chosen that would cover both ranges. Five 
calibrants covered a low range (females) and five a high range (males) with a sixth calibrant as 
an overlapping point (Table 3.4). 
 
Table 3.4 Calibrants selected (ng/mL) 
Steroid 1 2 3 4 5 6 7 8 9 10 11 
Testosterone 1 2 5 10 15 25 50 75 100 125 160 
Epitestosterone 1 2 5 10 15 25 50 75 100 125 160 
5 -DHT 1 2 4 8 12 16 20 25 30 35 40 
 
 
3.1.2 Method validation 
The method was validated against accepted criteria by the International Conference of 
Harmonisation (CPMP/ICH/281 & 381 guidelines) for linearity, specificity, lower limit of 
quantification (LLOQ), accuracy and precision. 
Linearity is determined using a standard curve with a minimum of six points that will define the 
assay range between the LLOQ and the higher limit of quantification (HLOQ). Its linear 
regression should have a correlation coefficient (r
2
) > 0.99 and the accuracy of the mean of any 
calibration point should be < 15 % at any calibration point, and < 20 % at the LLOQ. 
Specificity was assessed by testing at least 6 different batches of control biological matrix for 
the presence of chromatographic interferants, which could affect the assay performance. 
The LLOQ is the smallest concentration of analyte that the instrument can measure for which 
the S/N is 1:10, and where the concentrations replicates in sextuplicates have a CV < 20 %. 
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Accuracy is the difference between the measured concentration and the nominal one. This 
needs to be ± 15% of nominal concentration and is determined both within assay and between 
assays. 
Precision is the level of agreement between a set of measurements and needs to be < 10 %. It 
is measured in a single assay (repeatability) and also between assays (reproducibility). 
 
3.1.3 Study design 
The units of alcohol administered to our volunteers had to be enough to provoke inebriation but 
below toxicity levels.  
Assuming normal body composition, for a male weighing 70 kilograms (kg) drinking 4 units of 
alcohol, the blood alcohol concentration would be 0.45 g/kg of body weight (according to the 
Widmark Factor), or 67 mg/100 mL of blood, which is below the drink driving limit (80 mg/100 
mL of blood). For 8 units the blood alcohol concentration would be 0.9 g/kg of body weight or 
134 mg/100 mL, which is 1.7 times the drink driving limit. 
For a female, assuming normal body composition, and a weight of 60 kg, the blood alcohol 
concentration for 4 units would be 0.53 g/kg of body weight, or 96 mg/100 mL of blood which is 
1.2 times the drink driving limit. For 8 units, the results would be 1.06 g/kg of body weight or 
192 mg/100 mL of blood, which is 2.4 times the drink driving limit. 
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3.2 Material and methods 
3.2.1 Materials 
T, E, 5 -DHT were obtained from Promochem (Teddington, UK). Potassium carbonate, sodium 
sulphate, potassium dihydrogen orthophosphate, anyhydrous disodium hydrogen 
orthophospate, sodium chloride, sodium dihydrogen phosphate dehydrate, sodium hydroxide, 
hydrochloric acid, diethyl ether and methanol (HPLC grade) were all obtained from Fisher 
Scientific (Loughborough, UK). Ammonium iodide (both analytical grade) were obtained from 
BDH Chemicals (Leicestershire, UK). MSTFA was obtained from Sigma-Aldrich (Germany); and 
ethanethiol, urea, bovine albumin and creatinine from Sigma-Aldrich (Poole, UK). The 
deuterated internal standards d3T, d3E and d35 -DHT were supplied by the National Analytical 
Reference Laboratory (Sidney, Australia). Escherichia coli -glucuronidase (K-12) was obtained 
from Roche (Switzerland). Vacutainers™ and all the relevant blood paraphernalia were 
purchased from BD Diagnostics (Oxford, UK). 
 
3.2.2 Preparation of screen and calibrant standards 
3.2.2.1 Phosphate buffer 0.1 M, pH 6.2 
Potassium dihydrogen orthophosphate (11.3 g) and anhydrous disodium hydrogen 
orthophosphate (2.4 g) were added to 900 mL of purified water in a 1 L volumetric flask, and 
sonicated for 10 min. It was then made up to 1 L by adding purified water and transferred into a 
screw top container. The pH was checked (pH 6.2 ±0.1) and, if necessary, adjusted with glacial 
acetic acid (17.47 M) or sodium hydroxide solution (10 M), and stored in the fridge.  
 
3.2.2.2 Eschericia coli enzyme solution – hydrolysis solution 
To the 0.1 M phosphate buffer solution (3.2.2.1) 2 mL of E.coli -glucuronidase was added and 
then stored at +4ºC until needed. The acitivity of the enzyme as describe in its technical 
information sheet, is of 140 U/mg at 37 °C. This is defined when using 4-nitrophenyl- -D-
glucuronide as substrate (Roche Applied Science, 2012). 
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3.2.2.3 Combined internal standard mixture 
To prepare the stock solution the ampoules containing the internal standard of interest (d3T, d3E 
and d35 -DHT was broken and its contents (approximately 1 mg) dissolved in methanol and 
transferred into a 10 mL volumetric flask. The ampoule was washed with methanol 
approximately 10 times. The solutions were kept in the freezer at an indicated temperature        
-20 °C. The final concentration of each methanolic solution may be found in Appendix 8.14. To 
prepare the stock solution a dilution was made (Appendix 8.15). 
The volume corresponding to each deuterated steroid was approximately measured with a 
volumetric syringe and added to a 100 mL volumetric flask and made up in methanol. The 
solution was then transferred to a 200 mL bottle and 100 mL of purified water added to give the 
final internal standard working solution at concentrations of d3T and d3E at 25 ng/mL, and 
16 ng/mL of d35 -DHT. 
 
3.2.2.4 Derivatising reagent 
Ammonium iodide (100 mg) was weighed into a 20 mL round bottomed centrifuge tube and 
covered in foil. To this, MSTFA (5 mL) was added, and heated to 100 °C until the ammonium 
iodide had dissolved. After cooling, ethanethiol (300 L) was added and the tube flushed with 
nitrogen, sealed and mixed thoroughly. This gave a final stock solution of MSTFA:ammonium 
iodide:ethanethiol 100:2:6. 
The working solution was prepared by diluting the stock solution (4 mL) into a new bottle of 
MSTFA (25 g, 23.25 mL). This solution had a concentration of MSTFA:ammonium 
iodide:ethanethiol 1000:3:9. This was capped, mixed thoroughly and flushed with nitrogen 
before resealing. The mixture was then split into 2 mL amber glass vials, previously flushed with 
nitrogen, capped and kept in the fumehood. 
 
3.2.2.5 Synthetic urine 
The preparation of synthetic urine available in our laboratory was followed. Urea (36.5 g) was 
added to 1.5 L of purified water, and mixed until the crystals dissolved. Sodium chloride (15 g), 
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potassium chloride (9 g), sodium didhydrogen phosphate dihydrate (12.8 g) was also added to 
the solution and mixed until the solution was clear. Creatinine (4 g) and bovine serum albumin 
(100 mg) were added, the solution was thoroughly mixed and the pH adjusted to between 5 - 7 
with either hydrochloric acid 1 M, or sodium hydroxide 1 M. The specific gravity (SG) was 
measured and if it was higher than 1.020 ±0.002 the solution was diluted with purified water. 
 
3.2.2.6 Preparation of calibrants 
A stock solution of 1 mg/mL in methanol was prepared for all the compounds. Sub-stock 
solutions were prepared in synthetic urine at a concentration of 100 g/mL. A second sub-stock 
dilution was made from the 100 g/mL resulting in a working solution of 1 g/mL. The calibrants 
final concentration can be found in Table 3.4. 
 
3.2.2.7 Choice of quality controls 
Urine was collected from 17 members of the laboratory (2 females and 15 males) to be 
analysed for approximate steroid concentrations. Urine collections were made in Nalgene™ 
polypropylene bottles. 
 
3.2.3 Volunteer study and sample collection 
Ethical approval was sought and given by the National Research Ethics Committee in the 
United Kingdom, for the recruitment of 20 volunteers (10 females and 10 males) from whom we 
collected blood and urine after alcohol ingestion. 
The samples were labelled with an alphanumeric code, e.g. T F-4U- , where  is the number 
of the volunteer,  the letter indicating the type of sample (U for urine and S for serum), and  
the time of collection. 
The volunteers were aged between 18-35 years old (reflecting the typical age range of adult 
athletes) and were required to ingest 4 and 8 units of alcohol on two different occasions with a 
minimum of a two-week interval. The alcohol was in the form of vodka (40 %) – 1 unit equals to 
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8 grams of alcohol which equals 1 shot of 25 mL of vodka (40 % ABV), therefore 4 units of 
vodka would be slightly under half a glassful and 8 units slightly under a glassful – diluted in 300 
mL of tonic water or orange juice. 
On the screening day, which took place 1 week before the study, a physician assessed the 
volunteer's health and collected a blood sample (10 mL). The sample was sent for analysis of 
liver enzymes and blood coagulation factors. 
The volunteer also filled in a questionnaire providing information regarding their weight, height, 
ethnic origin (40 % of Asian population has a gene deletion and lacks the enzyme to metabolize 
acetaldehyde which is one of alcohol's metabolites and were therefore excluded from this 
study), if they were pregnant or using oral contraceptive, and which one (for females only), if 
they were taking any liver medication, if they had kidney failure, what were their drinking habits 
(how many units per week) and when was the last time they had drunk alcohol. The volunteers 
were asked to be alcohol-free for 3 days prior to sample donation, which is roughly the amount 
of time it takes until alcohol metabolites are not longer detectable. 
For the experiment day, the volunteers were asked once again to be alcohol-free for 3 days. 
The administration of alcohol to the subjects (5 people per group) was performed at lunch time 
(12 a.m.) accompanied by a light lunch (sandwiches), in the study suite at King’s College 
London, Waterloo campus. The participants were asked to have a light breakfast (non-cooked) 
on the morning of the study. 
The volunteers were cannulated by the physician at the beginning of the experiment prior to 
alcohol consumption for up to 6 h.  
The volunteers were asked to ingest their alcoholic drink over a 1 h period and were asked to 
drink 125 mL of water every hour for the first 7 hours post completion of administration to 
ensure the same water intake in all the participants. 
A 20 mL blood sample was taken prior to alcohol ingestion and hourly until 6 h, then singularly 
at 24 h and 48 h after alcohol intake. 
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Urine samples were collected prior to administration and every hour until 7 hour, then at 10 h, 
24 h, 48 h and 72 h. Urine and serum samples were stored at -20 °C prior to analysis.  
A breath test was performed before the volunteers were allowed to leave the facilities, to ensure 
that their breath alcohol concentration was below the drink driving limit (35 g/dL). 
Serum was analysed by liquid-chromatography tandem mass-spectrometry (LC-MS/MS) to 
measure T, E, its glucuronides and sulfates, androstenedione, ethyl glucuronide and ethyl 
sulphate. Immunoassay was used to measure LH. 
The urine samples were analysed by GC-MS to measure the T/E ratio, concentration of T, E 
and 5 -DHT, and by LC-MS/MS to measure EtG and  EtS. 
Alcohol measurements in serum were performed by Mr. Peter Streete from the Medical 
Toxicology Laboratory, GSTS Pathology, in St. Thomas’ Hospital. 
All the calibrants and samples were plotted using a linear weighted regression calibration using 
MultiCalc  2000 software program from PerkinElmer . 
The statistical treatment was performed using the software Statistical Package for Social 
Sciences (SPSS ), version 18, from SPSS  Inc, Chicago, IL, USA. The results were statistically 
treated by using a general linear model with repeated measures and the significance limit was 
set to p-value <0.05. This statistical treatment tests for any changes, and whether or not they 
are statistically significant. From the statistical graphs and tables it is then possible to verify if 
any significant changes are an increase or a decrease.  
 
3.2.4 Analysis of samples 
3.2.4.1 Extraction procedure 
For the extraction, 2 mL of each sample was pippeted into a polypropylene tubes along with 
100 L of internal standard, mixed in a vortex mixer and centrifuged at 140 g for 5 min. Isolute 
C8 cartridges were conditioned with methanol (3 mL) and equilibrated with water (3 mL). Each 
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sample was loaded onto the cartridge and washed with water (3 mL). The sample was then 
eluted with methanol (3 mL) and dried at 60° C ±5 °C degrees under nitrogen gas. 
For the hydrolysis, 1 mL of E.coli solution was added to each tube and incubated for 1 h at 
50° C ±5 °C degrees. 
After the incubation, potassium carbonate was added to each sample (100 mg) followed by 
5 mL of diethyl ether prior to vortex mixing for 30 seconds, with the organic layer subsequently 
removed and placed into a 20 mL glass tube. Anhydrous sodium sulphate was then added 
whilst vortexing and the sample allowed to stand for 2 min. The samples were centrifuged at 
700 rpm (100 g) for 5 min before decanting off the organic phase into a 10 mL glass tube and 
rinsed with 2 mL of diethyl ether, which was then pooled with the previous fraction. The  solvent 
was evaporated to dryness at 30 °C ±5 °C under nitrogen gas and put into a desiccator 
containing sodium hydroxide pellets and phosphorous pentoxide for at least 30 min. 
The test tubes were then flushed with nitrogen and 20 L of silylating reagent 
(MSTFA:NH4I:ethanethiol 1000:3:9) was immediately added. Samples were heated at 
60 °C ±5 °C for 20 min, and then allowed to cool. Finally 20 L of dodecane was added and the 
samples vortexed before transfering into an autosampler vial and analysed by GC-MS. 
 
3.2.4.2 GC-MS conditions 
The GC column was HP-1 (methylsiloxane) (25 m, 0.2 mm, 0.11 m) from Agilent. An initial 
oven temperature of 180 °C was held for 1 min, ramping at 2 °C/min until it reached 228 °C, and 
then 35 °C/min to 300°C and held for 2.50 min. The total run time was 29.56 min. 
The injection volume was 1 L in splitless mode. 
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3.3 Results and discussion 
3.3.1 Method validation  
The LLOQ was measured using the calibrant standards prepared in synthetic urine, and the 
lowest calibrant was prepared at the LLOQ, where S/R was 10:1. For T, E and 5 -DHT this was 
1 ng/mL. 
Preparing the calibrant standards in synthetic urine was the method of choice due to it being 
steroid free. To test the suitability of this synthetic matrix a comparison was made between a 
urine sample containing approximately 5 ng/mL of T and 6 replicates were extracted, together 
with 6 replicates of a calibrant standard at the same concentration. A two sample F-test 
variance was performed (p >0.05) indicative that the variances are not significantly different at 
least at 5 ng/mL, therefore the synthetic urine was used as a matrix for the calibration 
standards. 
The quality controls were prepared in urine in sufficient amount to last for the 3-day validation 
and for the sample analysis to ensure that no error in precision came from the original QC 
solution. Since two ranges of calibrants were being used, two QCs for each range were chosen. 
The low QC was closer to the lower point of the respective range, and the high QC closer to the 
highest calibrant. The QCs were labelled LOW1 QC and HIGH1 QC for the lowest range, and 
LOW2 QC and HIGH2 QC for the highest range. 
From the 17 urine samples collected, only 2 females and 2 males had the urinary 
concentrations of the steroids of interest in the desired range and they were asked to provide 
approximately 1 L of urine during 1 day to prevent differences in steroid concentration. The 
preliminary concentration of each steroid of interest calculated was done again by using a peak 
height ratio with the internal standard. The concentrations can be found in Table 3.5. 
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Table 3.5 Preliminary check for QC urinary concentrations (ng/mL) 
Steroid Urine A Urine B Urine C Urine D 
Testosterone 0.33 3.0 35.2 53.3 
Epitestosterone 2.62 6.5 32.7 32.1 
5 -DHT 12.8 15.0 38.1 36.8 
 
The ideal concentration for a low QC would be for it to be within 25 % of the lower end of the 
calibrant range, and for the high QC to be between 75-100 % of the highest concentration in the 
calibrant range. An appropriate concentration for the QCs was thus chosen, and urines A, B and 
D spiked with methanolic solutions (no more than 1 % of total volume) with the steroids of 
interest. The prepared concentrations may be found in Table 3.6.  
 
Table 3.6 Expected concentration for each QC (ng/mL) 
Steroid LOW1 HIGH1 LOW2 HIGH 2 
Testosterone 3 20 32 127 
Epitestosterone 3 21 31 130 
5 -DHT 12 15 22 35 
 
Validation was performed by extracting each QC six times on three different days. The 
concentration of each QC was calculated by plotting it against a calibration curve with standards 
prepared fresh on the day. The parameters used were: 
Equation 3.1 Accuracy (within assay) 
 
(< ± 20 % LLOQ, < ± 15 % other points) 
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Equation 3.2 Average accuracy (between assay) 
 
(< ± 10 %) 
 
Equation 3.3 Repeatability 
 
(< 10 %) 
Equation 3.4 Reproducibility 
 
(< 10 %) 
 
Equation 3.5 Average precision (between assay) 
 
(< 10 %) 
 
 The QCs were monitored in every run and they were within the acceptance criteria (±2 SD).  
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Figure 3.1 Low and High QC for testosterone in the low range 
 
 
Figure 3.2 Low and High QC for epitestosterone in the low range 
 
 




T LOW QC (low range)
Mean concentration = 3.8 ng/mL ( 0.3)
T HIGH QC (low range)
Mean concentration = 23.1 ng/mL ( 1.6)
S
D
E LOW QC (low range)
Mean concentration = 3.9 ng/mL ( 0.3)
E HIGH QC (low range)





5 -DHT LOW QC (low range)
Mean concentration = 4.0 ng/mL ( 0.3)
5 -DHT HIGH QC (low range)





T LOW QC (low range) 
Mean concentration = 3.8 ng/mL (± 0.3) 
 
T HIGH QC (low range) 
Mean concentration = 23.1 ng/mL (± 1.6) 
 
E LOW QC (low range) 
Mean concentration = 3.9 ng/mL (± 0.3) 
 
E HIGH QC (low range) 
Mean concentration = 22.9 ng/mL (± 1.9) 
 
5 -DHT LOW QC (low range) 
Mean concentration = 4.0 ng/mL (± 0.3) 
 
5 -DHT HIGH QC (low range) 
Mean concentration = 13.8 ng/mL (± 0.6) 
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Figure 3.4 Low and High QC for testosterone in the high range 
 
 
Figure 3.5 Low and High QC for epitestosterone in the high range 
 
 
Figure 3.6 Low and High QC for 5 -DHT in the high range 
 
T LOW QC (high range)
Mean concentration = 32.8 ng/mL ( 3.5)
T HIGH QC (high range)





E LOW QC (high range)
Mean concentration = 36.7 ng/mL ( 4.3)
E HIGH QC (high range)





5a-DHT LOW QC (high range)
Mean concentration = 21.6 ng/mL ( 0.14)
5a-DHT HIGH QC (high range)





T LOW QC (high range) 
Mean concentration = 32.8 ng/mL (± 3.5) 
 
T HIGH QC (high range) 
Mean concentration = 114.9 ng/mL (± 14.8) 
 
E LOW QC (high range) 
Mean concentration = 36.7 ng/mL (± 4.3) 
 
E HIGH QC (high range) 
Mean concentration = 100.1 ng/mL (± 8.4) 
 
5 -DHT QC (high range) 
Mean concentration = 21.6 ng/mL (± 0.14) 
 
5 -DHT HIGH QC (high range) 
Mean concentration = 31.5 ng/mL (± 3.3) 
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3.3.2 Method validation for the quantification of urinary T 
3.3.2.1 Lower limit of quantification 
The LLOQ, as mentioned previously, is defined by a S/N of 1:10 between the analyte’s peak 
and the adjacent peak. The LLOQ for T was 1 ng/mL (Figure 3.7). 
 
Figure 3.7 Typical chromatogram obtained at a lower limit of quantification for T (1 ng/mL) 
 
3.3.2.2 Calibration range 
The lowest calibrant, at the LLOQ, had a percentage accuracy (within assay) <±20%, and the 
remaining calibrants <±15 %, passing the validation criteria. The linearity of the calibration plots 
(r
2
 value), for the 3 day validation of T, from 1 to 25 ng/mL was 0.9987, 0.9995 and 0.9977; and 
from 25 to 160 ng/mL were 0.9900, 0.9963 and 0.9980, respectively. 
 
Chapter 3: Validation and sample analysis of a GC-MS method for urinary T, E and 5 -DHT 
 
- 135 - 
3.3.2.3 Quality controls validation  
Table 3.7 Validation of urinary T for LOW1 and HIGH1 QCs (low range) 
 Day 1 Day 2 Day 3   Day 1 Day 2 Day 3 
LOW1 QC 3.1 3.6 3.5  HIGH1 QC 21.3 21.3 25.2 
(ng/mL) 3.6 3.3 5.0  (ng/mL) 20.6 22.5 23.4 
 3.3 3.4 3.5   16.8 21.8 25.8 
 3.4 3.3 3.9   20.0 23.6 21.8 
 3.1 3.7 3.6   21.5 22.9 24.4 
 3.4 3.9 3.9   20.9 22.7 24.4 
Mean 
(ng/mL) 
3.3 3.5 3.9  
Mean 
(ng/mL) 
20.2 22.5 24.2 
% Accuracy -10.3 -4.4 6.1  % Accuracy -4.0 6.9 15.1 
SD (ng/mL) 0.2 0.3 0.6  SD (ng/mL) 1.8 0.8 1.4 
% CV 5.7 7.1 14.6  % CV 8.7 3.6 5.9 
Table 3.8 Validation parameters for urinary T LOW1 QC and HIGH1 QC 
LOW1 QC  HIGH1 QC 
%Accuracy (between assay) -2.9  %Accuracy (between assay) 7.3 
%Precision (within assay) 9.1  %Precision (within assay) 3.1 
%Precision (between assay) 9.4  %Precision (between assay) 5.9 
 
Table 3.9 Validation of urinary T for LOW2 and HIGH2 QCs (high range) 
 Day 1 Day 2 Day 3   Day 1 Day 2 Day 3 
LOW2 QC  24.7 31.9 35.9   HIGH2 QC 93.0 109.3 101.0 
 (ng/mL) 27.6 29.8 33.0  (ng/mL)  92.1 105.9 114.6 
  24.8 29.8 33.4    99.8 103.8 117.6 
  27.9 32.0 31.7    99.6 105.7 103.2 
  25.3 31.7 30.7    99.5 108.0 111.9 
 27.2 32.4 30.9   100.9 105.1 102.9 
Mean 
(ng/mL) 
26.2 31.3 32.6  
Mean 
(ng/mL) 
97.5 106.3 108.5 
% Accuracy -15.4 0.8 5.1  % Accuracy -12.2 -4.2 -2.2 
SD (ng/mL) 1.5 1.2 2.0  SD (ng/mL) 3.9 2.0 7.0 
% CV 5.6 3.7 6.0  % CV 4.0 1.9 6.5 
 
 
Table 3.10 Validation parameters of urinary T for LOW2 QC and HIGH2 QC 
LOW2 QC  HIGH2 QC 
%Accuracy (between assay) -3.2  %Accuracy (between assay) -6.2 
%Precision (within assay) 5.1  %Precision (within assay) 4.1 
%Precision (between assay) 5.1  %Precision (between assay) 4.1 
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The QCs in the low range and in the high range passed the criteria so the method was 
successfully validated for T. 
 
3.3.3 Method validation for the quantification of urinary E 
3.3.3.1 Lower limit of quantification 
The LLOQ for E was 1 ng/mL, lowest calibrant, and can be found in Figure 3.8. 
 
Figure 3.8 Typical chromatogram obtained at a lower limit of quantification for E at 1 ng/mL 
 
3.3.3.2 Calibration range 
All calibrants were accurate <±15 %, and <±20 % at the LLOQ. The low range (1-25 ng/mL) was 
linear (r
2
 value) throughout the 3 days with values of 0.9938, 0.9994 and 0.9995. The high 
range’s r
2
 values were 0.9906, 0.9966 and 0.9956, for a concentration range of 25-160 ng/mL. 
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3.3.3.3 Quality control validation  
Table 3.11 Validation of urinary E for LOW1 and HIGH1 QCs (low range) 
 Day 1 Day 2 Day 3   Day 1 Day 2 Day 3 
LOW1 QC  3.6 3.7 3.9   HIGH1 QC 21.9 20.7 23.5 
 (ng/mL) 4.0 3.8 5.3   (ng/mL) 21.0 21.2 22.6 
  3.8 3.5 4.1    18.0 20.1 25.6 
  3.4 3.6 3.9    20.5 21.0 21.0 
  3.4 3.5 4.2    20.4 21.3 24.0 
 3.3 3.9 3.7   20.5 21.3 25.1 
Mean 
(ng/mL) 
3.6 3.6 4.2  
Mean 
(ng/mL) 
22.3 20.9 23.6 
% Accuracy -3.5 -1.4 13.0  % Accuracy 1.3 -4.8 7.4 
SD (ng/mL) 0.3 0.2 0.6  SD (ng/mL) 1.3 0.5 1.7 
% CV 8.0 4.6 13.4  % CV 5.9 2.2 7.1 
 
Table 3.12 Validation parameters of urinary E for LOW1 QC and HIGH1 QC (low range) 
LOW2 QC  HIGH2 QC 
%Accuracy (between assay) 2.7  %Accuracy (between assay) 1.3 
%Precision (within assay) 8.7  %Precision (within assay) 5.1 
%Precision (between assay) 8.9  %Precision (between assay) 5.2 
 
Table 3.13 Validation of urinary E for LOW2 and HIGH2 QCs (high range) 
 Day 1 Day 2 Day 3   Day 1 Day 2 Day 3 
LOW2 QC  27.0 30.5 39.8  HIGH 2QC  88.6 96.2 95.1 
 (ng/mL) 29.1 31.6 37.3  (ng/mL)  98.8 93.2 109.7 
  26.3 30.1 35.8    98.9 92.9 105.4 
  26.6 29.8 34.8    95.6 93.1 105.6 
  31.0 30.7 34.8    93.1 95.0 104.6 
 28.8 29.7 34.8   99.1 88.9 100.2 
Mean 
(ng/mL) 
28.1 30.4 36.2  
Mean 
(ng/mL) 
95.7 93.2 103.4 
% Accuracy -14.7 -7.9 9.7  % Accuracy -2.4 -4.9 5.5 
SD (ng/mL) 1.8 0.7 2.0  SD (ng/mL) 4.2 2.5 5.1 
% CV 6.4 2.3 5.5  % CV 4.4 2.6 4.9 
 
Table 3.14 Validation parameters of urinary E for LOW2 QC and HIGH2 QC (high range) 
LOW2 QC  HIGH2 QC 
%Accuracy (between assay) -4.3  %Accuracy (between assay) -0.6 
%Precision (within assay) 4.8  %Precision (within assay) 4.0 
%Precision (between assay) 4.8  %Precision (between assay) 4.0 
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In both ranges, the QCs passed the validation criteria. 
 
3.3.4 Method validation for the quantification of urinary 5 -DHT 
3.3.4.1 Lower limit of quantification 
The LLOQ for 5 -DHT was 1 ng/mL, (S/N 1:10) as shown in Figure 3.9. 
 
Figure 3.9 Typical chromatogram obtained at a lower limit of quantification for 5 -DHT at 1 ng/mL 
 
3.3.4.2 Calibration range 
Calibrants for 5 -DHT were accurate <±15 %, and <±20 % at the LLOQ. For the concentration 
range 1-16 ng/mL (low range) the linearity (r
2
) throughout the 3 days were 0.9983, 0.9985 and 
0.9992. For the range 16-40 ng/mL (high range), the linearity values (r
2
) were 0.9987, 0.9964 
and 0.9928. 
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3.3.4.3 Quality control validation 
Table 3.15 Validation of urinary 5 -DHT for LOW1 and HIGH1 QCs (low range) 
 Day 1 Day 2 Day 3   Day 1 Day 2 Day 3 
 LOW1 QC 3.7 4.0 3.8   HIGH1 QC 14.5 13.4 13.9 
(ng/mL)  4.4 4.2 4.7   (ng/mL) 13.9 13.2 12.7 
  3.5 3.7 3.6    10.9 13.6 12.7 
  4.0 4.1 4.1    13.0 14.4 13.7 
  3.4 3.9 3.8    13.1 12.2 15.4 
 3.4 4.0 3.9   13.7 13.5 15.8 
Mean 
(ng/mL) 
3.7 4.0 4.0  
Mean 
(ng/mL) 
13.2 13.4 14.0 
% Accuracy -6.4 -1.1 -0.4  % Accuracy 1.4 3.1 7.9 
SD (ng/mL) 0.4 0.2 0.4  SD (ng/mL) 1.2 0.7 1.3 
% CV 10.4 3.8 10.2  % CV 9.4 5.2 9.5 
 
Table 3.16 Validation parameters of urinary 5 -DHT for LOW1 QC and HIGH1 QC (low range) 
LOW2 QC  HIGH2 QC 
%Accuracy (between assay) -2.6  %Accuracy (between assay) 4.1 
%Precision (within assay) 8.1  %Precision (within assay) 8.0 
%Precision (between assay) 8.1  %Precision (between assay) 8.1 
 
Table 3.17 Validation of urinary of 5 -DHT for LOW2 and HIGH2 QCs (high range) 
 Day 1 Day 2 Day 3   Day 1 Day 2 Day 3 
 LOW2 QC 20.1 21.8 22.2   HIGH2 QC 29.8 32.1 30.5 
 (ng/mL) 22.7 23.2 22.4  (ng/mL)  29.3 29.6 32.8 
  18.2 22.3 20.2    32.5 28.5 34.9 
  19.5 23.0 22.9    28.3 32.6 30.8 
  19.9 21.2 21.9    30.4 31.7 31.4 
 20.2 21.2 19.8   29.6 31.8 29.4 
Mean 
(ng/mL) 
20.1 22.1 21.6  
Mean 
(ng/mL) 
30.0 31.0 31.6 
% Accuracy -8.7 0.5 -1.9  % Accuracy -6.3 -3.1 -1.2 
SD (ng/mL) 1.4 0.9 1.2  SD (ng/mL) 1.4 1.6 2.0 
% CV 7.2 3.9 5.8  % CV 4.7 5.2 6.2 
 
Table 3.18 Validation parameters for urinary 5 -DHT LOW2 QC and HIGH2 QC (high range) 
LOW2 QC  HIGH2 QC 
%Accuracy (between assay) -3.4  %Accuracy (between assay) -3.5 
%Precision (within assay) 5.6  %Precision (within assay) 5.4 
%Precision (between assay) 5.6  %Precision (between assay) 5.4 
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For both the low and high ranges, the QCs successfully passed the validation criteria. 
 
3.3.5 Summary of validation criteria for T, E and 5 -DHT 
All the parameters taken into account for the validation were within the established accepted 
criteria (Table 3.19), except for LOW2 QC for T, which had a within assay accuracy of 15.4 %. 
Given the fact that the preliminary concentration was performed by using a peak height ratio, 
some error may have come from there. The difference from the accepted criteria was only 
0.4 %, and because for the other 2 days of validation the accuracy was within the criteria, this 
value was accepted. 
 
Table 3.19 Summary of validation criteria 
Validation parameters Criteria 
LLOQ S/N 1:10, sextuplicates’ CV % <±20 % 
Linearity r
2
 value > 0.99 
Accuracy (within assay) <±20 % for LLOQ, <±15 % other points 
Average accuracy (between assay) <±10 % 
Repeatability (precision in a single assay) <±10 % 
Reproducibility (precision within assay) <±10 % 
Reproducibility (precision between assay) <±10 % 
 
3.3.6 Sample analysis results and challenges encountered 
Urinary T/E, and the concentrations of the previously validated steroids were calculated. These 
concentrations vary greatly between individual and depend upon the urinary density, or specific 
gravity (SG), of the urine sample. Only values normalized for a SG of 1.020 can be compared.  
The SG of all urine samples was measured and the concentration of steroid adjusted according 
to the following equation: 
 
Chapter 3: Validation and sample analysis of a GC-MS method for urinary T, E and 5 -DHT 
 
- 141 - 
Equation 3.6 Adjusted concentrations 
 
 
In certain samples the concentration obtained was below the LLOQ (1 ng/mL). In cases where 
the concentration was between 0.5-1 ng/mL, a re-extraction of 4 mL was performed to verify if, 
by doubling the volume, the concentration would increase to the double. However, such was not 
the case and because we were just interested in the concentration differences rather than an 
absolute value, all the samples which had a concentration below the LLOQ were modified to 
0.5 ng/mL for statistical treatment purposes. It was also decided to do the same in samples 
where the SG was below 1.004 to avoid introducing errors in highly diluted urine samples. The 
samples that had an SG below 1.004 were, not surprisingly, part of the group of samples with a 
concentration below the LLOQ. 
This happened in 9 % of the samples analysed for T concentration, in 3.5 % in the samples for 
E concentration and in 26 % of the samples analysed for 5 -DHT concentration. The high 
percentage of samples below the LLOQ for 5 -DHT was expected since 5 -DHT glucuronide is 
excreted in very small amounts and in previous published data the undetectable percentage 
was in the order of 40 % (Kicman et al., 1995). 
Statistical treatment was done by averaging post-administration data irrespective of gender, 
time or units and normalizing the data using percentage increase against pre-administration as 
follows: 
 
Equation 3.7 Normalization for statistical treatment 
 
 
The 72 h sample was excluded from statistical treatment since 1 male and 1 female volunteer 
failed to provide this sample so there was no data. The samples collected at 24 h and 48 h had 
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already reached baseline values and a comparison between baseline value (baseline sample 
taken before alcohol ingestion) and these two samples were done to ascertain if the response 
was different for the 4 and 8 units. The results were not statistically significant with T/E 
p-value =0.173, T concentration p-value=0.329, E concentration p-value=0.854 and 5 -DHT 
concentration p-value=0.312 therefore the last two measurements (24 and 48 h) were excluded 
from the statistical treatment. 
As an added test of reliability for our baseline values, the mean of pre-administration sample, 
24 h and 48 h was used as the baseline value. 
During the study, 1 male volunteer dropped out (T3M), and it was not possible to collect blood 
from 1 female (T3F). 
The urinary T/E for females, their T, E and 5 -DHT urinary concentrations for 4 units may be 
found in Appendix 8.16 and for 8 units in Appendix 8.17. For males, urinary concentrations 
following administration of 4 units are shown in Appendix 8.18, and for 8 units in Appendix 8.19. 
The data will be presented for females first followed by the males. It will be compared against 
the WADA threshold and 97.5
th
 percentile reference values in a female Caucasian athlete 
population (n=1,004) and in a male Caucasian athlete population (n=2,027) recently published 
(Van Renterghem et al., 2010). 
 
3.3.6.1 Urinary T/E ratio 
The WADA action limit for follow-up work is set at T/E < 4, and the 97.5
th
 percentile in females is 
2.65 and for males it was 4.33. 
The 4 and 8 units were plotted in the same graph using a double axis, with the higher dose 
being below and with the y-axis on the right hand-side. 
For females, the results for 4 and 8 units may be seen in Figure 3.10, and for males in Figure 
3.11. 
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Figure 3.10 Urinary T/E in females, 4 and 8 units 
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The urinary T/E response is different for 4 and 8 units (p-value < 0.05) averaged over time and 
gender, and is also different for males and females (p <0.05) averaged over time and units, and 
these changes were significant over time (p <0.05) averaged over units and gender. 
Regarding gender and units effects, averaged over time, females may have a higher T/E 
response but it is the same type of response when the units increase (p >0.05), i.e., 4 and 8 
units have the same variation in T/E response for females and males. However, the time profile 
is different for females and males (p <0.05), averaged over gender, with the highest T/E for 
4 units for women at 3 h and in men at 2 h, and for 8 units in females peak time was at 5 h 
whereas for men it was at 2 h. 
There is also a statistically significant difference between time profiles for males and females, 
units combined (p <0.05). 
In females, at 4 units, 4 females showed a T/E 2.65 without any reaching the WADA’s action 
limit threshold of 4. At 8 units, 6 females had a peak T/E 2.65 and 4 showed a T/E 4, peaking 
at 5 h and decreasing afterwards until its values were closer to baseline at 10 h, completely 
reaching baseline at 24 h. 
In males, for 4 and 8 units, their T/E ratio increased at 2 h without ever exceeding the WADA 
threshold or the 97.5
th
 percentile. 
A graph from the statistical software SPSS with the normalized data (proportion increase from 
pre-administration sample) may be found in Figure 3.12 and . 
All the graphs from SPSS are shown herein with the estimated marginal means on the y-axis. 
This is the mean response for each factor, in our case the time interacting with the units of 
alcohol (4 or 8), adjusted for any other variable such as gender in the model used.  
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Figure 3.13 Normalized T/E in males. Units 1 = 4 units, 2 = 8 units 
 
In males, the individual value for urinary T/E varies by less than 30 % and in females the 
variation up to 60 % may occur between the suspicious and unaffected sample (Kicman and 
Cowan, 2009, World Anti - Doping Agency, 2004).  
Normalized urinary T/E vs. time in eugonadal males 
Time collection points 
Normalized urinary T/E values vs. time in eugonadal females 
Time collection points 
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To illustrate the amount of variation in the volunteers after 4 and 8 units of alcohol, the relative 
standard deviation was performed. To illustrate a ‘real-life’ sample with collections pre, during 
and post-administration, the samples used were pre-administration of alcohol (CTRL), average 
higher urinary T/E (for 4 and 8 units in males at 2 h, after 4 units in females at 3 h and after 8 
units at 5 h), and the 48 h sample (Table 3.20). 
If they vary by more than 30 % in males and 60 % in females, then that could be indicative of an 
individual that has discontinued T administration. 
 




4 units 8 units 4 units 8 units 
CTRL 0.7 0.7 0.8 0.6 
High 
T/E 
2.1 3.4 0.9 0.8 
48 h 0.7 0.6 0.7 0.6 
Mean 1.2 1.6 0.8 0.7 
SD 0.8 1.5 0.1 0.1 
RSD % 68.4 98.8 13.3 17.7 
 
The individual variation in males after 4 and 8 units did not exceed 30 %. However, in females 
the variation in urinary T/E was 68 % after 4 units and 99 % after 8 units, which in both cases 
exceeds the 60 % variation expected in females. 
 
3.3.6.2 Urinary T concentration 
Samples that have a T and E concentration higher than 200 ng/mL are considered suspect by 




 percentile for T concentration for females was measured to be 29.4 ng/mL and for 
males it was 103 ng/mL (Van Renterghem et al., 2010).  
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Due to the difference in females between the reference value and the WADA threshold it is 
clearer to present separate graphs rather than combined ones as in the previous section. 
Therefore, urinary T concentration for females 4 units may be found in Figure 3.14 and for 8 
units in Figure 3.15, followed by the male data. 
All the concentrations presented have been adjusted according to their SG. 
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Figure 3.15 Urinary T concentration (ng/mL) in females, 8 units 
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Figure 3.17 Urinary T concentration (ng/mL) in males, 8 units 
 
The urinary T concentration response is the same for 4 and 8 units (p >0.05), averaged over 
time and gender and it is also different from female to male (p <0.05) averaged over time and 
units. The females may have a higher response but it does not appear to change when the units 
increase (p >0.05), averaged over time. 
There were changes over time in the T concentration (p <0.05), averaged over units and 
gender. The concentration significantly increased over time after 4 to 8 units (p <0.05) averaged 
over gender, with the highest T concentration for 4 units in females at 3 h and males at 2 h, and 
for 8 units in females at 7 h and in males at 6 h. A different time profile was observed for female 
and male (units combined) with a p-value <0.05. 
None of the volunteers reached the WADA threshold, but 6 females and 1 male went above the 
97.5
th
 percentile in the 4 units intake; and 7 females and 4 males in the 8 units intake. 
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Figure 3.19 Normalized urinary T values in males. Units 1 = 4 units, 2 = 8 units 
 
Normalized urinary T values vs. time in eugonadal females 
Normalized urinary T values vs. time in eugonadal males 
Time collection points 
Time collection points 
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3.3.6.3 Urinary E concentration 
The 97.5
th
 percentile for E concentration in females is 28.5 ng/mL, and for males it is 
88.9 ng/mL (Van Renterghem et al., 2010). The WADA threshold is 200 ng/mL for both females 
and males. 
The plotted raw concentrations may be found in Figure 3.20 for females 4 units and in Figure 
3.21 for 8 units. 
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Figure 3.21 Urinary E concentration (ng/mL) in females, 8 units 
 
For males, the data may be found in Figure 3.22 for 4 units and in Figure 3.23 for 8 units. 
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Figure 3.23 Urinary E concentration (ng/mL) for males, 8 units 
 
With respect to urinary E concentration, no difference in average response for 4 or 8 units 
(p >0.05), averaged over time and gender was observed, nor for female and male (p>0.05). The 
males may have a higher response but it stays the same when the units increase averaged over 
time and units (p >0.05).  
There were changes over time in the E concentration (p <0.05) averaged over units and gender. 
The E concentration decreased albeit not significantly over time for 4 and 8 units (p >0.05) 
averaged over gender, with the lowest E concentration for 4 and 8 units in females being at 1 h, 
and with males at 1 h after 4 units and 3 h after 8 units.  
None of the volunteers went above the WADA threshold, but 3 females and 1 male in 4 units 
and 2 females in 8 units went above the 97.5
th
 percentile.  
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Figure 3.25 Normalized urinary E values in males. Units 1 = 4 units, 2 = 8 units 
 
3.3.6.4 Urinary 5 -DHT concentration 
The 97.5
th
 percentile for 5 -DHT concentration in females was 20.5 ng/mL, and for males it was 
21.5 ng/mL (Van Renterghem et al., 2010). 
Normalized urinary E values vs. time in eugonadal females 
Normalized urinary E values vs. time in eugonadal males 
Time collection points 
Time collection points 
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To date, WADA has not established a threshold for the urinary concentration of 5 -DHT. 
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Figure 3.27 Urinary 5 -DHT concentration (ng/mL) for females, 8 units 
 
In males, for the ingestion of 4 units of alcohol the results may be found in Figure 3.28, and for 8 
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Figure 3.28 Urinary 5 -DHT concentration (ng/mL) in males, 4 units 
 
 
Figure 3.29 Urinary 5 -DHT concentration (ng/mL) in males, 8 units 
 
With 5 -DHT concentration, the response is the same for 4 and 8 units (p>0.05) averaged over 
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The males may have a higher response but it stays the same when the units increase (p > 0.05) 
averaged over time. There were no changes over time in the 5 -DHT concentration (p >0.05) 
averaged over units and gender. The 5 -DHT concentration changes over time for 4 and 8 units 
(p <0.05) averaged over gender, with the highest 5 -DHT concentration for 4 units in females at 
4 h and 10 h and for males at 4 h; and 8 units for females and males at 10 h. The same time 
profile was observed for female and male (units combined) with a p-value >0.05. 
Only one male volunteer, 4 units, went above the 97.5
th
 percentile after 1 h.  











Normalized urinary 5 -DHT values vs. time in eugonadal females 
Time collection points 
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Figure 3.31 Normalized urinary 5 -DHT values in males. Units 1 = 4 units, 2 = 8 units 
 
In summary, both 4 and 8 units of alcohol administration cause an increase in T/E in both males 
and females with the increase being more accentuated in females and the time profiles varying 
depending on gender. 
With respect to SG adjusted T concentration, there were significant changes over time with 
females being more affected than men (higher increase in urinary T concentration) 
The urinary E concentration decreased over time due to alcohol. However, unlike T 
concentration, females and males are not affected differently.  
With urinary 5 -DHT, a product of T biosynthesis, there is a significant increase over time after 
4 and 8 units of alcohol, averaged over gender. Females and males are affected similarly, and 
the time profiles for each gender were not significantly different.  
 
3.3.6.5 Urinary EtG concentrations 
Concentrations of alcohol’s biomarkers (EtG and EtS) determined using LC-MS/MS were kindly 
provided by Dr. Alfonso Lostia’s project (submitted to Alcohol and Alcoholism). In brief, 
deuterated d5-EtG was added to the sample, QCs and standards and they were centrifuged at 
Normalized urinary 5 -DHT values vs. time in eugonadal males 
Time collection points 
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10,000 g for 5 min to remove sediments. A simple 1:10 dilution in mobile phase (99 % formic 
acid 0.1% / 1% acetonitrile) was performed and the sample was injected at a flow rate of 
200 μL/min using a validated ultra performance liquid chromatography-mass spectrometry 
(UPLC
®
-MS/MS) method. The transitions monitored were for the quantification of EtG was the 
precursor/product ion pair m/z 221 / 85 and the pair at m/z 125 / 80 for EtS.   
The concentrations of these analytes were investigated to determine possible correlation with 
the increase in urinary T/E. These data are presented here and correlated with urinary T/E 
further down. All data was normalized against urine volume and presented as mg excreted/h 
since the urinary concentrations of EtG and EtS are affected by water intake. Statistical 
treatment was performed up to the collection of 10 h in 4 units, and 24 h in 8 units since the 
analytes were detectable until this time. 
For females, a urinary EtG excretion rate time plot may be found in Figure 3.32 for 4 units, and 
for 8 units in Figure 3.33. 
  
























Urinary EtG mg excreted/h in females 4 units up to 10 h 
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Figure 3.33 Urinary EtG mg excreted/h in females 8 units  
 
In males, a urinary EtG excretion rate time plot may be found in Figure 3.34 for 4 units, and for 
8 units in Figure 3.35. 
























Urinary EtG mg excreted/h in females 8 units up to 24 h 
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Figure 3.34 Urinary EtG mg excreted/h concentration in males 4 units  
 
 

















































Urinary EtG mg excreted/h in males 8 units up to 24 h 
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Concerning the EtG urinary concentration, the response is different for 4 and 8 units, averaged 
over time and gender, with p <0.05; and different for females and males, averaged over time 
and units (p <0.05). EtG’s response is higher in females but it is still the same type of response 
when the units increase, i.e., 4 and 8 units are the same for females and males (p=0.596), 
averaged over time. 
There were changes over time in the EtG concentration (p <0.05) averaged over units and 
gender, and the time profile was different for 4 and 8 units (p <0.05), averaged over gender. The 
peak for 4 units was at 3 h and for 8 units, it peaked at 5 h. The same time profile was observed 
for female and male (units combined) with a p-value >0.05. 
The difference between the time profiles for 4 and 8 units is the same for females and males 
(p >0.05). 
 
3.3.6.6 Urinary EtS concentrations 
For females a urinary EtS excretion rate time plot may be found in Figure 3.36 for 4 units, and 
for 8 units in Figure 3.37. 
 





















Urinary EtS mg excreted/h in females 4 units up to 10 h 
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Figure 3.37 Urinary EtS mg excreted/h in females 8 units  
 
For males, a urinary EtS excretion rate time plote may be found in Figure 3.38 for 4 units, and 
for 8 units in Figure 3.39. 
 
















































Urinary EtS mg excreted/h in males 4 units up to 10 h
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Figure 3.39 Urinary EtS mg excreted/h in males, 8 units  
 
Regarding the EtS urinary concentration, the response is different for 4 and 8 units, averaged 
over time and gender, with p <0.05; but with no difference being observed for females and 
males, averaged over time and units (p >0.05). EtS’s response is higher in females but it is still 
the same type of response when the units increase, i.e., 4 and 8 units are the same for females 
and males and males (p >0.05), averaged over time. 
There were changes over time in the EtS concentration (p <0.05) averaged over units and 
gender, and the time profile was different for 4 and 8 units (p <0.05), averaged over gender. The 
peak for 4 units was at 2 h and for 8 units, it peaked at 5 h. The same time profile was observed 
for female and male (units combined) with a p-value >0.05. 
























Urinary EtS mg excreted/h in males 8 units up to 24 h 
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3.3.6.7 Urinary EtG/EtS  
The urinary ratio of EtG/EtS was plotted for females 4 units and 8 units, and males 4 and 8 units 
and may be found in Figure 3.40. 
 
Figure 3.40 Mean urinary EtG/EtS for females (n=10) and males (n=9) at 4 and 8 units 
 
With respect to EtG/EtS, a difference in response between 4 and 8 units, averaged over time 
and gender, was observed with p <0.05; and it is the same for females and males, averaged 
over time and units (p >0.05). EtG/EtS response is higher in females but it is still the same type 
of response when the units increase, i.e. 4 and 8 units are the same for females and males and 
males (p >0.05), averaged over time. 
There were changes over time in the EtG/EtS concentration (p <0.05) averaged over units and 
gender, and the time profile was different for 4 and 8 units (p <0.05), averaged over gender. The 
ratio increased in both units up to 7-10 h. The difference between the time profiles for 4 and 8 
units is the same for females and males (p >0.05). 
EtG/EtS ratio increase in urine samples of all volunteers as a function of time. The ratio EtG/EtS 
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In summary, the concentrations of EtG and EtS in urine behave almost similarly, except that 
EtG is gender dependant. With the 8 units intake, the urinary concentrations of both biomarkers 
increased. With EtG that increase was more than the double and with EtS was approximately 
double. 
EtG/EtS increased as a function of time after alcohol administration. 
 
3.3.7 Analysis of urinary T/E, EtG and EtS  
The urinary T/E was averaged and plotted together with the urinary average EtG concentration 
and EtS concentration for females and males after 4 and 8 units. 
The female data may be found below in Figure 3.41 and Figure 3.42. 
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Figure 3.42 Mean urinary T/E plotted with urinary EtG and EtS (mg excreted/h), females 8 units 
 
For males, and following the same analogy, mean T/E plotted with EtG and EtS concentrations 
for 4 units may be found in Figure 3.43. For 8 units please see Figure 3.44. 
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Figure 3.44 Mean urinary T/E plotted with EtG and EtS (mg excreted/h), males 8 units 
 
The analysis of the previous graphs clearly shows that urinary T/E increases with the increase 
in the EtG and EtS mg excreted/h, as well as the EtG/EtS at least for the first two hours post-
alcohol administration.  
 
3.3.8 Correlation between urinary T/E and EtG mg excreted/h 
A correlation between urinary T/E and EtG (one of alcohol’s biomarkers) was performed.  
In males, after 4 units, there was barely any correlation with no significant overall effect. After 8 
units, there was an overall correlation because two of the volunteers had a very strong 
correlation whereas the remainder did not. In females, after 4 and 8 units there is a strong 
overall correlation which is statistically significant, but there are different individual responses. 
Some females responded more slowly to the increase in EtG concentration than did others. As 
an example, after 4 units, female volunteer T5F had a T/E of approximately 2 with an EtG 
excretion rate (mass per unit of time) of 2 mg/h whereas female volunteer T8F showed a T/E of 




























Chapter 3: Validation and sample analysis of a GC-MS method for urinary T, E and 5 -DHT 
 
- 170 - 
similar behaviour. Volunteer T5F had a urinary T/E of 7 with an EtG of 2 mg/h volunteer T8F 
had an urinary T/E of 1.5 with a corresponding EtG concentration of 14 mg/h. 
Urinary T/E correlated with EtG concentration in some individuals (n=x, p<0.05).. 
If EtG were to be used as a marker of alcohol administration in doping in sports, it would be 
necessary to establish an individual threshold for each athlete. In order to do so, their response 
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3.4 Conclusions 
This study showed that 4 and 8 units of alcohol increases urinary T/E significantly. This increase 
is more evidentially significant in females than in males, and the mean T/E profile (the mean of 
each volunteer’s T/E per hour) is different between the genders as well as with the different 
units, with peak times changing from 3 h at 4 units for 5 h at 8 units. 
The reason why it affects females more than males is perhaps due to the fact that females 
produce less T and, probably more importantly, less E appears in urine than men, and any 
perturbances in that mechanism will disturb the T/E. 
In our study, the 4 units of alcohol were approximately 0.5 g/kg of alcohol and the 8 units were 
1 g/kg. Although previous studies have been done where volunteers are administed alcohol, our 
study has a higher number of samples, being more representative of the population. Previous 
studies have also administered their volunteers with alcohol, and obtained high T/E values only 
after the administration of 2 g/kg of alcohol. Although there was an increase in T/E due to 
alcohol, it was not as high as the T/E we obtained in our study with only half the dose.  
In females the highest T/E was 7.1, and in males it was 3.2. With a dose of 0.5 g/kg, Falk et al. 
had the highest T/E in males at 1.52; Karila et al. obtained the highest T/E in females at 4.4 and 
in males there was no increase due to alcohol but its highest T/E was 1.6; Mareck-Engelke et 
al. showed the highest T/E in females at 6.7 and in males at 2.4 (Falk et al., 1988, Karila et al., 
1996, Mareck-Engelke et al., 1996). Only Seppenwoolde-Waasdorp et al. administered the 
same dose as we did but obtained lower maximum T/E ratios, for females at 3.4 and for males 
at 1.2 (Seppenwoolde-Waasdorp et al., 1996). 
This was possibly because we administered the alcohol to our volunteers during 1 h period and 
in previous studies this was done during a 3 h or 4 h period, therefore we managed to 
demonstrate a more acute intoxication, provoking a higher T/E ratio (Falk et al., 1988, Karila et 
al., 1996, Geyer et al., 1996, Seppenwoolde-Waasdorp et al., 1996, Mareck-Engelke et al., 
1996). Another reason may be because we have have a more sensitive analysis technique. 
One study has related the increase in T/E with the increase in urinary EtG concentration 
(Grosse et al., 2009), however this was performed only in 4 males aged between 32-50. Our 
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study also correlates the increase of T/E with EtG showing that there is a subject based 
correlation.  
The use of these biomarkers is important for doping in sports to avoid that athlete’s samples are 
flagged when their T/E increases in their biological passport (Sottas et al., 2010). The biological 
passport is a longitudinal study recorded for every athlete that includes a steroid profile 
comprising individual measurements of monitored steroid concentrations and ratios.  When 
values go above the athlete’s personal averaged values, the athlete is ‘flagged’ and asked to 
provide samples more frequently. Perhaps the introduction of the measurement of urinary EtG 
and/or EtS in the WADA procedures when a T/E sample is above the athlete’s personal 
threshold, would prevent the athlete being flagged for the collection of more samples, thus 
saving time and money to the sports authorities.  
Thus, this work has shown that the two doses of alcohol alter the urinary T/E in both males and 
females, with females (after 8 units) going above the WADA’s action limit of 4. There was a 
significant increase over time in urinary T concentration, a decrease in urinary E concentration 
over time even if not significant, and a significant increase in urinary 5 -DHT concentration.  
Urinary T/E increases with the increase in urinary normalized EtG and EtS (mg excreted/h). 
In the following chapter we will verify if any increase in urinary T concentration could be caused 
by an increase in LH after alcohol administration. 
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4.1 Introduction 
4.1.1 LH and doping in sports 
In this chapter the hypothesis that ethanol administration increases LH concentration, thereby 
increasing urinary T concentration, is tested.   
LH is part of a feedback mechanism comprising the hypothalamus, the anterior pituitary and the 
gonads (testes in men, ovaries in women). 
In men, as described in Chapter 1, LH stimulates T production. Under normal conditions, a 
lowering of the circulating T concentration will result in a rise in GnRH and consequently LH and 
FSH and vice versa (Emanuele and Emanuele, 2001, Griffin and Wilson, 1992), thereby 
maintaining a steady state.   
Administration of T suppresses LH production resulting in lower circulating LH and, although 
there will be a higher excretion of T, there will be a lower excretion of LH. A ratio of T/LH in 
urine may thus be a useful indicator of T administration. This is valid only for males, since LH 
secretion is suppressed in females with oral contraception. Analysis of urine from 120 healthy 
males has shown that the reference range for T/LH is between 1-150 nmol/IU and urinary LH 
concentration in healthy males between 0.5 – 20 IU/L (Drug Control Centre, 2010) as measured 
by DELFIA  hLH assay (PerkinElmer, Northwich, UK). More details on this type of assay may 
be found in section 4.1.4.  
In a sports doping case (2005), the defendant with a T/E above the WADA threshold of 4, had a 
T concentration (adjusted by specific gravity, see Equation 4.1) of 257 ng/mL, above the WADA 
threshold of 200 ng/mL (World Anti - Doping Agency, 2004). Despite having a urinary T/LH 
within the reference range (45 nmol/IU), the athlete’s urinary LH concentration was considered 
abnormal with a value of 28.9 IU/L. 
The athlete’s blood alcohol concentration was estimated to be 350 mg% based on 
uncorroborated statements of the total amount of alcohol that the athlete had drunk.  
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4.1.2 LH concentrations in urine and serum 
Pre-menopausal women’s cycle phase comprises of menstruation, follicular phase, ovulatory (or 
mid-cycle) and luteal phase. It is during ovulation that the concentration of LH and FSH rise and 
trigger ovulation, which occurs around the 14
th
 day in 28 day-cycles. 
The urinary and serum LH concentrations for both men and women are displayed in the table 
below. 
 
Table 4.1 LH urinary and serum concentration for males and females 
Matrix Male (IU/L) Female (IU/L) References 
Urine 0.5-20 
Follicular phase: 1-25 
For males: (Drug Control Centre, 
2010) 
Mid-cycle: 15-95 
For females: (Inter Science 
Institute, 1995) 
Luteal phase: 2-20   
Postmenopausal: 40-110   
Serum 1-8 
Follicular phase: 1-12 
For females and males: (National 
Institute of Health, 2009) 
Mid-cycle: 17-77 
 Luteal phase: 0-15   
Postmenopausal: 11-40   
 
 
4.1.3 LH & Alcohol 
A literature review found only two papers in which LH had been analysed after alcohol 
administration. 
In one paper, the volunteers were females (n=9) and males (n=12) that had gone to the 
emergency room in the hospital suffering from acute alcohol intoxication. Their serum LH 
concentration when compared to a control group had not changed significantly (Frias et al., 
2002). 
In another study, with 4 females and 4 males to whom 1.2 g/kg and 2.0 g/kg of alcohol was 
administered in two separate occasions for a period of 5 h, showed that the serum LH 
concentration increased. In females, after the lower dose it increased by 58 %, and after the 
highest dose 66 %. In males, the lowest dose increased LH in 1 % and the highest dose by 
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97 %. Serum collections for LH analysis were performed pre-administration and post-
administration at 24 h and 48 h (Karila et al., 1996). Although the LH concentrations increased 
after both doses of alcohol, these changes did not reach statistical significance (p <0.05). 
The analysis of urinary LH concentration was not performed.  
 
4.1.4 Immunoassay 
LH is a heterodimeric glycoprotein with each monomeric unit being a glycoprotein molecule 
comprising of two non-covalently linked subunits, designated  and . Each monomeric subunit 
is not biologically active but when combined into the heterodimer the molecule binds to the LH 
receptor located in the gonads.  
The DELFIA  LH immunoassay used for this work is a two-site fluoroimmunometric assay. It 
consists of two highly specific monoclonal antibodies aimed against two separate epitopes of 
the LH molecule. An epitope is the antigen’s part recognised by the immune system. The 
standards, samples and quality controls that contain LH are incubated with immobilised 
monoclonal antibodies which are aimed to a specific antigenic site in the  sub-unit of the LH 
protein. 
The europium-labelled antibodies are targeted at a second site of the  sub-unit and will react 
with the intact LH or the  sub-unit that has been previously bound to the solid-phase antibody, 
thus creating a two-site ‘sandwich’. The enhancement solution will dissociate the europium from 
the antibodies it was attached to, forming fluorescent chelates with the enhancement solution. 
Fluorescence is measured in a time-resolved fluorometer and it is directly proportional to the 
quantity of LH in the sample. 
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4.2 Material and methods 
4.2.1 Materials 
Vacutainers  (SST™II Advance) for blood serum separation were obtained from BD Diagnostics 
(Oxford, UK). The 96-well immunoassay DELFIA  LH kits, the DELFIA  1296-026 platewasher 
with a Victor
3
 1420 multi-label counter, and the MultiCalc  2000 software program, were all 
obtained from PerkinElmer  (Northwhich, UK). 
 
4.2.2 Volunteer study and sample collection 
Samples from the volunteer study described in Chapter 3, section 3.2.3 were used. In summary, 
9 females and 9 males were recruited and the samples were labelled with an alphanumeric 
code, e.g. T F/M-4U- , where  is the number of the volunteer,  the letter indicating the type 
of sample (U for urine and S for serum),  the time of collection and F/M with F if volunteer was 
a female and M if it was male. 
The volunteers were administered with 4 and after with 8 units of alcohol on two different 
occasions, with at least 2 weeks apart, cannulated and blood was collected pre-alcohol 
administration, and post-administration hourly from 1 h to 6 h, then at 24 h and at 48 h. The 
blood was collected into Vacutainers  with a separating gel and allowed to stand for 30 min, 
after which it was centrifuged for 5 min at 1000 g.  
Urine was collected pre-administration, and post-administration hourly from 1 h to 7 h, then at 
10 h, 24 h, 48 h and 72 h. It was collected in Nalgene  500 mL bottles, and split into four 10 mL 
aliquots (when enough urine was available). 
The female volunteers were not receiving hormonal contraceptive therapy, and were asked to 
provide information pertaining to the last day of their period.  
 
4.2.2.1 Serum analysis 
The DELFIA  LH immunoassay kit was used as per the protocol provided with the kit, with 
urinary QCs described below (section 4.2.2.2). This assay has been validated by the 
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manufacturer according to the FDA guidelines, and the assay’s sensitivity is typically better than 
0.05 IU/L according to the manufacturer. 
 
4.2.2.2 Urine analysis 
The urinary LH method has been validated using a serum DELFIA
®
 LH kit by PerkinElmer
®
. 
This validation was performed following the WADA guidelines and it was carried out by certified 
analysts within the Drug Control Centre. The LOD was determined to be at 0.07 IU/L and the 
LLOQ was 0.14 IU/L.  
 
The statistical treatment for the volunteer’s samples was performed using the software 
Statistical Package for Social Sciences (SPSS ), version 18, from SPSS  Inc, Chicago, IL, 
USA. The results were statistically treated by using a general linear model with repeated 
measures and the significance limit was set to p-value <0.05. This statistical test verifies the 
effects of alcohol on LH concentration, and by inspection of statistical tables and graphs it is 
then possible to conclude if any significant changes are due to an increase or a decrease in LH 
concentration.  
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4.3 Results and discussion 
To adjust for urine volume dilution factors due to the alcohol ingestion, the LH concentrations 
were calculated taking into account the SG of each sample. Only values normalized for a SG of 
1.020 could be compared.   
Adjusting urinary concentrations for dilution factors using SG rather than creatinine is common 
practice especially in anti-doping laboratories. The use of creatinine is more commonly used for 
adjustments of variable sampling times and/or diurnal rhythm (Miller et al., 2004, Greenberg and 
Levine, 1989, Handelsman et al., 2009).  However, in sport, the use of creatine, which is readily 
converted to creatinine, is permitted and this makes adjustment to creatinine inappropriate. 
Thus, the SG of all urine samples was measured and the LH concentration adjusted according 
to the following equation: 
 
Equation 4.1 Adjusted concentrations 
 
 
Concentrations that were below the LLOQ of 0.14 IU/L were adjusted to half of this value for 
statistical treatment purposes. 
Statistical treatment was done by averaging post-administration data irrespective of gender, 
time or units and normalizing the data using proportion increase against pre-administration as 
follows: 
 
Equation 4.2 Normalization of values for statistical treatment 
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During the study, 1 male volunteer withdrew from the study (T3M), and it was not possible to 
collect blood from 1 female (T3F). 
The urinary 72 h sample was excluded from statistical treatment since 1 male and 1 female 
volunteer failed to provide this sample. The samples collected at 24 h and 48 h had already 
reached baseline values and a comparison between baseline value (baseline sample taken 
before alcohol ingestion) and these two samples were done to ascertain if the response was 
different for the 4 and 8 units. The results were not statistically significant with urinary LH 
p-value=0.234 and serum LH p-value=0.109 therefore the last two measurements (24 and 48 h) 
were excluded from the statistical treatment. As an added test of reliability for our baseline 
values, the mean of pre-administration, 24 h and 48 h samples was used as the baseline value. 
The serum LH concentration for females after 4 and after 8 units may be found in Appendix 
8.20. The urinary values for both doses may be found in Appendix 8.21. For males, serum 
concentration after 4 and after 8 units are shown in Appendix 8.22. The urinary LH follows in 
Appendix 8.23. 
The graphs supporting the statistical treatment will be presented as normalized values where 
the baseline concentration is represented as zero concentration, since our normalization 
involved proportion increase from the baseline. 
A graph with the mean raw values (before statistical treatment) after 8 units, for females and 
males will be presented as well. 
 
4.3.1 Serum analysis  
No female volunteer was receiving hormonal contraceptive (see exclusion criteria) to avoid 
possible effect on LH (Brun et al., 1987), and they were asked to provide the date of their last 
menstruation so to ascertain what phase of their menstrual cycle they were in. 
Females that had their pre-administration concentrations in the mid-cycle range were excluded 
from statistical treatment. Their higher values would have interfered with the statistical treatment 
and thus they were considered as outliers.  
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Statistical treatment of serum LH values showed no gender difference (p >0.05). There was no 
response difference for 4 and 8 units (p >0.05) and, although males showed a higher response 
averaged over time, it remains the same when dose increases (p >0.05). There was no change 
with time (p >0.05), and the LH concentration time plot for 4 and 8 units (gender averaged) was 
similar (p >0.05). 
Since there were no gender or time effects, the data will be presented in a graph with the mean 




Figure 4.1 LH normalized values in serum, for 4 and 8 units averaged over gender  
 
The graph above shows suppression up to 2 h in both 4 and 8 units, followed by an increase 
that goes above baseline only after 8 units that starts declining after 4 h, until it is close to 
baseline. 
Although there were no gender differences, the results for the 8 units were split by gender and a 
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Figure 4.2 LH serum mean normalized concentration for females and males averaged over 4 and 8 
units 
 
The statistical results are not significant for females or males, although in males p =0.068 
whereas in females the value was 0.518. These results, although intriguing, are not significant. 
The measured concentrations before statistical treatment after 8 units of alcohol, for females 
and males, may be found in Figure 4.3. 
 
 
Figure 4.3 LH serum mean concentrations before normalization (raw values), for females and males 





































































Mean LH serum raw concentration after 8 units of alcohol
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4.3.2 Urine analysis 
Urinary LH values were previously adjusted for SG in accordance with Equation 4.1 and graphs 
were plotted up to 10 h post-administration. 
As mentioned previously, there was no statistical difference between pre-administration 
collection and 24 h and 48 h, therefore the three values were averaged to give a more reliable 
baseline value. The two female volunteers that were considered outliers were removed from the 
urinary analysis, and so was one male since his baseline value was above the LH upper 
concentration limit of 20 IU/L. 
The statistical treatment performed in urinary LH also showed no gender difference (p >0.05). 
There was no response difference for 4 and 8 units (p >0.05), and, although males showed a 
greater response averaged over time, it remains the same when units increase (p-value > 0.05). 
There were changes with time (p-value < 0.05), and the LH concentration time plot for 4 and 8 
units (male and female averaged) was not significantly different (p >0.05). 
Since there was no gender effect, the data will be presented in a graph with the mean values for 
each collection point, for the different units (Figure 4.4). 
 
 
Figure 4.4 Urinary normalized LH mean concentrations, gender averaged, for 4 and 8 units, values 
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The graph shows suppression up to 2 h after administration of 4 units, followed by an increase 
up to 5 h that does not reach baseline, it then decreases between 5 h and 6h, increases up to 
7 h and decreases again until 10 h, without ever reaching baseline values. 
For 8 units, there is higher suppression than for 4 units up to 1 h. It then increases up to 3 h, 
decreases again until 5 h, increases afterwards until 7 h almost reaching baseline values, and 
decreases slightly up to 10 h.  
Similarly to what happened with serum LH, and although there were no statistically significant 
differences between both genders, the results from 8 units almost reaching baseline values lead 
us to analyse the data by splitting the genders. A graph with the mean values may be found 
below (Figure 4.5). 
 
 
Figure 4.5 LH urinary mean normalized concentrations, for females and males, after 4 and 8 units, 
values previously adjusted for SG 
 
Although in females there were significant changes over time (p-value < 0.05) with a decrease 
in LH concentration that was not the case in men as no statistically significant difference for 4 
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The data before statistical treatment after 8 units of alcohol, for females and males, will be 
presented in Figure 4.6.  
 
 
Figure 4.6 LH urinary mean concentrations before normalization, for females and males after 8 
units of alcohol 
 
4.3.3 Challenges encountered 
Most females were either in their luteal phase or their follicular phase when they took part in this 
study, which have similar LH concentration. However, female volunteer T5F in the 4 units 
experiment was in her mid-cycle phase on the day of the study and her LH values were very 
different from the other volunteers’. Volunteer T4F should have been in the follicular phase of 
her menstruation although her values are more similar to a mid-cycle phase. We attribute this to 
possible menstruation irregularities, or having provided the wrong date of her last cycle. These 
were the volunteers that were considered as outliers. 
One male was also removed from the urinary statistical treatment since his pre-administration 
baseline value was above the 20 IU/L upper limit and it was considered an outlier. This extreme 
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4.4 Conclusions 
Our study shows that 4 and 8 units of alcohol, administered on two different occasions, no 
change in serum LH concentration in females or males was observed.  
This is in accordance with previously published data (Karila et al., 1996, Frias et al., 2002). In 
the report by Karila et al., the dose administered to 4 females and 4 males was 1.2 g/kg and 2.0 
g/kg on two separate occasions for a period of 5 h. LH serum analysis showed an increase in 
concentration in females by 58 % and 66 %, and in males 1 % and 97 % (lowest and highest 
dose respectively), with one pre-administration collection and two post-administration 
collections at 24 h and 48 h. Although mean serum LH increased, these increases were not 
statistically significant. 
In our study, the females showed a decrease in serum LH concentration albeit not statistically 
significant. With male volunteers, the different units still had a not statistically significant p-
value > 0.05, but nevertheless intriguing (p-value = 0.068). It would be interesting to see the 
effect of alcohol in a bigger population of males.  
If a decrease in serum LH concentration was to be verified, it would most likely have to be 
concordant with an increase in serum T.  
Previous studies have shown that administration in men of approximately twice the 
physiological mean production rate (15 mg/day) of T, reduced LH concentration by 39 ±12 % 
(Loriaux et al., 1977). More recently, in a study by Geyer et al, 100 mg/day of testosterone was 
administered as a hydroalcoholic gel in eugonadal men (n=9), which is the recommended 
maximum dose for hypogonadal men on hormone replacement therapy. This dose was 
administered for 6 weeks, and serum T raised 2 to 3 fold, whereas serum LH decreased to less 
than 50 % of the pre-administration value in 6 men (Geyer et al., 2007).  
Similarly in urine, the administration of 4 and 8 units did not show a statistically significant 
difference in females and males. After splitting the genders for statistical purposes, averaged 
over time and units, the females had a statistical significant decrease in the concentrations over 
time. The athlete defending a doping violation described in the introduction who had a high 
urinary LH concentration (28.9 IU/L), had a theoretically calculated maximum blood alcohol 
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concentration of 350 mg%, whereas our highest male volunteer, T10M at 1 h after 8 units, had 
111 mg% (Appendix 8.25 for serum alcohol results) and a LH urinary concentration of 1.385 
IU/L. Although the alcohol concentration was three times inferior, the urinary LH concentration 
was twenty times less thus it seems unlikely that his high urinary LH concentration was due to 
alcohol. 
The hypothesis that ethanol administration increases LH concentration thereby increasing 
urinary T concentration was not confirmed. 
The following chapter will verify whether alcohol administration suppresses catabolism of T by 
enzyme inhibition, e.g. 17 -HSD2, in serum via LC-MS/MS analysis. 
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5.1 Introduction 
5.1.1 Serum T and alcohol 
The target steroids of this chapter were testosterone, epitestosterone, their conjugates 
(testosterone sulfate, testosterone glucuronide, epitestosterone sulfate and epitestosterone 
glucuronide), and androstenedione in serum. These steroids are amenable to measurement by 
LC-MS/MS, necessitating the developement of such an assay for these target analytes. Thus, 
much of this chapter is devoted to the development and validation of an LC-MS/MS method to 
quantify these steroids and their conjugates, in serum.  
The validated procedure was then employed to investigate whether alcohol administration 
suppresses catabolism of T by enzyme inhibition, e.g. 17 -HSD2.  
Previous studies have demonstrated that alcohol intake (0.5 g/kg) increased serum T in females 
(Sarkola et al., 2001, Sarkola and Eriksson, 2003, Sarkola et al., 2000). In males, a low dose of 
alcohol (0.5 g/kg) has been reported to significantly increase serum T (Sarkola and Eriksson, 
2003), but with a higher dose (2.0 g/kg) and in very inebriated patients taken to the emergency 
room the opposite is verified (Frias et al., 2002, Karila et al., 1996). 
The proposed pathway to explain the increase in serum T in females and the consequent 
decrease in AD comes from the suppression of the activity of the 17 -HSD2 enzyme, which is 
responsible for the catabolism of T into AD. In the oxidation of T to AD by 17 -HSD2, the 
cofactor NAD
+
 is reduced to NADH. The enzymes that oxidise ethanol within the liver are also 
dependent on the cofactor NAD
+
, and Sarkola et al. hypothesized that alcohol metabolism is 
favoured over that of T (Sarkola et al., 2001). Presumably, because the amount of this cofactor 
presence is limited (Figure 5.1):  
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Figure 5.1 Effect of alcohol in the steroid metabolism in the liver, adapted from Sarkola et al. (2001)  
 
Our research studied the effects of alcohol (4 and 8 units on two different occasions) in 
eugonadal volunteers (9 females and 9 males) on serum testosterone, epitestosterone, their 
conjugates (testosterone sulfate, testosterone glucuronide, epitestosterone sulfate and 
epitestosterone glucuronide) and androstenedione. 
  
5.1.2 Liquid-Chromatography Mass- Spectrometry 
In liquid chromatography (LC), separation is normally achieved by the partitioning of the solute 
between the stationary phase and the mobile phase which is a liquid.  
Reversed-phase LC stationary phases use non-polar groups (commonly C18) bonded onto 
silica whereas in capillary GC the stationary phase is normally a non-volatile liquid 
(i.e. polymethylsiloxane) supported on a capillary column (Harris, 2003). 
A detector to register the eluting analytes is connected to the end of the column, such as a MS 
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The signal produced is typically Gaussian, or bell shaped (Figure 5.2) that describes a random 
process around the mean of a number of factors such as molecular collision. 
Chromatographically speaking, the Gaussian peak describes the detector’s response (Y) vs 
retention time (X). 
 
Figure 5.2 Gaussian peak 
 
In LC, the sample is injected into the column and pressure is applied to force the solvent 
through the column. In reversed-phase chromatography, a polar mobile phase is used and the 
stationary phase is non polar. The solute can dissolve in the stationary phase, and separation is 
achieved by a partitioning process based on differences in solute polarity and its solubility.  
Although partitioning is the predominant type of separation in this case, there are always other 
types of interactions such as adsorption and desorption between the solute and the carbon 
chains of the stationary phase (Christian, 2004b) (Figure 5.3). 
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Figure 5.3 Solvent molecules compete with solute ones for binding sites on the stationary phase. 
a) Solute adsorbed in the stationary phase and b) solvent and solute adsorbed in the stationary 
phase (Christian, 2004b) 
 
Each column has a limit of the maximum concentration that can be injected, above which 
partitioning does not occur. Above this concentration, the column is being overloaded as the 
size of the sample overwhelms the column’s capacity to hold the solutes. The ‘capacity’ of a 
column is a measure of its ability to bind the amount of material in a sample onto the stationary 
phase and produce good separation (Harris, 2003, Rubinson and Rubinson, 2000b). 
A mass-spectrometer may be coupled to the LC system and used as a detector. The most 
common ion sources used are electrospray ionisation (ESI) and atmospheric pressure chemical 
ionisation (APCI), the latter being commonly used for large molecules and non-polar 
compounds. 
The ion source used in this research was ESI and a brief description may be found below. This 
type of ionisation is good for charged, polar, basic and acidic compounds.  
In this ionisation process, the LC eluent containing the analyte is sprayed from a tip to which a 
strong electric field is applied at atmospheric pressure. The electric field causes a charge 
accumulation on the liquid surface, forming charged droplets at the tip. These droplets will 
possess an excess of either positive or negative charge, depending on the polarity of the 
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capillary. The droplets then pass through a curtain of inert gas at atmospheric pressure or a 
heated chamber at reduced pressure to evaporate the solvent. After the solvent evaporates, the 
droplets will reduce to such a small size that ions of the same polarity will repel and generate a 
Coulombic explosion, causing their division. These droplets undergo a series of explosions, 
making smaller droplets which pass into the MS detector (Watson and Sparkman, 2007). 
The MS used is a triple quadrupole in the selected reaction monitoring (SRM) mode, where only 
the most intense precursor and product ions are selected to improve sensitivity. 
In the first quadrupole (Q1) only the selected precursor ion(s) pass into the second quadrupole 
(Q2), which acts as a collision cell and fragments the ion(s). Those fragments pass onto the 
third quadrupole (Q3) where they are separated according to mass to charge and detected 
(Figure 5.4). 
 
Figure 5.4 Schematic representation of a triple quadrupole mass analyser (adapted) (Scott, 2008)  
 
5.1.3 Analyte concentration range in serum 
Before starting the method development and validation, reconnaissance of the literature 
regarding the concentrations of the analytes of interest in serum was undertaken and the most 
salient findings displayed in Table 5.1. 
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nmol/L ng/mL Reference nmol/L ng/mL Reference
9
 
Androstenedione 1.05 – 6.98 0.3 – 1.9 
(National Institute of Health, 
2009) 
1.4 – 5.2 0.4 - 1.5 
(National Institute of 
Health, 2009) 
Epitestosterone Serum epitestosterone concentration is 15 - 30 times inferior than in 
males. 
0.10 - 1.25 0.03 - 0.361 (Dehennin, 1993) 
    
Epitestosterone glucuronide There have been no published reports of EG concentrations in blood as concentration is most likely too low. 
Epitestosterone sulphate 
   
0.87 - 4.32 0.32 - 1.59 (Dehennin, 1993) 
Testosterone 0.6 - 2.5 0.2 - 0.7 (Burger, 2002) 8.3 - 33 2.4 – 9.5 
(National Institute of 
Health, 2009) 
Testosterone glucuronide 
   
1.3 - 2.1 0.60 - 0.97 (Peng et al., 2002) 
Testosterone sulphate N/A
10
 N/A N/A 0.03 - 14.9 0.01 - 5.5 (Dehennin, 1993) 
    
1.1 - 6.3 0.40 - 2.32 (Saez et al., 1967) 
                                                     
9
 Only one reference is displayed for each steroid, with references to earlier relevant publications being therein. 
10
 N/A – Not Available. No concentration range was found in the literature. 
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5.1.4 Method development  
Solid-phase extraction (SPE) is commonly used to extract steroids from biological matrices. The 
extraction procedure used in this research project had been previously developed and used a 
liquid-liquid extraction (LLE) with ethyl acetate (EtOAc), followed by protein precipitation with 
acetonitrile and solid-phase extraction (SPE) using ‘Hydrophilic Lipophilic Balanced’ (HLB) 
reversed-phase cartridges (Welchman, 2007). For the extraction method, please see section 
5.2.4.1. 
A literature review performed on steroid analysis by LC-MS showed that LLE using methyl-
tertiary-butyl ether (MTBE) or diethyl ether were also used, and were sometimes followed by 
SPE. A summary of the methods used, as well as the ionisation modes, and LLOQs may be 
found in Table 5.2. For simplification, steroids that were not of interest were not added to the 
table.  
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5.1.5 Choice of calibrants and quality controls 
The choice of calibrants prepared took into account the reference range for eugonadal men and 
women, and also that sometimes the upper limit may be exceeded (in volunteers receiving T 
replacement therapy; (Chapter 6). (Electronic Medicines Compendium, 2011). 
The minimum number of calibrants used was 6 but, in some cases, a higher number of 
standards were employed to cover for both female and male reference ranges. With T, the 
range was split in two to cover both ranges with calibrant 6 being the overlapping point.   
Table 5.3 Calibrant concentration in ng/mL 
Steroid 1 2 3 4 5 6 7 8 9 10 11 
Testosterone 0.05 0.08 0.1 0.5 1 2.5 5 7.5 10 15 20 
Epitestosterone 0.05 0.08 0.1 0.25 0.5 0.75 - - - - - 
Androstenedione 0.25 0.5 0.75 1 1.5 2 - - - - - 
TG 0.05 0.1 0.25 0.5 0.75 1 1.5 2 - - - 
TS 0.25 0.5 0.75 1 1.5 2 5 7.5 - - - 
ES 0.5 0.75 1 1.5 2 2.5    - - 
EG 0.5 0.75 1 1.5 2 2.5    - - 
 
For the quality controls, serum from female and male volunteers was collected and steroid 
concentration measured. As mentioned in Chapter 3, the criteria for a low QC is to be ideally 
around 25 % of the calibration range, the medium QC in the middle range, and the high QC 
between 75-100 % of the highest concentration in the range. A low, medium and high QC was 
prepared for all the steroids, except for T where a low and high for each range was decided.  
The serum was spiked to achieve the appropriate QC concentration, which may be found in 
Table 5.4.  
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Table 5.4 QC range for serum analysis in LC-MS/MS (ng/mL) 
Steroid Low 1 High 1 Low 2 High 2 
Testosterone 0.06 1.25 3.00 17.00 
  Low  Medium High  
 
Epitestosterone 0.08 0.40 0.70 
 
Androstenedione 0.27 1.30 1.80 
 
TG 0.12 0.60 1.25 
 
EG 0.60 1.25 2.00 
 
TS 0.25 1.00 6.50 
 
ES 0.60 1.00 2.00 
 
 
5.1.6 Method validation 
The method was validated against accepted criteria (CPMP/ICH/281 & 381 guidelines) for 
linearity, specificity, lower limit of quantification (LLOQ), accuracy and precision. These were the 
same parameters as were used for validating the method in Chapter 3, section 3.1.2.  
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5.2 Material and methods 
5.2.1 Materials 
Vacutainers  (SST™II Advance) for blood serum separation were obtained from BD Diagnostics 
(Oxford, UK). T, E, AD, TG, EG, TS and ES were obtained from Promochem (Teddington, UK). 
Ammonium acetate, ethyl acetate, acetonitrile and methanol (both HPLC grade) were all 
obtained from Fisher Scientific (Loughborough, UK). The deuterated internal standards d3T, 
d3E, d3AD, d3TG, d3EG, d3TS and d3ES all labeled at positions 16, 16, 17  except for AD which 
is at position 19, were supplied by the National Analytical Reference Laboratory (Sidney, 
Australia). The Oasis
®
 HLB cartridges were obtained from Waters™ (Manchester, UK). The 
centrifuge tubes were purchased from Eppendorf™ (Cambridge, UK). PBS tablets and human 
albumin solution from Sigma-Aldrich (Poole, UK). 
 
5.2.2 Volunteer study and sample collection 
The serum samples used were those collected from the volunteer study described in Chapter 3, 
section 3.2.3. In summary, 9 females and 9 males were recruited and their samples labelled 
accordingly. The volunteers were administered with 4 or 8 units of alcohol at least 2 weeks later, 
cannulated and blood was collected pre-alcohol administration, and post-administration hourly 
from 1 h to 6 h, then at 24 h and at 48 h. The blood was collected into Vacutainers  with a 
separating gel and allowed to stand for 30 min, after which it was centrifuged for 5 min at 
1,000 g.  
The female volunteers were not on any hormonal contraceptive. 
The alcohol concentration in serum was measured by Mr. Peter Streete from the Medical 
Toxicology Laboratory at St. Thomas’ Hospital, GSTS Pathology (see Appendix 8.24, Appendix 
8.25, Appendix 8.26 and Appendix 8.27). 
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5.2.3 Preparation of calibrant standards and deuterated mixture 
5.2.3.1 Combined internal standard mixture 
To prepare the stock solution, the ampoules containing the liquid internal standard of interest at 
approximately 1 mg (d3T, d3E, d3AD, d3TG, d3EG, d3TS and d3ES) was opened and its contents 
dissolved in methanol and transferred into a 10 mL volumetric flask. The ampoule was washed 
with methanol approximately 10 times. The solutions were kept in the freezer at an indicated 
temperature -20 °C. The final internal standard mixture was prepared in 50/50 CH3OH/H2O 
(200 mL) at the concentrations shown in Appendix 8.29. To each calibrant and sample, 25 L of 
the mixture was added and the final concentration present in each sample shown in Appendix 
8.28 and Appendix 8.29. 
  
5.2.3.2 Artificial serum 
Artificial serum (Raggi et al., 1999) was prepared by spiking PBS (0.05 M) with human serum 
albumin (0.56 mM, 3.36 g in 10 mL) to better mimic the concentration found in human serum 
(Dunn et al., 1981). 
 
5.2.3.3 Preparation of calibrants 
All the calibrants were prepared in artificial serum. To 490 L of artificial serum, 10 L of 
previously prepared calibrants (in water) were added and spiked with 25 L of the internal 
standard mixture. 
 
5.2.4 Experimental design 
5.2.4.1 Extraction procedure 
For the extraction, 500 L of sample were transferred into 2 mL centrifuge tubes together with 
25 L of internal standard and 1 mL of ethyl acetate. The samples were vortex mixed then 
centrifuged for 5 min at 17,320 g. The supernant was transfered into a glass tube, and to the 
aqueous layer (serum) 1 mL of acetonitrile was added. The samples were vortex mixed and 
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centrifuged again as described previously. The supernant was transferred to the glass tube and 
the samples evaporated under nitrogen at 80°C ±5 °C for 20 min. The samples were then 
reconstituted in 500 L of PBS for loading onto SPE cartridges. The HLB cartridges were 
conditioned with methanol (1 mL) and equilibrated with water (1 mL). The samples (500 L) 
were then loaded onto the cartridge, washed with water (1 mL). Elution was with ethyl acetate 
(1 mL) and then methanol (1 mL), the organic layer solvent was then evaporated at 80°C ±5 °C 
under nitrogen for 15 min. 
The samples were reconstituted in 100 L of LC mobile phase and centrifuged under the same 
conditions as above. The supernants were transfered into autosampler vials and analysed by 
LC-MS/MS. 
 
5.2.4.2 LC-MS/MS conditions 
The LC-MS/MS method was developed and validated using a Waters™ XEVO TQS, (triple 
quadrupole) with an ESI source. The LC column used was a Waters™ C18 BEH phase, 2.1 x 50 
mm, 1.7 m particle size. The column temperature was kept at 30°C and the mobile phase was 
composed of 7.5 mM of ammonium acetate in water with 0.1 % acetic acid (A), and 7.5 mM of 
ammonium acetate in methanol with 0.1 % acetic acid (B). 
The elution conditions were as provided in Table 5.5. 
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5.2.5 Data analysis 
The statistical treatment in data analysis was performed using the software Statistical Package 
for Social Sciences (SPSS®), version 18, from SPSS® Inc, Chicago, IL, USA. The results were 
statistically treated using a general linear model with repeated measures. The significance limit 
was set to p-value <0.05. This statistical treatment tests for significant changes and by 
inspection of graphs and statistical tables it is possible to say if that change is an increase or a 
decrease. 
All the calibrants and samples were plotted using a linear weighted regression calibration. 
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5.3 Results and discussion 
5.3.1 Method validation 
The transitions for the analytes were determined by infusion. They were detected and quantified 
in selected reaction monitoring (SRM) mode and the transitions monitored for each analyte 
were the most intense ones shown in Table 5.6. The table shows the precursor, the quantifier 
and the qualifier ions, together with the transition’s collision energy and cone voltages. The 
integration period time for each peak was set to a few seconds before/after the peak 
started/finished, which was at approximately 0.20 min of the retention of the time of each peak’s 
maximum. 
 











Energy (V) of 
quantifier ion 
T 289 97 97, 109, 123 25 20 
d3T 292 97 97, 109 25 20 
E 289 97 97, 109, 123 38 22 
d3E 292 97 97, 109, 274 25 22 
AD 287 97 97, 109, 123 20 20 
d3AD 290 100 100, 109 25 20 
TG 465 289 289, 109, 253 34 18 
d3TG 468 97 97, 292, 109 25 25 
EG 465 289 289, 271, 109 25 10 
d3EG 468 97 97, 109 25 30 
TS 369 97 97, 109, 123 15 22 
d3TS 373 97 97, 109 25 22 
ES 369 271 271, 97 15 15 
d3ES 373 97 97, 109 25 24 
 
The capillary voltage was optimized for T and set at 1 kV. The desolvation temperature was 
500 °C and the gas flow 1,000 L/hr. 
With the current 6 min method, all the analytes were totally resolved (see Figure 5.5 showing 
the product ion chromatogram from the High QC).  Only the first 4 minutes of the run is 
displayed, as all the analytes had eluted within that time. 
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Figure 5.5 LC-MS/MS chromatogram of the high QC with the 7 analytes monitored: TG, TS, ES, EG, 
AD, T and E (ng/mL) 
 
To assure that in the serum samples to be analysed there would be no co-eluting analytes that 
would have the same retention time and transitions as our compounds, a long 18 minute-run 
method was performed to check that no co-eluting compounds were interfering in the 6 minute 
run. 
Both positive and negative mode were tried, and although the sulphates showed more intense 
peak transitions in negative mode, ES co-eluted with dehydroepiandrosterone (DHEA) sulphate. 
This compound has the same molecular weight and SRM transitions as ES and it is present in 
serum at concentrations between 800-5,600 ng/mL in males and 350-4,300 ng/mL in females 
(National Institute of Health, 2009), therefore preventing the detection and quantification of ES. 
DHEA sulphate was not detected in positive mode thus this was the mode chosen for 
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measuring ES, which does ionise in both negative and positive modes (although more sensitive 
in the former). 
 
5.3.1.1 Calibrant matrix 
A suitable matrix for calibrants was sought in order to be able to have good traceability of 
analyte concentration while reliably mimicking blood serum, the matrix of interest.  
Calf serum was analysed but found to contain the steroids being targetted and thus was 
excluded as a matrix.  
Steroid stripped serum was also investigated but also contained small amounts of target 
steroids and therefore a laborious method to strip the serum would have been required. 
Artificial serum was prepared (see section 5.2.3.2), spiked with 5 ng/mL of T (methanolic 
solution added with a glass syringe) and extracted in triplicate. This concentration was 
compared with a serum sample containing the same concentration (estimated by standard 
addition). 
Standard addition is a method in which the exact concentration of a sample is determined by 
adding constant increments of the analyte of interest. In this case, 5 ng/mL of testosterone 
(equivalent to the approximate concentration estimated to be present) were added, and, from 
the resulting line, the intercept calculated to determine the concentration in the original sample. 
A two-sample t-test assuming equal variance was performed on the concentrations of obtained 
from artificial serum and human serum.  The variances were not statistically different (p >0.05), 
strongly indicating that there was no difference in matrix effects regarding the measurement of T 
(and most likely the other target analytes). The artificial serum was, therefore, deemed suitable 
as a matrix for preparing the calibrants.  
 
5.3.1.2 LLOQ 
The LLOQ was measured using the smallest concentration of analyte that can be measured for 
which the S/N is 1:10 prepared in artificial serum. The concentration of the smallest analyte 
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should have an accuracy and precision of < 20 % and therefore each standard whose initial 
estimate of S/N was 10:1, was prepared and extracted 4 times. 
The LLOQs for T, E and TG were 0.05 ng/mL, 0.25 ng/mL for AD and TS and 0.5 ng/mL for EG 
and ES. 
 
5.3.1.3 Extraction recovery 
The extraction recovery was determined by comparing the signals (peak area) from analysis of 
extracted calibrants with un-extracted standards, in the low, medium and high range for T and in 
the low and high range for AD, the main analytes of interest. For T, at 0.5 ng/mL recovery was 
64 %, at 5 ng/mL 103 % and at 15 ng/mL it was 124 %. For AD, at 0.5 ng/mL it was 113 % and 
at 2 ng/mL it was 90 %. 
  
5.3.1.4 Carry-over 
Carry-over was tested by injecting a five times a mobile phase blank sample after the highest 
calibrant standard. The presence of any of the analytes was < 0.1 % of peak area.  
 
5.3.2 Validation criteria 
Validation was performed by extracting each QC three times on three different days. The 
concentration of each QC was calculated by plotting it against a calibration curve with standards 
prepared fresh on the day. The parameters used were the same ones as mentioned in Chapter 
3 which may be found below: 
Equation 5.1 Accuracy (within assay) 
 
(< ± 20 % LLOQ, < ± 15 % other points) 
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Equation 5.2 Average accuracy (between assay) 
 
(< ± 10 %) 
 
Equation 5.3 Repeatability 
 
(< 10 %) 
 
Equation 5.4 Reproducibility 
 
(< 10 %) 
 
Equation 5.5 Average precision (between assay) 
 
(< 10 %) 
 
The QCs were monitored in every run and they were within the acceptance criteria of ±2 SD). 
This represents 20 % of the relative standard deviation.  
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Figure 5.10 LOW QC monitoring for serum E 
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Figure 5.12 HIGH QC monitoring for serum E 
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Figure 5.19 LOW QC monitoring for serum TS 
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5.3.3 Method validation for the quantification of serum T 
5.3.3.1 Calibration range 
The lowest calibrant, at the LLOQ, had a percentage accuracy (within assay) <±20%, and the 
remaining calibrants <±15 %, passing the validation criteria. The linearity of the calibration plots 
(r
2
 value), for the 3 day validation of T, for both ranges was 0.99. 
 
5.3.3.2 Quality controls validation  
Table 5.7 Validation of serum T for LOW1 and HIGH1 QCs (low range) 
 
Day 1 Day 2 Day 3 
  
Day 1 Day 2 Day 3 
LOW1 QC 0.05 0.07 0.07 
 
HIGH1 QC 1.02 1.10 1.25 
(ng/mL) 0.05 0.07 0.07 
 
(ng/mL) 1.05 1.10 1.22 
 
0.05 0.07 0.06 
  
1.06 1.08 1.22 
Mean 
(ng/mL) 




1.0 1.1 1.2 
% Accuracy -20.3 15.3 4.5 
 
% Accuracy -16.7 -12.6 -1.6 
SD (ng/mL) 0.0 0.0 0.0 
 
SD (ng/mL) 0.0 0.0 0.0 
% CV 3.1 1.7 7.2 
 
% CV 1.9 1.3 1.1 
 




%Accuracy (between assay) -0.2 
 
%Accuracy (between assay) -10.3 
%Precision (within assay) 4.0 
 
%Precision (within assay) 1.4 
%Precision (between assay) 4.0 
 
%Precision (between assay) 1.4 
 
Table 5.9 Validation of serum T for LOW2 and HIGH2 QCs (high range) 
 
Day 1 Day 2 Day 3 
  
Day 1 Day 2 Day 3 
LOW2 QC 2.94 2.83 2.60 
 
HIGH2 QC 17.56 16.64 14.77 
(ng/mL) 2.97 2.85 2.66 
 
(ng/mL) 16.85 16.30 17.22 
 
2.95 2.77 2.72 
  
16.43 17.16 16.45 
Mean 
(ng/mL) 




16.9 16.7 16.1 
% Accuracy -1.5 -6.0 -11.4 
 
% Accuracy -0.3 -1.8 -5.0 
SD (ng/mL) 0.0 0.0 0.1 
 
SD (ng/mL) 0.6 0.4 1.3 
% CV 1 1 2 
 
% CV 3.4 2.6 7.8 
 




%Accuracy (between assay) -6.3 
 
%Accuracy (between assay) -2.4 
%Precision (within assay) 1.4 
 
%Precision (within assay) 4.6 
%Precision (between assay) 1.4 
 
%Precision (between assay) 4.5 
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The accuracy should be < ±15 % or < ±20 % if it is at the LLOQ and the CV < ±10 %. All the 
QCs in the low range and in the high range passed the criteria so the method was successfully 
validated for serum T. 
 
5.3.4 Method validation for the quantification of serum E 
5.3.4.1 Calibration range 
The lowest calibrant, at the LLOQ, had a percentage accuracy (within assay) <±20%, and the 
remaining calibrants <±15 %. The linearity of the calibration plots (r
2
 value), for the 3 day 
validation of E, from 0.05 to 0.75 ng/mL was 0.99. 
  
5.3.4.2 Quality controls validation  
Table 5.11 Validation of serum E for LOW, MEDIUM and HIGH QCs  
 
Day 1 Day 2 Day 3 
 
 
Day 1 Day 2 Day 3 
LOW QC 0.08 0.07 0.07 
 
MEDIUM QC 0.42 0.40 0.43 
(ng/mL) 0.08 0.08 0.07 
 
(ng/mL) 0.39 0.42 0.41 
 
0.08 0.08 0.07 
  
0.40 0.40 0.35 
Mean 
(ng/mL) 




0.40 0.40 0.39 
% Accuracy -3.5 -3.5 -9.1 
 
% Accuracy 0.4 0.7 -1.5 
SD (ng/mL) 0.0 0.0 0.0 
 
SD (ng/mL) 0.0 0.0 0.0 
% CV 0.6 5.5 3.3 
 
% CV 4.2 3.1 10.2 
 
 
Day 1 Day 2 Day 3 
HIGH QC 0.73 0.79 0.77 
(ng/mL) 0.72 0.76 0.76 
 
0.73 0.76 0.77 
Mean 
(ng/mL) 
0.73 0.77 0.77 
% Accuracy 3.9 10.3 9.7 
SD (ng/mL) 0.0 0.0 0.0 
% CV 0.8 2.4 0.7 
 




%Accuracy (between assay) -5.4 
 
%Accuracy (between assay) -0.1 
%Precision (within assay) 3.1 
 
%Precision (within assay) 5.8 
%Precision (between assay) 3.1 
 
%Precision (between assay) 5.8 
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HIGH QC 
%Accuracy (between assay) 8.0 
%Precision (within assay) 1.3 
%Precision (between assay) 1.3 
 
The accuracy and CV were below the required parameters, and the calibrants were within the 
acceptance criteria thus the QCs passed the criteria and the method was validated for serum E. 
 
5.3.5 Method validation for the quantification of serum AD 
5.3.5.1 Calibration range 
The lowest calibrant, at the LLOQ, had a percentage accuracy (within assay) <±20%, and the 
remaining calibrants <±15 %. The linearity of the calibration plots (r
2
 value), for the 3 day 
validation of AD, from 0.25 to 2 ng/mL was 0.99. 
  
5.3.5.2 Quality controls validation  
Table 5.13 Validation of serum AD for LOW, MEDIUM and HIGH QCs  
 
Day 1 Day 2 Day 3 
 
 
Day 1 Day 2 Day 3 
LOW QC 0.24 0.27 0.25 
 
MEDIUM QC 1.29 1.31 1.19 
(ng/mL) 0.22 0.29 0.26 
 
(ng/mL) 1.29 1.26 1.22 
 
0.23 0.30 0.23 
  
1.29 1.24 1.60 
Mean 
(ng/mL) 




1.29 1.27 1.34 
% Accuracy -16.2 5.4 -9.2 
 
% Accuracy -0.8 -2.3 3.1 
SD (ng/mL) 0.0 0.0 0.0 
 
SD (ng/mL) 0.0 0.0 0.2 
% CV 4.6 4.9 5.4 
 
% CV 0.3 2.9 16.9 
 
 
Day 1 Day 2 Day 3 
HIGH QC 2.00 1.73 1.38 
(ng/mL) 1.84 1.70 1.76 
 
1.77 1.75 1.71 
Mean 
(ng/mL) 
1.87 1.73 1.62 
% Accuracy 3.7 -4.1 -10.3 
SD (ng/mL) 0.1 0.0 0.2 
% CV 6.3 1.3 12.9 
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%Accuracy (between assay) -6.7 
 
%Accuracy (between assay) 0.0 
%Precision (within assay) 5.0 
 
%Precision (within assay) 6.7 
%Precision (between assay) 5.0 
 
%Precision (between assay) 6.9 
 
HIGH QC 
%Accuracy (between assay) -3.6 
%Precision (within assay) 6.8 
%Precision (between assay) 6.7 
 
Both accuracy and precision were within the required criteria as long as the calibrants linearity 
thus the QCs passed and the method was validated for serum AD. 
 
5.3.6 Method validation for the quantification of serum TG 
5.3.6.1 Calibration range 
The lowest calibrant, at the LLOQ, had a percentage accuracy (within assay) <±20%, but the 
2
nd
 calibrant was above the acceptance criteria of <±15 %. The linearity of the calibration plots 
(r
2 
value), for the 3 day validation of TG, from 0.05 to 2 ng/mL was 0.99, 0.99 and 0.98. The 
calibration range was thus accepted and the QC validation followed. 
  
5.3.6.2 Quality controls validation  
Table 5.15 Validation of serum TG for LOW, MEDIUM and HIGH QCs  
 
Day 1 Day 2 Day 3 
 
 
Day 1 Day 2 Day 3 
LOW QC 0.13 0.11 0.11 
 
MEDIUM QC 0.69 0.71 0.64 
(ng/mL) 0.13 0.10 0.12 
 
(ng/mL) 0.69 0.69 0.67 
 
0.14 0.11 0.13 
  
0.69 0.68 0.66 
Mean 
(ng/mL) 




0.69 0.69 0.65 
% Accuracy 13.2 -12.4 -2.7 
 
% Accuracy 15.3 15.2 9.1 
SD (ng/mL) 0.0 0.0 0.0 
 
SD (ng/mL) 0.0 0.0 0.0 
% CV 5.0 5.3 9.1 
 
% CV 0.3 2.0 2.3 
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Day 1 Day 2 Day 3 
HIGH QC 1.25 1.15 1.13 
(ng/mL) 1.17 1.11 1.07 
 
1.11 1.15 1.08 
Mean 
(ng/mL) 
1.18 1.14 1.09 
% Accuracy -5.9 -8.9 -12.7 
SD (ng/mL) 0.1 0.0 0.0 
% CV 5.7 1.9 3.1 
 




%Accuracy (between assay) -0.6 
 
%Accuracy (between assay) 13.2 
%Precision (within assay) 6.4 
 
%Precision (within assay) 1.5 
%Precision (between assay) 6.4 
 
%Precision (between assay) 1.5 
 
HIGH QC 
%Accuracy (between assay) -9.2 
%Precision (within assay) 3.6 
%Precision (between assay) 3.6 
 
Accuracy and precision were also within the acceptance criteria therefore the QCs passed and 
the method was validated for serum TG. 
 
5.3.7 Method validation for the quantification of serum EG 
5.3.7.1 Calibration range 
The lowest calibrant, at the LLOQ, had a percentage accuracy (within assay) <±20%, but the 
other calibrants failed to pass the acceptance criteria of <±15 %. The linearity of the calibration 
plots (r
2 
value), for the 3 day validation of EG, from 0. 5 to 2.5 ng/mL was 0.98, 0.96 and 0.92. 
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5.3.7.2 Quality controls validation  
Table 5.17 Validation of serum EG for LOW, MEDIUM and HIGH QCs 
 
Day 1 Day 2 Day 3 
 
 
Day 1 Day 2 Day 3 
LOW QC 0.51 0.58 0.57 
 
MEDIUM QC 1.32 1.11 1.00 
(ng/mL) 0.46 0.58 0.59 
 
(ng/mL) 1.38 1.06 1.05 
 
0.50 0.58 0.56 
  
0.99 1.17 1.05 
Mean 
(ng/mL) 




1.23 1.11 1.04 
% Accuracy -18.1 -3.6 -4.3 
 
% Accuracy -1.5 -11.1 -17.1 
SD (ng/mL) 0.0 0.0 0.0 
 
SD (ng/mL) 0.2 0.1 0.0 
% CV 6.1 0.8 3.2 
 
% CV 16.9 4.8 2.7 
 
 
Day 1 Day 2 Day 3 
HIGH QC 2.13 1.73 1.73 
(ng/mL) 2.31 1.89 1.92 
 
1.98 2.02 1.77 
Mean 
(ng/mL) 
2.14 1.88 1.81 
% Accuracy 7.0 -6.0 -9.6 
SD (ng/mL) 0.2 0.1 0.1 
% CV 7.8 7.6 5.6 
  




%Accuracy (between assay) -8.7 
 
%Accuracy (between assay) -9.9 
%Precision (within assay) 3.4 
 
%Precision (within assay) 8.1 
%Precision (between assay) 3.2 
 
%Precision (between assay) 8.6 
 
HIGH QC 
%Accuracy (between assay) -2.8 
%Precision (within assay) 7.0 
%Precision (between assay) 7.0 
 
Accuracy and precision for the QCs was within the acceptance criteria, but since some 
calibrants were not within the required accuracy range nor did the range show linearity (r
2 
> 
0.99), the method was not validated for serum EG. 
 
Chapter 5: Investigating the effect of alcohol on serum androgens in eugonadal men and women 
 
- 217 - 
5.3.8 Method validation for the quantification of serum TS 
5.3.8.1 Calibration range 
The lowest calibrant, at the LLOQ, did not have a percentage accuracy (within assay) <±20%, 
not did the 2
nd
 calibrant of <±15 % (it was approximately ±20 %). The linearity of the calibration 
plots (r
2 
value), for the 3 day validation of TS, from 0. 25 to 7.5 ng/mL was 0.99.  
 
5.3.8.2 Quality controls validation  
Table 5.19 Validation of serum TS for LOW, MEDIUM and HIGH QCs 
 
Day 1 Day 2 Day 3 
 
 
Day 1 Day 2 Day 3 
LOW QC 0.25 0.27 0.22 
 
MEDIUM QC 0.94 0.98 0.96 
(ng/mL) 0.24 0.27 0.25 
 
(ng/mL) 0.96 1.02 1.03 
 
0.22 0.28 0.21 
  
0.92 1.04 1.00 
Mean 
(ng/mL) 




0.94 1.01 1.00 
% Accuracy -5.8 9.5 -8.8 
 
% Accuracy -6.1 1.3 -0.2 
SD (ng/mL) 0.0 0.0 0.0 
 
SD (ng/mL) 0.0 0.0 0.0 
% CV 6.7 2.6 9.9 
 
% CV 1.9 3.0 3.6 
 
 
Day 1 Day 2 Day 3 
HIGH QC 6.44 6.13 6.89 
(ng/mL) 6.26 5.89 6.60 
 
6.08 6.14 6.44 
Mean 
(ng/mL) 
6.26 6.05 6.65 
% Accuracy -3.7 -6.9 2.2 
SD (ng/mL) 0.2 0.1 0.2 
% CV 2.9 2.4 3.4 
 




%Accuracy (between assay) -1.7 
 
%Accuracy (between assay) -1.7 
%Precision (within assay) 6.4 
 
%Precision (within assay) 2.8 
%Precision (between assay) 6.2 
 
%Precision (between assay) 2.9 
 
HIGH QC 
%Accuracy (between assay) -2.8 
%Precision (within assay) 2.9 
%Precision (between assay) 2.9 
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Despite the fact that the lowest calibrants were not within the acceptance criteria, the range 
showed linearity and the QCs were all within the required parameters, therefore TS was 
considered to have been validated. 
 
5.3.9 Method validation for the quantification of serum ES 
5.3.9.1 Calibration range 
The lowest calibrant, at the LLOQ, in the first day of validation did not have a percentage 
accuracy (within assay) <±20%, not did the 2
nd
 calibrant of <±15 %. The linearity of the 
calibration plots (r
2 
>0.99), for the 3 day validation of ES, from 0. 5 to 2.5 ng/mL was 0.93, 0.99 
and 0.99.  
5.3.9.2 Quality controls validation  
Table 5.21 Validation of serum ES for LOW, MEDIUM and HIGH QCs 
 
Day 1 Day 2 Day 3 
 
 
Day 1 Day 2 Day 3 
LOW QC 0.46 0.63 0.60 
 
MEDIUM QC 0.95 1.03 0.99 
(ng/mL) 0.51 0.62 0.64 
 
(ng/mL) 0.88 1.07 1.01 
 
0.46 0.58 0.56 
  
0.80 1.03 1.01 
Mean 
(ng/mL) 




0.87 1.04 1.00 
% Accuracy -20.9 1.6 -0.2 
 
% Accuracy -12.5 4.3 0.2 
SD (ng/mL) 0.0 0.0 0.0 
 
SD (ng/mL) 0.1 0.0 0.0 
% CV 6.1 4.0 6.4 
 
% CV 8.5 2.3 1.5 
 
 
Day 1 Day 2 Day 3 
HIGH QC 1.84 1.94 1.85 
(ng/mL) 1.72 1.88 1.74 
 
1.64 1.90 1.86 
Mean 
(ng/mL) 
1.73 1.91 1.81 
% Accuracy -13.5 -4.6 -9.3 
SD (ng/mL) 0.1 0.0 0.1 
% CV 5.9 1.4 3.8 
 




%Accuracy (between assay) -6.5 
 
%Accuracy (between assay) -2.6 
%Precision (within assay) 5.5 
 
%Precision (within assay) 4.1 
%Precision (between assay) 5.4 
 
%Precision (between assay) 3.9 
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HIGH QC 
%Accuracy (between assay) -9.1 
%Precision (within assay) 3.7 
%Precision (between assay) 3.6 
 
Despite the fact that the lowest calibrants were not within the acceptance criteria, the range 
showed linearity, apart from day 1, and the QCs were all within the required parameters, 
therefore ES was considered to have been validated. 
 
5.3.10 Comments on the validation  
It is not uncommon to have higher errors at the low end of the calibration range which, in 
principle, should not exceed an accuracy >20 %. In these situations, provided that there is 
linearity for the calibration range, the validation was considered to have passed. 
For the analytes where these situations occurred or even in the case of ES where in day 1 the 
range did not show linearity, the analyte was monitored carefully in each run to verify if linearity 
or differences in accuracy in the mid and high range occurred.  
Samples T9M-S-8U-2h and T9M-S-8U-6h (Appendix 8.32) were outliers in that they did not 
have a quantifiable TG concentration and the TS concentrations were higher than the group 
mean (approximately 27 times more).  
 
5.3.11 Serum sample analysis 
Statistical treatment was performed as for the previous chapters. The post-administration data 
was averaged irrespective of gender, time or units and the data was normalized using 
proportion increase against pre-administration as follows: 
 
Equation 5.6 Normalization of values for statistical treatment 
 
 
Chapter 5: Investigating the effect of alcohol on serum androgens in eugonadal men and women 
 
- 220 - 
A similar situation as to what happened in previous chapters occurred with this analysis, which 
was that the samples collected at 24 h and 48 h had already reached baseline values. A 
comparison between baseline value (baseline sample taken before alcohol ingestion) and these 
two samples was performed to ascertain if the response was different to the 4 and 8 units 
administered. The results were not statistically significant with serum T having a p-value =0.239 
and the value for AD being p-value =0.577 and hence the last two measurements (24 and 48 h) 
were excluded from the statistical treatment. As an added test of reliability of the baseline 
values, the mean of the values determined in the pre-administration, 24 h and 48 h samples 
was used as the baseline value. 
Except with T, all the analytes had certain samples in which the concentration obtained was 
below the LLOQ (Table 5.23). 
Table 5.23 Percentage of eugonadal samples with concentrations below the LLOQ, in LC-MS/MS 
Steroid 
Percentage of samples < LLOQ 







T - - - - 
E 36 % 100 % 52 % 98 % 
AD 9.7 % - 17 % 0.05 % 
TG 43 % 35 % 47 % 37 % 
TS 35 % 92 % 27 % 91 % 
ES 100 % 100 % 96 % 100 % 
 
In a series of samples from a particular volunteer, if there were more than 25 % of the post-
administration samples below the LLOQ, it was decided not to perform any statistical analysis 
since increases would most likely not be verified. 
The difference in quantifiable TG between volunteers may be related to an absence of the 
UGT2B17 enzyme (caused by a double deletion in the UGT2B17 gene) responsible for the 
conjugation of T.  Genetic tests on these samples have not been performed yet due to time 
constraints. 
Statistical analysis was done with T and AD in serum samples. Since we were interested in 
concentration differences and not absolute values per se, where samples had values < LLOQ, 
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after discussion with the statistician, we were advised to change that value to half of the LLOQ 
of the analyte for statistical treatment purposes. 
The serum concentrations for males and females after 4 units may be found Appendix 8.30 and 
Appendix 8.31, respectively. The concentrations for males and females after 8 units follow in 
Appendix 8.32 and Appendix 8.33. 
  
5.3.12 Serum T concentration analysis 
The normalized mean serum T response (proportion increased when compared with pre-
administration) was significantly different for 4 and 8 units (p <0.05) across time. There were 
gender differences (p <0.05) and although females showed a higher response averaged over 
time, that response was not significantly different between 4 and 8 units (p >0.05). At 4 units, 
serum T increases up to 3 h then it decreases reaching baseline at 5 h. After 8 units, it 
increases up to 6 h having reached baseline at 24 h. 
Since there were gender differences but no dose difference averaged over time and gender (p 
>0.5) the data will be presented in a graph with the mean normalized values for each collection 
point, averaged for the two units but independent of gender (Figure 5.25). 
The concentration of T in serum increased in the female volunteers following alcohol 
administration. By contrast, there was a decrease in the male volunteers. 
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Figure 5.25 Normalized mean serum T values, for males and females, units averaged 
 
The raw values (not normalized), after 8 units, for females and males have also been plotted 
and may be found in Figure 5.26. Since the serum T concentration in females is approximately 
one tenth that of males, these were plotted on a secondary axis on the right hand-side. 
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5.3.13 Serum AD concentration analysis 
Statistical treatment of serum AD values showed that there were no gender differences 
(p >0.05) after data normalization related to pre-administration values. The serum AD response 
was different for 4 and 8 units (p <0.05) averaged over time and gender. The type of response 
that females and males show, averaged over time is different when the units increase (p <0.05). 
There were changes with time (p <0.05), and the AD concentration time plot for 4 and 8 units 
(gender averaged) was different (p <0.05), showing a decrease in AD concentration.  
Since the unit dose was significantly different but there were no gender differences, the data will 
be presented in a graph with the mean normalized values for each collection point, averaged 
over gender for the two different units (Figure 5.27). 
There was a decrease after 4 and 8 units which was more accentuated in the latter. The 
concentration started increased after 1 h with 4 units and after 2 h with 8 units. However, that 
increase never reached baseline during the 6 h collection.  
 
  
Figure 5.27 Normalized serum AD values, for 4 and 8 units, gender averaged 
 
The mean raw concentrations for serum AD, after 8 units, for males and females may be found 
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Figure 5.28 Mean serum AD raw concentrations, for males and females, after 8 units 
5.3.14 Correlations 
Correlation statistics were applied to investigate whether there was any relationship between 
serum T and AD, serum T and urinary T/E, serum T and the serum alcohol concentration, as 
well as serum AD and serum alcohol concentration.  
Administration of alcohol to females resulted in an increase in serum T and a fall in serum AD. 
The correlation between serum T and AD, for females taking 4 units of alcohol, showed a 
significant difference between subjects (p <0.05), but there was no effect overall possibly due to 
the fact that each individual is so different that masks the overall effect. The suppression of AD 
has an effect in the interaction between AD and serum T but it is a subject-based one. 
With administration of 8 units of alcohol to females, overall there is a correlation that is 
significant, but it varies between subject, not being consistently negative meaning that it is not 
always the case that serum T increases when serum AD decreases. 
For males, with serum T and serum AD decreasing, after 4 units and 8 units of alcohol, there is 
barely any correlation. 
Serum T correlated with urinary T/E did not show any significant effect for females and males, 
after 4 units. After 8 units, there was an overall correlation but even the best-fitted trendline was 
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Considering serum T and serum alcohol concentration, there was an overall positive correlation 
but each individual showed different behaviours, some showing a negative correlation. This may 
be because the ‘clock-time’ for the metabolism of these analytes is different and we are 
analysing them at the same time.  
Finally, considering serum AD and serum alcohol concentration there was an overall negative 
correlation, which was clearer than with serum T. 
Most likely, T and AD are being necessary in other parts of metabolism that are not exclusive to 
alcohol, and the rate at which this is occurring is individual to each analyte. There is also the 
possibility of it being a ‘lag’ between the time alcohol enters the body and the time that it starts 
having an effect in the desired analytes. The metabolic rates of alcohol elimination have a 
considerable inter-individual variability (Eckardt et al., 1998). This is most likely due to allelic 
variants of the genes that encode ADH and ALDH. Functional polymorphisms in these genes 
have shown to increase the variance amongst individuals and this variance may be related to 
this ‘lag’.  
The same happening when correlating serum T with T/E, with the analytes being produced and 
excreted at different rates. 
It is not possible, in most cases, to have clear information since it would be necessary to have 
more data points to better correlate our data.  
In summary, it is not straightforward to correlate this data as more data points would have been 
necessary. Our initial experiment design was not set-up to determine these measurements but 
to verify if there were significant changes in the desired analytes due to alcohol, which was 
achieved. 
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5.4 Conclusions 
The analysis of serum samples via LC-MS/MS after 4 and 8 units of alcohol, (approximately 0.5 
and 1.0 g/kg) in eugonadal males and females, shows that males and females are affected 
differently. The serum T concentration time pattern varies with the different units, and between 
females and males.  
This agrees with the findings by Sarkola et al. where after 0.5 g/kg in females, there was an 
increase in serum T which was significantly different (Sarkola et al., 2001). It also agrees with 
the findings of Frias et al. in which alcohol suppressed serum T in males (Frias et al., 2002)  
However, the increases observed in eugonadal females in this study were more modest in 
comparison to the study by Sarkola et al. where a blood alcohol concentration of 5 mmol/L 
reflected an increase in plasma T from 0.14 ng/mL to 0.6 ng/mL (Sarkola et al., 2001) when 
compared to an increase from 0.26 to 0.34 ng/mL with a serum alcohol concentration of 
3.2 ng/mL. Although the analysis of alcohol concentration was undertaken with different 
matrices, it has been shown that serum and plasma are composed of approximately 92 % w/w 
water when compared to 80 % w/w in whole blood. If assumed that there are no differences in 
matrix (serum and plasma), the ratio of plasma/whole blood has been justified as 1.2 (Moffat et 
al., 2011, Iffland et al., 1999). 
The differences observed in serum T may be related to the analytical technique employed. In 
the study by Sarkola et al. the T concentrations were measured via immunoassay which may 
have cross-reacted with TG, thus increasing the serum T concentration. With mass-
spectrometry, the technique used in this research study, such does not happen. 
The statistically significant change in AD concentrations shows that there is evidence to relate 
its acute decrease to alcohol.  
The hypothesis that ethanol administration decreases serum AD by enzyme suppression thus 
increasing serum T was supported. The next, and final, chapter will verify whether alcohol has 
an effect on clearance of T (either  hepatic metabolism or renal clearance) by analysis of data in 
hypogonadal men. 
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6.1 Introduction 
This final data chapter aims to verify whether the ingestion of alcohol has an effect on the 
clearance of T (either by hepatic metabolism or renal clearance) by analysis of data in 
hypogonadal men. 
Investigating the effects of ethanol administration using as a model hypogonadal men receiving 
testosterone replacement therapy, will help to clarify the effect of the liver (or kidneys) to any 
transient effects in serum testosterone, as there should be a negligible contribution to circulating 
T from the testis. 
Clearance, as described in Chapter 1 is most commonly described as the volume of blood 
completely cleared of a substance (e.g. a drug) as measured in unit time (L/day), by a certain 
organ such as the liver or kidneys. Elimination is the excretion of the unchanged or metabolised 
drug via the urine, gut contents, or sweat. 
 
6.1.1 Hypogonadism & hormone replacement therapy 
Hypogonadism occurs when the sex glands (testes or ovaries) produce little or no hormones. In 
hypogonadal men, their testes produce little or no T. 
Male hormone replacement therapy is available to help restore androgens to their reference 
concentrations thus bringing the body to its normal physiological status restoring the secondary 
sexual characteristics (beard growth, body hair), somatic development (deepening of voice, 
increase in fat-free mass, bone mineral density and sexual function) (Snyder et al., 2000, Griffin 
and Wilson, 1992). 
There are two types of hypogonadism: hypergonadotropic and hypogonadotropic.  
Hypergonadotropic hypogonadism is related to primary gonadal disorders. There is a deficiency 
of steroid gonadal production (low serum T), which, due to the negative feedback mechanism in 
the HPG axis, leads to high concentrations of circulating LH and FSH. This type of primary 
gonadal failure is most commonly related to genetic disorders, such as Klinefelter syndrome in 
men and Turner syndrome in women (Grumbach and Styne, 1992, Dobs et al., 2005). 
Chapter 6: Investigating the effect of alcohol on metabolism and secretion of T in hypogonadal men  
 
- 229 - 
In Klinefelter syndrome, there is an extra X chromosome and males are referred to as being 47 
XXY. This syndrome occurs in 1 out of 1,000 men, and often results in small, firm testes, 
impaired spermatogenesis and a male phenotype of eunuchoid resemblance (Grumbach and 
Styne, 1992).  
In Turner syndrome, or gonadal dysgenesis, women lack one of their X chromosomes and are 
referred to as being 45 XO. This disorder is found in 1 out of 2,500 births and is characterized 
by short stature, sexual infantilism, infertility and low production of sexual hormones. 
In hypogonadotropic hypogonadism, or secondary hypogonadism, there is a pituitary deficiency 
which causes insufficient secretion of LHRH and GnRH, which affects the production of LH and 
FSH thus influencing the production of T and spermatogenesis. Gonadotropin deficiencies may 
be caused by CNS disorders (tumours, congenital malformations), chronic systemic disease 
and malnutrition, hypothyroidism, diabetes or Cushing’s disease, just to name a few. 
Formulations and routes of delivery for androgen replacement therapy for hypogonadal men 
vary and may be taken orally, as a gel, a patch, a pellet or an injection, the latter being the most 
common one, in the form of an ester. Esterification of testosterone (17 -hydroxyl group) renders 
it less polar and more lypophilic, and slowly absorbed by the body. 
The gel and patch are transdermal preparations of T and recent studies have shown that T gel 
replacement improved sexual function and mood, lean mass and muscle strength, and 
decreased fat mass in hypogonadal men with less skin irritation than T patch (Wang et al., 
2000). Although a T gel application could have been the therapy replacement of choice for the 
patients in this study, these transdermal formulations are designed to be applied daily and there 
was some concern that volunteers may forget to do so, i.e. a non-compliance issue.  
Testosterone injections composed of only one T ester was the chosen type of hormone 
replacement for this study. After injection, serum T concentration rises up to almost its upper 
reference limit (~10 ng/mL) or even beyond to supraphysiological concentration, followed by a 
decrease to eugonadal levels (Dobs et al., 2005). The chosen injection was Nebido
®
, composed 
only of T undecanoate. 
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6.1.2 Hypogonadism & urinary T/E analysis after alcohol 
In healthy men, alcohol appears to have little effect on serum testosterone and the increase in 
the urinary testosterone/epitestosterone (T/E) ratio is much smaller compared to women.  The 
data are limited and it is difficult to elucidate whether the effect in men is due simply because of 
inhibition of the hepatic enzyme 17β-hydroxysteroid dehydrogenase (17 β-HSD2), as reported 
in women (Sarkola et al., 2001), and verified in our study, or whether there is an acute effect on 
testicular production of testosterone (T) as opposed to a chronic effect that appears to have an 
effect on the hypothalamic – pituitary – gonadal axis by inhibiting testicular production of T 
(Ellingboe and Varanelli, 1979). Using as a model hypogonadal men which are on hormone 
replacement therapy, thus excluding any negligible contribution to T production from the testis, 
will elucidate the effect of the liver (or kidneys) to any changes in serum testosterone. 
For this part of the research study, a collaboration with the Medical Research Council (MRC) 
Simpson’s Centre for Reproductive Health in the University of Edinburgh, with Dr. Richard 
Anderson, Dr. Jyothis George and Mr. Nick Malone was established. 
Three volunteers were recruited, and the hormone replacement they were being administered 
was an intra-muscular injection of Nebido . The volunteers were asked to attend the study in 
two different occasions. One when they would be in a steady state period regarding their serum 
T concentration (within the reference range); and the other when they would be at a serum 
concentration greater than the upper reference limit (> 10 ng/mL) which happens up to one 
week after Nebido  injection (Electronic Medicines Compendium, 2011, Dobs et al., 2005). The 
reason for investigating both are that the latter would mimic a population of healthy men 
(athletes) that would have recently been administered a supraphysiological dose of T.  
The data analysis in this chapter is was performed using the urinary GC-MS analysis described 
in Chapter 3 and the serum LC-MS/MS analysis as described in Chapter 5. 
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6.2 Material and methods 
6.2.1 Materials 
For urinary analysis of T/E, T concentration, E concentration and 5 -DHT concentration please 
see Chapter 3. 
For serum analysis of T and AD, please see Chapter 5. 
 
6.2.2 Clinical study and sample collection 
Ethical approval was sought and given, for the recruitment of 3 male hypogonadal patients to 
whom 8 units of alcohol were administered and blood and urine collected were performed post-
alcohol ingestion. 
The samples were labelled with an alphanumeric code, e.g. T M- 8U- , where  is the 
number of the volunteer,  would either be SS for steady state or SP for supra-physiological, 
the letter indicating the type of sample (U for urine and S for serum), and  the time of 
collection. 
The volunteers followed the same inclusion criterion as the eugonadal men in the main study, 
described in Chapters 3-5, for example the alcohol abstinence for 3 days before the study. 
However, the upper age limit was raised to 50 years, it was reasoned that there should be no 
difference between a younger liver and the liver of a man slightly older. An exclusion criterion 
was a body mass index (BMI) <30 kg/m
2
. The volunteers were asked to provide blood and urine 
at the same time intervals as in the eugonadal study (Chapters 3, 5), except 48 h and 72 h, 
which we have decided to exclude for this study assuming the values of the metabolites of 
interest had already reached baseline similar to what was verified in the eugonadal study. 
Serum was analysed by liquid-chromatography tandem mass-spectrometry (LC-MS/MS) to 
measure T, E, its glucuronides and sulphates and androstenedione. The urine samples were 
analysed by GC-MS to measure the T/E ratio, concentration of T, E and 5 -DHT. 
Due to time constraints, the serum alcohol measurements were not performed in time for 
inclusion in this chapter.  
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The statistical treatment was performed using the software Statistical Package for Social 
Sciences (SPSS ), version 18, from SPSS  Inc, Chicago, IL, USA. The results were statistically 
treated by using a general linear model with repeated measures to test for any effects of alcohol 
in urinary T/E and the analytes of interest in urine and serum. The significance limit was set to 
p-value <0.05. 
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6.3 Results  
6.3.1 Sample analysis and challenges encountered 
Statistical treatment was performed as for the previous chapters. The post-administration data 
was averaged irrespective of the group (steady state or supraphysiological) and time and the 
data was normalized using proportion increase against pre-administration as follows: 
 
Equation 6.1 Normalization of values for statistical treatment 
 
 
The samples collected at 24 h had already reached baseline values (Appendix 8.34 and 
Appendix 8.35) and a comparison between baseline value (baseline sample taken before 
alcohol ingestion) and this sample was done to ascertain if the response was different. The 
results were not statistically significant with p-value >0.05. Hence, the last measurement was 
excluded from the statistical treatment. As an added test of reliability for our baseline values, the 
mean of pre-administration and 24 h sample was used as the baseline value. 
Urinary T/E, and the concentrations of the previously validated steroids (T, E and 5 -DHT) were 
calculated. Urinary concentrations of analytes vary between individual and are dependent of 
urinary density and specific gravity (SG). Only values normalized for a SG of 1.020 can be 
compared and therefore the SG of all urine samples was measured and the concentration of 
steroid adjusted according to the following equation: 
 
Equation 6.2 Adjusted concentrations 
 
In two urine samples analysed for E concentration samples were below the LLOQ and therefore 
they were changed to half the value of the LLOQ’s concentration, 0.5 ng/mL for statistical 
purposes (Appendix 8.34 and Appendix 8.35). 
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One volunteer in the supraphysiological phase had urinary T concentration values above the 
highest calibrant (160 ng/mL) without overloading the column (verified by chromatogram 
analysis). Since the purpose of this study is to verify if there is an increase in concentration, 
rather than measuring its exact value, due to time constraints it was not possible to dilute the 
sample in half, by extracting 1 mL rather than 2 mL, and because the calibration curve was 
linear (r
2
 >0.99) the values higher than 160 ng/mL were included in our data treatment. 
Considering serum, the measured concentrations are presented in Appendix 8.36 (steady state 
volunteers) and Appendix 8.37 (supraphysiological phase) the mean value of serum T 
concentrations in pre-administration samples in the volunteers in the steady state was 
5.7 ±2.6 ng/mL and in the supraphysiological phase it was 8.3 ±0.8 ng/mL. Although the 
supraphysiological phase is not above the serum T’s concentration upper reference limit of 
10 ng/mL when compared to the steady state pre-administration mean concentration, there was 
a 1.5-fold increase and thus these volunteers were considered as supraphysiological. Although 
the volunteers undertook the second administration of alcohol within a week of having had their 
Nebido
®
 injection, the reason for the serum T not to be above the upper reference limit may be 
that the T undecanoate present in the injection stabilizes faster (Electronic Medicines 
Compendium, 2011) and most likely not within a week as mentioned in the paper by Von 
Eckardstein et al. (Von Eckardstein and Nieschlag, 2002) 
The concentration of TG was above the LLOQ, unlike in samples collected from the eugonadal 
volunteers (Chapter 5). This seemed reasonable since the mean pre-administration 
concentrations of T in eugonadal men (8 units) were 3.31 ± 1.22 ng/mL, so 1.7-fold less than 
hypogonadal men in their steady state. Statistical analysis was not performed in this analyte 
since it was not thought to be relevant for this hypothesis. 
The normalized data is presented as SPSS graphs, except for the serum TG data. 
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6.3.2 Urine analysis 
6.3.2.1 Urinary T/E 
Urinary T/E for steady state and supraphysiological phase, normalized data (proportion increase 
from baseline) was plotted in Figure 6.1. 
 
  
Figure 6.1 Normalized urinary T/E in hypogonadal men after 8 units of alcohol 
 
The raw values may be found in Figure 6.2. The WADA threshold of 4 is also plotted for easier 
analysis. 
 
Normalized urinary T/E vs. time in hypogonadal men 
Time collection points 
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Figure 6.2 Mean urinary T/E in hypogonadal men in steady state and supraphysiological phase up 
to 10 h, after 8 units of alcohol 
 
All the samples showed a pre-administration T/E above the WADA threshold, and an increase is 
verified up to 5 h in the supraphysiological phase, and up to 4 h in the steady state. After this, 
the urinary T/E starts decreasing until it reaches baseline values at 24 h. 
Statistical treatment shows that there were changes over time due to alcohol intake (p <0.05), 
averaged over the two groups, and that there were no statistically significant differences 
between the groups (p >0.05) and T/E over time behaved similarly for the two groups (p >0.05). 
In Appendix 8.34 and 8.35, where the urinary T/E, the urinary T, E and 5 -DHT concentrations 
may be found, there are cases where the E concentration is 0.5 ng/mL. That was due to the 
sample being too diluted and hence below the LLOQ. For statistical purposes, the value given 
to such samples was half of the LLOQ because we are interested in changes in concentration 
rather than the concentration per se. 
 
6.3.2.2 Urinary T concentration 
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Figure 6.3 Normalized urinary T values in hypogonadal men after 8 units of alcohol 
 
The raw concentration (ng/mL) has been plotted in the figure below (Figure 6.4). The WADA 
threshold for T concentration has also been plotted and as one can see, in the 
supraphysiological phase after 6 h and until just before 10 h, the concentration goes above the 
threshold. 
 
Normalized urinary T vs. time in hypogonadal men 
Time collection points 
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Figure 6.4 Mean urinary T concentration (ng/mL) in hypogonadal men in steady state and 
supraphysiological phase up to 10 h, after 8 units of alcohol 
 
After statistical treatment, the increase in concentration of T over time, averaged over the 
groups, was statistically significant (p <0.05). The T concentration in both groups behaves 
differently (p <0.05), and the time pattern was similar for both groups (p >0.05), as one can see 
there is an increase up to 10 h in both groups, after which it decreases to baseline values. 
 
6.3.2.3 Urinary E concentration 
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Figure 6.5 Normalized E values in hypogonadal men after 8 units of alcohol 
 
The WADA threshold is the same as for T, which is 200 ng/mL. However, this was not plotted in 
the graph since the difference between the highest measured E concentration and the threshold 
concentration was very different and it was not thought to be necessary. The raw E 
concentration may be found in Figure 6.6. 
 
Normalized urinary E vs. time in hypogonadal men 
Time collection points 
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Figure 6.6 Mean urinary E concentration (ng/mL) in hypogonadal men in steady state and 
supraphysiological phase up to 10 h, after 8 units of alcohol 
 
From the analysis of the graph, one can realise that there is a decrease after alcohol intake but 
after 1 h, the E concentration starts increasing until it reaches baseline values. That differences 
in E concentration over time are statistically significant (p-value <0.05), averaged over both 
groups. The E concentration difference is similar in both groups (p -value >0.05), and the time 
pattern showed that both groups behaved differently (p-value <0.05), with E concentrations from 
the steady state going above the baseline, which does not happen in supraphysiological phase. 
From looking at the figure, it seems as if E is being formed from T since E is at a bigger 
concentration in the supraphysiological phase than in steady state. However, such is not likely 
since the main pathway for the biosynthesis of E is from conversion of DHEA to AD and then 
reduction to E as discussed in Chapter 1, section 1.3.3 (Biosynthesis of Epitestosterone) 
(Bellemare et al., 2005). 
 
6.3.2.4 Urinary 5 -DHT concentration 
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Figure 6.7 Normalized urinary 5 -DHT values for hypogonadal men after 8 units of alcohol 
 
Regarding the urinary concentration of 5 -DHT (ng/mL), the respective graph may be found in 
Error! Reference source not found.. 
 
Normalized urinary 5 -DHT vs. time in hypogonadal men 
Time collection points 
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Figure 6.8 Mean urinary 5 -DHT concentration (ng/mL) in hypogonadal men in steady state and 
supraphysiological phase up to 10 h, after 8 units of alcohol 
 
The difference in concentration over time after 1 h was statistically significant (p-value <0.05), 
averaged over both groups, and there was a difference in 5 -DHT response in the two groups 
(p-value <0.05). The time pattern was different for both groups (p-value <0.05), with the steady 
state concentrations increasing up to 6 h after 1 h, then decreasing up to 10 h but still remaining 
above baseline. With supraphysiological concentrations, there is an increase after 1 h, then a 
decrease down to 2 h that goes below the baseline, after which it starts increasing up to 7 h, 
going above the baseline at this time point. After 7 h, the concentration decreases but it is still 
above the baseline values. 
The adjusted concentrations may be found in Appendix 8.3. The concentration for T17M-U-1h 
may be considered as an outlier. 
 
6.3.3 Serum sample analysis 
6.3.3.1 Serum T concentration 
The serum T normalized values, where it is possible to see the proportion difference from the 
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Figure 6.9 Mean serum T normalized values in hypogonadal men, after 8 units, up to 6h 
 
The raw values were also plotted Figure 6.10.  
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The decrease in serum T is statistically significant, over time, averaged over both groups (p-
value <0.05). Both groups behave similarly (p-value >0.05), and the time pattern for both groups 
also showed a similar behaviour. 
 
6.3.3.2 Serum AD concentration 
The serum AD concentration was plotted in Figure 6.11. 
 
Figure 6.11 Serum AD normalized values in hypogonadal men after 8 units, up to 6 h 
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Figure 6.12 Mean serum AD concentration (ng/mL) in hypogonadal men, up to 6 h, after 8 units of 
alcohol 
 
There is a decrease in serum AD which was not statistically significant (p-value >0.05) over 
time, averaged over both groups. There was no difference between both groups (p-value >0.05) 
and the time pattern showed a similar behaviour (p-value>0.05) with both groups decreasing up 
to 1 h, then increasing up to 2 h in the supraphysiological phase and to 3 h in the steady state, 
then decreasing up to 4-5 h, and increasing after that without ever reaching baseline values. 
 
6.3.3.3 Serum TG concentration 
The concentration of serum TG was above the LLOQ in all the samples, unlike in samples 
collected from the eugonadal volunteers (Chapter 5) where approximately 50 % were below the 
LLOQ and hence no statistical treatment was performed on those samples.  
Testosterone glucuronide is one of testosterone’s phase 2 metabolites, the other being 
testosterone sulfate. The mean pre-administration concentration of serum T, in eugonadal men 
was 3.9 ± 1.2 ng/mL, so 32 % less than hypogonadal men in their steady state (5.7 ±2.6 ng/mL) 
and 53 % less than supraphysiological hypogonadal men (8.3 ±0.8 ng/mL). Due to the higher T 
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serum TG was presented in these volunteers at a higher concentration, which was possible to 
quantify. 
The serum TG concentration was plotted in Figure 6.13 as normalized values, showing a 
significant increase following alcohol administration over time (p-value <0.05), averaged for both 
steady phase and supraphysiological phase. There was no difference in TG response between 
both groups (p-value >0.05). 
 
Figure 6.13 Serum TG normalized concentrations in hypogonadal men, up to 6 h, after 8 units of 
alcohol 
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6.4 Discussion 
In this chapter, after 8 units of alcohol, all the hypogonadal volunteers (who do not produce T) 
showed statistically significant increases in urinary T/E, T concentration, E concentration and 
5 -DHT concentration. In Chapter 3, the study with eugonadal men showed a statistically 
significant increase in T/E, with urinary T concentration significantly increasing after 8 units as 
well as urinary 5 -DHT. The increase in urinary T/E, from the pre-administration value, in 
hypogonadal men was in the order of 120 % (for both steady state and hypogonadal groups), 
and 70 % in eugonadal men.  
There was a statistically significant effect on serum T, similar to what happened in eugonadal 
men. The serum T rapidly decreases and the concentrations remain below the baseline (pre-
administration) for 3 h. The serum TG concentration increased significantly over time.  
Androstenedione did not show a statistically significant difference in concentration.  
As the testicular steroidogenesis in hypogonadal men is considerably diminished, any influence 
of alcohol administration will be on elimination (metabolism and/or excretion) of T, the data not 
being confounded by an effect on gonadal production. It may be tentatively concluded that the 
metabolism of testosterone to androstenedione (the major intermediate in the metabolism of 
testosterone to the tetrahydro-17-oxo steroids, androsterone and etiocholanolone) is a rate-
limiting step, such that a reduction in the activity of the oxidoreductase 17 HSD2, is not 
sufficient to have much of a consequence on the pool of circulating T, either in eugonadal men 
or hypogonadal men receiving replacement therapy. In other words, any decrease in the 
phase 1 metabolism of T due to alcohol, which would result in a raised serum T, is masked by 
the large pool of circulating T. 
The increase in serum TG is a novel finding being unexpected, indicating an increase in phase 
2 metabolism of T, although further investigations are required to prove this increase in the rate 
of conjugation.  
Thus, the hypothesis that alcohol has an effect on hepatic metabolism of T (clearance) is 
supported by the data. 
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The population’s urinary T/E shows a bimodal distribution, with the modal values being 1 and 
0.2. The latter thought to be caused by the gene polymorphism UGT2B17 del/del that codes an 
isoform of glucuronyl transferase, which is largely responsible for the conjugation testosterone. 
Whether the majority or minority, the intra-individual variation in the T/E ratio in non-doped 
athletes is normally very small, but it is augmented by doping with testosterone or its precursors, 
e.g. androstenedione. The current WADA Technical Document (TD2004EAAS), states:   
‘In males, the individual T/E values have been shown to vary from their mean value by less than 
30% (screening values). In females, a low concentration of some urinary steroids such as 
epitestosterone and testosterone, close to the limit of detection using current analytical methods 
occurs. Normal variation of up to 60% may be expected.’ 
For T/E to provide reliable evidence of doping, it is highly desirable that no permitted factor 
increases the T/E ratio to a value that would exceed the upper limit expected with intra-
individual variation.   
The suspicion that alcohol, which is not a prohibited substance in sports, increases this ratio 
had to be further investigated. 
There is limited evidence in literature that alcohol could affect urinary T/E and thus this study 
aimed to better understand those mechanism(s) (Karila et al., 1996, Falk et al., 1988, 
Seppenwoolde-Waasdorp et al., 1996, Geyer et al., 1996, Mareck-Engelke et al., 1996). 
Due to the possibility of physiological outliers, the definitive technique employed is GC-C-IRMS. 
However, it is still possible to obtain a false negative result with exogenous preparations of T 
exhibiting the same isotope signature than endogenous testosterone. 
Furthermore, this technique is costly because of the instrumentation required and the skilled 
staff needed to operate it. 
Our first question was if alcohol in serum could reach a concentration that would be sufficient to 
displace T from its binding proteins such that free serum T is raised, which would be then 
available for conjugation and urinary excretion, resulting in a raised urinary T/E ratio. An in-vitro 
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study, with serum samples from 10 volunteers was performed to test this hypothesis, using a 
concentration of alcohol equivalent to 700 mg%, but no increase in free serum T was found.  
To better establish the origins of a urinary T/E increase after alcohol administration, two 
different doses of alcohol (4 and 8 units) were administered in different occasions to 10 
eugonadal females and males. This was approximately 0.5 g/kg of alcohol for the 4 units, and 
1 g/kg for 8 units. The highest dose of alcohol, 8 units, was administered to 3 hypogonadal men 
in two different occasions.  
These occasions were one within a week after having had their Nebido
®
 injection (hormone 
replacement therapy) where their serum T concentration is expected to be higher than the 
upper limit in eugonadal men (10 ng/mL) and were called ‘supraphysiological phase’; and 
another occasion over one week after having had their injection, where it is expected that their 
serum T concentrations would be within the eugonadal range, named ‘steady state phase’. 
In females and males, after 4 and 8 units, there was a statistically significant increase in T/E. 
None of the eugonadal males went above the WADA threshold of 4. However, in females, after 
8 units, three went above the WADA threshold and 6 above the 97.5
th
 percentile (2.65). 
Overall, after normalization to pre-administration value, the mean for females showed an 
increase in T/E from baseline of 420 % after 8 units, and 190 % after 4 units.  In the eugonadal 
males, the T/E increased 73 % from baseline after 8 units, and 36 % after 4 units. 
For convenience of the reader, the relevant graphical data presented in previous chapters 
pertaining to the conclusions may be found at the end of this chapter.  
There was a statistically significant effect in urinary T concentration, E concentration and in 5 -
DHT urinary concentrations as well. 
After 8 units, female volunteers urinary T concentration increased 217 % when compared to 
baseline, and after 4 units it increased 172 %. In eugonadal males, the urinary T concentration 
increased by 52 % after 8 units, and 32 % after 4 units. 
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The urinary E concentration showed a significant decrease in both females and males. Females 
decreased 55 % after 8 units, and 36 % after 4 units; whereas males showed a more modest 
decrease at 32 % after 8 units, and 22 % after 4 units. 
The fact that the relative increase in urinary T concentration in females is considerably higher 
than in the eugonadal males, combined with the larger relative decrease in the urinary E 
concentration, explains the higher increase in T/E when compared to males, where none went 
above the WADA threshold of 4. Therefore, the hypothesis that two different doses of alcohol 
ingested within an hour in two different occasions would influence urinary T/E in females and 
males due to an increase in excretion was not rejected, although ethanol ingestion has much 
more serious implications for female athletes, as the T/E threshold can be exceeded.  
Notwithstanding, in both male and female athletes, alcohol ingestion can cause sufficient 
variation to the T/E ratio to abnormally affect the intra-individual profile. Some athletes who may 
know, or get to learn of this influence, may consume alcohol deliberately, in advance of the 
short-notice of out-of-competition testing, to mask their use of testosterone. 
The analyst should consider that this is a possiblity and must use GC-C-IRMS in an attempt to 
ascertain whether such a manipulation has occurred. Conversely, with a GC-C-IRMS finding 
that is unremarkable, i.e., no hint of steroid administration, it would be fitting to conclude that 
alcohol ingestion was the innocent cause and that T/E result should not be included in future 
assessment’s of that individual’s T/E profile. 
The mechanism of the large increase in the T/E ratio in females may be related to the fact that 
alcohol increases the ratio of NADH/NAD
+
, which in turn may suppress the oxidation of T into 
AD, thus increasing the concentration of T.  
The increases in serum T in females are in agreement with decreases in serum LH (although 
these were not significant) and a significant decrease in urinary LH over time. The current 
investigation supported this supposition, as there was a significant increase in T, the relative 
increase being 60 % after 8 units, and a rapid decrease in AD in females (40 %). 
The fact that this study only showed a very modest increase in serum T in eugonadal males 
(2 %), following an initial dip of approximately 20 %, when compared to females does not mean 
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that there is a lack of inhibition of hepatic oxidation of testosterone in men, but rather that this 
effect is obscured by the larger pool of testosterone present.  
In eugonadal women, the pool of circulating T is considerably lower, the serum concentration 
being approximately a tenth of that found in eugonadal men, and if the enzymatic oxidation  of T 
to androstenedione is not saturated, the impact of alcohol on this conversion is such that there 
is a relatively large increase in the serum T concentration (approximately 5-fold), which is 
reflected in a relatively large increase in the urinary T concentrations and the urinary T/E ratio.  
In men, 17 -HSD2 may be saturated with testosterone, and so even with inhibition of its activity 
by ethanol, the amount of T that would have been otherwise converted to androstenedione, 
would be relatively small to the amount of testosterone circulating, i.e. an increase in the 
concentration of serum T would be expected, but this would be relatively small to that in 
females. Indeed, the increase in serum T was only 2 %  at 4 h, the time when the T/E ratio was 
maximising, nothing like the ~5-fold increase in serum T observed in the women at that time. 
The decrease in the urinary E concentrations in the women may also be rationalised by the 
effect on inhibition of activity of 17 -HSD2. Just as there will be an increase in serum T, there 
should be a decrease in androstenedione and this was the case. One of the precursors of E 
formation is androstenedione, and it is likely that any hepatic conversion of androstenedione will 
be to E, which will then be available for phase 2 metabolism as EG, (which after hydrolysis for 
urinary analysis is treated as E). Although androstenedione is probably the minor of the two 
biosynthetic precursors of epitestosterone, the major one being DHEA, it is a precursor 
nonetheless (Starka, 2003). Thus a fall in hepatic androstenedione production would be 
expected to result in a modest fall in E glucuronide production, explaining the modest decrease 
in urinary E following alcohol administration.    
In eugonadal men, there was a similar decrease in the concentration of serum AD and there 
was a minor decrease in urinary E concentration, which may also explain the modest decrease 
in urinary E in man.  
If serum T is decreasing following an increase in metabolism thus increasing its phase 2 
metabolite, TG, it is also possible that E, which follows the same excretion pathway as T, is 
being metabolized into EG (its phase 2 metabolite).  
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The study with hypogonadal men on hormone replacement therapy, where gonadal production 
of T has been eliminated as a contributing factor, shed some light on our previous findings. 
This part of the research study, showed a statistically significant effect in urinary T/E, urinary T, 
E and 5 -DHT concentrations; and serum T. No significant effect was shown in AD 
concentration. 
The steady state group had an increase in urinary T/E from its pre-administration value of 
120 % after 3 h, whereas the supraphysiological group had an increase of 130 % from their pre-
administration value after 5 h. With the eugonadal volunteers, after 8 units, the increase from 
their pre-administration value was approximately 70 % after 2 h. 
The significant increase in urinary T/E was consistent with a significant urinary T increase, of 
134 % in supraphysiological volunteers and 50 % in steady state. The urinary E concentration 
decreased 19 % from their baseline values in volunteers in their supraphysiological state and 
increased in steady state volunteers by 56 %.  
The fact that there is a higher increase in T/E in supraphysiological men is consistent with a 
higher increase in urinary T concentration in supraphysiological volunteers together with a 
decreased urinary E concentration, when compared to steady state volunteers. 
These increases were followed by suppression in serum T in the first few hours after alcohol 
administration, which could be indicative that the increase in urinary T/E is related to hepatic 
clearance of T and/or renal excretion.  
The serum concentration of TG, a phase 2 metabolite of T, was measured in hypogonadal men. 
In eugonadal volunteers this was not possible since approximately 50 % of the samples were 
below the LLOQ.  
Therefore, our final hypotheses, that alcohol has an effect on hepatic clearance of T has not 
been rejected. 
To reiterate, the increase in urinary T/E in eugonadal and hypogonadal males follows an 
increase in urinary total concentrations (aglycone plus free fraction) of T and E. With alcohol 
acting as a diuretic, the urinary flow rate increases, thus increasing glomerular filtration in the 
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kidneys and urinary TG concentration would be likely to increase. The serum T concentration 
decreased and serum TG increased (only measurable in hypogonadal volunteers), indicative of 
an increase in metabolism.  
In females, the increase in urinary T/E is linked to the high urinary T concentration, dissociated 
from any increase in urinary E concentration. This is most likely a reflection of the increase in 
serum T, due to the suppression in the activity of the enzyme 17 -HSD2, thus shifting the 
conversion of T into AD, towards T. 
The increase in serum T in females in this research study was not as accentuated as in the 
study by Sarkola et al.(Sarkola et al., 2001). The differences observed in serum T may be 
related to the analytical technique employed, where the T concentrations were measured via 
immunoassay which may have cross-reacted with TG, thus increasing the serum T 
concentration. With mass-spectrometry, the technique used in our research study, such does 
not happen. 
Analysis of serum LH concentration showed a decrease in females after 4 and after 8 units, and 
a decrease in males after 4 units and an increase after 8 units but these results were not 
statistically significant. These results contradict those of Karila et al., where a serum increase in 
LH was verified after 2 g/kg of alcohol, even though not significant (Karila et al., 1996). The 
study performed by Karila et al. was done in 4 females and 4 males, with serum collection 24h 
and 48 h after alcohol administration which may have introduced variability in the results. 
Urinary LH concentration had a significant decrease in females over time, and any changes in 
males were not significant. Due to its negative feedback mechanism, a decrease in LH would be 
in agreement with an increase in serum T, which was verified in females.  
Thus the hypothesis that any increase in urinary T concentration is due to an increase in LH 
was discounted. 
In this study, we found that both females and males had an increased T/E when compared to 
their baseline values, with females showing an evidential increase afer 8 units. Our study had a 
different experiment design when compared to previous published studies (Falk et al., 1988, 
Karila et al., 1996, Seppenwoolde-Waasdorp et al., 1996, Mareck-Engelke et al., 1996).  
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Our study shows consistency. It was performed with a bigger population (n=10 for females and 
n=9 for males) decreasing inter-individual variability, urine and blood were collected hourly 
which aided in the understanding of the clearance (metabolic and/or excretion) of T and E and 
their conjugates and gives more reliability to the statistical treatment. Our study also recruited 
hypogonadal men on hormone replacement therapy to exclude the possiblity of gonadal 
production of T influence the urinary T/E ratio due to alcohol. 
Concerning further work, it would be interesting to perform this study in a bigger population and 
with smaller collection windows so as to be able to perform an appropriate correlation between 
serum T and AD, serum T and urinary T/E, and both of these with the blood alcohol 
concentration. 
Regarding EtG urinary concentration, perhaps this test ought to be included in the athlete’s 
biological passport to help prevent an ‘atypical finding’ from flagging an athlete. Although it does 
not seem possible to establish a universal threshold due to individual variation, it could be 
fruitful nevertheless, to perform this type of study in athletes so that at least there could be an 
individual threshold established. 
One way of testing the hypothesis that the increase in urinary T/E after alcohol administration is 
due an increase in metabolism and/or renal excretion, would be to administer stable labelled TG 
and T, and verify any changes in clearance (hepatic and/or renal).  
In summary, females are overall more affected by alcohol than men with its effects being 
translated into an increase in urinary T/E that exceed the WADA threshold. In men, there is also 
a significant increase but with the amount of alcohol administered, it was not enough to go 
above the threshold. 
Our data seems to indicate that the increase in urinary T/E in males is either due to an increase 
in hepatic clearance or an increase in the excretion of T, not to an increase in production; and in 
females most likely due to a suppression of T metabolism, which will then increase circulating 
serum T concentration and hence increase the urinary T/E ratio. 
Due to the different production sites of T, women seem to have their urinary T/E affected in a 
more acute way.  
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This makes an interesting correlation with the poem from the American writer Ogden Nash, in 
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Figure 7.2 Normalized urinary T values in males. Units 1 = 4 units, 2 = 8 units 
 
 
Normalized urinary T/E vs. time in eugonadal males 
Normalized urinary T values vs. time in eugonadal males 
Time collection points 
Time collection points 
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Figure 7.4 Normalized serum T values in eugonadal men. Units 1 = 4 units, 2 = 8 units 
Normalized urinary E values vs. time in eugonadal males 
Normalized serum T values vs. time in eugonadal males 
Time collection points 
Time collection points 
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Figure 7.5 Normalized serum AD values in eugonadal men. Units 1 = 4 units, 2 = 8 units 
 




Figure 7.6 Normalized T/E in females. Units 1 = 4 units, 2 = 8 units 
 
Normalized urinary T/E values vs. time in eugonadal females 
Normalized serum AD values vs. time in eugonadal males 
Time collection points 
Time collection points 
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Figure 7.8 Normalized urinary E values in females. Units 1 = 4 units, 2 = 8 units 
 
Normalized urinary T values vs. time in eugonadal females 
Normalized urinary E values vs. time in eugonadal females 
Time collection points 
Time collection points 
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Figure 7.10 Normalized serum AD values in eugonadal females. Units 1 = 4 units, 2 = 8 units 
Normalized serum T values vs. time in eugonadal females 
Normalized serum AD values vs. time in eugonadal females 
Time collection points 
Time collection points 
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Figure 7.12 Normalized urinary T values in hypogonadal men after 8 units of alcohol 
Normalized urinary T/E values vs time in hypogonadal males 
Normalized urinary T values vs. time in hypogonadal males 
Time collection points 
Time collection points 
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Figure 7.14 Normalized serum T values in hypogonadal men after 8 units of alcohol 
 
Normalized urinary E values vs. time in hypogonadal males 
Normalized serum T values vs time in hypogonadal males 
Time collection points 
Time collection points 
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Figure 7.16 Normalized serum TG values in hypogonadal men after 8 units of alcohol 
 
Normalized serum AD values vs. time in hypogonadal males 
Normalized serum TG values vs. time in hypogonadal males 
Time collection points 
Time collection points 
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8.1 Endocrine glands 
Appendix 8.1 Endocrine glands 
Endocrine 
gland 
Function Secreting hormones 
Brain (including 
hypothalamus) 
 Controls nervous system but is one of 
the most important endocrine gland 
 Specialized nerve cells in hypothalamus 
responsible for hormone synthesis 
 Hormones are transported along the 
axon to the nerve terminal where they 
are released into the portal blood 
system, that carries them to the pituitary 
gland, just beneath the hypothalamus 
 These hormones control salt and water 
balance, sexual function and behaviour, 




hormone (CRH) or factor 
(CRF) 
 Dopamine (prolactin-
inhibiting hormone – PIF) 
 Growth-hormone releasing 
hormone (GRH) 
 Gonadotropin-releasing 








Pituitary gland  Synthesis of hormones that control 
many of the other endocrine glands 
 Composed of different lobes (anterior, 
posterior and intermediate) that are 







 Luteinizing hormone (LH) 
 Prolactin 
 Thyrotropin (thyroid-
stimulating hormone – 
TSH) 
 Growth hormone (GH) 
Posterior: 
 Oxytocin 
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Thyroid gland  In humans, it adheres to, and is located 
in front of the trachea 
 Iodine is used for the synthesis of 
thyroid hormones. Low levels of iodine 
cause hyper- and hypothyroidism 
 Thyroxine (T4) 
 Tri-iodothyronine (T3) 
Parathyroid 
gland 
 Integrated in thyroid gland 
 Its hormone is responsible for 
controlling levels of calcium and 
phosphate in the blood 




 In thyroid’s follicles  Calcitonin 
Adrenal glands  Situated above the kidneys 
 Composed of cortex (outer layer) and 
medulla (inner layer) 
 Cortex produces steroid hormones 
 Medulla produces catecholamines 
Cortex: 
 Glucocorticoids (eg. 
cortisol) 
 Mineralocorticoids (eg. 
aldosterone) 









 Cells spread around the larger exocrine 




 Pancreatic polypeptide 
                                                     
11
 An endocrine gland is a gland that produces hormones and secretes them directly into the blood stream rather than 
through a duct (eg. adrenal glands, pituitary gland, testes, ovaries and the thyroid gland). An exocrine gland secretes its 
products (not known as hormones) into ducts which lead to the outside environment (e.g. sweat glands, salivary glands 
and mammary glands). 
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Ovary  Major female reproductive gland  Estrogen 
 Progesterone 
 Relaxin 
Testis  Major male reproductive gland  Testosterone 
 Inhibin 




 Largest endocrine organ 
 Produces several autocrine, paracrine 
and endocrine hormones 
12
 
 Cholecystokinin (CCK) 





 Substance P 
 Vasoactive intestinal 
peptide (VIP) 
Pineal gland  Situated in brain 
 Involved in rhythms, such as 
reproductive rhythms of animals which 
breed seasonally 
 Role in humans still unknown 
 Melatonin 
Kidney  Filters soluble waste products and 
drugs from circulation 
 Produces hormones involved in the 
control of blood pressure and 




Placenta  Organ of pregnancy serving the 
developing fetus 
 Chorionic gonadotropin 
(CG, hCG – h for human) 
Thymus  Essential for normal fetal growth 
 Retains immature lymphocytes and 
processes them to a mature state, 
crucial for the immune system 
 Thymopoietin 
 Thymulin 
                                                     
12
 Endocrine hormones are the ones that are secreted into the blood and are carried by it to the cells they will act on, 
autocrine hormones act on the secretory cell itself and paracrine act on contiguous cells PORTERFIELD, S. P. 2001a. 
Chapter 1 - Introduction to the endocrine system. Endocrine physiology. 2nd ed. Missouri: Mosby. 
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8.2 Intra-assay variability for calibrants 0.15, 0.30 and 2.5 ng/mL 
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Expected dialysate T of 0.15 ng/mL 
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Expected dialysate T of 0.30 ng/mL 
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Expected T dialysate of 2.5 ng/mL 
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8.3 Testosterone in aqueous solution 
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Expected dialysate T of 0.15 ng/mL 
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Expected dialysate T of 0.30 ng/mL 
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Expected dialysate T of 2.5 ng/mL 
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8.4 Testosterone aqueous solution with alcohol at room 
temperature 
 
Appendix 8.4 Testosterone aqueous solution with alcohol at room temperature 
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8.5 Testosterone & SHBG aqueous solution at room temperature 
Appendix 8.5 Testosterone & SHBG aqueous solution at room temperature 
 
Appendices    Doping in Sports: The effect of alcohol on the urinary increase of T/E 
- 281 - 
 
Appendices    Doping in Sports: The effect of alcohol on the urinary increase of T/E 
- 282 - 
8.6 Serum testosterone equilibrium at room temperature 
Appendix 8.6 Serum testosterone equilibrium at room temperature 
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8.7 Serum testosterone with 350 mg% alcohol at room temperature 
Appendix 8.7 Serum testosterone with 350 mg% alcohol at room temperature 
 
 
Appendices    Doping in Sports: The effect of alcohol on the urinary increase of T/E 
- 285 - 
8.8 Serum testosterone with 350 mg% alcohol at 37ºC 
Appendix 8.8 Serum testosterone with 350 mg% alcohol at 37ºC 
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8.9 Serum testosterone with 700 mg% alcohol at room temperature 
Appendix 8.9 Serum testosterone with 700 mg% alcohol at room temperature 
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8.10 Serum testosterone in a 250 mL volume of buffer with 350 mg% 
of EtOH at room temperature 
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8.11 Serum testosterone in tube dialysis at room temperature 
Appendix 8.11 Serum testosterone in tube dialysis at room temperature 
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8.12 Serum testosterone in tube dialysis at 37ºC 
Appendix 8.12 Serum testosterone in tube dialysis at 37ºC 
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8.13 Ultrafiltration results 
Appendix 8.13 Ultrafiltration results 
i 
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8.14 Concentration of internal standard 
Appendix 8.14 Concentration of internal standard 
Deuterated steroid 




d3-testosterone 0.902 90.2 
d3-epitestosterone 0.925 92.5 
d35 -DHT 0.83 83 
 
 
8.15 Internal standard mixture (stock solution) 
Appendix 8.15 Internal standard mixture (stock solution) 
Deuterated 
steroid 
Amount to be 




d3-testosterone 100 0.5 1.11 mL o f 90.2 g/mL 
d3-epitestosterone 100 0.5 1.10 mL o f 92.5 g/mL 
d35 -DHT 64 0.32 0.770 mL of 83 g/mL 
 
8.16 Urinary T/E, T, E and 5 -DHT concentrations (ng/mL) for 
females after 4 units 
Appendix 8.16 Urinary T/E, T, E and 5 -DHT concentrations (ng/mL) for females after 4 units 
Sample H after intake T/E T conc E conc 5 -DHT conc SG 
T1F  0 0.30 9.71 35.8 9.48 1.012 
T1F  1 0.67 11.8 14.9 5.00 1.002 
T1F  2 0.75 10.8 12.8 2.50 1.004 
T1F  3 0.63 6.42 9.74 3.56 1.008 
T1F  4 0.52 8.97 14.1 2.50 1.004 
T1F  5 0.28 6.89 22.1 3.84 1.015 
T1F  6 0.26 7.08 24.4 4.73 1.021 
T1F  7 0.29 12.0 38.6 10.1 1.022 
T1F  10 0.32 6.82 19.4 5.07 1.007 
T1F  24 0.27 6.83 23.8 6.03 1.014 
T1F  48 0.48 13.0 25.7 9.62 1.003 
T2F 0 1.20 13.5 12.1 3.65 1.006 
T2F 1 2.04 15.4 5.00 5.00 1.002 
T2F 2 2.94 14.9 5.96 2.00 1.005 
T2F 3 3.50 24.3 6.15 3.80 1.009 
T2F 4 3.43 30.3 6.92 5.29 1.008 
T2F 5 2.10 13.2 5.12 3.74 1.012 
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T2F 6 1.47 11.0 4.88 3.73 1.014 
T2F 7 1.54 12.3 13.5 3.63 1.007 
T2F 10 1.88 27.2 9.26 5.23 1.005 
T2F 24 1.06 7.51 8.22 3.52 1.007 
T2F 48 0.80 6.02 6.55 3.15 1.007 
T3F  0 0.66 11.1 16.8 6.81 1.004 
T3F  1 2.44 36.8 16.4 3.33 1.003 
T3F  2 2.41 14.6 6.67 2.00 1.005 
T3F  3 2.68 72.8 29.9 10.0 1.001 
T3F  4 2.95 81.8 29.9 10.0 1.001 
T3F  5 3.13 33.2 11.7 4.42 1.005 
T3F  6 2.25 25.0 10.5 3.50 1.011 
T3F  7 1.61 19.7 13.5 4.97 1.013 
T3F  10 1.03 16.7 17.8 5.62 1.010 
T3F  24 0.66 11.3 16.8 5.70 1.010 
T3F  48 0.58 26.9 53.3 20.3 1.003 
T4F  0 0.43 5.18 11.6 3.90 1.007 
T4F  1 1.12 8.33 7.98 2.00 1.005 
T4F  2 1.19 9.87 8.71 2.18 1.014 
T4F  3 1.63 17.5 10.1 2.38 1.013 
T4F  4 1.79 20.3 11.3 2.65 1.01 
T4F  5 1.48 20.0 12.6 3.69 1.015 
T4F  6 0.86 11.1 12.3 3.37 1.018 
T4F  7 0.63 12.5 19.4 4.55 1.020 
T4F  10 0.44 6.47 13.9 2.32 1.020 
T4F  24 0.50 7.64 14.5 2.73 1.009 
T4F  48 0.45 5.62 11.9 1.25 1.008 
T5F 0 0.46 29.1 66.1 6.64 1.011 
T5F 1 1.28 40.9 30.0 5.00 1.002 
T5F 2 1.68 90.1 54.6 10.0 1.001 
T5F 3 1.68 67.3 34.3 6.84 1.004 
T5F 4 1.52 55.8 31.6 6.74 1.005 
T5F 5 1.02 34.7 34.4 6.51 1.007 
T5F 6 0.68 31.1 50.4 5.85 1.012 
T5F 7 0.58 31.8 48.9 8.42 1.009 
T5F 10 0.58 30.3 51.5 10.5 1.002 
T5F 24 0.56 16.9 30.3 3.33 1.003 
T5F 48 0.58 20.2 32.4 4.86 1.008 
T6F  0 1.14 19.5 16.5 9.88 1.003 
T6F  1 1.94 16.5 9.10 7.19 1.003 
T6F  2 2.40 23.4 7.51 7.84 1.013 
T6F  3 2.48 27.2 8.58 8.17 1.015 
T6F  4 1.55 37.6 14.3 12.8 1.023 
T6F  5 0.86 17.3 11.0 11.6 1.022 
T6F  6 0.83 15.0 9.03 8.19 1.021 
T6F  7 1.18 20.9 11.5 11.1 1.017 
T6F  10 1.42 11.0 6.65 7.39 1.008 
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T6F  24 1.29 14.9 9.78 8.73 1.007 
T6F  48 1.30 11.3 8.33 10.1 1.006 
T7F  0 0.54 9.53 16.0 2.47 1.012 
T7F  1 1.38 26.9 19.2 5.00 1.002 
T7F  2 1.18 20.4 16.0 2.60 1.008 
T7F  3 1.11 34.1 20.2 2.68 1.018 
T7F  4 1.12 20.0 14.5 2.56 1.013 
T7F  5 0.73 9.04 11.7 1.67 1.006 
T7F  6 0.49 8.31 14.4 2.14 1.011 
T7F  7 0.39 11.0 20.0 2.45 1.018 
T7F  10 0.45 8.73 15.2 2.77 1.011 
T7F  24 0.35 14.3 29.6 10.3 1.019 
T7F  48 3.06 127 33.4 4.05 1.013 
T8F  0 0.35 3.33 14.2 7.93 1.003 
T8F  1 0.88 12.0 11.6 5.00 1.002 
T8F  2 1.14 15.0 12.4 2.00 1.005 
T8F  3 1.31 27.0 17.5 4.28 1.014 
T8F  4 1.07 16.1 13.3 3.00 1.01 
T8F  5 0.64 11.3 15.9 12.5 1.008 
T8F  6 0.59 10.1 15.7 3.31 1.010 
T8F  7 0.51 14.0 21.4 5.81 1.011 
T8F  10 0.55 12.4 20.3 6.24 1.006 
T8F  24 0.34 7.99 19.0 4.16 1.009 
T8F  48 0.42 10.1 22.4 6.30 1.004 
T9F  0 0.89 11.0 11.0 5.45 1.023 
T9F  1 2.58 25.7 9.05 3.33 1.003 
T9F  2 3.49 51.5 11.8 6.78 1.026 
T9F  3 3.42 59.8 12.8 6.66 1.031 
T9F  4 3.16 63.6 15.1 9.29 1.03 
T9F  5 1.74 32.6 14.8 7.27 1.027 
T9F  6 1.36 19.0 10.6 5.45 1.016 
T9F  7 1.27 12.4 10.9 3.33 1.003 
T9F  10 1.17 25.0 17.2 8.52 1.026 
T9F  24 0.94 6.85 6.47 2.18 1.017 
T9F  48 0.65 11.6 14.6 6.17 1.019 
T10F  0 1.19 26.5 16.3 10.4 1.026 
T10F  1 2.46 13.5 4.43 4.65 1.014 
T10F  2 2.66 12.2 4.31 3.10 1.009 
T10F  3 2.26 17.7 6.53 4.90 1.012 
T10F  4 1.70 8.74 13.5 8.20 1.009 
T10F  5 1.62 10.3 6.54 6.78 1.005 
T10F  6 1.62 13.8 7.73 7.38 1.007 
T10F  7 1.64 14.2 8.16 10.7 1.008 
T10F  10 1.69 19.7 8.48 14.7 1.021 
T10F  24 0.99 24.3 16.7 15.9 1.027 
T10F  48 1.24 11.3 7.74 7.50 1.013 
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8.17 Urinary T/E, T, E and 5 -DHT concentrations (ng/mL) for 
females after 8 units 
Appendix 8.17 Urinary T/E, T, E  and 5 -DHT concentrations (ng/mL) for females after 8 units 
Sample H after intake T/E T conc E conc 5 -DHT conc SG 
T1F  0 0.60 7.02 12.1 11.68 1.019 
T1F  1 1.22 5.00 5.00 5.00 1.002 
T1F  2 1.33 7.95 3.33 3.33 1.003 
T1F  3 1.89 9.71 4.86 3.75 1.007 
T1F  4 2.25 14.53 6.22 5.20 1.012 
T1F  5 2.82 17.13 2.75 5.49 1.01 
T1F  6 1.82 13.23 7.97 6.35 1.011 
T1F  7 1.15 10.08 9.56 7.35 1.009 
T1F  10 0.87 11.26 12.8 8.11 1.014 
T1F  24 0.59 4.20 8.48 6.86 1.018 
T1F  48 0.62 3.33 8.09 3.3 1.003 
T2F 0 1.09 20.7 19.5 1.25 1.008 
T2F 1 1.29 7.95 3.33 3.33 1.003 
T2F 2 1.62 12.0 3.33 3.33 1.003 
T2F 3 3.11 24.6 9.32 2.50 1.004 
T2F 4 3.44 28.4 8.72 2.66 1.008 
T2F 5 4.62 34.9 8.62 3.08 1.013 
T2F 6 4.21 35.3 8.11 5.17 1.007 
T2F 7 4.67 52.0 13.4 5.30 1.012 
T2F 10 2.01 26.7 13.5 9.58 1.003 
T2F 24 0.77 9.39 10.9 2.50 1.004 
T2F 48 0.09 15.4 14.6 2.00 1.005 
T3F  0 0.61 17.2 24.9 7.58 1.006 
T3F  1 1.48 18.9 10.9 3.33 1.003 
T3F  2 2.08 27.5 12.4 5.00 1.002 
T3F  3 2.45 36.0 13.2 5.00 1.002 
T3F  4 2.68 37.4 12.7 5.00 1.002 
T3F  5 2.39 30.4 12.3 3.33 1.003 
T3F  6 2.54 38.2 14.9 4.57 1.005 
T3F  7 1.78 31.0 16.4 3.33 1.003 
T3F  10 0.98 12.3 11.1 3.33 1.003 
T3F  24 0.55 11.2 17.7 5.28 1.009 
T3F  48 0.47 7.89 14.7 4.78 1.009 
T4F  0 0.91 5.59 5.62 1.99 1.015 
T4F  1 1.50 3.33 3.33 3.33 1.003 
T4F  2 1.45 5.00 5.00 5.00 1.002 
T4F  3 2.07 8.24 3.54 1.43 1.007 
T4F  4 2.60 8.07 2.81 1.11 1.009 
T4F  5 3.26 9.94 2.95 1.84 1.014 
T4F  6 3.67 18.6 5.71 2.46 1.017 
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T4F  7 2.74 16.4 5.19 2.04 1.014 
T4F  10 0.89 5.00 6.02 5.00 1.002 
T4F  24 0.87 8.43 8.38 0.5 1.023 
T4F  48 0.88 5.44 5.37 1.67 1.006 
T5F 0 0.72 8.77 10.3 2.00 1.005 
T5F 1 2.33 17.6 3.33 3.33 1.003 
T5F 2 2.91 20.9 5.00 5.00 1.002 
T5F 3 4.39 21.7 5.00 5.00 1.002 
T5F 4 5.21 18.3 3.33 3.33 1.003 
T5F 5 7.10 26.1 3.33 5.66 1.006 
T5F 6 6.00 24.9 3.46 5.28 1.009 
T5F 7 4.93 41.7 7.35 9.59 1.015 
T5F 10 1.98 25.6 11.5 6.82 1.008 
T5F 24 0.95 10.2 9.09 3.33 1.006 
T5F 48 0.73 20.9 27.5 0.7 1.015 
T6F  0 1.02 8.63 8.21 2.00 1.005 
T6F  1 1.88 11.8 5.76 5.0 1.002 
T6F  2 2.27 13.1 5.30 2.50 1.004 
T6F  3 2.93 18.8 6.20 2.89 1.008 
T6F  4 2.82 24.2 7.69 3.54 1.019 
T6F  5 3.26 31.0 9.24 3.60 1.016 
T6F  6 3.65 28.0 7.41 3.52 1.008 
T6F  7 3.90 52.5 13.3 7.47 1.013 
T6F  10 2.21 23.2 9.62 5.01 1.013 
T6F  24 1.04 14.5 12.8 6.90 1.012 
T6F  48 1.15 14.2 11.8 7.61 1.010 
T7F  0 0.26 12.7 44.5 4.0 1.017 
T7F  1 0.60 13.2 21.7 5.0 1.002 
T7F  2 1.39 18.6 23.4 5.00 1.002 
T7F  3 0.67 18.3 25.4 2.00 1.005 
T7F  4 0.65 15.6 20.7 2.84 1.016 
T7F  5 0.94 20.0 19.9 3.01 1.013 
T7F  6 1.00 29.2 25.8 3.01 1.012 
T7F  7 0.62 33.7 51.3 4.69 1.020 
T7F  10 0.24 11.1 42.6 4.62 1.022 
T7F  24 0.23 9.03 38.5 2.5 1.004 
T7F  48 0.25 8.10 31.8 3.36 1.008 
T8F  0 0.38 5.00 22.5 5.00 1.002 
T8F  1 0.60 5.00 10.0 5.00 1.002 
T8F  2 0.67 5.00 11.7 5.00 1.002 
T8F  3 0.88 14.9 16.5 6.04 1.008 
T8F  4 1.33 18.2 14.1 6.64 1.02 
T8F  5 1.47 35.2 22.7 9.15 1.022 
T8F  6 1.39 35.4 26.5 8.98 1.022 
T8F  7 0.88 22.7 27.7 0.83 1.012 
T8F  10 0.54 13.1 26.4 7.76 1.015 
T8F  24 0.37 6.21 15.9 4.35 1.009 
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T8F  48 0.51 6.43 11.5 5.18 1.004 
T9F  0 0.94 11.3 12.9 6.30 1.009 
T9F  1 2.24 14.2 5.0 5.00 1.002 
T9F  2 2.89 21.4 8.19 2.50 1.004 
T9F  3 2.89 23.4 8.02 5.36 1.014 
T9F  4 3.11 47.9 15.8 9.89 1.004 
T9F  5 4.53 31.2 8.38 4.72 1.009 
T9F  6 3.81 33.7 9.43 4.98 1.005 
T9F  7 4.64 54.6 11.1 7.17 1.010 
T9F  10 1.26 45.7 28.2 19.80 1.026 
T9F  24 0.86 11.2 12.8 5.99 1.017 
T9F  48 0.79 9.59 12.0 4.61 1.015 
T10F  0 0.86 25.9 25.2 11.7 1.024 
T10F  1 1.49 15.9 10.6 2.5 1.004 
T10F  2 1.80 19.3 10.1 4.48 1.009 
T10F  3 1.97 27.3 12.1 5.23 1.015 
T10F  4 2.70 41.6 15.0 6.29 1.012 
T10F  5 3.17 55.1 18.2 9.32 1.019 
T10F  6 2.54 35.1 12.5 7.19 1.018 
T10F  7 2.06 35.2 16.8 11.7 1.019 
T10F  10 1.12 13.5 11.9 7.25 1.019 
T10F  24 0.55 29.1 40.1 18.6 1.026 
T10F  48 0.60 27.2 34.3 12.1 1.024 
 
 
8.18 Urinary T/E, T, E and 5 -DHT concentrations (ng/mL) for 
eugonadal males after 4 units 
Appendix 8.18 Urinary T/E, T, E and 5 -DHT concentrations (ng/mL) for eugonadal males after 4 
units 
Sample H after intake T/E T conc E conc 5 -DHT conc SG 
T1M  0 0.09 2.78 26.9 2.16 1.012 
T1M  1 0.11 1.67 23.2 1.67 1.006 
T1M  2 0.14 2.67 17.3 2.51 1.008 
T1M  3 0.12 2.37 17.5 2.56 1.009 
T1M  4 0.11 4.21 33.9 5.03 1.022 
T1M  5 0.11 4.46 30.6 5.08 1.024 
T1M  6 0.13 3.15 20.7 3.14 1.021 
T1M  7 0.14 3.17 24.8 3.75 1.020 
T1M  10 0.12 3.01 19.4 2.30 1.025 
T1M  24 0.10 2.00 30.4 2.00 1.005 
T1M  48 0.13 1.43 16.8 1.43 1.007 
T2M 0 1.00 58.0 56.0 7.53 1.01 
T2M 1 1.07 79.1 73.8 7.81 1.011 
T2M 2 1.26 56.3 44.5 6.03 1.004 
T2M 3 1.08 68.9 64.0 7.51 1.011 
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T2M 4 0.95 53.4 53.0 6.94 1.010 
T2M 5 0.99 76.1 70.6 8.86 1.012 
T2M 6 1.09 83.8 69.7 9.00 1.016 
T2M 7 1.09 50.3 46.2 7.03 1.004 
T2M 10 1.22 42.2 35.5 5.70 1.005 
T2M 24 1.27 69.4 54.8 7.25 1.02 
T2M 48 0.96 36.1 36.8 5.36 1.006 
T4M 0 0.43 26.0 6.25 5.32 1.007 
T4M 1 0.55 16.9 30.1 2.50 1.004 
T4M 2 0.57 34.8 7.36 4.35 1.019 
T4M 3 0.46 23.4 50.4 4.38 1.011 
T4M 4 0.43 32.8 65.0 6.82 1.012 
T4M 5 0.39 29.6 70.9 6.01 1.011 
T4M 6 0.39 29.5 69.8 6.13 1.007 
T4M 7 0.41 39.8 88.4 9.80 1.016 
T4M 10 0.42 23.9 56.6 5.59 1.005 
T4M 24 0.33 34.3 100 6.68 1.010 
T4M 48 0.31 32.8 101 6.06 1.010 
T5M 0 0.23 13.4 50.1 4.01 1.026 
T5M 1 0.26 5.11 17.0 1.67 1.006 
T5M 2 0.28 6.05 17.0 2.59 1.017 
T5M 3 0.31 4.74 13.7 1.93 1.011 
T5M 4 0.27 6.89 22.9 2.61 1.011 
T5M 5 0.23 5.61 20.6 2.55 1.019 
T5M 6 0.24 4.38 16.2 1.89 1.016 
T5M 7 0.30 7.27 21.2 2.62 1.020 
T5M 10 0.29 6.07 17.8 2.22 1.023 
T5M 24 0.31 12.9 34.9 3.07 1.021 
T5M 48 0.29 10.3 25.6 2.30 1.022 
T6M 0 0.06 3.49 44.7 1.83 1.011 
T6M 1 0.06 1.99 27.4 0.91 1.011 
T6M 2 0.07 2.00 21.1 2.00 1.005 
T6M 3 0.09 2.50 28.1 2.50 1.004 
T6M 4 0.07 2.73 33.2 1.94 1.015 
T6M 5 0.08 2.00 24.2 2.00 1.005 
T6M 6 0.11 2.50 23.8 2.50 1.004 
T6M 7 0.08 3.41 44.4 1.11 1.009 
T6M 10 0.04 2.40 40.8 1.48 1.021 
T6M 24 0.04 3.17 60.8 2.18 1.024 
T6M 48 0.05 1.87 31.9 0.67 1.015 
T7M 0 1.11 65.4 58.2 6.45 1.022 
T7M 1 1.32 46.6 35.1 5.00 1.002 
T7M 2 1.33 52.5 38.8 3.79 1.008 
T7M 3 1.12 45.5 38.0 5.42 1.009 
T7M 4 1.01 31.3 31.5 4.57 1.005 
T7M 5 0.97 31.5 30.2 3.60 1.007 
T7M 6 0.97 18.4 19.3 2.44 1.010 
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T7M 7 0.95 27.8 27.5 3.54 1.010 
T7M 10 1.10 45.7 37.4 5.11 1.019 
T7M 24 0.82 37.1 40.2 5.00 1.017 
T7M 48 0.67 44.9 61.9 6.84 1.017 
T8M  0 2.21 81.4 33.3 8.12 1.018 
T8M  1 3.11 60.5 19.7 2.50 1.004 
T8M  2 3.37 81.8 24.6 7.33 1.011 
T8M  3 2.72 48.1 18.3 8.83 1.013 
T8M  4 2.90 54.1 19.4 6.88 1.016 
T8M  5 2.82 52.2 17.3 6.95 1.016 
T8M  6 2.22 44.0 18.2 5.11 1.007 
T8M  7 2.45 59.7 21.3 5.90 1.007 
T8M  10 3.02 38.9 11.9 4.15 1.011 
T8M  24 1.35 33.9 24.8 3.15 1.006 
T8M  48 1.69 39.6 21.1 3.54 1.007 
T9M 0 1.53 84.9 53.7 15.6 1.010 
T9M 1 1.62 52.3 25.2 47.7 1.005 
T9M 2 1.99 191.5 89.9 27.6 1.005 
T9M 3 1.94 33.7 16.6 7.60 1.009 
T9M 4 1.99 32.3 15.4 8.26 1.007 
T9M 5 1.81 27.3 14.9 6.98 1.008 
T9M 6 1.87 28.5 13.6 7.60 1.009 
T9M 7 1.88 29.8 15.8 10.8 1.012 
T9M 10 2.46 20.5 7.91 7.88 1.020 
T9M 24 1.78 41.5 22.7 8.02 1.014 
T9M 48 2.23 22.7 10.2 7.48 1.006 
T10M 0 0.13 4.79 38.0 3.09 1.029 
T10M 1 0.14 3.45 25.7 1.92 1.024 
T10M 2 0.16 2.84 19.3 2.56 1.024 
T10M 3 0.16 3.46 23.6 3.40 1.025 
T10M 4 0.18 2.70 17.5 2.80 1.022 
T10M 5 0.15 2.94 23.2 2.02 1.022 
T10M 6 0.14 2.53 24.9 2.60 1.023 
T10M 7 0.14 2.55 23.3 1.80 1.022 
T10M 10 0.14 1.20 17.0 1.80 1.021 
T10M 24 0.14 3.75 25.2 1.98 1.022 
T10M 48 0.11 3.14 27.4 1.58 1.014 
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eugonadal males after 8 units 
Appendix 8.19 Urinary T/E, T, E and 5 -DHT concentrations (ng/mL) for eugonadal males after 8 
units 
Sample H after intake T/E T conc E conc 5a-DHT conc SG 
T1M  0 0.09 3.43 35.3 2.93 1.017 
T1M  1 0.16 10.00 46.5 10.0 1.001 
T1M  2 0.11 1.67 28.9 1.67 1.006 
T1M  3 0.10 2.91 25.5 1.43 1.007 
T1M  4 0.13 3.92 29.0 1.67 1.006 
T1M  5 0.11 4.35 35.3 3.42 1.006 
T1M  6 0.10 3.68 29.7 2.62 1.017 
T1M  7 0.10 2.66 24.7 2.59 1.010 
T1M  10 0.09 3.23 33.1 3.76 1.010 
T1M  24 0.08 2.74 31.0 2.05 1.012 
T1M  48 0.08 3.03 33.7 2.70 1.010 
T2M 0 0.90 42.7 45.9 5.00 1.002 
T2M 1 1.13 59.2 46.4 7.27 1.004 
T2M 2 1.33 49.2 35.7 5.00 1.002 
T2M 3 1.41 59.8 39.4 6.08 1.004 
T2M 4 1.38 92.9 59.6 9.38 1.008 
T2M 5 1.29 102 65.9 9.10 1.014 
T2M 6 1.21 105 73.6 11.2 1.015 
T2M 7 1.05 69.9 55.1 12.8 1.013 
T2M 10 1.01 65.2 57.4 10.8 1.006 
T2M 24 0.80 60.8 65.9 8.67 1.008 
T2M 48 0.85 63.0 67.1 8.49 1.013 
T4M 0 0.31 30.0 79.4 9.16 1.021 
T4M 1 0.51 12.5 23.8 3.33 1.003 
T4M 2 0.55 27.3 42.5 4.17 1.006 
T4M 3 0.61 24.2 33.9 4.04 1.009 
T4M 4 0.58 34.7 53.4 5.12 1.011 
T4M 5 0.55 40.9 66.0 5.85 1.014 
T4M 6 0.53 31.8 52.6 5.38 1.011 
T4M 7 0.42 28.9 60.7 7.51 1.014 
T4M 10 0.53 33.0 58.5 9.59 1.008 
T4M 24 0.32 31.7 88.8 7.45 1.006 
T4M 48 0.34 34.7 82.3 8.21 1.006 
T5M 0 0.24 5.95 23.4 2.55 1.011 
T5M 1 0.26 5.00 11.9 5.0 1.002 
T5M 2 0.32 2.50 8.9 2.50 1.004 
T5M 3 0.30 3.17 10.2 1.67 1.006 
T5M 4 0.24 3.35 11.7 1.61 1.013 
T5M 5 0.31 3.58 11.1 1.64 1.014 
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T5M 6 0.28 4.82 14.3 2.06 1.012 
T5M 7 0.25 5.89 17.4 2.39 1.01 
T5M 10 0.29 3.33 11.1 3.33 1.003 
T5M 24 0.20 3.54 13.5 2.34 1.012 
T5M 48 0.23 4.79 17.4 1.85 1.014 
T6M 0 0.07 2.81 46.0 0.50 1.020 
T6M 1 0.06 2.50 28.4 2.50 1.004 
T6M 2 0.12 5.00 25.7 5.00 1.002 
T6M 3 0.10 5.00 26.6 5.00 1.002 
T6M 4 0.09 2.50 32.3 2.50 1.004 
T6M 5 0.07 1.11 35.6 2.47 1.009 
T6M 6 0.06 1.63 29.7 4.36 1.013 
T6M 7 0.08 3.27 37.6 3.79 1.013 
T6M 10 0.06 2.00 40.5 6.02 1.005 
T6M 24 0.05 1.43 43.4 3.41 1.007 
T6M 48 0.04 2.35 49.0 0.63 1.016 
T7M 0 0.97 48.7 37.7 5.27 1.019 
T7M 1 1.02 39.0 31.8 5.03 1.004 
T7M 2 1.45 51.5 32.2 3.33 1.003 
T7M 3 1.45 122 73.8 15.7 1.003 
T7M 4 1.29 71.3 42.1 5.72 1.018 
T7M 5 1.16 67.3 53.4 7.16 1.022 
T7M 6 1.39 101 68.6 6.43 1.02 
T7M 7 1.10 41.3 41.5 6.38 1.005 
T7M 10 0.99 19.2 19.9 2.50 1.004 
T7M 24 0.76 25.6 33.6 2.50 1.004 
T7M 48 0.65 31.3 50.1 5.01 1.007 
T8M  0 1.61 54.2 38.2 7.42 1.012 
T8M  1 2.49 68.6 28.3 3.33 1.003 
T8M  2 3.03 87.2 32.4 5.98 1.006 
T8M  3 3.18 136 43.5 8.65 1.018 
T8M  4 3.18 155 47.1 9.62 1.022 
T8M  5 3.11 157 48.8 10.0 1.022 
T8M  6 2.98 138 47.5 11.1 1.018 
T8M  7 2.71 94.3 37.9 11.8 1.006 
T8M  10 2.77 89.2 34.8 8.95 1.014 
T8M  24 1.27 43.0 34.5 5.00 1.002 
T8M  48 1.84 52.6 29.7 6.60 1.004 
T9M 0 1.47 65.1 40.9 10.3 1.019 
T9M 1 1.79 42.8 26.4 4.29 1.009 
T9M 2 2.09 139 69.4 13.3 1.004 
T9M 3 2.16 44.8 22.2 4.05 1.007 
T9M 4 2.01 46.9 23.0 4.62 1.007 
T9M 5 2.81 61.2 22.4 4.65 1.014 
T9M 6 2.57 67.4 27.8 6.31 1.014 
T9M 7 2.50 91.8 36.2 8.70 1.016 
T9M 10 1.71 36.9 21.6 7.83 1.015 
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T9M 24 1.27 49.2 40.9 11.8 1.017 
T9M 48 1.41 89.4 60.9 18.8 1.02 
T10M 0 0.07 4.77 59.8 3.07 1.030 
T10M 1 0.15 2.50 9.3 2.50 1.004 
T10M 2 0.19 3.33 15.7 3.33 1.003 
T10M 3 0.16 2.50 16.2 2.50 1.004 
T10M 4 0.11 2.14 20.7 1.87 1.014 
T10M 5 0.11 2.68 23.3 1.87 1.018 
T10M 6 0.13 2.63 21.9 1.95 1.016 
T10M 7 0.13 2.30 18.0 2.31 1.013 
T10M 10 0.13 2.50 24.4 2.50 1.004 
T10M 24 0.09 2.06 22.2 2.23 1.019 
T10M 48 0.12 1.25 21.9 1.25 1.008 
 
8.20 Serum LH concentration for females after 4 units and after 8 
units 











T1F - S - 4U - CT 3.172 
 
T1F - S - 8U - CT 2.741 
T1F - S - 4U - 1h 6.293 
 
T1F - S - 8U - 1h 1.379 
T1F - S - 4U - 2h 3.604 
 
T1F - S - 8U - 2h 2.816 
T1F - S - 4U - 3h 5.546 
 
T1F - S - 8U - 3h 2.12 
T1F - S - 4U - 4h 5.392 
 
T1F - S - 8U - 4h 3.126 
T1F - S - 4U - 5h 4.484 
 
T1F - S - 8U - 5h 1.835 
T1F - S - 4U - 6h 10.082 
 
T1F - S - 8U - 6h 2.582 
T1F - S - 4U - 24h N/A 
 
T1F - S - 8U - 24h 2.972 
T1F - S - 4U - 48h 7.961 
 
T1F - S - 8U - 48h 3.677 
T2F - S - 4U - CT 6.739 
 
T2F - S - 8U - CT 7.97 
T2F - S - 4U - 1h 4.911 
 
T2F - S - 8U - 1h 5.638 
T2F - S - 4U - 2h 4.66 
 
T2F - S - 8U - 2h 7.543 
T2F - S - 4U - 3h 3.674 
 
T2F - S - 8U - 3h 4.246 
T2F - S - 4U - 4h 2.245 
 
T2F - S - 8U - 4h 2.653 
T2F - S - 4U - 5h 5.712 
 
T2F - S - 8U - 5h 1.963 
T2F - S - 4U - 6h 2.786 
 
T2F - S - 8U - 6h 1.797 
T2F - S - 4U - 24h 3.947 
 
T2F - S - 8U - 24h 6.681 
T2F - S - 4U - 48h 4.038 
 
T2F - S - 8U - 48h 7.917 
T4F - S - 4U - CT 32.399 
 
T4F - S - 8U - CT 1.281 
T4F - S - 4U - 1h 26.917 
 
T4F - S - 8U - 1h 2.187 
T4F - S - 4U - 2h 21.479 
 
T4F - S - 8U - 2h 1.269 
T4F - S - 4U - 3h 18.562 
 
T4F - S - 8U - 3h 0.861 
T4F - S - 4U - 4h 19.316 
 
T4F - S - 8U - 4h 0.538 
T4F - S - 4U - 5h 18.518 
 
T4F - S - 8U - 5h 0.432 
T4F - S - 4U - 6h 32.395 
 
T4F - S - 8U - 6h 2.834 
T4F - S - 4U - 24h 10.674 
 
T4F - S - 8U - 24h 3.2 
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T4F - S - 4U - 48h 3.628 
 
T4F - S - 8U - 48h 2.386 
T5F - S - 4U - CT 23.033 
 
T5F - S - 8U - CT 2.556 
T5F - S - 4U - 1h 17.893 
 
T5F - S - 8U - 1h 1.801 
T5F - S - 4U - 2h 11.549 
 
T5F - S - 8U - 2h 1.054 
T5F - S - 4U - 3h 11.16 
 
T5F - S - 8U - 3h 1.764 
T5F - S - 4U - 4h 15.721 
 
T5F - S - 8U - 4h 0.92 
T5F - S - 4U - 5h 11.751 
 
T5F - S -8U - 5h 1.185 
T5F - S - 4U - 6h 14.095 
 
T5F - S - 8U - 6h 0.51 
T5F - S - 4U - 24h 5.726 
 
T5F - S - 8U - 24h 1.757 
T5F - S - 4U - 48h 4.466 
 
T5F - S - 8U - 48h 2.397 
T6F - S - 4U - CT 12.368 
 
T6F - S - 8U - CT 5.513 
T6F - S - 4U - 1h 4.911 
 
T6F - S - 8U - 1h 5.136 
T6F - S - 4U - 2h 5.872 
 
T6F - S - 8U - 2h 3.337 
T6F - S - 4U - 3h 3.217 
 
T6F - S - 8U - 3h 5.654 
T6F - S - 4U - 4h 3.069 
 
T6F - S - 8U - 4h 8.058 
T6F - S - 4U - 5h 2.489 
 
T6F - S - 8U - 5h 7.495 
T6F - S - 4U - 6h 2.335 
 
T6F - S - 8U - 6h 7.635 
T6F - S - 4U - 24h 3.356 
 
T6F - S - 8U - 24h 6.686 
T6F - S - 4U - 48h 4.665 
 
T6F - S - 8U - 48h 5.863 
T7F - S - 4U - CT 9.708 
 
T7F - S - 8U - CT 6.266 
T7F - S - 4U - 1h 10.287 
 
T7F - S - 8U - 1h 2.657 
T7F - S - 4U - 2h 8.927 
 
T7F - S - 8U - 2h 5.872 
T7F - S - 4U - 3h 8.596 
 
T7F - S - 8U - 3h 3.263 
T7F - S - 4U - 4h 8.843 
 
T7F - S - 8U - 4h 6.293 
T7F - S - 4U - 5h 9.493 
 
T7F - S - 8U - 5h 7.195 
T7F - S - 4U - 6h 6.865 
 
T7F - S - 8U - 6h 5.605 
T7F - S - 4U - 24h 23.006 
 
T7F - S - 8U - 24h 5.555 
T7F - S - 4U - 48h 23.051 
 
T7F - S - 8U - 48h 4.5 
T8F - S - 4U - CT 12.098 
 
T8F - S - 8U - CT 3.626 
T8F - S - 4U - 1h 13.897 
 
T8F - S - 8U - 1h 6.925 
T8F - S - 4U - 2h 9.624 
 
T8F - S - 8U - 2h 4.044 
T8F - S - 4U - 3h 15.323 
 
T8F - S - 8U - 3h 3.077 
T8F - S - 4U - 4h 18.518 
 
T8F - S - 8U - 4h 7.575 
T8F - S - 4U - 5h 20.648 
 
T8F - S - 8U - 5h 6.779 
T8F - S - 4U - 6h 12.85 
 
T8F - S - 8U - 6h 4.353 
T8F - S - 4U - 24h 8.154 
 
T8F - S - 8U - 24h 2.493 
T8F - S - 4U - 48h 8.913 
 
T8F - S - 8U - 48h 7.904 
T9F - S - 4U - CT 3.708 
 
T9F - S - 8U - CT 5.555 
T9F - S - 4U - 1h 2.326 
 
T9F - S - 8U - 1h 5.122 
T9F - S - 4U - 2h 4.313 
 
T9F - S - 8U - 2h 7.431 
T9F - S - 4U - 3h 4.365 
 
T9F - S - 8U - 3h 4.039 
T9F - S - 4U - 4h 4.277 
 
T9F - S - 8U - 4h 4.788 
T9F - S - 4U - 5h 4.248 
 
T9F - S - 8U - 5h 5.872 
T9F - S - 4U - 6h 5.762 
 
T9F - S - 8U - 6h 5.365 
T9F - S - 4U - 24h 6.151 
 
T9F - S - 8U - 24h 6.456 
T9F - S - 4U - 48h 10.462 
 
T9F - S - 8U - 48h 10.793 
T10F - S - 4U -CT 4.994 
 
T10F - S - 8U -CT 8.366 
T10F - S - 4U - 1h 4.656 
 
T10F - S - 8U - 1h 5.665 
T10F - S - 4U - 2h 4.134 
 
T10F - S - 8U - 2h 6.438 
T10F - S - 4U - 3h 3.396 
 
T10F - S - 8U - 3h 5.925 
T10F - S - 4U - 4h 3.605 
 
T10F - S - 8U - 4h 6.385 
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T10F - S - 4U - 5h 4.574 
 
T10F - S - 8U - 5h 7.986 
T10F - S - 4U - 6h 4.656 
 
T10F - S - 8U - 6h 7.796 
T10F - S - 4U-24h 6.084 
 
T10F - S – 8U-24h 5.05 
T10F - S - 4U-48h 5.934 
 
T10F - S - 8U-48h 23.557 
 
 
8.21 Urinary LH concentration for females after 4 and after 8 units 








(IU/L)   (IU/L) 
T1F - U - 4U - CT 12.183   T1F - U - 8U - CT 5.471 
T1F - U - 4U - 1h 6.240   T1F - U - 8U - 1h 0.700 
T1F - U - 4U - 2h 3.955   T1F - U - 8U - 2h 2.880 
T1F - U - 4U - 3h 6.088   T1F - U - 8U - 3h 2.503 
T1F - U - 4U - 4h 5.290   T1F - U - 8U - 4h 3.228 
T1F - U - 4U - 5h 8.445   T1F - U - 8U - 5h 2.720 
T1F - U - 4U - 6h 6.051   T1F - U - 8U - 6h 3.064 
T1F - U - 4U - 7h 13.895   T1F - U - 8U - 7h 3.380 
T1F - U - 4U - 10h 5.977   T1F - U - 8U - 10h 4.696 
T1F - U - 4U - 24h 8.826   T1F - U - 8U - 24h 4.152 
T1F - U - 4U - 48h 4.027   T1F - U - 8U - 48h 2.573 
T1F - U - 4U - 72h 5.431   T1F - U - 8U - 72h -0.005 
T2F - U - 4U - CT 6.547   T2F - U - 8U - CT 11.878 
T2F - U - 4U - 1h 3.430   T2F - U - 8U - 1h 2.927 
T2F - U - 4U - 2h 4.188   T2F - U - 8U - 2h 3.853 
T2F - U - 4U - 3h 4.558   T2F - U - 8U - 3h 7.445 
T2F - U - 4U - 4h 4.958   T2F - U - 8U - 4h 5.133 
T2F - U - 4U - 5h 6.528   T2F - U - 8U - 5h 3.878 
T2F - U - 4U - 6h 5.996   T2F - U - 8U - 6h 2.957 
T2F - U - 4U - 7h 3.271   T2F - U - 8U - 7h 8.557 
T2F - U - 4U - 10h 4.336   T2F - U - 8U - 10h 3.913 
T2F - U - 4U - 24h 4.174   T2F - U - 8U - 24h 5.720 
T2F - U - 4U - 48h 5.154   T2F - U - 8U - 48h 12.328 
T2F - U - 4U - 72h 6.507   T2F - U - 8U - 72h 10.890 
T3F - U - 4U - CT 14.955   T3F - U - 8U - CT 20.240 
T3F - U - 4U - 1h 11.667   T3F - U - 8U - 1h 5.713 
T3F - U - 4U - 2h 2.412   T3F - U - 8U - 2h 6.250 
T3F - U - 4U - 3h 6.660   T3F - U - 8U - 3h 3.190 
T3F - U - 4U - 4h 10.760   T3F - U - 8U - 4h 2.870 
T3F - U - 4U - 5h 6.532   T3F - U - 8U - 5h 3.253 
T3F - U - 4U - 6h 7.062   T3F - U - 8U - 6h 4.384 
T3F - U - 4U - 7h 8.431   T3F - U - 8U - 7h 4.520 
T3F - U - 4U - 10h 16.866   T3F - U - 8U - 10h 6.353 
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T3F - U - 4U - 24h 17.830   T3F - U - 8U - 24h 14.922 
T3F - U - 4U - 48h 55.820   T3F - U - 8U - 48h 11.591 
T3F - U - 4U - 72h 2.140   T3F - U - 8U - 72h 8.072 
T4F - U - 4U - CT 38.737   T4F - U - 8U - CT 2.223 
T4F - U - 4U - 1h 18.908   T4F - U - 8U - 1h 0.953 
T4F - U - 4U - 2h 21.380   T4F - U - 8U - 2h 0.700 
T4F - U - 4U - 3h 20.094   T4F - U - 8U - 3h 1.337 
T4F - U - 4U - 4h 19.816   T4F - U - 8U - 4h 1.082 
T4F - U - 4U - 5h 27.664   T4F - U - 8U - 5h 1.059 
T4F - U - 4U - 6h 25.324   T4F - U - 8U - 6h 3.040 
T4F - U - 4U - 7h 70.171   T4F - U - 8U - 7h 3.220 
T4F - U - 4U - 10h 72.127   T4F - U - 8U - 10h 2.160 
T4F - U - 4U - 24h 112.362   T4F - U - 8U - 24h 3.879 
T4F - U - 4U - 48h 10.160   T4F - U - 8U - 48h 3.410 
T4F - U - 4U - 72h 8.727   T4F - U - 8U - 72h 2.980 
T5F - U - 4U - CT 63.627   T5F - U - 8U - CT 4.828 
T5F - U - 4U - 1h 10.000   T5F - U - 8U - 1h 1.873 
T5F - U - 4U - 2h 14.760   T5F - U - 8U - 2h 1.820 
T5F - U - 4U - 3h 17.900   T5F - U - 8U - 3h 0.700 
T5F - U - 4U - 4h 19.864   T5F - U - 8U - 4h 2.193 
T5F - U - 4U - 5h 25.080   T5F - U - 8U - 5h 2.897 
T5F - U - 4U - 6h 31.107   T5F - U - 8U - 6h 2.933 
T5F - U - 4U - 7h 43.558   T5F - U - 8U - 7h 3.931 
T5F - U - 4U - 10h 25.720   T5F - U - 8U - 10h 2.013 
T5F - U - 4U - 24h 4.440   T5F - U - 8U - 24h 1.637 
T5F - U - 4U - 48h 24.860   T5F - U - 8U - 48h 8.057 
T5F - U - 4U - 72h 8.760   T5F - U - 8U - 72h 2.520 
T6F - U - 4U - CT 3.080   T6F - U - 8U - CT 2.864 
T6F - U - 4U - 1h 1.400   T6F - U - 8U - 1h 0.700 
T6F - U - 4U - 2h 1.238   T6F - U - 8U - 2h 0.350 
T6F - U - 4U - 3h 2.325   T6F - U - 8U - 3h 1.900 
T6F - U - 4U - 4h 2.390   T6F - U - 8U - 4h 4.246 
T6F - U - 4U - 5h 1.841   T6F - U - 8U - 5h 4.885 
T6F - U - 4U - 6h 2.229   T6F - U - 8U - 6h 4.355 
T6F - U - 4U - 7h 2.601   T6F - U - 8U - 7h 5.872 
T6F - U - 4U - 10h 1.478   T6F - U - 8U - 10h 5.106 
T6F - U - 4U - 24h 1.971   T6F - U - 8U - 24h 4.118 
T6F - U - 4U - 48h 1.847   T6F - U - 8U - 48h 5.776 
T6F - U - 4U - 72h 2.353   T6F - U - 8U - 72h 8.268 
T7F - U - 4U - CT 2.063   T7F - U - 8U - CT 13.991 
T7F - U - 4U - 1h 1.520   T7F - U - 8U - 1h 0.700 
T7F - U - 4U - 2h 1.128   T7F - U - 8U - 2h 1.780 
T7F - U - 4U - 3h 1.700   T7F - U - 8U - 3h 3.048 
T7F - U - 4U - 4h 4.094   T7F - U - 8U - 4h 3.906 
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T7F - U - 4U - 5h 1.040   T7F - U - 8U - 5h 4.718 
T7F - U - 4U - 6h 2.807   T7F - U - 8U - 6h 5.718 
T7F - U - 4U - 7h 2.687   T7F - U - 8U - 7h 10.882 
T7F - U - 4U - 10h 2.245   T7F - U - 8U - 10h 8.533 
T7F - U - 4U - 24h 18.917   T7F - U - 8U - 24h 4.375 
T7F - U - 4U - 48h 22.743   T7F - U - 8U - 48h 4.830 
T7F - U - 4U - 72h 23.417   T7F - U - 8U - 72h 5.072 
T8F - U - 4U - CT 2.520   T8F - U - 8U - CT 3.870 
T8F - U - 4U - 1h 3.110   T8F - U - 8U - 1h 1.860 
T8F - U - 4U - 2h 3.324   T8F - U - 8U - 2h 3.760 
T8F - U - 4U - 3h 4.786   T8F - U - 8U - 3h 4.720 
T8F - U - 4U - 4h 3.558   T8F - U - 8U - 4h 4.989 
T8F - U - 4U - 5h 10.723   T8F - U - 8U - 5h 6.916 
T8F - U - 4U - 6h 5.858   T8F - U - 8U - 6h 7.997 
T8F - U - 4U - 7h 4.993   T8F - U - 8U - 7h 7.685 
T8F - U - 4U - 10h 4.703   T8F - U - 8U - 10h 8.539 
T8F - U - 4U - 24h 4.709   T8F - U - 8U - 24h 5.573 
T8F - U - 4U - 48h 4.765   T8F - U - 8U - 48h 6.970 
T8F - U - 4U - 72h 3.876   T8F - U - 8U - 72h 5.710 
T9F - U - 4U - CT 6.120   T9F - U - 8U - CT 11.409 
T9F - U - 4U - 1h 1.027   T9F - U - 8U - 1h 2.850 
T9F - U - 4U - 2h 1.772   T9F - U - 8U - 2h 3.795 
T9F - U - 4U - 3h 3.131   T9F - U - 8U - 3h 5.333 
T9F - U - 4U - 4h 1.983   T9F - U - 8U - 4h 10.855 
T9F - U - 4U - 5h 2.475   T9F - U - 8U - 5h 6.064 
T9F - U - 4U - 6h 1.934   T9F - U - 8U - 6h 7.088 
T9F - U - 4U - 7h 2.227   T9F - U - 8U - 7h 10.582 
T9F - U - 4U - 10h 3.056   T9F - U - 8U - 10h 15.600 
T9F - U - 4U - 24h 3.809   T9F - U - 8U - 24h 9.714 
T9F - U - 4U - 48h 5.568   T9F - U - 8U - 48h 10.068 
T9F - U - 4U - 72h 6.861   T9F - U - 8U - 72h 12.004 
T10F - U - 4U-CT 1.888   T10F - U - 8U-CT 8.705 
T10F - U - 4U - 1h 0.993   T10F - U - 8U - 1h 2.705 
T10F - U - 4U - 2h 0.516   T10F - U - 8U - 2h 2.449 
T10F - U - 4U - 3h 0.600   T10F - U - 8U - 3h 2.819 
T10F - U - 4U - 4h 1.018   T10F - U - 8U - 4h 2.788 
T10F - U - 4U - 5h 0.884   T10F - U - 8U - 5h 3.600 
T10F - U - 4U - 6h 0.829   T10F - U - 8U - 6h 3.781 
T10F - U - 4U - 7h 0.980   T10F - U - 8U - 7h 4.805 
T10F - U - 4U-10h 1.691   T10F - U - 8U-10h 8.377 
T10F - U - 4U-24h 1.973   T10F - U - 8U-24h 38.135 
T10F - U - 4U-48h 1.109   T10F - U - 8U-48h 19.593 
T10F - U - 4U-72h 2.809   T10F - U - 8U-72h 14.852 
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8.22 Serum LH concentration for eugonadal males after 4 and after 8 
units 











T1M - S - 4U - CT 1.956 
 
T1M - S - 8U - CT 1.512 
T1M - S - 4U - 1h 2.707 
 
T1M - S - 8U - 1h 1.245 
T1M - S - 4U - 2h 1.701 
 
T1M - S - 8U - 2h 2.526 
T1M - S - 4U - 3h 4.092 
 
T1M - S - 8U - 3h 2.224 
T1M - S - 4U - 4h 2.848 
 
T1M - S - 8U - 4h 1.566 
T1M - S - 4U - 5h 2.33 
 
T1M - S - 8U - 5h 1.091 
T1M - S - 4U - 6h 1.402 
 
T1M - S - 8U - 6h 2.33 
T1M - S - 4U - 24h 3.528 
 
T1M - S - 8U - 24h 2.296 
T1M - S - 4U - 48h 3.178 
 
T1M - S - 8U - 48h 1.362 
T2M - S - 4U - CT 2.738 
 
T2M - S - 8U - CT 2.645 
T2M - S - 4U - 1h 3.151 
 
T2M - S - 8U - 1h 3.063 
T2M - S - 4U - 2h 4.2 
 
T2M - S - 8U - 2h 3.142 
T2M - S - 4U - 3h 2.676 
 
T2M - S - 8U - 3h 2.014 
T2M - S - 4U - 4h 3.188 
 
T2M - S - 8U - 4h 2.257 
T2M - S - 4U - 5h 3.445 
 
T2M - S - 8U - 5h 1.657 
T2M - S - 4U - 6h 2.737 
 
T2M - S - 8U - 6h 1.99 
T2M - S - 4U - 24h N/A 
 
T2M - S - 8U - 24h 3.784 
T2M - S - 4U - 48h 3.985 
 
T2M - S - 8U - 48h 2.36 
T4M - S - 4U - CT 1.17 
 
T4M - S - 8U - CT 1.634 
T4M - S - 4U - 1h 2.525 
 
T4M - S - 8U - 1h 2.87 
T4M - S - 4U - 2h 2.146 
 
T4M - S - 8U - 2h 1.73 
T4M - S - 4U - 3h 1.596 
 
T4M - S - 8U - 3h 2.791 
T4M - S - 4U - 4h 3.413 
 
T4M - S - 8U - 4h 2.866 
T4M - S - 4U - 5h 2.638 
 
T4M - S - 8U - 5h 2.088 
T4M - S - 4U - 6h 1.66 
 
T4M - S - 8U - 6h 1.443 
T4M - S - 4U - 24h 1.906 
 
T4M - S - 8U - 24h 2.498 
T4M - S - 4U - 48h 3.099 
 
T4M - S - 8U - 48h 2.12 
T5M - S - 4U - CT 7.436 
 
T5M - S - 8U - CT 5.351 
T5M - S - 4U - 1h 5.932 
 
T5M - S - 8U - 1h 2.923 
T5M - S - 4U - 2h 5.406 
 
T5M - S - 8U - 2h 2.634 
T5M - S - 4U - 3h 8.237 
 
T5M - S - 8U - 3h 6.378 
T5M - S - 4U - 4h 8.736 
 
T5M - S - 8U - 4h 4.719 
T5M - S - 4U - 5h 5.694 
 
T5M - S - 8U - 5h 9.605 
T5M - S - 4U - 6h 5.726 
 
T5M - S - 8U - 6h 6.95 
T5M - S - 4U - 24h 7.085 
 
T5M - S - 8U - 24h 7.203 
T5M - S - 4U - 48h 5.627 
 
T5M - S - 8U - 48h 6.449 
T6M - S - 4U -CT 10.767 
 
T6M - S - 8U - CT 10.158 
T6M - S - 4U - 1h 12.027 
 
T6M - S - 8U - 1h 13.121 
T6M - S - 4U - 2h 10.801 
 
T6M - S - 8U - 2h 10.376 
T6M - S - 4U - 3h 14.455 
 
T6M - S - 8U - 3h 12.834 
T6M - S - 4U - 4h 14.184 
 
T6M - S - 8U - 4h 10.637 
T6M - S - 4U - 5h 11.807 
 
T6M - S - 8U - 5h 15.457 
T6M - S - 4U - 6h 14.754 
 
T6M - S - 8U - 6h 11.732 
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T6M - S - 4U - 24h 11.068 
 
T6M - S - 8U - 24h 12.041 
T6M - S - 4U - 48h 10.999 
 
T6M - S - 8U - 48h 10.683 
T7M - S - 4U - CT 3.594 
 
T7M - S - 8U - CT 2.447 
T7M - S - 4U - 1h 2.431 
 
T7M - S - 8U - 1h 1.541 
T7M - S - 4U - 2h 1.931 
 
T7M -  S - 8U - 2h 1.438 
T7M - S - 4U - 3h 1.934 
 
T7M - S - 8U - 3h 3.484 
T7M - S - 4U - 4h 1.375 
 
T7M - S - 8U - 4h 3.2 
T7M - S - 4U - 5h 1.82 
 
T7M - S - 8U - 5h 3.44 
T7M - S - 4U - 6h 1.693 
 
T7M - S - 8U - 6h 3.07 
T7M - S - 4U - 24h 3.701 
 
T7M - S -8U - 24h 2.473 
T7M - S - 4U - 48h 4.041 
 
T7M - S - 8U - 48h 3.224 
T8M - S - 4U - CT 4.068 
 
T8M - S - 8U - CT 3.54 
T8M - S - 4U - 1h 3.448 
 
T8M - S - 8U - 1h 7.543 
T8M - S - 4U - 2h 2.759 
 
T8M - S - 8U - 2h 4.099 
T8M - S - 4U - 3h 2.526 
 
T8M - S - 8U - 3h 4.464 
T8M - S - 4U - 4h 5.292 
 
T8M - S - 8U - 4h 6.718 
T8M - S - 4U - 5h 6.637 
 
T8M - S - 8U - 5h 4.282 
T8M - S - 4U - 6h 4.573 
 
T8M - S - 8U - 6h 3.732 
T8M - S - 4U - 24h 5.226 
 
T8M - S - 8U - 24h 4.447 
T8M - S - 4U - 48h 8.097 
 
T8M - S - 8U - 48h 3.169 
T9M - S - 4U - CT 2.728 
 
T9M - S - 8U - CT 3.989 
T9M - S - 4U - 1h 3.192 
 
T9M - S - 8U - 1h 6.408 
T9M - S - 4U - 2h 2.702 
 
T9M - S - 8U - 2h 3.503 
T9M - S - 4U - 3h 2.313 
 
T9M - S - 8U - 3h 3.576 
T9M - S - 4U - 4h 1.921 
 
T9M - S - 8U - 4h 4.655 
T9M - S - 4U - 5h 1.579 
 
T9M - S - 8U - 5h 5.419 
T9M - S - 4U - 6h 1.536 
 
T9M - S - 8U - 6h 5.817 
T9M - S - 4U - 24h 3.448 
 
T9M - S - 8U - 24h 3.057 
T9M - S - 4U - 48h 1.883 
 
T9M - S - 8U - 48h 3.67 
T10M - S - 4U - CT 4.434 
 
T10M - S - 8U-CT 3.794 
T10M - S - 4U - 1h 2.602 
 
T10M - S - 8U - 1h 3.394 
T10M - S - 4U - 2h 3.243 
 
T10M - S - 8U - 2h 4.905 
T10M - S - 4U - 3h 2.412 
 
T10M - S - 8U - 3h 4.454 
T10M - S - 4U - 4h 3.081 
 
T10M - S - 8U - 4h 4.662 
T10M - S - 4U - 5h 2.847 
 
T10M - S - 8U - 5h 3.508 
T10M - S - 4U - 6h 3.119 
 
T10M - S - 8U - 6h 4.086 
T10M - S - 4U - 24h 4.99 
 
T10M - S - 8U - 24h 3.314 
T10M - S - 4U - 48h 5.126 
 
T10M - S - 8U - 48h 3.061 
  
 
8.23 Urinary LH concentration for eugonadal males after 4 and after 
8 units  











T1M - U - 4U - CT 3.758 
 
T1M - U - 8U - CT 2.700 
T1M - U - 4U - 1h 2.810 
 
T1M - U - 8U - 1h 0.070 
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T1M - U - 4U - 2h 2.358 
 
T1M - U - 8U - 2h 2.537 
T1M - U - 4U - 3h 3.691 
 
T1M - U - 8U - 3h 2.894 
T1M - U - 4U - 4h 6.741 
 
T1M - U - 8U - 4h 2.250 
T1M - U - 4U - 5h 5.569 
 
T1M - U - 8U - 5h 1.687 
T1M - U - 4U - 6h 4.793 
 
T1M - U - 8U - 6h 3.313 
T1M - U - 4U - 7h 6.709 
 
T1M - U - 8U - 7h 2.958 
T1M - U - 4U - 10h 5.353 
 
T1M - U - 8U - 10h 2.208 
T1M - U - 4U - 24h 3.232 
 
T1M - U - 8U - 24h 3.970 
T1M - U - 4U - 48h 2.154 
 
T1M - U - 8U - 48h 2.272 
T1M - U - 4U - 72h 3.829 
 
T1M - U - 8U - 72h 2.961 
T2M - U - 4U - CT 4.242 
 
T2M - U - 8U - CT 0.700 
T2M - U - 4U - 1h 4.344 
 
T2M - U - 8U - 1h 2.800 
T2M - U - 4U - 2h 2.055 
 
T2M - U - 8U - 2h 0.700 
T2M - U - 4U - 3h 3.636 
 
T2M - U - 8U - 3h 2.055 
T2M - U - 4U - 4h 3.768 
 
T2M - U - 8U - 4h 3.215 
T2M - U - 4U - 5h 3.958 
 
T2M - U - 8U - 5h 3.356 
T2M - U - 4U - 6h 4.390 
 
T2M - U - 8U - 6h 4.251 
T2M - U - 4U - 7h 1.625 
 
T2M - U - 8U - 7h 4.360 
T2M - U - 4U - 10h 1.764 
 
T2M - U - 8U - 10h 3.247 
T2M - U - 4U - 24h 5.315 
 
T2M - U - 8U - 24h 4.455 
T2M - U - 4U - 48h 2.357 
 
T2M - U - 8U - 48h 4.643 
T2M - U - 4U - 72h 4.356 
 
T2M - U - 8U - 72h 3.172 
T4M - U - 4U - CT 1.720 
 
T4M - U - 8U - CT 3.018 
T4M - U - 4U - 1h 2.800 
 
T4M - U - 8U - 1h 1.467 
T4M - U - 4U - 2h 3.108 
 
T4M - U - 8U - 2h 2.487 
T4M - U - 4U - 3h 2.142 
 
T4M - U - 8U - 3h 3.591 
T4M - U - 4U - 4h 3.755 
 
T4M - U - 8U - 4h 4.456 
T4M - U - 4U - 5h 3.236 
 
T4M - U - 8U - 5h 2.904 
T4M - U - 4U - 6h 2.971 
 
T4M - U - 8U - 6h 2.407 
T4M - U - 4U - 7h 2.541 
 
T4M - U - 8U - 7h 3.144 
T4M - U - 4U - 10h 0.812 
 
T4M - U - 8U - 10h 2.230 
T4M - U - 4U - 24h 4.850 
 
T4M - U - 8U - 24h 2.453 
T4M - U - 4U - 48h 6.240 
 
T4M - U - 8U - 48h 3.743 
T4M - U - 4U - 72h 3.853 
 
T4M - U - 8U - 72h 0.923 
T5M - U - 4U - CT 25.857 
 
T5M - U - 8U - CT 12.678 
T5M - U - 4U - 1h 6.960 
 
T5M - U - 8U - 1h 2.170 
T5M - U - 4U - 2h 8.818 
 
T5M - U - 8U - 2h 3.585 
T5M - U - 4U - 3h 11.851 
 
T5M - U - 8U - 3h 6.140 
T5M - U - 4U - 4h 19.015 
 
T5M - U - 8U - 4h 11.598 
T5M - U - 4U - 5h 13.308 
 
T5M - U - 8U - 5h 8.786 
T5M - U - 4U - 6h 12.739 
 
T5M - U - 8U - 6h 13.778 
T5M - U - 4U - 7h 16.910 
 
T5M - U - 8U - 7h 9.258 
T5M - U - 4U - 10h 15.775 
 
T5M - U - 8U - 10h 3.367 
T5M - U - 4U - 24h 23.361 
 
T5M - U - 8U - 24h 12.908 
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T5M - U - 4U - 48h 17.721 
 
T5M - U - 8U - 48h 13.591 
T5M - U - 4U - 72h 17.564 
 
T5M - U - 8U - 72h 7.247 
T6M - U - 4U - CT 6.218 
 
T6M - U - 8U - CT 5.882 
T6M - U - 4U - 1h 5.424 
 
T6M - U - 8U - 1h 2.815 
T6M - U - 4U - 2h 3.544 
 
T6M - U - 8U - 2h 1.520 
T6M - U - 4U - 3h 4.130 
 
T6M - U - 8U - 3h 0.700 
T6M - U - 4U - 4h 4.379 
 
T6M - U - 8U - 4h 3.110 
T6M - U - 4U - 5h 3.408 
 
T6M - U - 8U - 5h 3.238 
T6M - U - 4U - 6h 4.080 
 
T6M - U - 8U - 6h 3.837 
T6M - U - 4U - 7h 8.998 
 
T6M - U - 8U - 7h 4.582 
T6M - U - 4U - 10h 5.940 
 
T6M - U - 8U - 10h 2.848 
T6M - U - 4U - 24h 6.256 
 
T6M - U - 8U - 24h 6.997 
T6M - U - 4U - 48h 4.956 
 
T6M - U - 8U - 48h 4.781 
T6M - U - 4U - 72h 10.398 
 
T6M - U - 8U - 72h 4.093 
T7M - U - 4U - CT 4.656 
 
T7M - U - 8U - CT 3.031 
T7M - U - 4U - 1h 1.820 
 
T7M - U - 8U - 1h 1.880 
T7M - U - 4U - 2h 2.763 
 
T7M - U - 8U - 2h 2.747 
T7M - U - 4U - 3h 2.476 
 
T7M - U - 8U - 3h 12.767 
T7M - U - 4U - 4h 1.756 
 
T7M - U - 8U - 4h 6.293 
T7M - U - 4U - 5h 1.637 
 
T7M - U - 8U - 5h 5.039 
T7M - U - 4U - 6h 1.320 
 
T7M - U - 8U - 6h 5.338 
T7M - U - 4U - 7h 2.678 
 
T7M - U - 8U - 7h 1.860 
T7M - U - 4U - 10h 2.934 
 
T7M - U - 8U - 10h 1.160 
T7M - U - 4U - 24h 3.549 
 
T7M - U - 8U - 24h 1.980 
T7M - U - 4U - 48h 4.319 
 
T7M - U - 8U - 48h 2.980 
T7M - U - 4U - 72h 3.754 
 
T7M - U - 8U - 72h 2.435 
T8M - U - 4U - CT 4.904 
 
T8M - U - 8U - CT 3.620 
T8M - U - 4U - 1h 1.810 
 
T8M - U - 8U - 1h 2.213 
T8M - U - 4U - 2h 2.558 
 
T8M - U - 8U - 2h 2.430 
T8M - U - 4U - 3h 2.298 
 
T8M - U - 8U - 3h 3.832 
T8M - U - 4U - 4h 2.986 
 
T8M - U - 8U - 4h 2.684 
T8M - U - 4U - 5h 3.650 
 
T8M - U - 8U - 5h 2.525 
T8M - U - 4U - 6h 2.371 
 
T8M - U - 8U - 6h 3.392 
T8M - U - 4U - 7h 2.326 
 
T8M - U - 8U - 7h 2.397 
T8M - U - 4U - 10h 1.925 
 
T8M - U - 8 - 10h 3.253 
T8M - U - 4U - 24h 1.623 
 
T8M - U - 8U - 24h 1.900 
T8M - U - 4U - 48h 1.860 
 
T8M - U - 8U - 48h 1.415 
T8M - U - 4U - 72h 0.000 
 
T8M - U - 8U - 72h 2.380 
T9M - U - 4U - CT 15.834 
 
T9M - U - 8U - CT 4.427 
T9M - U - 4U - 1h 4.664 
 
T9M - U - 8U - 1h 1.242 
T9M - U - 4U - 2h 15.144 
 
T9M - U - 8U - 2h 9.780 
T9M - U - 4U - 3h 1.847 
 
T9M - U - 8U - 3h 1.669 
T9M - U - 4U - 4h 2.406 
 
T9M - U - 8U - 4h 1.974 
T9M - U - 4U - 5h 3.288 
 
T9M - U - 8U - 5h 1.967 
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T9M - U - 4U - 6h 4.071 
 
T9M - U - 8U - 6h 2.431 
T9M - U - 4U - 7h 8.257 
 
T9M - U - 8U - 7h 10.355 
T9M - U - 4U - 10h 5.423 
 
T9M - U - 8U - 10h 5.537 
T9M - U - 4U - 24h 6.343 
 
T9M - U - 8U - 24h 10.292 
T9M - U - 4U - 48h 4.237 
 
T9M - U - 8U - 48h 14.525 
T9M - U - 4U - 72h 1.750 
 
T9M - U - 8U - 72h 10.167 
T10M - U - 4U - CT 5.637 
 
T10M - U - 8U -CT 5.857 
T10M - U - 4U - 1h 3.639 
 
T10M - U - 8U - 1h 1.385 
T10M - U - 4U - 2h 2.277 
 
T10M - U - 8U - 2h 3.793 
T10M - U - 4U - 3h 2.401 
 
T10M - U - 8U - 3h 1.815 
T10M - U - 4U - 4h 2.644 
 
T10M - U - 8U - 4h 3.511 
T10M - U - 4U - 5h 3.247 
 
T10M - U - 8U - 5h 3.291 
T10M - U - 4U - 6h 3.674 
 
T10M - U - 8U - 6h 2.694 
T10M - U - 4U - 7h 3.795 
 
T10M - U - 8U - 7h 2.792 
T10M - U - 4U -10h 2.031 
 
T10M - U - 8U-10h 3.385 
T10M - U - 4U -24h 4.638 
 
T10M - U - 8U-24h 2.962 
T10M - U - 4U -48h 3.224 
 
T10M - U - 8U-48h 2.300 
T10M - U - 4U -72h 4.107 
 
T10M - U - 8U-72h 2.274 
 
8.24 Serum alcohol concentrations in eugonadal males, after 4 units 
of alcohol 
Appendix 8.24 Serum alcohol concentrations in males, after 4 units of alcohol 
Male serum 4 units 
Serum alcohol  Serum alcohol  
concentration g/L concentration mg% 
T1M - S - 4U - CT 0 0.00 
T1M - S - 4U - 1h 0.23 23.00 
T1M - S - 4U - 2h 0.14 14.00 
T1M - S - 4U - 3h 0.05 5.00 
T1M - S - 4U - 4h 0.01 1.00 
T1M - S - 4U - 5h 0.01 1.00 
T1M - S - 4U - 6h 0 0.00 
T1M - S - 4U - 24h 0 0.00 
T2M - S - 4U - CT 0 0.00 
T2M - S - 4U - 1h 0.25 25.00 
T2M - S - 4U - 2h 0.15 15.00 
T2M - S - 4U - 3h 0.07 7.00 
T2M - S - 4U - 4h 0.03 3.00 
T2M - S - 4U - 5h 0.01 1.00 
T2M - S - 4U - 6h 0.01 1.00 
T4M - S - 4U - CT 0 0.00 
T4M - S - 4U - 1h 0.25 25.00 
T4M - S - 4U - 2h 0.1 10.00 
T4M - S - 4U - 3h 0.02 2.00 
T4M - S - 4U - 4h 0.01 1.00 
T4M - S - 4U - 5h 0 0.00 
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T4M - S - 4U - 6h 0 0.00 
T4M - S - 4U - 24h 0 0.00 
T5M - S - 4U - CT 0 0.00 
T5M - S - 4U - 1h 0.28 28.00 
T5M - S - 4U - 2h 0.14 14.00 
T5M - S - 4U - 3h 0.06 6.00 
T5M - S - 4U - 4h 0.02 2.00 
T5M - S - 4U - 5h 0.01 1.00 
T5M - S - 4U - 6h 0.01 1.00 
T5M - S - 4U - 24h 0 0.00 
T6M - S - 4U -CT 0 0.00 
T6M - S - 4U - 1h 0.4 40.00 
T6M - S - 4U - 2h 0.29 29.00 
T6M - S - 4U - 3h 0.18 18.00 
T6M - S - 4U - 4h 0.07 7.00 
T6M - S - 4U - 5h 0.03 3.00 
T6M - S - 4U - 6h 0.01 1.00 
T6M - S - 4U - 24h 0 0.00 
T7M - S - 4U - CT 0 0.00 
T7M - S - 4U - 1h 0.32 32.00 
T7M - S - 4U - 2h 0.13 13.00 
T7M - S - 4U - 3h 0.04 4.00 
T7M - S - 4U - 4h 0.01 1.00 
T7M - S - 4U - 5h 0 0.00 
T7M - S - 4U - 6h 0 0.00 
T7M - S - 4U - 24h 0 0.00 
T8M - S - 4U - CT 0 0.00 
T8M - S - 4U - 1h 0.2 20.00 
T8M - S - 4U - 2h 0.05 5.00 
T8M - S - 4U - 3h 0.01 1.00 
T8M - S - 4U - 4h 0 0.00 
T8M - S - 4U - 5h 0 0.00 
T8M - S - 4U - 6h 0 0.00 
T8M - S - 4U - 24h 0 0.00 
T9M - S - 4U - CT 0 0.00 
T9M - S - 4U - 1h 0.27 27.00 
T9M - S - 4U - 2h 0.17 17.00 
T9M - S - 4U - 3h 0.05 5.00 
T9M - S - 4U - 4h 0 0.00 
T9M - S - 4U - 5h 0.01 1.00 
T9M - S - 4U - 6h 0 0.00 
T9M - S - 4U - 24h 0 0.00 
T10M - S - 4U - CT 0 0.00 
T10M - S - 4U - 1h 0.38 38.00 
T10M - S - 4U - 2h 0.21 21.00 
T10M - S - 4U - 3h 0.1 10.00 
T10M - S - 4U - 4h 0.04 4.00 
T10M - S - 4U - 5h 0.01 1.00 
T10M - S - 4U - 6h 0 0.00 
T10M - S - 4U - 24h 0 0.00 
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8.25 Serum alcohol concentrations in eugonadal males, after 8 units 
of alcohol 
Appendix 8.25 Serum alcohol concentrations in males, after 8 units of alcohol 
Male serum 8 units 
Serum alcohol  Serum alcohol  
concentration g/L concentration mg% 
T1M - S - 8U - CT 0 0 
T1M - S - 8U - 1h 0.89 89 
T1M - S - 8U - 2h 0.83 83 
T1M - S - 8U - 3h 0.71 71 
T1M - S - 8U - 4h 0.53 53 
T1M - S - 8U - 5h 0.37 37 
T1M - S - 8U - 6h 0.17 17 
T1M - S - 8U - 24h 0 0 
T2M - S - 8U - CT 0 0 
T2M - S - 8U - 1h 0.83 83 
T2M - S - 8U - 2h 0.74 74 
T2M - S - 8U - 3h 0.55 55 
T2M - S - 8U - 4h 0.36 36 
T2M - S - 8U - 5h 0.16 16 
T2M - S - 8U - 6h 0.04 4 
T2M - S - 8U - 24h 0 0 
T4M - S - 8U - CT 0 0 
T4M - S - 8U - 1h 0.95 95 
T4M - S - 8U - 2h 0.8 80 
T4M - S - 8U - 3h 0.6 60 
T4M - S - 8U - 4h 0.39 39 
T4M - S - 8U - 5h 0.18 18 
T4M - S - 8U - 6h 0.04 4 
T4M - S - 8U - 24h 0 0 
T5M - S - 8U - CT 0 0 
T5M - S - 8U - 1h 0.88 88 
T5M - S - 8U - 2h 0.7 70 
T5M - S - 8U - 3h 0.55 55 
T5M - S - 8U - 4h 0.4 40 
T5M - S - 8U - 5h 0.26 26 
T5M - S - 8U - 6h 0.25 25 
T5M - S - 8U - 24h 0 0 
T6M - S - 8U - CT 0 0 
T6M - S - 8U - 1h 1.04 104 
T6M - S - 8U - 2h 0.94 94 
T6M - S - 8U - 3h 0.88 88 
T6M - S - 8U - 4h 0.76 76 
T6M - S - 8U - 5h 0.57 57 
T6M - S - 8U - 6h 0.43 43 
T6M - S - 8U - 24h 0 0 
T7M - S - 8U - CT 0 0 
T7M - S - 8U - 1h 0.86 86 
T7M -  S - 8U - 2h 0.71 71 
T7M - S - 8U - 3h 0.53 53 
T7M - S - 8U - 4h 0.38 38 
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T7M - S - 8U - 5h 0.19 19 
T7M - S - 8U - 6h 0.05 5 
T7M - S -8U - 24h 0 0 
T8M - S - 8U - CT 0 0 
T8M - S - 8U - 1h 0.64 64 
T8M - S - 8U - 2h 0.8 80 
T8M - S - 8U - 3h 0.42 42 
T8M - S - 8U - 4h 0.27 27 
T8M - S - 8U - 5h 0.08 8 
T8M - S - 8U - 6h 0.01 1 
T8M - S - 8U - 24h 0 0 
T9M - S - 8U - CT 0 0 
T9M - S - 8U - 1h 0.81 81 
T9M - S - 8U - 2h 0.88 88 
T9M - S - 8U - 3h 0.65 65 
T9M - S - 8U - 4h 0.48 48 
T9M - S - 8U - 5h 0.39 39 
T9M - S - 8U - 6h 0.1 10 
T9M - S - 8U - 24h 0 0 
T10M - S - 8U-CT 0 0 
T10M - S - 8U - 1h 1.11 111 
T10M - S - 8U - 2h 0.78 78 
T10M - S - 8U - 3h 0.78 78 
T10M - S - 8U - 4h 0.56 56 
T10M - S - 8U - 5h 0.37 37 
T10M - S - 8U - 6h 0.15 15 
T10M -S - 8U - 24h 0 0 
 
 
8.26 Serum alcohol concentrations in females, after 4 units of 
alcohol 
Appendix 8.26 Serum alcohol concentrations in females, after 4 units of alcohol 
Female serum 4 units 
Serum alcohol  Serum alcohol  
concentration g/L concentration mg% 
T1F - S - 4U - CT 0 0 
T1F  - S - 4U - 1h 0.3 30 
T1F - S - 4U - 2h 0.09 9 
T1F - S - 4U - 3h 0.01 1 
T1F - S - 4U - 4h 0.01 1 
T1F - S - 4U - 5h 0.01 1 
T1F - S - 4U - 6h 0 0 
T1F - S - 4U - 24h 0 0 
T2F - S - 4U - CT 0 0 
T2F - S - 4U - 1h 0.51 51 
T2F - S - 4U - 2h 0.34 34 
T2F - S - 4U - 3h 0.19 19 
T2F - S - 4U - 4h 0.04 4 
T2F - S - 4U - 5h 0.01 1 
T2F - S - 4U - 6h 0 0 
T2F - S - 4U - 24h 0 0 
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T4F - S - 4U - CT 0 0 
T4F - S - 4U - 1h 0.61 61 
T4F - S - 4U - 2h 0.47 47 
T4F - S - 4U - 3h 0.27 27 
T4F - S - 4U - 4h 0.11 11 
T4F - S - 4U - 5h 0.03 3 
T4F - S - 4U - 6h 0.01 1 
T4F - S - 4U - 24h 0 0 
T5F - S - 4U - CT 0 0 
T5F - S - 4U - 1h 0.53 53 
T5F - S - 4U - 2h 0.35 35 
T5F - S - 4U - 3h 0.18 18 
T5F - S - 4U - 4h 0.06 6 
T5F - S - 4U - 5h 0.01 1 
T5F - S - 4U - 6h 0 0 
T5F - S - 4U - 24h 0 0 
T6F - S - 4U - CT 0 0 
T6F - S - 4U - 1h 0.55 55 
T6F - S - 4U - 2h 0.4 40 
T6F - S - 4U - 3h 0.2 20 
T6F - S - 4U - 4h 0.08 8 
T6F - S - 4U - 5h 0.05 5 
T6F - S - 4U - 6h 0.03 3 
T6F - S - 4U - 24h 0 0 
T7F - S - 4U - CT 0 0 
T7F - S - 4U - 1h 0.53 53 
T7F - S - 4U - 2h 0.38 38 
T7F - S - 4U - 3h 0.15 15 
T7F - S - 4U - 4h 0.02 2 
T7F - S - 4U - 5h 0 0 
T7F - S - 4U - 6h 0 0 
T7F - S - 4U - 24h 0 0 
T8F - S - 4U - CT 0 0 
T8F - S - 4U - 1h 0.59 59 
T8F - S - 4U - 2h 0.4 40 
T8F - S - 4U - 3h 0.19 19 
T8F - S - 4U - 4h 0.06 6 
T8F - S - 4U - 5h 0.01 1 
T8F - S - 4U - 6h 0 0 
T8F - S - 4U - 24h 0 0 
T9F - S - 4U - CT 0 0 
T9F - S - 4U - 1h 0.48 48 
T9F - S - 4U - 2h 0.32 32 
T9F - S - 4U - 3h 0.14 14 
T9F - S - 4U - 4h 0.03 3 
T9F - S - 4U - 5h 0.01 1 
T9F - S - 4U - 6h 0 0 
T9F - S - 4U - 24h 0 0 
T10F - S - 4U - CT 0 0 
T10F - S - 4U - 1h 0.28 28 
T10F - S - 4U - 2h 0.14 14 
T10F - S - 4U - 3h 0.02 2 
T10F - S - 4U - 4h 0.01 1 
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T10F - S - 4U - 5h 0 0 
T10F - S - 4U - 6h 0 0 
T10F - S - 4U - 24h 0 0 
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8.27 Serum alcohol concentrations in females, after 8 units of 
alcohol 
Appendix 8.27 Serum alcohol concentrations in females, after 8 units of alcohol 
Female serum 8 units 
Serum alcohol  Serum alcohol  
concentration g/L concentration mg% 
T1F - S - 8U - CT 0 0 
T1F - S - 8U - 1h 1.02 102 
T1F - S - 8U - 2h 0.9 90 
T1F - S - 8U - 3h 0.64 64 
T1F - S - 8U - 4h 0.29 29 
T1F - S - 8U - 5h 0.1 10 
T1F - S - 8U - 6h 0.02 2 
T1F - S - 8U - 24h 0 0 
T2F - S - 8U - CT 0 0 
T2F - S - 8U - 1h 1.23 123 
T2F - S - 8U - 2h 1.18 118 
T2F - S - 8U - 3h 1 100 
T2F - S - 8U - 4h 0.71 71 
T2F - S - 8U - 5h 0.6 60 
T2F - S - 8U - 6h 0.36 36 
T2F - S - 8U - 24h 0 0 
T4F - S - 8U - CT 0 0 
T4F - S - 8U - 1h 1.08 108 
T4F - S - 8U - 2h 0.92 92 
T4F - S - 8U - 3h 0.75 75 
T4F - S - 8U - 4h 0.61 61 
T4F - S - 8U - 5h 0.39 39 
T4F - S - 8U - 6h 0.23 23 
T4F - S - 8U - 24h 0 0 
T5F - S - 8U - CT 0 0 
T5F - S - 8U - 1h 1.31 131 
T5F - S - 8U - 2h 1.13 113 
T5F - S - 8U - 3h 0.95 95 
T5F - S - 8U - 4h 0.53 53 
T5F - S -8U - 5h 0.76 76 
T5F - S - 8U - 6h 0.29 29 
T5F - S - 8U - 24h 0 0 
T6F - S - 8U - CT 0 0 
T6F - S - 8U - 1h 1.39 139 
T6F - S - 8U - 2h 1.33 133 
T6F - S - 8U - 3h 1.06 106 
T6F - S - 8U - 4h 0.86 86 
T6F - S - 8U - 5h 0.59 59 
T6F - S - 8U - 6h 0.36 36 
T6F - S - 8U - 24h 0 0 
T7F - S - 8U - CT 0 0 
T7F - S - 8U - 1h 1.27 127 
T7F - S - 8U - 2h 1.12 112 
T7F - S - 8U - 3h 0.88 88 
T7F - S - 8U - 4h 0.63 63 
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T7F - S - 8U - 5h 0.41 41 
T7F - S - 8U - 6h 0.24 24 
T7F - S - 8U - 24h 0 0 
T8F - S - 8U - CT 0 0 
T8F - S - 8U - 1h 1.42 142 
T8F - S - 8U - 2h 1.29 129 
T8F - S - 8U - 3h 1.1 110 
T8F - S - 8U - 4h 0.87 87 
T8F - S - 8U - 5h 0.63 63 
T8F - S - 8U - 6h 0.43 43 
T8F - S - 8U - 24h  0 0 
T9F - S - 8U - CT 0 0 
T9F - S - 8U - 1h 1.11 111 
T9F - S - 8U - 2h 1.13 113 
T9F - S - 8U - 3h 0.97 97 
T9F - S - 8U - 4h 0.8 80 
T9F - S - 8U - 5h 0.65 65 
T9F - S - 8U - 6h 0.41 41 
T9F - S - 8U - 24h 0 0 
T10F - S - 8U - CT 0 0 
T10F - S - 8U - 1h 1.08 108 
T10F - S - 8U - 2h 0.9 90 
T10F - S - 8U - 3h 0.67 67 
T10F - S - 8U - 4h 0.49 49 
T10F - S - 8U - 5h 0.31 31 
T10F - S - 8U - 6h 0.13 13 
T10F - S - 8U - 24h 0 0 
 
8.28 Internal standard mixture (working solution) in ng/mL 
Appendix 8.28 Internal standard mixture (working solution) in ng/mL 
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8.29 Internal standard mixture at the concentration present in 
sample (ng/mL) 
Appendix 8.29 Internal standard mixture at the concentration present in sample (ng/mL) 










8.30 Serum eugonadal male concentrations of T, E, AD, TG, TS and 
ES (ng/mL) after 4 units (LC-MS/MS)13 
Appendix 8.30 Serum eugonadal male concentrations after 4 units (LC-MS/MS) 
Male serum 4 units 
T conc E conc AD conc TG conc TS conc ES conc 
(ng/mL) (ng/mL) (ng/mL) (ng/mL) (ng/mL) (ng/mL) 
T1M - S - 4U - CT 5.404 0.040 0.420 -0.092 0.623 0.166 
T1M - S - 4U - 1h 3.479 0.029 0.280 -0.099 0.867 0.097 
T1M - S - 4U - 2h 3.840 0.025 0.382 -0.094 0.869 0.132 
T1M - S - 4U - 3h 3.082 0.334 0.421 -0.099 0.790 0.072 
T1M - S - 4U - 4h 3.759 0.023 0.293 -0.088 0.792 0.075 
T1M - S - 4U - 5h 3.074 0.024 0.299 -0.101 0.677 0.069 
T1M - S - 4U - 6h 2.842 0.019 0.243 -0.099 0.675 0.070 
T1M - S - 4U - 24h 4.859 0.034 0.529 -0.087 0.707 0.181 
T2M - S - 4U - CT 3.970 0.059 0.274 0.745 -0.088 0.016 
T2M - S - 4U - 1h 2.930 0.394 0.182 0.746 -0.061 -0.001 
T2M - S - 4U - 2h 3.212 0.049 0.259 0.707 -0.061 0.073 
T2M - S - 4U - 3h 3.188 0.042 0.203 0.587 -0.027 -0.024 
T2M - S - 4U - 4h 3.495 0.044 0.201 0.652 -0.077 0.013 
T2M - S - 4U - 5h 3.099 0.039 0.248 0.642 -0.098 0.067 
T2M - S - 4U - 6h 3.110 0.044 0.328 0.676 -0.136 0.018 
T2M - S - 4U - 48h 4.146 0.076 0.464 0.653 -0.027 0.085 
T4M - S - 4U - CT 1.774 0.041 0.456 0.207 -0.273 0.088 
T4M - S - 4U - 1h 2.209 0.044 0.488 0.203 -0.279 -0.026 
                                                     
13
 The negative concentrations found in these tables were the ones below the LLOQ. 
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T4M - S - 4U - 2h 2.319 0.035 0.243 0.233 -0.245 0.063 
T4M - S - 4U - 3h 2.430 0.103 0.434 0.178 -0.219 -0.005 
T4M - S - 4U - 4h 2.454 0.184 0.433 0.203 -0.254 0.007 
T4M - S - 4U - 5h 2.513 0.057 0.356 0.221 -0.310 0.016 
T4M - S - 4U - 6h 2.506 0.062 0.340 0.233 -0.262 0.021 
T4M - S - 4U - 24h 2.891 0.082 0.362 0.277 -0.247 0.069 
T5M - S - 4U - CT 5.688 0.067 0.694 0.071 4.112 0.359 
T5M - S - 4U - 1h 5.068 0.023 0.422 -0.079 6.146 0.381 
T5M - S - 4U - 2h 5.054 0.032 0.622 -0.074 7.075 0.385 
T5M - S - 4U - 3h 5.353 0.039 0.554 -0.083 6.226 0.367 
T5M - S - 4U - 4h 4.787 0.027 0.555 -0.087 4.812 0.328 
T5M - S - 4U - 5h 4.702 0.061 0.516 0.050 4.852 0.347 
T5M - S - 4U - 6h 4.803 0.032 0.485 -0.072 4.831 0.349 
T5M - S - 4U - 24h 6.273 0.033 0.717 -0.081 4.826 0.408 
T6M - S - 4U -CT 3.475 0.051 0.786 -0.095 0.227 0.206 
T6M - S - 4U - 1h 3.475 0.040 0.310 -0.100 0.463 0.164 
T6M - S - 4U - 2h 4.065 0.043 0.350 -0.104 0.639 0.208 
T6M - S - 4U - 3h 3.009 0.041 0.535 -0.103 0.658 0.198 
T6M - S - 4U - 4h 3.274 0.041 0.723 -0.099 0.611 0.166 
T6M - S - 4U - 5h 2.590 0.042 0.406 -0.106 0.563 0.161 
T6M - S - 4U - 6h 2.557 0.040 0.340 -0.099 0.459 0.151 
T6M - S - 4U - 24h 2.496 0.044 0.681 -0.099 0.190 0.183 
T7M - S - 4U - CT 4.290 0.056 0.456 0.590 0.549 0.222 
T7M - S - 4U - 1h 3.114 0.036 0.383 0.584 0.678 0.167 
T7M - S - 4U - 2h 3.202 0.049 0.476 0.578 0.718 0.225 
T7M - S - 4U - 3h 2.763 0.061 0.383 0.427 0.523 0.145 
T7M - S - 4U - 4h 3.364 0.051 0.568 0.407 0.644 0.239 
T7M - S - 4U - 5h 3.361 0.053 0.508 0.409 0.555 0.287 
T7M - S - 4U - 6h 3.339 0.049 0.526 0.320 0.506 0.237 
T7M - S - 4U - 24h 3.747 0.071 0.683 0.427 0.409 0.179 
T8M - S - 4U - CT 3.724 0.044 0.723 0.707 1.791 0.382 
T8M - S - 4U - 1h 3.497 0.043 0.396 0.928 2.638 0.361 
T8M - S - 4U - 2h 3.054 0.031 0.651 0.710 2.888 0.299 
T8M - S - 4U - 3h 2.926 0.031 0.642 0.503 2.381 0.288 
T8M - S - 4U - 4h 2.549 0.034 0.729 0.563 2.363 0.415 
T8M - S - 4U - 5h 2.853 0.041 0.886 0.720 2.162 0.473 
T8M - S - 4U - 6h 3.491 0.045 0.546 0.652 2.066 0.454 
T8M - S - 4U - 24h 3.929 0.082 0.980 0.561 1.494 0.442 
T9M - S - 4U - CT 2.945 0.048 0.540 0.441 0.056 0.227 
T9M - S - 4U - 1h 2.442 0.042 0.383 0.622 0.184 0.144 
T9M - S - 4U - 2h 2.397 0.041 0.443 0.445 0.204 0.153 
T9M - S - 4U - 3h 3.126 0.044 0.598 0.478 0.358 0.228 
T9M - S - 4U - 4h 2.646 0.051 0.686 0.443 0.211 0.253 
T9M - S - 4U - 5h 2.379 0.037 0.728 0.274 0.162 0.252 
T9M - S - 4U - 6h 1.622 0.038 0.591 0.251 0.086 0.185 
T9M - S - 4U - 24h 2.424 0.056 0.751 0.501 0.012 0.158 
T10M - S - 4U - CT 4.889 0.062 0.551 -0.072 0.979 0.302 
T10M - S - 4U - 1h 3.319 0.028 0.219 -0.107 2.117 0.150 
T10M - S - 4U - 2h 4.400 0.028 0.240 -0.097 2.609 0.174 
T10M - S - 4U - 3h 4.218 0.034 0.240 -0.081 2.470 0.145 
T10M - S - 4U - 4h 4.530 0.037 0.278 -0.086 1.748 0.140 
T10M - S - 4U - 5h 5.760 0.035 0.451 -0.088 1.467 0.334 
T10M - S - 4U - 6h 5.140 0.035 0.350 -0.104 1.493 0.191 
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T10M - S - 4U - 24h 5.126 0.074 0.504 -0.046 0.979 0.238 
 
8.31 Serum female concentrations of T, E, AD, TG, TS and ES 
(ng/mL) after 4 units (LC-MS/MS) 
Appendix 8.31 Serum female concentrations after 4 units (LC-MS/MS) 
Female serum 4 
units 
T conc E conc AD conc TG conc TS conc ES conc 
(ng/mL) (ng/mL) (ng/mL) (ng/mL) (ng/mL) (ng/mL) 
T1F - S - 4U - CT 0.300 0.028 1.330 -0.029 0.285 -0.014 
T1F  - S - 4U - 1h 0.314 0.024 0.739 0.019 0.233 -0.071 
T1F - S - 4U - 2h 0.311 0.034 0.968 0.009 0.217 -0.071 
T1F - S - 4U - 3h 0.300 0.026 1.146 -0.024 0.253 -0.015 
T1F - S - 4U - 4h 0.339 0.030 0.961 -0.014 0.237 -0.062 
T1F - S - 4U - 5h 0.302 0.027 0.946 -0.039 0.242 -0.056 
T1F - S - 4U - 6h 0.282 0.026 1.063 -0.044 0.227 -0.040 
T1F - S - 4U - 24h 0.271 0.032 1.481 -0.059 0.122 -0.042 
T2F - S - 4U - CT 0.216 0.029 1.456 0.039 -0.106 0.001 
T2F - S - 4U - 1h 0.275 0.018 0.753 0.099 -0.155 -0.069 
T2F - S - 4U - 2h 0.323 0.020 1.096 0.127 -0.078 0.011 
T2F - S - 4U - 3h 0.279 0.020 1.025 0.203 -0.048 -0.049 
T2F - S - 4U - 4h 0.236 0.016 1.056 0.031 -0.017 -0.031 
T2F - S - 4U - 5h 0.254 0.020 1.137 -0.001 -0.008 -0.040 
T2F - S - 4U - 6h 0.212 0.021 1.100 0.007 -0.024 -0.026 
T2F - S - 4U - 24h 0.210 0.021 1.600 0.013 -0.096 0.107 
T4F - S - 4U - CT 0.243 0.037 1.024 0.053 -0.155 0.000 
T4F - S - 4U - 1h 0.267 0.028 0.902 0.085 -0.179 -0.024 
T4F - S - 4U - 2h 0.282 0.035 0.965 0.225 -0.193 0.090 
T4F - S - 4U - 3h 0.348 0.035 1.120 0.197 -0.159 0.047 
T4F - S - 4U - 4h 0.330 0.039 1.079 0.189 -0.159 -0.013 
T4F - S - 4U - 5h 0.246 0.031 0.909 0.077 -0.148 -0.053 
T4F - S - 4U - 6h 0.227 0.028 0.908 0.002 -0.074 -0.038 
T4F - S - 4U - 24h 0.282 0.050 1.267 -0.033 -0.172 0.064 
T5F - S - 4U - CT 0.415 0.047 1.640 0.104 -0.201 -0.037 
T5F - S - 4U - 1h 0.611 0.046 0.992 0.386 0.048 0.021 
T5F - S - 4U - 2h 0.606 0.041 0.848 0.447 0.157 0.004 
T5F - S - 4U - 3h 0.518 0.039 0.865 0.384 0.098 -0.042 
T5F - S - 4U - 4h 0.355 0.042 1.190 0.289 0.148 -0.027 
T5F - S - 4U - 5h 0.316 0.043 1.130 0.144 0.032 0.007 
T5F - S - 4U - 6h 0.343 0.037 1.277 0.090 -0.042 -0.033 
T5F - S - 4U - 24h 0.432 0.048 1.629 0.035 -0.151 -0.028 
T6F - S - 4U - CT 0.224 0.031 1.176 0.042 0.419 -0.056 
T6F - S - 4U - 1h 0.253 0.031 0.972 0.160 0.043 -0.018 
T6F - S - 4U - 2h 0.229 0.022 1.089 0.152 0.051 -0.070 
T6F - S - 4U - 3h 0.300 0.028 1.632 0.235 0.084 0.040 
T6F - S - 4U - 4h 0.295 0.058 1.762 0.081 0.390 0.008 
T6F - S - 4U - 5h 0.327 0.066 1.307 0.038 0.474 -0.026 
T6F - S - 4U - 6h 0.265 0.035 1.151 0.051 0.316 -0.070 
T6F - S - 4U - 24h 0.201 0.032 1.828 0.067 0.219 0.054 
T7F - S - 4U - CT 0.448 0.025 1.386 0.061 -0.340 -0.015 
T7F - S - 4U - 1h 0.546 0.009 0.935 0.195 -0.310 -0.058 
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T7F - S - 4U - 2h 0.505 0.007 0.961 0.157 -0.308 -0.055 
T7F - S - 4U - 3h 0.465 0.016 1.037 0.179 -0.356 -0.060 
T7F - S - 4U - 4h 0.410 0.014 1.148 0.092 -0.331 -0.054 
T7F - S - 4U - 5h 0.390 0.014 1.057 0.059 -0.346 -0.091 
T7F - S - 4U - 6h 0.375 0.011 1.051 0.025 -0.342 -0.092 
T7F - S - 4U - 24h 0.384 0.024 1.275 0.069 -0.360 0.024 
T8F - S - 4U - CT 0.267 0.011 1.016 -0.017 -0.258 -0.065 
T8F - S - 4U - 1h 0.348 0.006 0.747 0.054 -0.254 -0.096 
T8F - S - 4U - 2h 0.419 0.007 0.845 0.157 -0.238 -0.036 
T8F - S - 4U - 3h 0.432 0.011 0.917 0.123 -0.215 -0.047 
T8F - S - 4U - 4h 0.324 0.025 1.058 0.063 -0.233 -0.042 
T8F - S - 4U - 5h 0.293 0.009 1.176 0.035 -0.219 -0.059 
T8F - S - 4U - 6h 0.254 0.008 1.028 0.068 -0.250 -0.069 
T8F - S - 4U - 24h 0.223 0.015 1.060 0.009 -0.288 0.033 
T9F - S - 4U - CT 0.212 -0.004 0.803 -0.018 -0.174 -0.040 
T9F - S - 4U - 1h 0.284 -0.005 0.533 0.216 -0.228 -0.020 
T9F - S - 4U - 2h 0.238 -0.004 0.498 0.162 -0.242 -0.111 
T9F - S - 4U - 3h 0.255 -0.007 0.668 0.207 -0.196 -0.075 
T9F - S - 4U - 4h 0.231 0.003 0.975 0.136 -0.136 -0.008 
T9F - S - 4U - 5h 0.257 -0.002 0.848 0.070 -0.165 -0.056 
T9F - S - 4U - 6h 0.217 -0.006 0.846 0.020 -0.140 -0.068 
T9F - S - 4U - 24h 0.201 -0.001 0.945 0.013 -0.171 -0.052 
T10F - S - 4U - CT 0.122 -0.004 0.939 0.060 -0.362 -0.025 
T10F - S - 4U - 1h 0.207 -0.001 0.640 0.226 -0.273 -0.093 
T10F - S - 4U - 2h 0.217 -0.003 0.788 0.209 -0.252 -0.091 
T10F - S - 4U - 3h 0.248 -0.003 1.065 0.218 -0.283 0.020 
T10F - S - 4U - 4h 0.252 0.006 1.124 0.157 -0.290 -0.029 
T10F - S - 4U - 5h 0.282 0.004 1.158 0.184 -0.307 0.007 
T10F - S - 4U - 6h 0.274 -0.003 1.122 0.176 -0.312 -0.054 
T10F - S - 4U - 24h 0.239 -0.004 1.594 0.170 -0.295 -0.022 
 
8.32 Serum eugonadal male concentrations of T, E, AD, TG, TS and 
ES (ng/mL) after 8 units (LC-MS/MS) 
Appendix 8.32 Serum male concentrations after 8 units (LC-MS/MS) 
Male serum 8 
units 
T conc E conc AD conc TG conc TS conc ES conc 
(ng/mL) (ng/mL) (ng/mL) (ng/mL) (ng/mL) (ng/mL) 
T1M - S - 8U - CT 4.937 0.084 0.335 0.024 0.792 0.028 
T1M - S - 8U - 1h 4.198 0.039 0.205 -0.008 1.142 0.085 
T1M - S - 8U - 2h 3.865 0.035 0.190 0.034 1.340 0.051 
T1M - S - 8U - 3h 4.905 0.041 0.272 -0.029 1.558 0.096 
T1M - S - 8U - 4h 5.038 0.045 0.285 -0.003 1.414 0.062 
T1M - S - 8U - 5h 4.469 0.032 0.272 -0.034 1.621 0.045 
T1M - S - 8U - 6h 2.970 0.030 0.191 -0.048 1.306 -0.022 
T1M - S - 8U - 24h 4.472 0.046 0.393 -0.057 1.218 0.077 
T1M - S - 4U - 48h 5.275 0.049 0.474 -0.039 1.355 0.178 
T2M - S - 8U - CT 4.114 0.085 1.303 0.559 0.071 -0.096 
T2M - S - 8U - 1h 3.024 0.043 0.493 0.747 0.217 -0.102 
T2M - S - 8U - 2h 3.407 0.045 0.197 0.879 0.252 -0.134 
T2M - S - 8U - 3h 3.638 0.056 0.189 0.878 0.202 -0.133 
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T2M - S - 8U - 4h 3.721 0.056 0.202 0.919 0.208 -0.116 
T2M - S - 8U - 5h 3.638 0.055 0.286 0.773 0.193 -0.071 
T2M - S - 8U - 6h 3.501 0.058 0.534 0.543 0.221 -0.103 
T2M - S - 4U - 24h 4.541 0.186 0.496 0.560 0.145 -0.081 
T2M - S - 4U - 48h 3.213 0.089 0.699 0.758 0.110 0.110 
T4M - S - 8U - CT 2.228 0.063 0.603 0.251 -0.164 0.257 
T4M - S - 8U - 1h 1.720 0.048 0.760 0.293 -0.121 0.099 
T4M - S - 8U - 2h 1.871 0.050 0.463 0.365 -0.120 0.037 
T4M - S - 8U - 3h 2.072 0.057 0.322 0.372 -0.154 0.101 
T4M - S - 8U - 4h 2.386 0.062 0.378 0.431 -0.096 0.137 
T4M - S - 8U - 5h 2.338 0.061 0.538 0.394 -0.105 0.152 
T4M - S - 8U - 6h 2.285 0.059 0.493 0.316 -0.089 0.125 
T4M - S - 8U - 24h 2.205 0.063 0.405 0.276 -0.125 0.257 
T4M - S - 8U - 48h 2.218 0.062 0.646 0.299 -0.125 0.261 
T5M - S - 8U - CT 5.574 0.029 0.660 -0.040 3.352 0.542 
T5M - S - 8U - 1h 2.542 0.015 1.135 -0.037 4.364 0.233 
T5M - S - 8U - 2h 2.046 0.011 0.286 -0.041 4.431 0.289 
T5M - S - 8U - 3h 1.796 0.016 0.846 -0.039 4.285 0.151 
T5M - S - 8U - 4h 3.403 0.018 0.407 -0.042 4.256 0.191 
T5M - S - 8U - 5h 3.029 0.014 0.460 -0.039 4.644 0.235 
T5M - S - 8U - 6h 3.199 0.043 0.419 0.740 0.397 0.266 
T5M - S - 4U - 24h 3.852 0.019 0.692 -0.035 3.888 0.344 
T5M - S - 8U - 48h 3.766 0.021 0.765 -0.038 3.855 0.384 
T6M - S - 8U - CT 3.609 0.061 0.736 -0.032 0.306 0.238 
T6M - S - 8U - 1h 3.595 0.054 0.831 -0.043 0.537 0.242 
T6M - S - 8U - 2h 3.462 0.052 0.539 -0.045 0.649 0.194 
T6M - S - 8U - 3h 4.015 0.050 0.404 -0.040 0.729 0.201 
T6M - S - 8U - 4h 3.442 0.058 0.499 -0.036 0.806 0.192 
T6M - S - 8U - 5h 3.324 0.060 0.459 -0.034 0.783 0.179 
T6M - S - 8U - 6h 2.970 0.046 0.443 0.004 0.689 0.171 
T6M - S - 8U - 24h 3.481 0.052 0.397 -0.035 0.449 0.191 
T6M - S - 8U - 48h 4.231 0.069 0.624 -0.015 0.599 0.266 
T7M - S - 8U - CT 3.164 0.064 0.901 0.506 0.391 0.191 
T7M - S - 8U - 1h 2.452 0.042 0.502 0.530 0.631 0.156 
T7M -  S - 8U - 2h 2.188 0.055 0.356 0.492 0.627 0.180 
T7M - S - 8U - 3h 2.874 0.059 0.414 0.576 0.610 0.139 
T7M - S - 8U - 4h 3.288 0.069 0.405 0.711 0.647 0.214 
T7M - S - 8U - 5h 3.056 0.071 0.402 0.731 0.655 0.266 
T7M - S - 8U - 6h 2.855 0.058 0.599 0.599 0.644 0.198 
T7M - S -8U - 24h 2.943 0.049 0.619 0.326 0.333 0.252 
T7M - S -8U - 48h 3.597 0.063 0.663 0.275 0.380 0.250 
T8M - S - 8U - CT 5.005 0.066 0.837 0.603 2.015 0.663 
T8M - S - 8U - 1h 4.069 0.068 0.782 1.088 3.202 0.477 
T8M - S - 8U - 2h 3.840 0.072 0.378 1.105 2.999 0.453 
T8M - S - 8U - 3h 5.384 0.051 0.492 1.300 4.134 0.440 
T8M - S - 8U - 4h 5.179 0.043 0.525 1.430 4.376 0.411 
T8M - S - 8U - 5h 5.040 0.045 0.636 1.248 4.867 0.484 
T8M - S - 8U - 6h 4.249 0.033 0.828 1.182 4.969 0.536 
T8M - S - 8U - 24h 4.967 0.055 0.970 0.504 2.319 0.475 
T8M - S - 8U - 48h 3.585 0.036 0.716 0.885 2.172 0.467 
T9M - S - 8U - CT 2.187 0.032 0.538 0.475 0.101 0.185 
T9M - S - 8U - 1h 2.163 0.029 0.239 0.450 0.176 0.102 
T9M - S - 8U - 2h 2.942 0.016 0.168 -0.051 1.069 0.088 
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T9M - S - 8U - 3h 2.435 0.027 0.340 0.545 0.205 0.130 
T9M - S - 8U - 4h 2.897 0.034 0.474 0.666 0.322 0.151 
T9M - S - 8U - 5h 2.683 0.029 0.598 0.613 0.269 0.164 
T9M - S - 8U - 6h 3.561 0.010 0.709 -0.051 5.514 0.259 
T9M - S - 8U - 24h 2.161 0.023 0.558 0.441 0.159 0.186 
T9M - S - 8U - 48h 2.406 0.026 0.741 0.492 0.203 0.224 
T10M - S - 8U-CT 3.09 0.02 0.28 -0.03 0.85 0.15 
T10M - S - 8U - 1h 2.73 0.01 0.18 -0.04 1.25 0.13 
T10M - S - 8U - 2h 3.05 0.04 0.24 0.54 0.25 0.11 
T10M - S - 8U - 3h 3.44 0.02 0.15 -0.08 1.29 0.08 
T10M - S - 8U - 4h 3.58 0.03 0.21 -0.08 1.47 0.09 
T10M - S - 8U - 5h 3.49 0.03 0.21 -0.10 1.40 0.12 
T10M - S - 8U - 6h 3.45 0.03 0.22 -0.08 1.47 0.12 
T10M - S - 8U-24h 3.71 0.03 0.39 -0.10 1.04 0.17 
T10M - S - 8U-48h 3.90 0.03 0.38 -0.07 0.90 0.15 
 
8.33 Serum female concentrations of T, E, AD, TG, TS and ES 
(ng/mL) after 8 units (LC-MS/MS) 
Appendix 8.33 Serum female concentrations after 8 units (LC-MS/MS) 
Female serum 8 
units 
T conc E conc AD conc TG conc TS conc ES conc 
(ng/mL) (ng/mL) (ng/mL) (ng/mL) (ng/mL) (ng/mL) 
T1F - S - 8U - CT 0.208 0.027 0.753 -0.027 0.133 -0.038 
T1F - S - 8U - 1h 0.096 0.010 0.197 -0.033 -0.102 -0.050 
T1F - S - 8U - 2h 0.252 0.009 0.538 0.094 0.104 -0.040 
T1F - S - 8U - 3h 0.250 0.010 0.507 0.081 0.067 -0.030 
T1F - S - 8U - 4h 0.320 0.012 0.746 0.138 0.098 -0.029 
T1F - S - 8U - 5h 0.264 0.015 0.812 0.092 0.090 -0.018 
T1F - S - 8U - 6h 0.258 0.011 0.691 0.014 0.239 -0.020 
T1F - S - 8U - 24h 0.226 0.015 1.125 -0.013 0.114 0.013 
T1F - S - 8U - 48h 0.234 0.014 1.189 -0.001 -0.012 0.014 
T2F - S - 8U - CT 0.226 0.013 0.699 0.159 0.035 -0.037 
T2F - S - 8U - 1h 0.254 0.025 1.521 0.157 0.005 0.041 
T2F - S - 8U - 2h 0.244 0.015 0.892 0.225 0.012 -0.016 
T2F - S - 8U - 3h 0.225 0.011 0.687 0.158 0.012 -0.041 
T2F - S - 8U - 4h 0.252 0.013 0.829 0.205 -0.023 -0.041 
T2F - S - 8U - 5h 0.272 0.012 0.904 0.244 0.013 -0.020 
T2F - S - 8U - 6h 0.288 0.021 1.027 0.343 0.076 0.032 
T2F - S - 8U - 24h 0.276 0.018 1.892 0.035 0.011 0.036 
T2F - S - 8U - 48h 0.235 0.020 1.299 0.028 -0.001 -0.016 
T4F - S - 8U - CT 0.157 0.015 0.637 -0.022 -0.160 0.008 
T4F - S - 8U - 1h 0.153 0.014 0.278 0.005 -0.191 -0.046 
T4F - S - 8U - 2h 0.146 0.010 0.219 0.001 -0.216 -0.050 
T4F - S - 8U - 3h 0.133 0.010 0.187 -0.006 -0.208 -0.052 
T4F - S - 8U - 4h 0.140 0.011 0.156 -0.005 -0.220 -0.040 
T4F - S - 8U - 5h 0.172 0.012 0.264 0.020 -0.175 -0.037 
T4F - S - 8U - 6h 0.186 0.013 0.378 0.060 -0.176 -0.023 
T4F - S - 8U - 24h 0.129 0.012 0.445 -0.026 -0.111 -0.015 
T4F - S - 8U - 48h 0.119 0.010 0.444 -0.051 -0.166 -0.029 
T5F - S - 8U - CT 0.251 0.023 1.022 0.009 -0.122 -0.037 
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T5F - S - 8U - 1h 0.363 0.018 0.381 0.277 0.072 -0.017 
T5F - S - 8U - 2h 0.386 0.021 0.302 0.116 0.086 0.038 
T5F - S - 8U - 3h 0.395 0.011 0.295 0.129 0.160 0.042 
T5F - S - 8U - 4h 0.346 0.015 0.247 0.134 0.205 0.050 
T5F - S -8U - 5h 0.395 0.017 0.310 0.164 0.198 0.118 
T5F - S - 8U - 6h 0.405 0.021 0.354 0.223 0.233 0.078 
T5F - S - 8U - 24h 0.165 0.019 0.898 0.029 0.134 0.099 
T5F - S - 8U - 48h 0.163 0.017 0.912 0.047 0.218 0.107 
T6F - S - 8U - CT 0.284 0.018 1.749 0.018 0.519 0.117 
T6F - S - 8U - 1h 0.205 0.031 0.856 0.128 0.208 0.107 
T6F - S - 8U - 2h 0.194 0.013 0.862 0.176 0.158 0.147 
T6F - S - 8U - 3h 0.216 0.107 0.876 0.143 0.252 0.112 
T6F - S - 8U - 4h 0.209 0.024 1.027 0.184 0.260 0.102 
T6F - S - 8U - 5h 0.300 0.037 1.310 0.263 0.319 0.138 
T6F - S - 8U - 6h 0.380 0.301 1.529 0.318 0.324 0.138 
T6F - S - 8U - 24h 0.237 0.032 2.043 0.054 0.695 0.196 
T6F - S - 8U - 48h 0.231 0.025 1.933 0.075 0.575 0.226 
T7F - S - 8U - CT 0.520 0.054 1.943 0.048 -0.267 0.112 
T7F - S - 8U - 1h 0.588 0.038 1.131 0.142 -0.300 0.095 
T7F - S - 8U - 2h 0.643 0.036 1.337 0.128 -0.321 0.167 
T7F - S - 8U - 3h 0.538 0.030 0.992 0.105 -0.302 0.086 
T7F - S - 8U - 4h 0.653 0.038 1.304 0.173 -0.289 0.137 
T7F - S - 8U - 5h 0.653 0.041 1.264 0.206 -0.274 0.109 
T7F - S - 8U - 6h 0.653 0.036 1.300 0.243 -0.268 0.075 
T7F - S - 8U - 24h 0.395 0.047 1.526 0.014 -0.310 0.065 
T7F - S - 8U - 48h 0.407 0.073 1.753 -0.013 -0.309 0.042 
T8F - S - 8U - CT 0.185 0.026 1.036 -0.038 -0.255 0.101 
T8F - S - 8U - 1h 0.262 0.019 0.582 -0.032 -0.195 0.052 
T8F - S - 8U - 2h 0.321 0.021 0.718 0.034 -0.195 0.026 
T8F - S - 8U - 3h 0.339 0.024 0.639 0.045 -0.176 0.039 
T8F - S - 8U - 4h 0.343 0.015 0.614 0.078 -0.202 -0.037 
T8F - S - 8U - 5h 0.348 0.015 0.646 0.118 -0.178 -0.045 
T8F - S - 8U - 6h 0.394 0.788 0.708 0.171 -0.168 -0.038 
T8F - S - 8U - 24h 0.117 0.006 0.627 -0.005 -0.275 -0.038 
T8F - S - 8U - 48h 0.155 0.012 0.794 -0.034 -0.261 -0.018 
T9F - S - 8U - CT 0.232 0.007 1.400 0.008 -0.232 0.061 
T9F - S - 8U - 1h 0.165 0.007 0.544 0.080 -0.243 -0.048 
T9F - S - 8U - 2h 0.159 0.005 0.515 0.107 -0.229 -0.079 
T9F - S - 8U - 3h 0.159 0.002 0.497 0.076 -0.256 -0.080 
T9F - S - 8U - 4h 0.192 0.002 0.755 0.124 -0.264 -0.031 
T9F - S - 8U - 5h 0.197 0.002 0.585 0.159 -0.248 -0.061 
T9F - S - 8U - 6h 0.220 0.003 0.663 0.223 -0.238 -0.050 
T9F - S - 8U - 24h 0.154 0.006 0.692 -0.026 -0.220 -0.055 
T9F - S - 8U - 48h 0.181 0.116 1.000 0.041 -0.250 -0.049 
T10F - S - 8U - CT 0.140 0.012 1.091 0.046 -0.353 -0.081 
T10F - S - 8U - 1h 0.115 0.004 0.697 0.141 -0.303 -0.050 
T10F - S - 8U - 2h 0.175 0.007 0.859 0.208 -0.276 -0.034 
T10F - S - 8U - 3h 0.194 0.012 0.938 0.211 -0.275 -0.014 
T10F - S - 8U - 4h 0.234 0.005 1.177 0.388 -0.233 0.060 
T10F - S - 8U - 5h 0.230 0.007 0.831 0.253 -0.222 -0.018 
T10F - S - 8U - 6h 0.233 0.008 0.913 0.268 -0.200 -0.006 
T10F - S - 8U - 24h 0.188 0.170 1.719 0.051 -0.320 0.015 
T10F - S - 8U - 48h 0.155 0.012 1.460 0.109 -0.334 0.051 
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Appendix 8.34 Urinary T/E, and urinary concentrations of T, E and 5 -DHT for hypogonadal men in 
their steady state of hormone replacement therapy 
Sample T/E T conc E conc 5 -DHT conc SG 
T11M-U-CT  4.88 34.09 7.43 7.53 1.012 
T11M-U-1h  5.64 26.71 4.67 4.74 1.009 
T11M-U-2h 7.85 49.53 7.33 6.46 1.014 
T11M-U-3h  7.05 50.18 8.26 6.74 1.016 
T11M-U-4h 6.82 60.98 9.54 8.53 1.021 
T11M-U-5h  6.63 57.37 10.16 9.80 1.021 
T11M-U-6h  5.29 51.27 11.06 12.64 1.021 
T11M-U-7h  4.73 52.18 12.12 12.62 1.019 
T11M-U-10h  7.48 70.78 11.36 14.57 1.022 
T11M-U-24h 5.92 28.70 5.44 7.77 1.015 
T12M-U-CT  10.55 28.26 0.50 7.84 1.006 
T12M-U-1h  10.07 24.83 0.50 4.74 1.007 
T12M-U-2h 26.92 48.64 1.89 6.57 1.014 
T12M-U-3h  29.21 72.85 2.65 8.63 1.017 
T12M-U-4h 27.28 85.16 3.39 11.23 1.017 
T12M-U-5h  25.23 83.11 3.74 13.57 1.017 
T12M-U-6h  22.82 96.86 4.88 18.06 1.021 
T12M-U-7h  18.77 66.65 3.82 17.89 1.016 
T12M-U-10h  20.25 51.72 2.40 10.07 1.010 
T12M -U-24h 9.50 45.26 5.22 10.07 1.007 
T13M-U-CT  10.18 58.54 6.73 9.88 1.026 
T13M-U-1h  10.34 27.49 0.50 4.57 1.007 
T13M-U-2h 21.00 42.69 2.42 4.97 1.019 
T13M-U-3h  25.05 79.56 3.33 7.86 1.027 
T13M-U-4h 27.25 95.00 3.95 9.66 1.029 
T13M-U-5h  24.12 111.99 5.16 12.19 1.030 
T13M-U-6h  23.23 119.84 6.03 15.98 1.030 
T13M-U-7h  20.50 105.44 5.86 16.40 1.028 
T13M-U-10h  21.05 126.80 7.08 15.01 1.031 
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Appendix 8.35 Urinary T/E, and urinary concentrations of T, E and 5 -DHT for hypogonadal men in 
their supraphysiological phase of hormone replacement therapy 
Sample T/E T conc E conc 5 -DHT conc SG 
T16M-U-CT  20.60 125.18 9.65 21.72 1.024 
T16M-U-1h  28.44 120.29 0.50 12.65 1.004 
T16M-U-2h 52.75 15.98 3.16 13.28 1.009 
T16M-U-3h  50.86 168.18 4.30 15.07 1.016 
T16M-U-4h 55.01 227.41 5.74 19.92 1.021 
T16M-U-5h  65.07 272.10 5.10 21.16 1.022 
T16M-U-6h  64.48 267.93 6.03 26.05 1.022 
T16M-U-7h  53.24 342.30 7.45 41.55 1.023 
T16M-U-10h  40.78 294.38 9.83 39.05 1.024 
T16M -U-24h 18.72 167.48 13.63 31.39 1.027 
T17M-U-CT  11.71 157.85 15.74 19.60 1.012 
T17M-U-1h  11.04 95.83 9.49 48.40 1.006 
T17M-U-2h 13.50 138.35 12.37 16.22 1.010 
T17M-U-3h  15.22 153.21 12.45 14.82 1.014 
T17M-U-4h 12.61 123.93 12.74 15.28 1.019 
T17M-U-5h  13.48 153.95 13.34 18.40 1.019 
T17M-U-6h  12.75 146.52 15.62 25.90 1.020 
T17M-U-7h  12.12 155.40 16.04 25.67 1.019 
T17M-U-10h  12.97 136.64 13.23 22.07 1.019 
T17M -U-24h 10.23 137.00 16.44 21.77 1.013 
T18M-U-CT  16.65 95.31 6.36 16.39 1.007 
T18M-U-1h  18.90 75.31 4.40 11.44 1.006 
T18M-U-2h 26.43 88.28 3.70 9.06 1.014 
T18M-U-3h  31.78 124.35 4.34 11.12 1.018 
T18M-U-4h 35.68 124.91 4.11 11.11 1.016 
T18M-U-5h  38.22 158.60 4.63 13.73 1.016 
T18M-U-6h  33.72 115.49 4.43 13.32 1.016 
T18M-U-7h  35.03 120.75 3.93 18.40 1.012 
T18M-U-10h  36.72 158.40 5.28 22.89 1.010 
T18M -U-24h 15.94 112.28 7.18 17.93 1.008 
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therapy 
Appendix 8.36 Serum concentration of T, E, AD, TG, TS and ES for hypogonadal men in their 
steady state of hormone replacement therapy 
Volunteer code 
T conc E conc AD conc TG conc TS conc ES conc 
(ng/mL) (ng/mL) (ng/mL) (ng/mL) (ng/mL) (ng/mL) 
T11M - S - 8U - CT 5.46 0.01 2.17 0.89 -0.19 0.16 
T11M - S - 8U - 1h 4.41 -0.01 0.76 0.87 -0.27 -0.04 
T11M - S - 8U - 2h 5.33 0.00 0.87 1.08 -0.25 -0.04 
T11M - S - 8U - 3h 4.99 -0.01 1.06 1.08 -0.25 0.01 
T11M - S - 8U - 4h 5.99 -0.01 1.03 1.03 -0.24 -0.07 
T11M - S - 8U - 5h 5.68 -0.01 0.95 0.92 -0.18 -0.06 
T11M - S - 8U - 6h 5.82 0.00 1.20 0.84 -0.22 0.04 
T11M - S - 8U - 24h 8.01 0.00 0.83 0.82 -0.21 -0.06 
T12M - S - 8U - CT 8.31 -0.01 0.82 0.71 -0.11 -0.09 
T12M - S - 8U - 1h 7.74 -0.01 0.46 0.84 -0.08 -0.09 
T12M - S - 8U - 2h 8.46 -0.01 0.77 1.02 -0.05 -0.10 
T12M - S - 8U - 3h 11.16 0.00 0.98 1.01 -0.03 -0.08 
T12M - S - 8U - 4h 10.42 -0.01 0.76 1.10 -0.04 -0.08 
T12M - S - 8U - 5h 7.75 0.01 0.62 0.82 -0.12 0.00 
T12M - S - 8U - 6h 7.80 0.00 0.59 0.90 -0.13 0.02 
T12M - S - 8U - 24h 5.82 0.00 0.51 0.65 -0.18 0.04 
T13M - S - 8U - CT 3.19 0.01 0.82 0.37 -0.27 0.03 
T13M - S - 8U - 1h 2.02 0.00 0.30 0.57 -0.28 -0.01 
T13M - S - 8U - 2h 2.53 0.00 0.24 0.86 -0.26 -0.01 
T13M - S - 8U - 3h 2.79 0.00 0.26 0.95 -0.25 0.04 
T13M - S - 8U - 4h 3.82 0.00 0.39 0.99 -0.25 0.00 
T13M - S - 8U - 5h 3.29 0.00 0.41 1.08 -0.22 0.00 
T13M - S - 8U - 6h 2.96 0.00 0.42 0.89 -0.24 0.00 
T13M - S - 8U - 24h 3.81 0.00 0.48 0.78 -0.28 -0.01 
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Appendix 8.37 Serum concentration of T, E, AD, TG, TS and ES for hypogonadal men in their 
supraphysiological phase of hormone replacement therapy 
Volunteer code 
T conc E conc AD conc TG conc TS conc ES conc 
(ng/mL) (ng/mL) (ng/mL) (ng/mL) (ng/mL) (ng/mL) 
T16M - S - 8U - CT 9.07 0.00 0.91 1.71 -0.13 0.06 
T16M - S - 8U - 1h 7.88 0.01 0.59 1.97 -0.10 0.05 
T16M - S - 8U - 2h 8.28 0.00 0.54 2.07 -0.10 0.00 
T16M - S - 8U - 3h 9.58 0.00 0.71 2.44 -0.08 0.05 
T16M - S - 8U - 4h 10.09 0.00 0.63 2.62 -0.08 0.03 
T16M - S - 8U - 5h 10.11 0.00 0.65 2.70 -0.10 0.02 
T16M - S - 8U - 6h 10.68 0.01 0.63 2.70 -0.09 0.04 
T16M - S - 8U - 24h 8.04 0.00 0.74 2.10 -0.14 0.03 
T17M - S - 8U - CT 7.47 0.01 1.17 1.30 -0.21 0.11 
T17M - S - 8U - 1h 7.04 0.00 0.69 1.55 -0.19 0.01 
T17M - S - 8U - 2h 8.43 0.00 1.24 1.62 -0.19 0.03 
T17M - S - 8U - 3h 8.16 0.00 0.86 1.72 -0.19 0.07 
T17M - S - 8U - 4h 9.12 0.08 0.92 1.64 -0.18 0.03 
T17M - S - 8U - 5h 9.48 0.01 0.89 1.81 -0.18 0.03 
T17M - S - 8U - 6h 8.68 0.00 1.02 1.46 -0.18 0.07 
T17M - S - 8U - 24h 9.65 0.00 0.88 1.86 -0.18 -0.01 
T18M - S - 8U - CT 8.45 0.08 1.03 0.91 -0.17 0.11 
T18M - S - 8U - 1h 5.27 0.00 0.26 1.08 -0.06 -0.01 
T18M - S - 8U - 2h 7.60 0.00 0.45 1.38 0.03 0.02 
T18M - S - 8U - 3h 10.72 0.00 0.49 1.68 0.02 0.01 
T18M - S - 8U - 4h 9.86 0.00 0.49 1.75 0.03 0.01 
T18M - S - 8U - 5h 9.60 0.01 0.61 1.81 0.04 0.03 
T18M - S - 8U - 6h 10.63 0.01 0.71 1.69 0.03 0.01 
T18M - S - 8U - 24h 13.09 0.00 0.75 1.19 -0.11 0.02 
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